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ABSTRACT 
 
Dynamin I (referred to here as dynamin) is a GTPase enzyme enriched in nerve 
terminals which mediates vesicle fission during synaptic vesicle endocytosis (SVE) to 
release new vesicles into the cell cytoplasm.  It is a critical regulator of synaptic 
transmission in the nervous system.  The enzyme is alternatively spliced in its middle 
domain and proline rich domain (PRD), producing multiple cellular variants.  It is 
subjected to complex regulation in neurons that coordinates its recruitment to sites of 
endocytosis in cells, promotes its oligomerisation into a ring or collar that is directly 
responsible for vesicle fission and which stimulates GTP binding and hydrolysis.  The 
best understood dynamin regulatory mechanisms are reversible phosphorylation and 
interactions with proteins containing src homology 3 (SH3) domains.  These control its 
ability to oligomerise into rings or helices. 
A range of SH3 domain proteins stimulate ring oligomerisation with an associated 
increase in dynamin GTPase activity.  The oligomerisation is proposed to specifically 
stimulate its GTPase activity to complete endocytosis, suggesting that oligomerisation 
correlates with dynamin activation.  There are at least 300 SH3 domain proteins in the 
human genome and 25 that bind dynamin, 13 of which are involved in or linked to 
endocytosis.  Although some stimulate oligomerisation and some stimulate GTPase 
activity no previous study has systematically compared dynamin modulation by multiple 
SH3 domains to determine which may be of greatest possible functional relevance for 
endocytosis. 
In Chapter 3 a systematic parallel screening was performed of the relative 
effectiveness of the glutathione-S-transferase (GST)-tagged ‘endocytic’ SH3 domains to 
stimulate dynamin oligomerisation and activity in vitro.  The aims were to identify the 
most potent, to test the hypothesis of a correlation between oligomerisation and activity 
and to search for potential differences in the response of two dynamin I middle domain 
isoforms.  All 13 recombinant GST-tagged SH3 domains bound dynamin and stimulated 
its GTPase activity to varying extents.  No correlation was found between their binding 
and potency of activation.  A similar disconnect was revealed between their ability to 
stimulate oligomerisation and activity, challenging the prevailing hypothesis that 
dynamin oligomerisation is required for its stimulated activity.  Performing the GTPase 
assays at higher ionic assay conditions (150 mM NaCl, similar to intracellular levels), 
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more stringent conditions for oligomerisation, abolished or inhibited the activity 
stimulation by most SH3 domains.  However, the GST-SNX9 (Sorting nexin 9) and 
intersectin I A SH3 domains remained strong dynamin activators, suggesting their higher 
likelihood of significance to dynamin regulation in endocytosis.  Dynamin 
oligomerisation is mediated by its middle domain.  Therefore, the 13 endocytic SH3s 
were examined against two alternatively spliced middle domain variants, ab and bb 
(where the first a or b refers to the middle domain splice site and the second b refers to 
the PRD splice variant).  They preferentially stimulated dynamin Ibb relative to Iab, 
revealing a surprising role for the middle domain in transmitting signals from the SH3-
PRD interaction to the GTPase (or G) domain. 
In Chapter 4 the role of the GST-tag in the function of the SH3 domains was 
examined.  Most previous studies on SH3 domains have used the protein in the presence 
of the GST expression tag.  Removing it can determine whether the known ability of GST 
to dimerise might contribute to the ability of the tagged SH3 domains to stimulate 
dynamin.  Ten endocytic SH3 domains were reassessed after removal of the GST-tag by 
proteolytic cleavage.  This abolished their ability to oligomerise or stimulate dynamin.  
Only the GST cleaved SH3 domain of SNX9 (CL-SNX9 SH3) retained both properties, 
indicating that this protein uses a distinct mechanism of dynamin activation.  Therefore, 
the GST-tag has a major influence.  Statistical comparison of the ability of CL-SNX9 
SH3 to stimulate or oligomerise dynamin revealed that the two properties can be 
decoupled.  Thus, GTPase active dynamin was always oligomerised, but oligomerisation 
dynamin did not always show stimulated activity, refuting published hypotheses.  
Overall, this work highlighted that the SH3 domain of SNX9 is acting on dynamin by a 
unique mechanism. 
In Chapter 5 the SNX9 binding mechanism was determined in detail by mapping its 
binding site within the PRD of dynamin I.  This included determining the effect of 
dynamin phosphorylation on this binding and searching for potential novel elements to 
this binding such as the possibility of secondary binding sites.  SH3 domains mainly bind 
to PxxP amino acid motifs (where P is proline and x is any amino acid) of which there are 
13 in dynamin PRD, numbered Sites 1-13.  SNX9 was found to have at least two 
independent PxxP binding sites, Site 2 and Site 10, with interaction at the latter site 
shown to be isoform-specific.  A role for the central region of the PRD in SNX9 binding 
was identified, with this region most likely serving as a proximal binding element to 
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improve binding at the nearby PxxP, Site 2.  The binding of SNX9 to both Sites 2 and 10 
was regulated by phospho-mimetic mutations, suggesting that their interaction is 
regulated by phosphorylation.  By detailed comparison of SNX9 binding with that of 3 
other SH3 proteins, the results show that SNX9 has a unique mechanism of binding to the 
dynamin I PRD, which might ultimately help to explain its unique ability to stimulate 
dynamin activity, GTP binding and oligomerisation. 
This study revealed important new insights into dynamin modulation, isoform 
functional diversity and therefore potential function in endocytosis.  Through a 
systematic approach, the observations overturn conclusions of several previous studies 
and reveal many new insights into dynamin activation and the remarkable diversity in the 
way SH3 domains stimulate dynamin.  The work highlights the SH3 domain of SNX9 as 
the most potent and consistent in vitro regulator of dynamin I oligomerisation and 
activity.  It also mapped the unique binding site for SNX9 on dynamin and revealed that 
their interaction is potentially phospho-regulated.  This sheds new light on the 
understanding of the role of SNX9 in endocytosis in neurons. 
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CHAPTER 1: Introduction 
 
1.1 Dynamin 
The plasma membrane is the interface between the inside of all eukaryotic cells and 
their harsh external environment.  This highly dynamic structure segregates the 
chemically distinct intracellular content (cytoplasm and organelles) from the extracellular 
environment by regulating and coordinating the entry and exit of small and large 
molecules.  One major way molecules are internalised into the cell is by a process called 
endocytosis.  This involves the formation of membrane-bound vesicles derived by their 
internal invagination (or budding) followed by their fission to release sections of the 
plasma membrane inside the cell, typically as vesicles.  The newly endocytosed vesicles 
contain specific extracellular cargo molecules either in the soluble or the lipid fractions or 
bound to membrane proteins.  These are then able to be moved (trafficked) to different 
locations within the cell. 
Likewise, the release of material from cells is mediated by the fusion of internal 
membrane-enclosed vesicles with the plasma membrane to release their contents outside 
the cell or to insert new proteins into the membrane, a process known as exocytosis.  
Endocytosis and exocytosis play major roles in a variety of important cellular functions.  
In particular, they are both highly specialised in the nervous system via brain-specific 
gene analogues to also mediate synaptic transmission.  This involves the release of 
neurotransmitter-filled synaptic vesicles (SVs) by exocytosis, which is followed by the 
recycling of those empty SVs via synaptic vesicle endocytosis (SVE) (Baldwin, 2004).  
The protein, dynamin, which is the focus of this section of the review, is one the key 
proteins involved in endocytosis. 
Mammalian dynamin has three main forms, dynamin I, II and III, encoded by three 
different genes, DNM1, DNM2 and DNM3.  The three proteins are closely related, having 
a similar molecular weight of 94 kDa and overall 70% amino acid sequence identity 
(Sontag et al., 1994).  Each dynamin gene has multiple splice variants, which generate a 
diversity of expressed proteins.  Dynamin I is primarily expressed in the nervous system 
and in other excitable cells such as the adrenal chromaffin cell.  In neurons, it is enriched 
in nerve terminals, where it has a specialised function in the recycling of SVs, which is 
the synaptic mode of endocytosis (Powell & Robinson, 1995).  Dynamin II is expressed 
ubiquitously in cells and tissues and is involved in the classical and ubiquitous mode of 
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endocytosis, clathrin-mediated endocytosis (CME) (Sontag et al., 1994; Cook et al., 
1994).  Dynamin III has restricted tissue distributions but is found in neurons and in the 
testis at similar expression levels (Nakata et al., 1993; Cook et al., 1996).  Dynamin III 
has not been studied in detail and its functional role remains unclear.  All three proteins 
are simultaneously expressed in the same neurons and within nerve terminals there is 50 
times more dynamin I protein than II and about double the amount of dynamin III relative 
to dynamin II (Ferguson et al., 2007). 
Dynamin was first discovered in the 1970s as part of a fly mutagenesis screen by 
David Suzuki, with the mutant fly shibire (Poodry et al., 1973).  In parallel, dynamin was 
identified in the 1970s by the lab of Nobel laureate Paul Greengard as a 96 kDa synaptic 
protein showing remarkably rapid stimulus-dependent dephosphorylation in nerve 
terminals (Andersen et al., 1985).  The protein was extensively studied as “P96” in 
synaptosomes from the 1980s by Dunkley and Robinson (Bailly et al., 1991; Akagi et al., 
2000; Ahn et al., 1991; Robinson & Dunkley, 1983; Robinson & Dunkley, 1985) and was 
renamed “dephosphin” in the 1990s (Fu et al., 1998) until it was discovered to be the 
same protein as the earlier described ‘dynamin’.  Dynamin was also independently 
discovered by the lab of Richard Vallee as a microtubule binding protein (Shpetner & 
Vallee, 1989) and later as a protein that co-purified with mitotic spindles (primarily 
comprising microtubules) (Sauer et al., 2005).  The cloning of dynamin in 1990 by the 
Vallee lab (Obar et al., 1990) and of dephosphin/P96 in 1993 by the Robinson and 
Sudhof labs (Robinson et al., 1993b) revealed them to be the same protein, now known as 
dynamin I.   
Dynamin was initially proposed to have a microtubule cross-linking, bundling and 
sliding activity (Shpetner & Vallee, 1989), similar to that of known microtubule motor 
proteins like kinesin and dynein (Vallee & Shpetner, 1990).  The guanosine 
triphosphatase (GTPase) activity of dynamin was stimulated to high levels of activity by 
microtubules (Shpetner & Vallee, 1992) and dynamin formed helical polymers around 
microtubules by a process called oligomerisation (Maeda et al., 1992).  This early 
evidence for a role of dynamin as a motor protein in microtubule dynamics proved to be 
unsustained, as the microtubule bundling and sliding activity was ultimately ascribed to 
sample contamination with kinesin (Vale, 1992).  No evidence remains that dynamin is a 
microtubule motor protein in cells, although it certainly binds them in vitro.  Instead, 
dynamin is widely understood to play a mechanochemical role at the fission step of 
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endocytosis.  Initial evidence of this came from studies on the temperature sensitive 
mutant of the shibire gene mentioned above, which is the D. melanogaster dynamin 
homolog (Chen et al., 1991; van der Bliek & Meyerowitz, 1991; Koenig & Ikeda, 1989).  
At non-permissive temperature (greater than 29°C) the mutant shibire fly had a block in 
SVE, which was reversible upon cooling.  Shibire mutants accumulate endocytic clathrin-
coated pits (CCPs) connected to the plasma membrane by elongated tubules and encircled 
by an electron-dense collar or helix which was later identified as dynamin (Takei et al., 
1995; Hinshaw & Schmid, 1995).  These seminal studies were augmented by dynamin 
being found to be required for CME in mammalian cells (Herskovits et al., 1993a; van 
der Bliek et al., 1993).  It is now known that dynamin is also involved in a number of 
physiological processes other than endocytosis, such as actin dynamics, the cytokinesis 
during mitosis and intracellular membrane trafficking (Ferguson & De Camilli, 2012; 
Smith & Chircop, 2012; Menon & Schafer, 2013; Sever et al., 2013).  This functional 
versatility of dynamin has made it an enduring candidate for research. 
 
1.1.1 Dynamin family 
Dynamin is the founding member of the GTPase family called the dynamin family of 
dynamin-like proteins (DLPs) (Praefcke & McMahon, 2004; Anggono & Robinson, 
2009).  In turn, the dynamin family is part of a larger superfamily of GTPase enzymes 
with multiple classes, including the small GTP-binding Ras proteins and the 
heterotrimeric G proteins (Anggono & Robinson, 2009).  The structure and sequence of 
the GTP-binding domain of dynamin places it in a distinct dynamin family with seven 
sub-families, within which the original three dynamins are now termed the “classical 
dynamin” sub-family (Praefcke & McMahon, 2004; Anggono & Robinson, 2009).  The 
diverse roles of the proteins belonging to this family are summarised in Table 1.1 and 
their domain structure is illustrated in Figure 1.1. 
The dynamin family members all share a similar basic domain organisation and 
similar catalytic mechanism of GTP hydrolysis, which is distinct from the small 
regulatory GTPases of the Ras family (Chappie et al., 2010; Gasper et al., 2009).  The 
dynamin family members have lower nucleotide affinity compared to the Ras family and, 
unlike them, do not require accessory proteins such as GAPs (GTPase activating proteins) 
and GEFs (guanine nucleotide exchange factors) to bind GTP.  The dynamins have the 
conserved property of stabilising the transition state during GTP hydrolysis, although 
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divergent stabilising mechanisms exist between proteins of this family (Gasper et al., 
2009). 
Table 1.1: Table of dynamin family proteins, their cellular localisation and 
proposed function.  Modified from (Ferguson & De Camilli, 2012). 
 
Another conserved aspect of the dynamin family members is the nucleotide-dependent 
dimerisation of their GTPase (G) domains.  This induces structural changes in the active 
site to stimulate GTP hydrolysis (Chappie et al., 2010; Ford et al., 2011; Faelber et al., 
2011).  This property is closely coupled to the cellular function of the dynamin family 
proteins and in the case of some classes such as the classical dynamins, to 
oligomerisation.  The hydrolysis of GTP produces a conformational change which is 
transmitted along the dynamin polymer to exert a force on membranes.  This is in 
contrast to the Ras family regulatory GTPases where the GTP cycle mediates protein-
protein interactions via the recruitment and release of effector proteins (Reuther & Der, 
2000; Ehrhardt et al., 2002).  Both the GTPase activity of dynamin and its ability to 
oligomerise are necessary for the role of dynamin in endocytosis and these are the main 
topics of investigations in this thesis. 
 
1.1.2 Role of dynamin in cellular processes 
1.1.2.1 Endocytosis 
Endocytosis is the recycling or internalisation of plasma membrane.  It is a critical 
biological process which allows for the uptake of cargo that cannot otherwise pass though 
the plasma membrane and for the retrieval of activated receptors to down-regulate them 
as part of their signalling pathways.  It occurs by membrane remodelling to form 
intracellular vesicles containing the extracellular cargo or cell surface signalling proteins.  
Protein Localisation Function 
Classical dynamins Sites of endocytosis in plasma 
membrane 
Endocytic membrane/ vesicle 
fission 
Dlp1/Drp1 Mitochondrial outer membrane, 
peroxisomes and endoplasmic 
reticulum 
Mitochondrial fission and 
peroxisome division 
OPA1 Mitochondrial inner membrane Mitochondrial fusion 
Mitofusin 1 and 2 Mitochondrial outer membrane Mitochondrial fusion 
Atlastin Endoplasmic reticulum (ER) Fusion of ER membranes, ER 
morphology and axonal growth 
MxA/MxB Smooth endoplasmic reticulum Viral resistance 
Guanylate binding 
proteins (GBP) 
Intracellular vesicles, cytoplasm 
and Golgi 
Viral and bacterial resistance 
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Exocytosis is conceptually the opposite of endocytosis and involves the internal vesicles, 
containing cargo such as soluble neurotransmitters or integral membrane proteins such as 
receptors, to fuse with plasma membrane.  This releases their contents into the 
extracellular space or inserts new proteins into the plasma membrane.  Endocytosis 
occurs by multiple different modes and not all involve dynamin.  These modes have been 
broadly classified on the basis of their dependence on the vesicle protein clathrin: as 
clathrin-independent endocytosis (CIE) and clathrin-mediated endocytosis (CME).   
Clathrin is a cytosolic protein which can form a “cage” structure or a coat around the 
nascent vesicle restricting its size.  Dynamin mediates all known CME and some modes 
of CIE and endocytosis could equally be classified as being dynamin-dependent or 
independent.  The variety of endocytic modes, classified by clathrin and dynamin 
involvement, are summarised in Table 1.2. 
  
12 
 
Table 1.2:  Summary of the modes of clathrin-mediated endocytosis (CME) and 
clathrin-independent endocytosis (CIE). 
 Neuronal/ 
Non-Neuronal 
Dynamin 
involvement 
Other main 
proteins involved 
Cargo 
examples 
CME 
Clathrin-mediated 
endocytosis (CME, 
formerly called 
receptor-mediated 
endocytosis)) 
All eukaryotic 
cells (including 
neurons) 
Well 
established 
(Dynamin II) 
Amphiphysin, 
endophilin, AP2, 
epsin, eps15, 
intersectin, 
AP180, 
calmodulin, 
synaptojanin 
Receptor 
tyrosine 
kinases (RTKs), 
GPCRs, 
transferrin 
receptors 
Synaptic vesicle 
endocytosis (SVE) 
Neuronal Well 
established 
(Dynamin I) 
Same as above 
except different 
isoforms (no 
evidence for 
SNX9 yet). 
None (empty 
vesicles) 
CIE 
Clathrin-independent 
carriers/GPI-
enriched endocytic 
compartments  
(CLIC/GEEC) 
Neuronal & Non-
neuronal 
Not involved Graf1 and actin Fluid phase 
markers, GPI 
tagged proteins 
Phagocytosis Non-neuronal 
phagocytes 
e.g.  
Macrophages 
Implicated 
(Dynamin II) 
Actin, 
amphiphysin I 
and IQGAP I. 
Pathogens, 
cellular 
remnants 
Macropinocytosis Neuronal & Non-
neuronal 
Implicated 
(Dynamin II) 
Actin, PAK1, PI3K  
Ras and SNX 
family proteins 
such as SNX5 
RTKs, fluids, 
antigens 
Activity dependent 
bulk endocytosis 
Neuronal Well 
established 
(Dynamin I) 
Established roles 
for Syndapin I, 
Calcineurin and 
GSK3 
None (empty 
endososme 
which forms 
vesicles) 
Caveolae Non-neuronal Some 
evidence 
(Dynamin II) 
Caveolins and 
actin 
Viral 
components, 
GPI tagged 
proteins 
 
It is well established that dynamin acts twice during CME.  It is initially involved in 
the rate-limiting step, where dynamin is GTP bound but unoligomerised and functions as 
a fidelity monitor (Mettlen et al., 2009; Aguet et al., 2013).  This first point of action has 
been called the “endocytic checkpoint” for CME, because failure at this point in the 
process results in the CCP aborting and thus not undergoing fission (Aguet et al., 2013).  
The second stage involves dynamin constricting the invaginating vesicle by 
oligomerisation-stimulated GTPase activity around the membrane neck (Hinshaw & 
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Schmid, 1995; Mettlen et al., 2009).  The process of dynamin stimulation and 
oligomerisation and the mechanism of scission are discussed in greater detail below in 
Section 1.1.5. 
At least three endocytic modes are specifically involved in SV recycling in neurons 
(Kiss-and-run (K&R), SVE and activity-dependent bulk endocytosis (ADBE)) and are 
summarised in Table 1.3 and visually represented in Figure 1.2.  K&R is a rapid and 
economical form of endocytosis occurring by a reversal of the fusion pore step of 
exocytosis.  The SV releases neurotransmitters into the synaptic space and is retrieved 
intact before collapse of the SVs into the plasma membrane occurs.  K&R is well defined 
in adrenal chromaffin cells (Alabi & Tsien, 2012) with strong evidence for K&R in 
neuronal synapses (Zhang et al., 2007).  Due to the vesicle not fully collapsing into the 
membrane, virtually nothing is known about the molecular mechanisms of this process.  
However, dynamin is known to be a regulator of the fusion pore dynamics in K&R, 
independently of its endocytic role (Graham et al., 2002; Holroyd et al., 2002; Gonzalez-
Jamett et al., 2013).  Therefore, both SVE and ADBE will be considered in greater detail 
in the following section. 
Table 1.3: The main neuronal endocytic modes: Kiss-and-run (K&R), synaptic 
vesicle endocytosis (SVE) and activity-dependent bulk endocytosis (ADBE). 
 K&R SVE ADBE 
Speed Fast (msec) Slow (~15-30 sec) Fast (<1 sec) 
Capacity Low-Single SV Low-Single SV High - Endosome buds 
multiple SVs 
Trigger Ca2+ dependent 
exocytosis 
Constitutive Elevated neuronal activity 
Mechanism Not known Well characterised Well characterised 
Visualisation Cannot readily be 
visualised without 
quantum dots 
Electron microscopy 
(EM): horse radish 
peroxidase (HRP) and 
the fluorescent dyes 
FM1-43 and FM-2-10 
Electron microscopy (EM): 
horse radish peroxidase 
(HRP), the fluorescent dye 
FM1-43 and dextran 
 
Clathrin-mediated endocytosis (CME) 
The majority of CME is targeted towards retrieval of specific membrane-bound 
receptors that bind to extracellular ligands and the process was therefore previously 
called receptor-mediated endocytosis (RME), a term that has been abandoned (Doherty & 
McMahon, 2009).  The formation of clathrin-coated vesicles (CCVs) is not limited to 
14 
 
CME but CCV budding and membrane fission also occurs at multiple points along the 
secretory pathway such as from endosomes, the endoplasmic reticulum (ER) and the 
Golgi complex.  Although strictly not endocytosis, budding is a mechanistically related 
process.  The molecular mechanism of CCV budding tends to be analogous to CME, 
requiring much the same set of proteins but, typically, different adaptor proteins 
(Nicoziani et al., 2000).  
SVE is a specialised form of CME adapted to synaptic nerve terminals.  Many 
laboratories do not make this important distinction, causing literature confusion.  SVE 
involves the retrieval of single vesicles, one at a time.  Retrieval by this mode is a 
relatively slow process in nerve terminals, with a time constant of approximately 15 
seconds at 20°C (Granseth et al., 2006).  This seems to be a fixed rate of activity across 
multiple species which is largely independent of the neuronal stimulation intensity 
(Jockusch et al., 2005; Balaji & Ryan, 2007).  Of all the endocytic modes SVE is the best 
characterised at the molecular level due to the extensive studies done on the analogous 
CME pathway in non-neuronal cells.  There are key differences in the protein isoforms 
involved in these two endocytic modes and unique regulatory elements.  This can cause 
difficulties in interpreting published data and translating the roles of certain proteins from 
CME to SVE.  As one of many examples, CME is mediated by dynamin II whereas 
dynamin I is involved in SVE, yet a role for dynamin II in SVE cannot be fully ruled out 
(Ferguson et al., 2007).  Despite these differences there is considerable conceptual 
overlap in the molecular mechanisms of CME and SVE, which has provided researchers 
with tools and ideas to study each process. 
Dynamin I knock-out (KO) mice are indistinguishable from wild type mice at birth, 
suggesting dynamin I is not essential during embryonic development (Ferguson et al., 
2007).  However, immediately following birth, the KO mice exhibit dysfunctional motor 
coordination and die within two weeks.  Primary cultured neurons from the KO mice 
show an accumulation of CCPs and the presence of several abnormally large vesicles.  
Electron tomography reveals these clathrin-coated structures to be buds connected to the 
plasma membrane by interconnected tubular invaginations.  This shows that the fission of 
CCVs is impaired and indicates dynamin I has a role in the fission process.  SV recycling 
is only affected during elevated neuronal activity when dynamin I is essential (Ferguson 
et al., 2007).  However, after termination of the elevated stimulus, SV recycling resumes 
efficiently, suggesting the existence of redundant endocytic pathways to produce SVs 
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which are dynamin I-independent.  In neurons from double KO mice lacking dynamin I 
and III, the defect in activity-dependent SVE is slightly enhanced, suggesting 
cooperativity between these enzymes (Raimondi et al., 2011).  Triple dynamin KO 
fibroblast cells have been generated but they do not exhibit any additional defects relative 
to the double KO cell lines, shedding no additional light on the role of dynamin III (Park 
et al., 2013).  Dynamin II KO mice are embryo lethal and have not provided further 
insight on its role in SVE (Liu et al., 2008). 
SVE is the dominant SV retrieval mode during periods of low neuronal activity 
(Granseth et al., 2006).  However, due to its fixed rate, SVE has a limited membrane 
retrieval capacity (Sankaranarayanan et al., 2000).  Thus, it cannot meet the increased 
endocytic demand that occurs during high-intensity stimulation where exocytosis rates 
can considerably exceed endocytic rates (Clayton et al., 2008).  During elevated neuronal 
activity, an alternate SV retrieval mode is triggered, ADBE, which equips neurons to 
maintain responses under continuous and high-intensity stimuli. 
A full review of the molecular mechanisms of CME is beyond the scope of this review 
but many excellent reviews are available (Doherty & McMahon, 2009; McMahon & 
Boucrot, 2011; Rao et al., 2012; Jackson et al., 2012; Wu et al., 2014a).  The sequential 
stages in CME and the endocytic proteins involved have been summarised in Figure 1.3. 
 
Activity-dependent bulk endocytosis (ADBE) 
ADBE is a high capacity SV retrieval mode, first observed in the amphibian 
neuromuscular junction (Miller & Heuser, 1984).  This is a non-clathrin mediated mode 
of endocytosis and is associated with large invaginations of the plasma membrane, which, 
upon fission, form bulk endosomes.  SVs can bud from the bulk endosomes at a later 
point in time or alternatively the endosomes can mature into lysosomes (Clayton et al., 
2009).  This mode of endocytosis is potentially a stress response, following extensive 
exocytosis which allows for the recovery of large amounts of plasma membrane, 
preventing the nerve terminal from catastrophic swelling.  There is also evidence for the 
importance of ADBE to neuronal physiology.  By controlling plasma membrane volume 
and the rate of large-scale new SV regeneration it is a key modulator of synaptic 
transmission and plasticity, with the inhibition of ADBE shown to relieve synaptic 
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depression in hippocampal slices (Clayton et al., 2010; Cheung et al., 2010; Wenzel et 
al., 2012; Korber et al., 2012). 
ADBE is a triggered process that requires increased neuronal activity above a 
threshold of stimulus intensity (Leenders et al., 2002; Clayton et al., 2007; Clayton et al., 
2008; Wenzel et al., 2012).  In primary cultured neurons derived from dynamin I KO 
mice, defects in endocytosis are observed only during strong but not mild neuronal 
activity (Ferguson et al., 2007).  Activation of the protein phosphatase calcineurin (CaN) 
is the trigger for ADBE activation (Clayton et al., 2009).  This leads to dynamin I site-
specific dephosphorylation within its proline-rich domain (PRD, discussed in detail later 
in Section 1.1.3.4).  This permits the binding of syndapin I to dynamin I (Anggono et al., 
2006).  Multiple lines of evidence have shown this specific interaction has a role in 
ADBE.  For example, the over-expression of dominant negative dynamin I mutants 
which cannot interact with syndapin I, disrupts ADBE (Clayton et al., 2009).  Disruption 
of this interaction with competitive peptides or RNAi knock-down of syndapin I arrests 
ADBE without disrupting CME (Clayton & Cousin, 2009b).  Following cessation of the 
nerve terminal stimulus, dynamin I is re-phosphorylated by the sequential action of the 
two protein kinases, cyclin-dependent kinase (cdk5) and glycogen synthase kinase 3 
(GSK3), acting on the dynamin I PRD residues S778 and S774 respectively (Tan et al., 
2003; Evans & Cousin, 2007a; Clayton et al., 2010).  Pharmacologically blocking either 
kinase prevents ADBE and demonstrates the importance of re-phosphorylation of 
dynamin in this process (Tan et al., 2003). 
The above studies provide strong evidence that ADBE requires dynamin.  This 
conclusion has been supported in other studies in hippocampal neurons (Watanabe et al., 
2013).  Paradoxically, in neurons from mice lacking dynamin I (Hayashi et al., 2008) and 
in neurons from conditional double KO of dynamins I and III, ADBE appears to be 
unaltered (Wu et al., 2014b).  These apparently contradictory findings have not yet been 
resolved but one hypothesis is that there may be more than one mode of ADBE with a 
second pathway that bypasses the requirement for clathrin and dynamin. 
Unlike SVE, which persists after stimulation, ADBE arrests following the termination 
of the high action potential (Wu & Wu, 2007).  It appears to occur only (or primarily) 
above a threshold of >20 Hz in cerebellar granule neurons, while SVE occurs at all 
stimulus intensities (Cousin, 2009).  ADBE is a fast process, with most studies revealing 
the bulk endosomes to be formed less than 1 second or at most 1-2 seconds after the 
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appropriate stimulation (Miller & Heuser, 1984; Marxen et al., 1999; Leenders et al., 
2002; Clayton et al., 2008; Teng et al., 2007; Wenzel et al., 2012).  ADBE occurs in a 
wide range of nerve terminals such as calyx of Held synapses (de Lange et al., 2003), 
retinal bipolar neurons (Holt et al., 2003), primary cultures of cerebellar granule neurons 
(Evans & Cousin, 2007a), hippocampal neurons (Wenzel et al., 2012) and in awake 
animals (Korber et al., 2012).  Its occurrence varies with neuronal specialisation and 
activity: 20% of functional terminals in hippocampal neurons (Wenzel et al., 2012), 
higher rates for GABAergic neurons (Hayashi et al., 2008; Wenzel et al., 2012) and 35% 
of cerebellar granule neuron terminals (Clayton & Cousin, 2009a). 
While a higher than normal neuronal activity is required to trigger ADBE, this super-
threshold activity can still be within the physiological range (Paillart et al., 2003; Clayton 
et al., 2008)Korber et al., 2012).  This indicates that ADBE may well play an important 
role in biological events that are associated with elevated neuronal activity.  Since SVs 
generated by this endocytic mode take longer to rejoin the recycling pool, ADBE could 
play a role in the biological response to epilepsy, which is characterised by sustained 
bursts of increased exocytosis resulting in excess neurotransmitter release and localised 
brain injury (Richards et al., 2000; Evans & Cousin, 2007b). 
The budding of new SVs from bulk endosomes after ADBE provides an alternative 
mechanism for large-scale SV biogenesis to SVE.  Bulk endosomes require as long as 60 
minutes to mostly disappear from nerve terminals after stimulus cessation, with about 
50% reduction in their volume in 15 minutes (Marxen et al., 1999; Evans & Cousin, 
2007a).  There is a parallel increase in SV number commencing within 5 minutes and 
peaking around 15 minutes on recovery (Marxen et al., 1999; de Lange et al., 2003).  
Budding from bulk endosomes is presumed to occur by a mechanism paralleling CME 
from the plasma membrane but this has only partly been tested (Koenig & Ikeda, 1989; 
Teng & Wilkinson, 2000; Richards et al., 2000; Kasprowicz et al., 2008; Heerssen et al., 
2008; Saheki & De Camilli, 2012).  It is clathrin- and dynamin-dependent (Kononenko et 
al., 2014; Watanabe et al., 2014), yet the involvement of either the classical CME adaptor 
protein complex AP-2 or the Golgi and endosome cargo sorting complexes AP-1 and AP-
3 is controversial (Cheung & Cousin, 2012; Korber et al., 2012; Kononenko et al., 2014).  
Budding is not dependent on neuronal activity but requires Ca2+ efflux from within the 
bulk endosome into the nerve terminal cytoplasm (Cheung & Cousin, 2013).  It also 
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requires ongoing CaN activity, which is sustained by this Ca2+ efflux (Cheung & Cousin, 
2013). 
 
1.1.2.2 Regulation of the actin cytoskeleton 
Dynamin has a major role in regulation of the actin cytoskeleton in cells, both directly 
and indirectly through actin polymerisation regulators.  These roles have been difficult to 
decipher due to an intimate role of actin in CME, however the balance of evidence 
suggests it is a direct dynamin function, independent of its role in CME.  Monomeric 
globular actin monomers (G-actin) are 42 kDa ATPases that can spontaneously assemble 
into filaments (F-actin) when bound to ATP.  Its slow ATPase activity results in 
degradation of the actin filaments.  Actin filaments are polar, with the addition of the G-
actin occurring at the barbed (+) end and the degradation at the pointed (-) end.  Actin 
polymerisation in vivo requires nucleation factors, which include proteins such as the 
actin-related protein 2/3 (Arp2/3) complex and in turn the proteins that activate this 
complex.  The Arp2/3 complex has seven protein subunits, two of which, ARP2 and 
ARP3, structurally resemble monomeric actin and serve as nucleation sites for new actin 
filaments (Rotty et al., 2013; Pollard, 2007; Goley & Welch, 2006).  Actin 
polymerisation is promoted by proteins such as N-WASP, which activates the Arp2/3 
complex and regulated by gelsolin which caps the filament at the barbed end thereby 
preventing its elongation. 
Dynamin can directly bind short actin filaments (F-actin) via an alternatively spliced 
α-helix in its middle domain (Gu et al., 2010) (see details below in Section 1.1.3.3).  
Dynamin has been identified as potentially having a specific role in the uncapping and 
bundling of actin (Gu et al., 2010).  Short filaments of actin have been associated with 
promoting the oligomerisation of dynamin into ring structures 35-40 nm in diameter and 
consisting of 24-28 dynamin molecules.  These in turn can uncap the gelsolin from the 
barbed end to promote actin filament extension.  The uncapping activity of dynamin can 
occur by GTPγS binding which promotes the formation of dynamin rings.  In vivo knock-
down of dynamin, or mutations that block its GTPase activity cause global alterations in 
the cellular actin cytoskeleton in a variety of cell types (Damke et al., 1994; Mooren et 
al., 2009).  Dynamin II associates with various actin rich structures in many cell types, 
such as phagocytic cups (Gold et al., 1999), podosomes (Ezekowitz et al., 1991) and 
lamellipodia (Yamada et al., 2009a). 
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In CME, dynamin and actin have been proposed to act in a synergistic fashion where 
dynamin may provide the trigger and the actin the force through provision of tension for 
fission (Merrifield et al., 2002; Anitei & Hoflack, 2012) but it is not clear how the direct 
dynamin-actin interaction fits into these mechanisms.  An apparent feedback mechanism 
exists between dynamin and actin during the lead up to fission, whereby the two proteins 
modulate the recruitment of each other to the site of endocytosis (Taylor et al., 2012).  
Dynamin GTPase activity regulates the kinetics of actin recruitment and the prevention of 
actin polymerisation by latrunculin significantly decreases dynamin recruitment and 
scission (Taylor et al., 2012).  Alternatively, mutations in the dynamin I middle domain 
that disrupt actin polymerisation do not seem to affect the rate of CME (Gu et al., 2010).  
The precise mechanisms of dynamin-mediated actin polymerisation in endocytosis 
therefore remain unclear. 
The interaction between dynamin and actin in CME may also be mediated by Src-
Homology 3 (SH3) domains of several proteins.  These include SH3 domains of proteins 
that play direct roles in actin filament polymerisation and maintenance such as cortactin, 
actin-binding protein 1 (Abp1) and SPIN90 (McNiven et al., 2000; Schafer et al., 2002; 
Kim et al., 2005; Otsuka et al., 2009).  They also include the SH3 domains of endocytic 
proteins such as syndapin, sorting nexin 9 (SNX9) and amphiphysin, which each regulate 
actin dynamics by binding both dynamin and N-WASP (Kessels & Qualmann, 2002; 
Shin et al., 2007; Yamada et al., 2009b).  The role of SH3 domains in regulating dynamin 
mediated actin dynamics is discussed more fully in Section 1.2.2.4. 
 
1.1.2.3 Mitosis/Cytokinesis 
A third key physiological role of dynamin is in mitosis, where it is required for the 
cytokinesis which is the final step in cellular division, resulting in two daughter cells 
(Smith & Chircop, 2012; Zhang et al., 2014).  Cytokinesis involves the formation of an 
actomyosin based contractile ring which causes the ingression of the cell membrane, 
forming the midbody structure.  The resulting intracellular bridge between the two 
daughter cells is a region of high membrane remodelling and vesicle trafficking (Gromley 
et al., 2005).  The final step is abscission which completes the formation of the daughter 
cells. 
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Dynamin II localises along microtubules in the midbody region/intracellular bridge 
during cytokinesis (Konopka et al., 2006).  Dynamin II KO studies revealed elongated 
membrane tubules and accumulation of midbodies (Skop et al., 2004; Liu et al., 2008).  
The role of dynamin II in cytokinesis is dependent on its phosphorylation status.  
Phosphorylation at S764 by cdk1/cyclin B1 localises dynamin II to the midbody region 
where it forms dual phospho-dynamin rings flanking the midbody (Chircop et al., 2011b; 
Chircop et al., 2010).  At the midbody dynamin II co-localises with the phosphatase CaN 
and the dephosphorylation of dynamin by CaN is essential for triggering abscission and 
completing the process of cell division (Chircop et al., 2011b).  Treatment of cells with 
inhibitors of dynamin and CaN results in cell cycle arrest at the midbody stage, abscission 
failure, multinucleation and finally cell death (Joshi et al., 2010; Chircop et al., 2011a).  
Dynamin II has therefore emerged as a novel target in the development of anti-cancer 
drugs.  Inhibition of dynamin by compounds such as MiTMAB™ and OcTMAB™ 
triggers caspase-mediated cell apoptosis and inhibits proliferation in human cancer cells 
(Joshi et al., 2011).  Apart from its function in cytokinesis dynamin is also proposed to be 
involved in centrosome cohesion (Thompson et al., 2004).  The centrosome is the main 
microtubule organising centre and is integral for the progression of cell cycle (Doxsey, 
2005).  Together these studies suggest that there may be additional dynamin functions yet 
to be uncovered. 
 
1.1.3 Dynamin domains 
In common with other members of the larger dynamin-like family, dynamin 
oligomerises into higher order assembly states, depending on the experimental 
conditions: tetramer, ring and helices.  The dynamin tetramer is the building block for the 
formation of rings and helices.  Dynamin rings have been functionally associated with 
actin dynamics (Gu et al., 2010) and the formation of the helix is proposed to stimulate 
dynamin GTPase activity to complete vesicle formation during endocytosis (Koenig & 
Ikeda, 1990; Sweitzer & Hinshaw, 1998).  The terms “oligomerisation” and “assembly” 
are used interchangeably to refer to dynamin transitioning from the tetramer building 
block to either a ring or a helix depending on the context.  It therefore follows that the 
terms “dynamin oligomer” or “assembled dynamin” can refer to dynamin as a ring or 
helix. 
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The oligomerisation of dynamin, its interaction with other proteins and, its subsequent 
role in endocytosis is mediated by specific functional domains that make up the whole 
protein.  These are: the N-terminal GTPase domain (also called the G domain), the 
bundle signalling element (BSE, which includes the GTPase effector domain (GED)), the 
middle domain, the pleckstrin-homology (PH) domain and proline-rich domain (PRD) 
located at the C-terminus.  GED is no longer considered to be a unique domain, since 
crystal structures revealed that half of it comprises the BSE and the other half is part of 
the middle domain.  These dynamin domains are represented in the line diagram in Figure 
1.4A, which is colour coded to represent the domains in the dynamin dimer crystal 
structure in Figure 1.4B. 
 
1.1.3.1 GTPase domain 
The dynamin G domain is located at the N-terminus and is the most highly conserved 
region within the dynamin family of proteins, showing similarity with even distant 
relatives such as atlastin and also with ATPases in the EHD protein family (Warnock & 
Schmid, 1996; Daumke et al., 2007; Bian et al., 2011).  Mutations within this domain of 
dynamin I cause severe epilepsy in humans (see Section 1.1.4.1 below).  Within the 
dynamin family the G domain is relatively large, being nearly twice the size of those in 
the Ras family of proteins.  Crystal structures of the classical dynamins reveal the 
presence of a number of insertions which distinguish it from the Ras G domain despite 
structural similarities between them (Reinhard et al., 2001; Niemann et al., 2001; 
Chappie et al., 2010; Ford et al., 2011; Faelber et al., 2011). 
The dynamin GTPases share the common properties of a low binding affinity for 
guanine nucleotides but, compared to the Ras proteins, they have a higher intrinsic or 
basal GTPase activity (Warnock & Schmid, 1996).  Both GTP binding to dynamin and 
hydrolysis of the GTP is required to drive vesicle fission (Song et al., 2004b; Itoh et al., 
2005).  The K44A or K44E mutation in the G domain is defective in GTP binding and 
inhibits endocytosis when expressed in cells (van der Bliek et al., 1993; Damke et al., 
1994; Ullrich & Südhof, 1994). 
Purified dynamin has a relatively low intrinsic GTPase activity, referred to as its basal 
activity, but has a higher stimulated activity.  Dynamin has two distinct levels of elevated 
activity associated with its oligomerisation, rings (Figure 1.4C) and helices (Figure 1.4D). 
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Firstly, it can self-assemble to form rings, resulting in a tenfold increase in GTPase 
activity relative to the basal activity (Warnock et al., 1996).  No other factors are required 
to be present for self-assembly, apart from high dynamin concentrations.  Secondly, it can 
assemble further into helices in the presence of templates to encircle, such as L- α-
phosphatidyl-L-serine (PS) liposomes, lipid nanotubes or microtubules, resulting in up to 
100-fold increase in GTPase activity (Hinshaw & Schmid, 1995; Stowell et al., 1999; 
Song et al., 2004b).  The link between the assembly state of dynamin and its GTPase 
activity is discussed in greater detail below in Section 1.1.5. 
A variety of studies show that the G domain is required for CME.  These commenced 
with the mutations reported in shibire flies (Chen et al., 1991; van der Bliek & 
Meyerowitz, 1991; Koenig & Ikeda, 1989).  Point mutations in the GTP-binding motif 
were demonstrated to block CME, with the K44A and T65N mutants subsequently 
becoming tools of extremely widespread use in cell biology (van der Bliek et al., 1993; 
Damke et al., 1994; Marks et al., 2001).  Mutational analysis of dynamin G domain has 
exhibited differential and graded effects on Km and Kcat for GTP hydrolysis (Song et al., 
2004a).  Transferrin uptake assays revealed a strong correlation between the rate of 
endocytosis and the calculated rates for both basal and assembly-stimulated GTP 
hydrolysis.  GTP binding was concluded to be not sufficient but that GTP hydrolysis is 
required for CME in vivo.  Thus, the scission activity of dynamin GTPase depends not 
just on GTP binding but also on GTP hydrolysis, further distinguishing the dynamin 
family from other GTPases. 
 
1.1.3.2 Pleckstrin homology domain 
The pleckstrin homology (PH) domain is stretch of 100 amino acids restricted to the 
classical dynamin sub-family (Anggono & Robinson, 2009).  The PH domain is present 
in more than 250 different proteins and represents the 11th most common domain in the 
human genome (Scheffzek & Welti, 2012).  Mutations within many PH domain modules 
are associated with human diseases, including mutations in that of dynamin II (Kenniston 
& Lemmon, 2010) (see below, Section 1.1.4.2).  The positively charged PH domain is 
responsible for the interaction of dynamin with negatively charged phospholipid 
membranes, such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) (Zheng et al., 
1996).  The PH domain has a role in targeting dynamin to the membrane, with the 
PI(4,5)P2 interaction promoting its recruitment (Lemmon & Ferguson, 2000; Di Paolo & 
23 
 
De, 2006).  Other studies however, paint a more complex picture, suggesting the PH 
domain may directly interfere with membrane properties and regulate endocytosis by 
altering the local distribution of PI(4,5)P2 (Bethoney et al., 2009).  The PH domain of 
dynamin also mediates protein-protein interactions with the β-gamma subunits of 
heterotrimeric G-proteins (Liu et al., 1997; Touhara et al., 1994) but the functional 
significance of this still remains unclear. 
The PH domain is required for CME (Salim et al., 1996; Vallis et al., 1999; Ferguson 
& De Camilli, 2012).  For example, a point mutation K535A in the PH domain disrupts 
binding to PI(4,5)P2 and inhibits CME, demonstrating the importance of this electrostatic 
interaction (Vallis et al., 1999).  The dynamin PH domain is necessary for endocytic 
vesicle scission by direct insertion into the first monolayer of the membrane mediated by 
amino acids from variable loop 1 (Burger et al., 2000; Ramachandran et al., 2009).  The 
functional importance of the PH domain is further demonstrated by the use of small 
molecule dynamin inhibitors targeted to this region.  These compounds inhibit lipid 
binding and prevent dynamin recruitment to the plasma membrane and inhibit CME of 
transferrin and epidermal growth factor receptors (EGFR) (McGeachie et al., 2013; Quan 
et al., 2007).  Therefore, by mediating dynamin lipid binding, the PH domain is indirectly 
responsible for stimulation of dynamin assembly and GTPase activity. 
There are more direct links between the PH domain and dynamin oligomerisation.  Its 
ability to insert into the membrane appears responsible for a hemi-fission state via 
membrane wedging of the PH domain (Shnyrova et al., 2013).  The isolated PH domain 
cannot bend membranes on its own but senses high membrane curvature through 
hydrophobic insertion into the membrane bilayer (Mehrotra et al., 2014).  This appears to 
control the dynamics of the dynamin polymer by variations in the morphology of 
membrane-bound dynamin helices. 
 
1.1.3.3 Middle domain, bundle signalling element (BSE) and GTPase effector domain 
(GED) 
The dynamin middle domain (sometimes called the stalk) is centrally located in each 
dynamin family member between the G domain and the previously named GED (Figure 
1.1 and 1.4A).  Once the near complete dynamin I crystal structure was resolved it 
became clear that the middle domain is not a continuous domain within the dynamin 
sequence, but includes an α-helix from the N-terminal half of the GED, which together 
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forms a 4-helix bundle (Ford et al., 2011; Faelber et al., 2011).  The oligomerisation 
activity of the middle domain requires that it interacts with the novel structure of the 
bundle signalling element (BSE), where half of GED is now known to be localised 
(Ramachandran et al., 2007).  The middle domain of dynamin does not share sequence 
homology with any known structural motif but is present across the whole dynamin 
family.  It is critical for the formation of dynamin tetramers and other higher order 
structures and specific mutations in this domain weaken the assembly-stimulated GTPase 
activity (Ramachandran et al., 2007).  It plays a similar role in all other dynamin family 
members examined to date (Chang et al., 2010; Byrnes & Sondermann, 2011; Gao et al., 
2010). 
Low resolution cryo-electron microscopy originally showed the middle domain and 
GED to form a ‘stalk’ connecting the ‘leg’ of the PH domain to the G domain which 
forms the ‘head’ (Zhang & Hinshaw, 2001).  The GED was also sometimes known as the 
assembly domain, since it is proposed to be a regulator of dynamin oligomerisation (Liu 
et al., 2013).  It is now clear from the more complete crystal structures that the middle 
domain and GED are distinct modules within dynamin (Ford et al., 2011; Faelber et al., 
2011). 
The BSE can best be understood as a ‘hinge’ between the G domain and middle 
domain (Chappie et al., 2009; Srinivasan et al., 2014).  BSE comprises three α-helices 
from different regions of dynamin (one from the GED and two from the G domain) 
coming together (Figure 1.4A and B).   Mutations in the GED regions that are part of the 
BSE adversely affect the GTP hydrolysis in both basal and assembly-stimulated activity 
(Sever et al., 1999; Song et al., 2004b) and this region is postulated to function as an 
intramolecular GTPase activating protein (GAP) for dynamin (Sever et al., 1999; 
Narayanan et al., 2005).  Mutations within the BSE prevent assembly-stimulated GTPase 
activity and modulate kinetics of endocytosis (Chappie et al., 2009).  Though the middle 
domains and BSE together play important roles in dynamin oligomerisation and activity 
the molecular details of how they achieve this remain poorly understood. 
Strikingly, an entire α-helix of the middle domain, the 45 residue α2 helix, is 
alternatively spliced as two alternate forms in both dynamin I and II but not III (Robinson 
et al., 1993b; Sontag et al., 1994).  Little has been done towards characterising these 
splice variants, with most biochemical studies having focussed on purified endogenous 
dynamin I/II, containing a mixture of both splice variants (and others).  These variants are 
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called splice variant dynamin IaX, IbX, IIaX and IIbX (X refers to the presence of a 
second splice site at the C-terminus, also called a, b, c etc., see below) and are each 
distinct.  The variants are likely to have different functions because differential mutations 
have distinct disease outcomes in mice (see below, Section 1.1.4.1).  The spliced α-helix 
from each dynamin is the proposed common F-actin binding site. 
 
1.1.3.4 Proline-rich domain (PRD) 
The C-terminus of each classical dynamin is rich in proline (~30%) and basic residues 
such as arginine (with an overall pI ~12) (Hinshaw, 2000; Anggono & Robinson, 2009).  
The PRD mediates many different protein-protein interactions and contains 13 PxxP 
motifs (where P is proline and x is any amino acid) which are the core binding sites for 
other proteins through their SH3 domains and also seems to be required for binding to 
microtubules (Barylko et al., 1998).  Binding of Grb2 or microtubules to the PRD and 
phosphoinositides to the PH domain of dynamin at the same time appears to have a 
synergistic effect in stimulating dynamin GTPase activity (Barylko et al., 1998).  The 
SH3 domain containing binding partners for the PRD include amphiphysin, endophilin, 
SNX9, syndapin and growth factor receptor-bound protein 2 (Grb2) (Grabs et al., 1997; 
Anggono & Robinson, 2007).  While the precise physiological role of most of these 
interactions is not clear, they are likely to regulate dynamin assembly state and hence its 
mechanochemical properties on the membrane surface.  They may also act as scaffolding 
or recruitment proteins to link dynamin to other functions such as regulation of the actin 
cytoskeleton.  The functional and physiological studies of SH3 domain protein interaction 
with the dynamin PRD is reviewed in more detail below in Section 1.2.2. 
In addition to binding to SH3 domain containing proteins, the PRD of dynamin I 
mediates protein-protein interactions that do not involve a PxxP motif.  The first is a 
direct interaction with the protein phosphatase CaN (Xue et al., 2011; Bodmer et al., 
2011).  This interaction occurs at a PRITIS motif found in only one of the alternatively 
spliced dynamin tails (see below) and is involved in neurotrophin receptor endocytosis 
and axonal growth (Bodmer et al., 2011).  The second is a direct interaction of the PRD 
with the enzyme nucleoside-diphosphate kinase (NDPK) (Baillat et al., 2002; Chen et al., 
2014a).  NDPK produces GTP through ATP-driven conversion from GDP and provides 
dynamin with GTP to allow it to operate in cell with high thermodynamic efficiency 
(Chen et al., 2014a). 
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Dynamin constructs, where the PRD has been deleted, do not seem to affect the 
assembly of dynamin into rings but result in its mis-localisation in cells (Sweitzer & 
Hinshaw, 1998) and failure of dynamin to accumulate at CCPs (Okamoto et al., 1997).  
Such constructs also abolish the ability of dynamin to rescue endocytosis defects in 
dynamin KO fibroblasts (Ferguson et al., 2009).  Therefore, one major function of the 
PRD is its ability to target dynamin to the site of endocytosis by interacting with other 
endocytic proteins.  However, its recruitment of CaN and NDPK reveal further critical 
biological roles. 
PRDs are primarily disordered structures, with limited secondary and no specific 
tertiary structure.  The first crystal structures of near full-length dynamin lacked the PRD 
but showed that it must be in the region of the G domain (Ford et al., 2011; Faelber et al., 
2011).  A recent study addressed this by combining cryo-EM using full-length dynamin 
with crystallography of the dynamin mutant (K44A), in which the GTP hydrolysis 
reaction transition-state is defective (Sundborger et al., 2014).  Significantly, the protein-
lipid tube formed by this transition-state defective mutant was far more constricted than 
with previously observed dynamin constructs.  The data also suggests the putative 
location of the PRD is close to a surface-accessible region of the G domain that is found 
only in dynamin and not in other dynamin-related proteins that lack a PRD (Sundborger 
et al., 2014).  The easy accessibility of the PRD to the G domain may allow binding 
partners such as SH3 to modulate function even in the final stages of CME.  Indeed the 
endophilin cryo-EM map could be docked on this K44A superconstricted density map, 
revealing that its SH3 domain lies within 8 nm of the PRD.  This data raises the 
possibility that the two regions may interact physically within the preassembled and 
superconstricted state.  Therefore, SH3 domain proteins may potentially influence the 
activity of the preassembled dynamin ring. 
 
PRD phosphorylation and splice variants 
Dynamin I and II functions can be regulated by site-specific phosphorylation in the 
PRD.  Dynamin I was originally named dephosphin (Fu et al., 1998), but after being 
renamed, the term ‘dephosphin’ was broadened to include a larger family of endocytic 
proteins regulated by dephosphorylation via CaN (Robinson et al., 1993b; Cousin & 
Robinson, 2001).  Dephosphins are endocytic proteins, detected as being constitutively 
phosphorylated in resting nerve terminals and rapidly dephosphorylated following 
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depolarisation by CaN (Robinson & Dunkley, 1983; Cousin & Robinson, 2001).  They do 
not appear to share common protein kinases.  Dynamin I was the first dephosphin and 
candidate protein kinases such as PKC (Robinson et al., 1993a), dyrk1 (Chen-Hwang et 
al., 2002) and cdk5 (Tan et al., 2003) were initially used to determine the in vitro 
phosphosites of dynamin I.  However, in vitro phosphorylation studies often produced 
misleading results that do not hold up in vivo (Tan et al., 2003).  These studies were 
therefore complemented by identification of the in vivo phosphosites, providing 
information about the abundance of each (Graham et al., 2007).  Seven phosphosites in 
dynamin I were identified and the PRD contained all the major phosphosites (in terms of 
abundance and response to neuronal stimuli). 
S774 and S778 in the PRD are the most heavily phosphorylated in neurons, accounting 
for up to 69% of the total dynamin I phosphorylation (Anggono et al., 2006; Graham et 
al., 2007).  They are located in the first half of the PRD in a sequence called the phospho-
box-1.  The biological significance of these sites was further indicated by the fact that 
following depolarisation they accounted for much of the dephosphorylation.  The only 
unambiguous evidence for a physiological role for the phosphosites is the phospho-
dependent interaction of dynamin I with syndapin I in ADBE, which is mediated by S774 
and S778 (Anggono et al., 2006).  The functional role of the other dynamin I 
phosphosites remains unknown.  Dynamin II has a single known phosphosite at S764 in 
its PRD, in a homologous position to S774 in dynamin I, and phosphorylation of this 
residue is assosciated with cytokinesis (Chircop et al., 2011b). However, no phospho-
regulated interacting partner has yet been described.  Despite this, the location of key 
phosphosites in the PRD of dynamin I and II suggest they regulate protein-protein 
interactions with SH3 domain containing proteins, analogous to that of dynamin I and 
syndapin I. 
There are three known dynamin splice variants within the dynamin I PRD that have a 
similar nomenclature as their middle domain counterparts, a through d.  Of the three 
variants, the short form (dynamin IXb) and long form (dynamin IXa) are the best 
characterised (X indicates the first splice site in the middle domain, which can be a or b 
variants).  The short dynamin I is unique in being able to specifically bind CaN (Xue et 
al., 2011).  Inhibition of this interaction prevents the activity-dependent 
dephosphorylation of the dynamin tail which is necessary for its involvement in ADBE 
(Xue et al., 2011).  While both the dynamin I isoforms contain the phosphosites S774 and 
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S778 in phospho-box-1, the long tail contains two additional phosphosites S851 and S857 
in a region called phospho-box-2 located almost at the C-terminus (Graham et al., 2007).  
They are also stimulus-responsive (Graham et al., 2007) but their biological roles are 
unknown. 
 
1.1.4 Dynamin-related diseases 
Several links have emerged between mutations in dynamin and diseases due to 
functional abnormality in dynamin.  Mutations in dynamin I have been linked to epilepsy 
in humans and neurological disease in animals.  At least three human diseases have been 
linked to a number of mutations in dynamin II.  There is no evidence yet for the 
involvement of dynamin III in any mammalian disease. 
 
1.1.4.1 Dynamin I-linked diseases 
Mutations in dynamin I reported to date specifically affect the nervous system.  A de 
novo single nucleotide mutation in this protein was initially associated with epileptic 
encephalopathy in humans (Allen et al., 2013).  Although this correlation was not 
significant at the time, their follow-up exome sequencing study found five de novo 
DNM1 mutations that cause epileptic encephalopathy in humans (Appenzeller et al., 
2014).  Early infantile epileptic encephalopathy is a severe form of epilepsy with frequent 
tonic seizures or spasms beginning in infancy and typically associated with severe 
intellectual development disabilities.  This is a genetically heterogeneous disorder caused 
by defects in multiple genes including CDKL5, SLC25A22, STXBP1, SPTAN1 and the 
SCN1A genes.  Four of the human mutations are in the G domain (T65N, A177P, K206N 
and R237W) and one (G359A) in the middle domain (Figure 1.5).  All five are highly 
conserved amino acids across species.  The T65N mutation was previously well known 
from cell biology studies to block GTP hydrolysis (Marks et al., 2001). 
A spontaneously arising dynamin I mutation in the fitful mouse also causes epilepsy 
(Boumil et al., 2010).  Mice with this mutation have recurrent and non-lethal seizures.  
The fitful mutation, A408T, resides in the middle domain of dynamin I (Figure 1.5).  It 
likely interferes with the ability of dynamin I to oligomerise into high ordered structure 
which is necessary for its role in endocytosis.  The disease mutation A408T is isoform-
specific and has an effect only in the dynamin IaX middle domain spliced α2 helix 
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variant but not the dynamin IbX (Boumil et al., 2010; Allen et al., 2013).  This supports 
the likelihood of different functional roles for the two forms of this spliced helix. 
Another dynamin I mutation occurs in exercise-induced collapse, a recessive 
pathology observed in dogs (Patterson et al., 2008).  The underlying mutation, R256K, is 
located in the boundary between the G domain and BSE.  The animals display severe 
muscle weakness following high-excitement and high intensity exercise.  This is 
proposed to occur due to an insufficient amount of SV recycling to sustain neuro-
muscular transmission, resulting in a reversible loss of motor function (Patterson et al., 
2008).  This is reminiscent of the temperature-sensitive dynamin I mutation in shibire 
flies where the flies exhibit paralysis (Kosaka & Ikeda, 1983). 
 
1.1.4.2 Dynamin II linked diseases 
Mutations in dynamin II have been associated with leukaemia and with two autosomal 
dominant neuromuscular genetic conditions: Charcot-Marie-Tooth disease (CMT) 
(Zuchner et al., 2005) and centronuclear myopathy (CNM) (Bitoun et al., 2005).  CMT is 
a demyelinating disease which affects the peripheral nerves and is characterised by 
muscular weakness of the extremities (Tanabe & Takei, 2012).  CNM is an inherited 
muscular dystrophy characterised by atrophy of muscles particularly in the facial area 
(Susman et al., 2010; Fischer et al., 2006; Jeannet et al., 2004).  Table 1.4 summarises 
some of the common CNM and CMT mutations and the impairment of cellular process 
with which they are associated. 
Table 1.4: Common mutations of Charcot-Marie-Tooth disease (CMT) and 
centronuclear myopathy (CNM).  Modified from (Gonzalez-Jamett et al., 2014). 
 
CNM MUTATIONS CMT MUTATIONS PHENOTYPE DISRUPTED 
R465W, R522H, 
E560K 
K558E, K562E CME in COS-1 and COS-7 cells 
 G358R,G537C, 
K562E, L570H 
CME in RT4 Schwann cells 
E368K, R465W L570H Clathrin-independent endocytosis 
E368K, R465W L570H Raft-dependent endocytosis of Cholera toxin 
E368K, R465W L570H Protein export from Golgi to plasma membrane 
 G358R, K562E Myelination and de-myelination in dorsal root 
ganglia 
R465W  Autophagy and autophagosome maturation 
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The CMT associated mutations are frequently found at the N-terminal side of the PH 
domain while the CNM associated mutations tend to cluster at the C-terminal side of the 
PH domain (Durieux et al., 2010).  It is interesting however, that structurally these 
mutations cluster at the interface between the PH and stalk domains of dynamin and are 
thereby likely to modulate dynamin oligomerisation (Faelber et al., 2011).  How these 
abnormalities in dynamin II result in these disease conditions remains unclear. 
Dynamin II mutations are also associated with T-cell acute lymphoblastic leukaemia 
(T-ALL).  This is a subset of ALL, the most common malignancy of childhood (Zhang et 
al., 2012a; Neumann et al., 2013).  There are 17 somatic mutations (not inherited) 
associated with T-ALL, limiting their impact to hematopoietic cells (Zhang et al., 2012a; 
Neumann et al., 2013).  These mutations are widely distributed throughout the DNM2 
gene in each functional domain, including the PRD.  The mutations include missense, 
nonsense, splice site and frameshift mutations and all are likely to result in loss of 
dynamin II function.  It is not known how they might increase cell proliferation and it is 
unclear whether DNM2 mutations are the only defects in these patients. 
 
1.1.5 Dynamin oligomerisation 
Most of the functions of dynamin have been linked to its ability to deform cellular 
membranes.  In order to do this dynamin binds and assembles into oligomers at the 
membrane sites.  Dynamin has three assembly states, any of which can predominate, 
depending on the assay conditions.  Purified unstimulated dynamin exists in vitro 
primarily as a tetramer structure (Liu et al., 1996; Liu et al., 2013; Binns et al., 1999).  It 
can self-assemble into rings at high dynamin concentrations and low ionic conditions 
(Hinshaw & Schmid, 1995).  At lower dynamin concentrations dynamin can be 
stimulated to form rings in the presence of various agents, as listed in Figure 1.6.   With 
the addition of an external template, such as anionic lipids, dynamin forms helical arrays, 
structures which are reminiscent of dynamin collars formed around invaginating vesicle 
necks during endocytosis in vivo (Takei et al., 1995; Sweitzer & Hinshaw, 1998; Stowell 
et al., 1999).  Oligomerisation into helical structures results in a drastic stimulation of its 
GTPase activity above basal and both are essential for its mechanochemical activity 
during CME (Warnock et al., 1996; Stowell et al., 1999).  An example of the assembly-
stimulated increase in GTPase activity by different agents is shown in Figure 1.7. 
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The ability to self-assemble or to assemble around lipid templates has been observed 
in other dynamin-like proteins such as Drp1 (Shin et al., 1999; Yoon et al., 2001), MxA 
(Kochs et al., 2002; Accola et al., 2002) atlastin (Muriel et al., 2009), Opa1 (Ban et al., 
2010) and a bacterial dynamin-like protein (Low & Lowe, 2006; Low et al., 2009) and is 
likely a property of the entire dynamin family.  However, to date only the classical 
dynamins are known to undergo stimulus-dependent assembly, such as that induced by 
SH3 domain proteins.  In all examples to date, oligomerisation of any member of the 
dynamin family results in elevated GTPase activity (Kochs et al., 2002; Syguda et al., 
2012).  Therefore, all available evidence suggests that the functions of dynamin are 
dependent on its assembly state and the resulting stimulation of GTPase activity, a 
concept deeply embedded in this field.  This is further demonstrated by the various 
mutations impairing GTP binding and assembly leading to defects in endocytosis 
(Schmid & Frolov, 2011).  A better understanding of the factors influencing dynamin 
oligomerisation and its activity will provide important insights into how dynamin 
performs its physiological roles. 
 
1.1.5.1 Dimer and Tetramer 
While unstimulated dynamin in solution exists in a monomer-tetramer equilibrium 
(Liu et al., 1996; Liu et al., 2013; Binns et al., 1999), the basic ‘building block’ for 
oligomerisation appears to be based on dimers (Figure 1.4B).  Crystal structure studies 
revealed that dynamin which has been mutated such that it cannot oligomerise, consists 
of a ‘dimer of dimers’ (Ford et al., 2011; Faelber et al., 2011).  Similarly, cryo-EM 
studies on dynamin helices around PS liposomes demonstrate that the dynamin dimer is 
likely to be the basic building block for further assembly (Zhang & Hinshaw, 2001).  The 
dimer structures have not been observed as independent complexes in solution and are 
detected under artificial conditions, such as dynamin mutations in the middle domain or 
chemical crosslinking (Ramachandran et al., 2007; Chappie et al., 2011).  They seem to 
form the minimal unit of dynamin and exist as part of stable tetramers. 
Dynamin forms the dimer building blocks via the middle domain which dimerises in a 
cross-like fashion to form a T-shaped structure (Faelber et al., 2011; Ford et al., 2011).  
Assembly-stimulated GTPase activity requires a pair of G domains to be oriented face-to-
face (Chappie et al., 2010).  However, the dynamin dimer has the two G domains 
oriented in opposite directions facing outwards in an extended structure.  The G domains 
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are clearly not in contact with each other, potentially accounting for basal GTPase 
activity.  The dimerisation of the G domains resulting from tetramerisation and further 
assembly is essential for GTP hydrolysis and helps explain the increased GTPase activity 
with assembly.  The dynamin tetramer is essential for dynamin to form rings or helices 
since it may act as the intermediate structure for further assembly (Ramachandran et al., 
2007; Gao et al., 2010; Chappie et al., 2011). The crystal structure of the dynamin 
tetramer shows the 4 molecules to make multiple contacts that are not static but exist in a 
state of dynamic equilibrium with multiple conformations present (Reubold et al., 
2015).  The tetramer has an autoinhibitory 'closed' conformation and the transition to an 
'open' conformation allows the formation oligomers.  The tetramer itself however has no 
known independent function. 
 
1.1.5.2 Rings 
The dynamin dimer/tetramer oligomerises to either single rings (Hinshaw & Schmid, 
1995) or continuous helices (Takei et al., 1995).  On its own (i.e. absence of an added 
template and at elevated concentrations in the presence of low salt <50 mM) dynamin can 
oligomerise into single rings of 35-40 nm in diameter with an estimated 24-28 
monomeric dynamin molecules (or ~12-14 dimers) (Hinshaw & Schmid, 1995; Zhang & 
Hinshaw, 2001; Pawlowski, 2010).  This assembly of dynamin into rings in vitro 
stimulates its GTPase activity (Warnock et al., 1996).  Dynamin rings and associated 
GTPase activity can also be stimulated by a range of small dynamin modulating 
compounds (referred to as Ryngo® compounds, data from the host lab at CMRI, USA 
Patent 8,809,386, see also (Gu et al., 2014)).  Rings have also been detected by electron 
microscopy (EM) analysis.  Rings detected by EM are also induced by the SH3 domains 
of a variety of proteins such as endophilin, intersectin and cortactin (Ross et al., 2011; 
Knezevic et al., 2011; Yamada et al., 2013).  There is also increasing evidence that 
suggests an association between dynamin rings and actin assembly. In in vitro studies, 
short F-actin filaments are able to promote the formation of dynamin rings, which act by 
uncapping gelsolin (an actin- capping protein), resulting in actin polymerisation and 
elongation (Gu et al., 2010). Mutant dynamin forms, which favour the ring state, have 
been demonstrated to stabilise actin cytoskeleton in podocytes (Sever et al., 2007).  These 
rings can also form in cells, as revealed by a recent fluorescence resonance energy 
transfer (FRET) study, with in vivo ring assembly specifically associated with actin 
33 
 
dynamics (Gu et al., 2014).  These results suggest dynamin rings they have a biological 
role distinct from that of helices.  
Oligomerisation appears to involve two domains of dynamin to bring about extensive 
packing of the dimer and bring the GTPase domains together: the G and middle domains.  
While the dimer keeps the two G domains at opposite ends of the extended structure, 
GTP binding appears to induce oligomerisation by their dimerisation from different 
dimers.  This is also controlled by the angle between two middle domain dimers (Chappie 
et al., 2010; Faelber et al., 2011; Ford et al., 2011). 
 
1.1.5.3 Helices 
Dynamin helices differ from the above ring structures in needing a template to 
assemble around, most commonly flexible L-α-phosphatidyl-L-serine (PS) liposomes or 
rigid lipid nanotubes but also microtubules (Shpetner & Vallee, 1989; Maeda et al., 1992; 
Sweitzer & Hinshaw, 1998; Hinshaw, 1999).  In vitro assays show dynamin preferentially 
interacts with highly curved membranes, which is consistent with its role in forming a 
collar around the deeply invaginated coated pits during endocytosis (Ramachandran & 
Schmid, 2008). 
Within a helix, single turns are called rungs.  The individual rungs within dynamin 
helices have a diameter similar to that of a dynamin ring and the length of helix in vivo is 
estimated to be limited to 2-5 turns (Pawlowski, 2010; Bashkirov et al., 2008), although 
there may be hundreds of turns in vitro.  The helices formed in vitro and in vivo also 
differ in their pitch (distance between adjacent rungs), partly owing to the effect of 
accessory proteins in the cell and partly due to the different conditions inside cells versus 
a laboratory.  The pitch with dynamin only in vitro is 10-13 nm, whereas the pitch in vivo 
is 18–20 nm (Hinshaw & Schmid, 1995; Itoh et al., 2005).  The bent shape of the 
tetramer determines the assembly of dynamin into a right-handed helix and defines 
helical morphology, factors which have important implications for its role in membrane 
constriction (Reubold et al., 2015). 
Dynamin helices are the most catalytically active form of the enzyme, presumably 
because they are both more highly ordered and they have the potential for G domain 
dimerisation between adjacent rungs of the helices (Faelber et al., 2011).  On forming 
helices at the base of vesicle pits, it is the GTP hydrolysis of the helical dynamin that 
34 
 
drives membrane scission and vesicle release (Koenig & Ikeda, 1990; Sweitzer & 
Hinshaw, 1998).  Using new genome editing strategies, the last ~20 seconds of CME was 
demonstrated to be accompanied by a stable recruitment of ~26 molecules of dynamin to 
the CCP (Grassart et al., 2014).  This is sufficient capacity to form at least a single loop 
around the vesicle neck (Hinshaw & Schmid, 1995; Zhang & Hinshaw, 2001; Sundborger 
et al., 2014). 
 
1.1.5.4 Potential mechanisms of membrane scission by the dynamin helix 
While there have been important advances in understanding the structure of dynamin, 
the mechanism by which dynamin drives membrane fission remains unclear and is an 
area of intense debate.  Much of the debate centres on the extent of dynamin transient 
oligomerisation at the vesicle neck and the precise role of the GTP hydrolysis cycle of 
dynamin.  One unresolved consideration is whether dynamin functions as a single turn of 
the helix (26-28 monomers), or requires multiple turns which would allow dynamin-
dynamin interactions between helical rungs.  While two- or three-rung helices are 
observed in shibire flies (Koenig & Ikeda, 1989) and essentially limitless rungs occur in 
vitro on lipid templates (Takei et al., 1995; Stowell et al., 1999), in one major study only 
sufficient dynamin monomers to form a single loop were demonstrated to be recruited to 
the CCP (Grassart et al., 2014).  Resolution of this issue will underpin all subsequent 
models of dynamin GTPase function in CME. 
The next main consideration has been the precise role of its GTPase activity.  Does it 
drive constriction of the helix against the underlying membrane, expansion of the helix to 
push a vesicle off one end, or the subsequent helix disassembly?  GTPase activation was 
thought to destabilise the helix and induce dynamin disassembly, thus completing an 
oligomerisation cycle (Warnock et al., 1996; Sever et al., 2006; Bashkirov et al., 2008; 
Pucadyil & Schmid, 2008).  However, this model does not explain fission. 
A number of different models of dynamin-mediated membrane fission have been 
proposed using living cells and minimal systems using purified dynamin.  The model 
with most experimental support and which is widely accepted is the constriction model, 
sometimes referred to as the “pinchase” model.  This involves GTP hydrolysis-dependent 
structural reorganisation of the dynamin oligomer around the endocytic bud triggering 
constriction of the membrane (Roux et al., 2006; Bashkirov et al., 2008; Pucadyil & 
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Schmid, 2008).  Structural studies of the dynamin polymer have shown GTP hydrolysis 
by the G domain dimer triggers a lever-like movement in the adjacent BSE domain, this 
is now referred to as the ‘powerstroke’ of dynamin (Chappie et al., 2011).  This 
conformational change is proposed to spread from one helical rung to the next, leading to 
the constriction of the underlying lipid tubule and providing the mechanical force for 
vesicle release (Bian et al., 2011; Byrnes & Sondermann, 2011; Chappie et al., 2011). 
There are some important shortcomings of the above model.  It is unlikely that 
constriction alone can drive fission since lipid membranes, while flexible, are elastic and 
difficult to stretch apart.  One study has shown fission to occur at the interface between 
dynamin-coated and -uncoated parts of the membrane (Morlot et al., 2012).  This 
mechanism has the advantage of exploiting the change in membrane curvature to reduce 
the energy barrier for fission to occur spontaneously from that point.  This model is 
consistent with previous studies, which predict long helical coats are able to reduce 
fission efficiency (Sever et al., 2006; Bashkirov et al., 2008; Pucadyil & Schmid, 2008).  
However, the authors could not find evidence for GTP-induced depolymerisation and 
conclude that oligomerised dynamin forms 10 nm radius tubules on the underlying lipid 
that needs further GTP-dependent constriction to be cut, accounting for the GTP energy 
expenditure of dynamin (Morlot et al., 2012). 
In summary, membrane tension and bending rigidity are factors influencing fission, in 
addition to GTP hydrolysis which drives conformational change in dynamin.  These 
forces appear to act together to overcome the elastic energy barrier on the underlying 
lipid at the edge of the dynamin helix and promote spontaneous fission.  It remains 
unclear whether these mechanistic insights may be relevant to understanding other 
intracellular membrane fission events, such as for ESCRT-III-mediated fission at 
endosomes. 
 
1.2 SH3 domains 
The overwhelming majority of protein interactions with dynamin and the only protein 
interactions known, apart from self-assembly, to regulate its oligomerisation and activity 
are those between the dynamin PRD and SH3 domain-containing proteins.  These 
interactions represent the primary focus of this thesis and therefore the properties of SH3 
domains will be reviewed here. 
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1.2.1 SH3 domain family 
Many cellular processes are regulated by protein-protein interactions between the 
domains of different proteins.  One such interaction is the binding of SH3 domains to 
proline-rich sequence motifs in target proteins (Musacchio et al., 1992; Pawson & 
Schlessinger, 1993; Zarrinpar et al., 2003).  SH3 domains are 50-70 amino acid modules 
that are structurally folded and are conserved in a diverse array of proteins.  These 
domains are among the most abundant binding modules in eukaryotes.  For example, 
whole genome sequencing and sequence homology searches revealed 28 SH3 domains in 
the budding yeast S. cerevisiae, 84 in the nematode worm C. elegans and ~300 in humans 
(Letunic et al., 2009; Finn et al., 2008).  Their presence within a wide of variety of 
proteins indicates their involvement in broad cellular signalling processes. 
The SH3 domains function as adaptor proteins, as they lack intrinsic enzymatic 
activity of their own but link proteins together.  The specific targets of SH3 domains are a 
variety of short amino acid motifs and domains, providing a large pool of ligands and 
cellular functions for this family (Agrawal & Kishan, 2002; Musacchio, 2002).  This 
diversity also makes it difficult to decipher how the specificity of the hundreds of human 
SH3 domains is regulated in a cell to ensure their proper functions (Kaneko et al., 2008). 
 
1.2.1.1 SH3 structure 
The basic fold of SH3 domains consists of a core of 5 anti-parallel β-strands linked 
together by 3-10 (3 residues per turn) helical loops, which pack together to form a β-
barrel structure (Figure 1.8).  The core contains a number of conserved aromatic 
hydrophobic residues which form the binding site for the conserved proline-rich motifs 
located within the sequence of the target PRD (a binding example is shown in Figure 
1.8).  The hydrophobic side chains are the main contributors to binding PRDs and this is 
a low specificity interaction (Wu et al., 1995).  The hydrophobic residues are surrounded 
by two charged and variable amino acid loops: the RT loop and the n-Src loop.  These 
two loops form a key part of the target binding pocket and provide much of the 
specificity in polyproline target sequence recognition (Lim et al., 1994; Noble et al., 
1993).  The acidic residues found in most n-Src loops coordinate with basic residues 
found in the target PRD to contribute to target specificity (Owen et al., 1998).  The SH3 
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domain also has a distal loop, which occupies a position opposite the SH3 ligand binding 
site and contributes to binding specificity. 
 
1.2.1.2 Proline-rich motifs 
Proline-rich motifs are biologically amenable for protein-protein interactions due to 
several unique properties (Li, 2005).  Proline is an atypical amino acid, with its side-chain 
cyclised onto the backbone nitrogen, thereby imposing conformational constraints on the 
proline.  This results in proline-rich amino acid sequences adopting an unusual secondary 
structure called the polyproline type II (PPII) helix.  This is an extended left-handed helix 
with a pitch of 3 residues per turn, as opposed to a non-proline helix which has 3.6 
residues per turn.  The backbone carbonyls in the PPII helix project out into the solution 
at regular intervals and with the absence of an amide proton on proline, the carbonyls are 
free to have intermolecular interactions with the target ligand.  Due to existing steric 
constraints in a polyproline-rich sequence there is a reduced entropic cost on binding 
(Zarrinpar et al., 2003).  The PPII helical structure is stable and can incorporate a number 
of different residue insertions.  Therefore, its integrity can be maintained even with the 
addition of various non-proline residues. 
Proline also has the property of acting as a breaker of ordered secondary structures 
such as α-helices and β-sheets (Castagnoli et al., 2004).  This frequently exposes the 
proline motif to the solvent rather than being buried with the protein core and improves 
their accessibility to the SH3 target.  This is enhanced by the fact that the target PRD 
module in proteins most frequently occurs at its N- or C-termini (Farley & Auerbach, 
1986). 
 
1.2.1.3 SH3 binding to proline-rich domains 
Most SH3 domains bind the conserved consensus amino acid motif PxxP in the PRD, 
with the motif fitting into a hydrophobic groove between the RT and n-Src loop (the 
groove is arbitrarily referred to as the ‘top’ of the SH3 domain).  SH3s have differences 
in binding preferences at positions surrounding this common motif.  They can bind the 
PRD ligands in two possible orientations: class 1 PRD ligand binding has the consensus 
sequence [RK]xxPxxP and class II ligands have PxxPx[RK] (where [RK] refers to either 
of the positively charged amino acids arginine or lysine) (Feng et al., 1994).  The 
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orientation of these flanking basic residues relative to the PxxP sequences helps achieve 
specificity and binding orientation.  These flanking residues often increase the binding 
affinity of both class I and class II proline-rich peptides to SH3 domains, however these 
flanking basic sequences alone cannot bind SH3 domains independently of a PxxP motif 
(Kami et al., 2002). These basic residues make strong ionic interactions with the acidic 
aspartate or glutamate residues in the binding groove of the SH3 domain, with the 
hydrophobic interaction making up the principal contribution to the binding interface 
(Agrawal & Kishan, 2002).  For example, a crystal complex of C3G PRD and adaptor 
protein C-Crk SH3 domain exhibit the typical fold of PRD and SH3 interaction (Li, 
2005).  The C-Crk SH3 domain adopts a classical β-barrel, where the RT loop and n-Src 
loop form a binding groove for the PRD.  The W169 and F146 aromatic residues form 
hydrophobic interactions with prolines from the C3G PRD.  The acidic residue (D15) 
adjacent to the PxxP core determines the orientation and the specificity of the PRD 
binding to SH3. 
Several SH3 domains recognise motifs other than PxxP, with more than a third of 
yeast SH3 domains not matching either class.  For example, the SH3 domain of Eps8 
recognises a PxxDY motif (Mongiovi et al., 1999) and that of Gads protein recognises an 
RxxK motif (Berry et al., 2002).  Another group of unusual SH3 domains are found in the 
mammalian membrane-associated guanylate kinase homologs (MAGUKs), which 
associate with an adjacent guanylate kinase domain in an intra- or intermolecular fashion 
(McGee et al., 2001). 
 
1.2.1.4 Short and long distance regulation of SH3 binding to PRD 
While the binding of SH3s to PxxP motifs is well characterised, residues distant to this 
core motif are also important.  These so called “extensions” seem to work together with 
the core motif in enhancing binding specificity of protein-protein interactions (Bauer et 
al., 2005; Edmondson et al., 2009; Batra-Safferling et al., 2010).  However, these 
residues alone are not sufficient for binding to take place independently of the PxxP motif 
(Kami et al., 2002).  For example, a sequence located 11 amino acids apart from the PxxP 
motif in the herpes virus tyrosine kinase interacting protein (Tip) results in more than an 
order of magnitude greater affinity for Lyn SH3 domain than for other closely related 
members of the Src family (Bauer et al., 2005). 
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Unpublished data from our lab (generated by Dr. Lin Luo) has demonstrated the role 
of extension residues for dynamin interaction with SH3 domains of endophilin and 
syndapin.  The extension residues have been classified as short distance elements (SDE) 
or long distance elements (LDE), based on their distance from the PxxP.  The SDE can be 
5 to 15 residues from the core motif and mutating them can significantly reduce or 
abolish SH3 binding to the PRD proteins, indicating an important functional role for 
these residues.  Endophilin, in addition to the established dynamin PRD PxxP motif, was 
shown to bind independently at a site on the distal end of the PRD.  The binding to this 
new site is significantly reduced in the ‘short’ dynamin I-Xb splice variant which lacks its 
SDE.  Syndapin SH3 binds to previously unidentified elements in the middle and distal 
ends of the dynamin PRD which make up the SDE and LDE respectively.  The presence 
of these two binding elements in dynamin gives rise to a 23-fold increase in binding 
affinity to syndapin.  Both endophilin and syndapin were shown to utilise the entire 
dynamin PRD for their interaction rather than the short canonical PxxP motifs.  Overall, 
this data indicates the key role of sequences within the target protein for an SH3 domain 
that are far removed from the PxxP motif yet confer high affinity binding. 
 
1.2.2 Endocytic role of SH3 domain proteins 
Among the 300 or so mammalian SH3 domain proteins are the sub-group that function 
in endocytosis and/or actin dynamics (McPherson, 1999), which form the focus of this 
thesis (Table 1.5).  The domain structure of many of the endocytic proteins that harbour 
one to five SH3 domains is shown in Figure 1.9.  Grb2 is an SH3 domain protein which 
has not been extensively utilised in this thesis but has been a focus of many previous 
studies and has therefore been included as a comparator in this list. 
Table 1.5:  Endocytic SH3 domain proteins classified into functionally distinct 
groups (Ferguson & De Camilli, 2012). 
FUNCTION SH3 DOMAIN PROTEINS 
Membrane remodelling (BAR domain 
mediated) 
Endophilin, SNX9, Amphiphysin I/II, Syndapin, 
Graf1, FBP17 and CIP4 
Actin dynamics 
Indirect (N-WASP-
mediated) 
SNX9, Syndapin, FBP17, CIP4, Tuba, Myosin 1e 
Direct actin binding Cortactin, Abp1, CD2AP/CIN85 
Scaffolding 
Intersectin, Endophilin, Vav, SPIN90, 
CD2AP/CIN85 
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Each of these SH3 domain-containing proteins binds dynamin and acts as a molecular 
adaptor during endocytosis, linking dynamin to proteins or lipids.  The type of additional 
modules present in these proteins allows SH3 domain proteins to be further sub-classified 
into functionally distinct groups, comprising membrane remodelling proteins, molecules 
regulating actin dynamics and scaffolding proteins, with some proteins belonging to more 
than one group (Table 1.5).  The table includes some SH3 domain proteins which are not 
considered in this thesis (Graf1, Tuba, Myosin 1e, CD2AP/CIN85, Vav and SPIN90) and 
is partly based on the following review (Ferguson & De Camilli, 2012). 
In addition to these functional roles, there are other roles for SH3 domains they may 
potentially have in common.  The first is that they may stimulate the activity of their 
target protein, such as stimulating dynamin GTPase activity and/or oligomerisation.  The 
second is that they are thought to recruit or localise their target PRD-containing protein to 
themselves or to a specific subcellular site of action.  The next sections review these 
common functions of this set of SH3 domain proteins before discussing their more 
specialised functions listed in Table 1.5.  This will be done with a particular focus on the 
effects of their interaction with dynamin and their potential role in endocytosis. 
 
1.2.2.1 SH3 domain proteins and dynamin GTPase activity 
The GTPase activity of dynamin, along with being required for the membrane 
scission, seems to be important for dynamin localisation to the site of membrane 
invagination (Taylor et al., 2012).  SH3 domains can stimulate the GTPase activity of 
dynamin in the absence of any phospholipids, which suggests a regulatory role for SH3 
domains rather than simply being required for scaffolding and localisation. 
Initial studies demonstrating SH3 domain stimulation of dynamin GTPase activity 
were done using non-endocytic proteins and indicated diverse SH3 domains to stimulate 
activity to different extents (Gout et al., 1993; Herskovits et al., 1993b).  This was 
extremely important observation at the time, as it showed that such domains were more 
than simple scaffold proteins.  Following this, in vitro assays demonstrated dynamin 
GTPase to be stimulated by endocytic SH3 domain proteins such as SNX9, endophilin 
and intersectin, i.e. not solely by signalling proteins (Soulet et al., 2005; Ross et al., 
2011; Knezevic et al., 2011).  This increase in GTPase activity is associated with the 
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assembly of dynamin into oligomers, shown by centrifugation to result in sedimentable 
dynamin pellets.  This was confirmed by EM showing dynamin ring formation in these 
pellets, induced in the presence of SH3 domain proteins Grb2, amphiphysin I, endophilin 
II, cortactin, or intersectin I (SH3A) (Lin et al., 1997; Yoshida et al., 2004; Ross et al., 
2011; Knezevic et al., 2011; Yamada et al., 2013). 
While the above experiments demonstrate SH3 domain mediated dynamin activity and 
assembly, there has been no systematic approach comparing the diverse SH3 domain 
proteins.  Moreover, it is hard to discern the specific effect of the SH3 domain itself from 
these studies, since they either contain the GST purification tag or more commonly 
employ the full-length form of the protein containing other domains.  There is evidence 
suggesting the GST-tag promotes dimerisation of the tagged protein which could lead to 
potentially artefactual cross-linking of dynamin and change its catalytic properties 
(Warnock et al., 1995; Barylko et al., 1998).  Since many of the endocytic proteins 
contain the dimerising Bin-Amphiphysin-Rvs (BAR) domains, using the full-length 
protein in experiments with dynamin can make it more challenging to determine the 
specific effect of the SH3 domain (Ross et al., 2011).  Table 1.6 summarises the studies 
of dynamin GTPase activity stimulation by SH3 domain proteins and the form of the 
protein that was used. 
Table 1.6: Summary of studies using SH3 domain proteins which increase 
dynamin GTPase activity and the form of protein used. 
 Full-length (FL) SH3 domain alone 
Protein GST-tag Untagged GST-tag Untagged 
Grb2 
 
(Barylko et al., 
1998) 
 
(Barylko et al., 
1998) 
  
SNX9  
(Soulet et al., 2005)  
 
(Soulet et al., 2005)  
Endophilin  
  
(Ross et al., 
2011) 
  
Intersectin   
 
(Knezevic et al., 
2011) 
 
Cortactin  
 
(Yamada et 
al., 2013) 
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Of the listed proteins, Grb2 is the only one to have been studied in both the GST-
tagged and untagged forms.  The absence of the GST-tag results in decreased GTPase 
activity and assembly, pointing to a cross-linking effect of the purification tag (Barylko et 
al., 1998).  Curiously, full-length GST-SNX9 had a stimulatory effect on dynamin but not 
the GST-SNX9 SH3 domain (Soulet et al., 2005).  No study as yet has been performed of 
the dynamin binding SH3 domain alone in the absence of the GST-tag.  Interpreting the 
results of these studies is further complicated by the use of varying buffer conditions and 
high dynamin concentration (>1 µM) between each.  The latter is an issue due to 
propensity of dynamin to self-assemble under these concentrations which makes it harder 
to discern to what extent the increase in activity is mediated by the SH3 domain protein.  
The primary aim of this thesis involves a study of the SH3 domains simultaneously and 
systematically, to determine their effect on dynamin under different conditions. 
 
1.2.2.2 Subcellular localisation of dynamin by binding SH3 domains 
Some SH3 domain proteins can recruit dynamin to sites of active endocytosis and it is 
widely proposed, often without experimental support, that most dynamin-binding SH3 
proteins recruit dynamin to a specific site in a cell (Shpetner et al., 1996).  The lipid 
binding PH domain on dynamin is thought to not be sufficient on its own to translocate 
dynamin from the cytosol to the plasma membrane (Lemmon & Ferguson, 2000).  
Truncation of the PRD leads to the mis-localisation of the protein, highlighting the 
significance of the interaction with SH3 containing proteins (Shpetner et al., 1996).  SH3 
domains which do not bind dynamin, such as those of c-Abl and intersectin I SH3B and 
SH3D (two of the five found SH3s in the mammalian gene), fail to disrupt endocytosis 
using in vitro transferrin uptake assays (Sparks et al., 1996; Simpson et al., 1999).  Not 
all dynamin-binding SH3 domains disrupt endocytosis and transfection of those from 
Grb2 and spectrin into fibroblast cells are two examples (Wigge et al., 1997).  This shows 
that not all dynamin binding SH3 domains can recruit dynamin to CCPs, suggesting there 
may be core and non-core SH3 proteins involved in endocytosis. 
Amphiphysin was the first SH3 domain protein shown to be involved in recruiting 
dynamin for endocytosis (David et al., 1996; Slepnev et al., 1998).  Amphiphysin has two 
gene products: the brain enriched amphiphysin I and the ubiquitously expressed 
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amphiphysin II (Zhang & Zelhof, 2002; Wu et al., 2009).  The SH3 domain of 
amphiphysin I has a dominant negative effect on endocytosis when transfected into both 
lamprey nerve terminals (lamprey eels are a class of jawless fish) (Shupliakov et al., 
1997) and fibroblast cells (Wigge et al., 1997).  Similarly, transfection of the SH3 of 
amphiphysin II blocks endocytosis in cells (Owen et al., 1998).  However, mutating the 
acidic residues in the SH3 domain n-Src loop that are involved in dynamin binding did 
not elicit such inhibition.  It can be safely assumed that excess free SH3 domain, lacking 
the rest of the amphiphysin modules, sequesters dynamin into the cell cytosol and thereby 
disrupts specific recruitment.  Many other studies of dynamin localisation have utilised 
SH3 domain deletion, over-expression and knock-downs.  While widely cited, such 
approaches do not necessarily reveal whether the observed effect on endocytosis is 
specific to the SH3-dynamin PRD interaction, since these studies typically do not show 
the dynamin is the sole binding target of these SH3 domains.  For example, some 
competing proline-rich peptides used in such studies have been shown to be highly 
promiscuous blockers of multiple SH3 domain-mediated interactions in cells (Anggono 
& Robinson, 2007), suggesting strong off-target potential. 
Endophilin is another key endocytic protein which binds dynamin through its SH3 
domain and which has a strong dynamin localisation action (Sundborger et al., 2011; 
Kjaerulff et al., 2011).  Blocking this interaction increases the number of constricted 
CCPs in cells, indicating a role at an endocytosis stage before fission (Gad et al., 2000).  
The perturbation of SH3-PRD interaction in this study was achieved by using a short 
synaptojanin-derived proline peptide, PP19, which is claimed to selectively inhibit the 
endophilin-dynamin interaction, partly overcoming the specificity issues mentioned 
above.  A more detailed study using the same approach showed that selective endophilin-
dynamin disruption reduces the amount of dynamin at the vesicle neck and leads to a 
complete block of fission (Sundborger et al., 2011).  Moreover, endophilin was shown to 
localise dynamin to a very restricted part of the invaginating vesicle neck, the bottom of 
the clathrin coat.  With the disruption in binding, there was a decrease in tubulation 
efficiency, which prevents the formation of elongated necks coated with dynamin 
associated with endocytosis. 
Intersectin I is a multi-domain endocytic scaffolding protein found on chromosome 21 
and thus over-expressed in Down syndrome (Pechstein et al., 2010; Tsyba et al., 2011; 
Hunter et al., 2013; Ma et al., 2008).  Its structure includes five tandem SH3 domains 
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(SH3A-SH3E but only four in lamprey species).  In mammals, only three of these, SH3A, 
C and E, bind proteins like dynamin and synaptojanin (Yamabhai et al., 1998).  The role 
of SHB and D is not known but one possibility is an involvement in intramolecular 
interactions with intersectin rather than with an exogenous protein.  These multiple SH3s 
have been proposed to act as platforms for endocytic protein recruitment and there is 
evidence that intersectin SH3s have a unique role in both CME (Simpson et al., 1999; 
Koh et al., 2004; Wang et al., 2008; Rose et al., 2007) and ADBE (Winther et al., 2013).  
For example, KO studies in worms and flies show decreased SV numbers and reduced 
synaptic vesicle recycling (Koh et al., 2004; Wang et al., 2008; Rose et al., 2007).  In 
synapses from lamprey eels, the intersectin-dynamin interaction was acutely perturbed by 
both microinjection of intersectin I specific antibodies and over-expression of the SH3C 
domain (Evergren et al., 2007).  This results in inhibition of SV recycling with change in 
dynamin distribution at CCPs.  Similar studies in mammalian cells show only mild 
endocytic phenotypes in cerebral cortical neurons lacking intersectin I (Yu et al., 2008), 
yet a strong inhibitory effect was found on fast neurotransmitter release at the calyx of 
Held (Sakaba et al., 2013).  Interestingly, intersectin I and the SH3 domain protein 
syndapin I, despite their very different modular composition, are both involved in SV 
recycling evoked by intense stimulation (Andersson et al., 2008; Winther et al., 2013).  
This is in contrast to the amphiphysin and endophilin studies in lamprey synapse 
discussed above, which perturb SV recycling following only mild stimulation 
(Shupliakov et al., 1997; Evergren et al., 2007).  Thus, the endocytic role of intersectin 
may ultimately prove to not be classical CME but another mode such as ADBE. 
The role of intersectin SH3 domains in endocytosis is not limited to its interaction with 
dynamin in neurons.  It plays a broader role in an expanding number of cell signalling 
pathways, including multiple Ras family GTPases, EGFR, JNK, WNKs, aPKC and 
SHIP2 (Hunter et al., 2013).  For example, its interaction with the PRD of the protein Cbl 
triggers EGFR endocytosis (Martin et al., 2006). 
SNX9 is a member of the sorting nexin (SNX) family of proteins (see below for more 
details) and is another major adaptor in endocytosis via its SH3 domain.  The use of SH3-
deleted SNX9 constructs and RNAi interference revealed its requirement for dynamin 
recruitment to the membrane (Lundmark & Carlsson, 2003; Lundmark & Carlsson, 
2004).  In neuronal cells, overexpression of the SNX9 SH3 domain reduced the rate of 
endocytosis (Shin et al., 2007).  SNX18, another SH3 domain containing member of the 
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SNX family, was shown to share a redundant role with SNX9 in regulating endocytosis at 
the plasma membrane (Park et al., 2010). 
Taken together, these studies show a range of different SH3 domain proteins function 
to regulate the concentration of dynamin at the endocytic site.  Studies in this thesis will 
further explore these interactions to better understand their consequence for dynamin 
function.  However, the studies also highlight redundancy in the molecular mechanisms 
involved in this process, revealing subtleties in SH3 domain function, which are not yet 
fully understood.  The studies show endocytosis to be a complex process with the need 
for different SH3 domain proteins at different stages.  The existence of multiple 
endocytic modes also means that dissection of the precise role of each SH3 protein 
remains challenging. 
 
1.2.2.3 SH3 domain proteins and membrane remodelling 
Many SH3 domain proteins also contain the lipid binding BAR domain (Ren et al., 
2006; Frost et al., 2009; Rao & Haucke, 2011; Daumke et al., 2014), including 5 that are 
part of this study (Figure 1.9).  This domain provides both further specificity of subcellar 
dynamin localisation and confers on the host protein the ability to remodel membranes to 
assist the lipid bending required for endocytosis.  The BAR domains are found in a broad 
array of proteins, many of which are also SH3 domain-containing proteins.  Based on 
structure and function, there are several BAR domain subfamilies; the classical BAR, the 
N-terminal amphipathic α-helix BAR (N-BAR), the BAR-Pleckstrin Homology (BAR-
PH), the PhoX-BAR (PX-BAR), the Fes-CIP4 homology BAR (F-BAR) and the inverse-
BAR (I-BAR) domain (Frost et al., 2009; Saarikangas et al., 2009; Aspenstrom, 2009).  
They have elongated, crescent-shaped structures, with a set of positive residues on one 
surface which senses and binds with negatively charged curved lipid membranes, 
particularly those enriched with PI(4,5)P2 (Peter et al., 2004; Di Paolo & De, 2006).  The 
BAR domains undergo dimerization and in addition to sensing curvature are themselves 
involved in the membrane remodelling which is necessary for endocytosis (Antonny, 
2006). 
An important property of BAR domains in vitro is their ability to induce tubulation of 
liposomes through assembly of the BAR domain proteins into a filament (Peter et al., 
2004; Itoh et al., 2005).  BAR domain filaments are tip-to-tip oligomers involving 
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intensive hydrogen-bonding and ionic interactions between the neighbouring symmetry-
related dimers (Shimada et al., 2007; Frost et al., 2008).  Dynamin also tubulates 
liposomes but BAR proteins do not appear to mediate lipid fusion or fission on their own.  
Dynamin assembly into helices around liposomes enhances its GTPase activity.  The 
simultaneous addition to liposomes of BAR domain proteins amphiphysin I and formin 
binding protein 17 (FBP17) with full-length dynamin produces a hybrid dynamin helix 
with dramatically altered diameter and pitch, indicating a cooperative action of 
BAR+SH3 domain proteins and dynamin oligomerisation (Takei et al., 1999; Itoh et al., 
2005).  This is accompanied by synergistic stimulation of dynamin GTPase activity in the 
presence of endophilin II or SNX9 proteins (Soulet et al., 2005; Ross et al., 2011).  This 
in vitro enhancement of the GTPase activity by the BAR+SH3 proteins mimics the 
destabilisation of the membrane associated with the fission step of endocytosis. 
While the SH3 domain is necessary for interaction with dynamin, it may not always be 
involved in recruitment or targeting.  For example, the BAR domain of endophilin is 
unique in being able to be recruited to the base of the CCPs even when the SH3 domain 
has been deleted (Milosevic et al., 2011).  This indicates that the endophilin SH3 is not 
required for targeting endophilin to the membrane.  However, the disruption of 
endophilin BAR dimerisation by an L215D mutation results in changes not just in 
membrane deforming activities but also the binding partnership of endophilin SH3 
domain to dynamin (Gortat et al., 2012).  Liposome binding assays showed the 
destabilisation of the BAR domain reduces SH3 binding to a well characterised partner 
such as dynamin.  This is indicative of a functional relationship between the BAR and 
SH3 domains where the BAR is therefore required for localisation and the SH3 for other 
interactions. 
 
1.2.2.4 SH3 domains and actin dynamics in endocytosis 
Many of the SH3 domain-containing proteins interact with the cellular actin 
cytoskeleton, some relatively directly and others indirect.  The actin cytoskeleton is 
involved in a number of cellular processes such as cytokinesis, cell motility and 
determining cell shape.  There is considerable evidence for the involvement of actin in 
regulating endocytosis.  Many actin regulators directly or indirectly interact with 
dynamin, suggesting dynamin-actin cooperativity occurs during the late stages of CME 
(Menon & Schafer, 2013).  Actin and the force generated by its ATP-hydrolysis activity 
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are thought to contribute to membrane invagination and constriction of the vesicle neck 
(Kaksonen et al., 2006; Fricke et al., 2010).  The invagination of CCVs is immediately 
preceded by a burst of transient actin assembly followed by dynamin recruitment 
(Grassart et al., 2014).  This indicates a precise temporal and quantitative regulation of 
dynamin recruitment influenced by actin polymerisation.  Disruption of actin 
polymerisation with latrunculin B results in a dramatic reduction in membrane scission 
(Merrifield et al., 2002; Taylor et al., 2011).  The role of actin in CME appears to result 
from production of membrane tension (Boulant et al., 2011), which in turn, is a known 
determinant in optimal dynamin-mediated membrane fission in vitro (Morlot et al., 
2012). 
Actin involvement in endocytosis requires it to polymerise into branched F-actin, 
proximal to the plasma membrane, which is mediated by nucleation factors and motors 
(Kaksonen et al., 2005).  The primary actin nucleation factor at the membrane is the 
Arp2/3 complex which is activated by N-WASP or Cordon-bleu (among others such as 
formins, Ena/VASP, spire and Lmod) (Anitei & Hoflack, 2012; Ahuja et al., 2007; 
Takenawa & Suetsugu, 2007).  Upstream of all this, actin dynamics is regulated by SH3 
domain-containing proteins which are implicated in activating N-WASP (Caron, 2002).  
The SH3 domains of several endocytic proteins bind the PRD in N-WASP (Qualmann et 
al., 1999; Tsujita et al., 2006; Yamada et al., 2009b).  This binding is thought to relieve 
N-WASP from its inactive, auto-inhibited, conformation and contribute to the Arp2/3-
mediated activation of actin dynamics.  For example, the SH3 of SNX9 is involved in 
actin dynamics (Yarar et al., 2007) and is discussed further in Section 1.3.2. 
Other BAR and SH3 domain containing proteins also nucleate actin via N-WASP.  
These include syndapin, FBP17 and Cdc42 interacting protein 4 (CIP4), which can 
recruit N-WASP to membrane tubules in cultured cells and activate actin polymerisation 
(Kessels & Qualmann, 2002; Itoh & De Camilli, 2006; Tsujita et al., 2006).  The 
evidence for a number of BAR-SH3 proteins being involved in N-WASP mediated actin 
dynamics indicates interplay between membrane deformation and actin assembly. 
The mechanism by which the BAR domain could be involved in this process remains 
unknown.  One possible explanation could lie in the ability of BAR domains to form 
homo- or heterodimers.  The dimerisation of full-length proteins would also result in the 
dimerisation of the associated SH3 domains and dimeric SH3 domains have been 
demonstrated to relieve N-WASP auto-inhibition more efficiently than monomeric SH3 
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domains (Padrick et al., 2008).  Additionally, there is evidence showing FBP17 and 
Toca1 stimulate N-WASP-dependent actin dynamics in the presence of membranes of a 
specific curvature (Takano et al., 2008).  This indicates the BAR domain proteins induce 
curvature-dependent actin polymerisation in coordination with their SH3 domains. 
While the above the studies demonstrate the involvement of SH3 domain proteins in 
actin dynamics, the link to endocytosis is weaker.  The block in transferrin uptake, 
following syndapin SH3 over-expression, being rescued by N-WASP over-expression, 
demonstrates the evidence for the involvement of syndapin SH3/N-WASP interaction in 
endocytosis (Kessels & Qualmann, 2002).  Rather than showing the importance of actin 
dynamics, this could simply indicate N-WASP sequestering a certain amount of the SH3 
and relieving the dominant negative effect of SH3 over-expression. 
How does one SH3 domain regulate multiple binding partners?  Most SH3 domains 
shown to bind dynamin, also bind N-WASP (and other common proteins such as 
synapsin and synaptojanin) (Qualmann & Kelly, 2000).  If engaged in an interaction with 
N-WASP how could an SH3 domain protein regulate the PRD of dynamin at the same 
time?  There could be sequential shift between the role of SH3s in recruiting and 
assembling dynamin to the activation of N-WASP or there could be separate pools of 
SH3 domain proteins for these separate interactions.  A co-expression/rescue experiment 
for SNX9-SH3 in hippocampal neurons showed N-WASP to rescue the endocytic defect 
by less than 30%, in contrast to co-expression of the dynamin PRD which resulted in full 
rescue of endocytosis (Shin et al., 2007).  This indicates that SH3/N-WASP complex 
mediated actin dynamics makes only a minor contribution to endocytosis compared to the 
interaction with dynamin. 
Cortactin and Abp1 are two non-BAR SH3 domain proteins which overcome some of 
the above problems by regulating actin dynamics independently from their SH3 domain.  
The SH3 domain of Abp1 also relieves N-WASP auto-inhibition but the role of this 
interaction in actin dynamics relates to neuro-morphogenesis rather than endocytosis 
(Pinyol et al., 2007).  However, mammalian Abp1 is recruited to areas of actin dynamics 
in cells and there is evidence for direct F-actin binding to regulate the role of Abp1 in 
endocytosis (Kessels et al., 2000).  Thus, the endocytic block caused by Abp1-SH3 
overexpression can be rescued by the gradual re-addition of the actin binding module of 
Abp1 (Kessels et al., 2001).  This indicates a physical and functional link between the 
actin cytoskeleton and endocytosis mediated by Abp1. 
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Cortactin is not known to bind N-WASP but it synergistically stimulates Arp2/3 by 
competing with N-WASP for direct Arp2/3 binding (Weaver et al., 2002).  Cortactin has 
an N-terminal acidic domain that binds to Arp2/3 complexes, F-actin-binding cortactin 
repeats and a C-terminal SH3 domain.  It is therefore capable of more direct actin 
regulation.  Microinjection of anti-cortactin antibody or cortactin SH3 transfection 
disrupts CME (Cao et al., 2003).  Furthermore, cortactin associates with the Arp2/3 
complex as well as actin filaments associated with CCPs (Cao et al., 2003; Yamada et al., 
2013; Kaksonen et al., 2000).  Cortactin promotes actin polymerisation by directly 
associating with the Arp2/3 complex (Uruno et al., 2001; Weaver et al., 2001).  The 
binding of cortactin to Arp2/3 in the presence of polymerised F-actin improves its affinity 
for dynamin by more than 7 fold (Zhu et al., 2005).  Upon exposure to cytochalasin D in 
vivo, the previously observed co-localisation of cortactin and dynamin is abolished.  
Similarly, cortactin lacking the Arp2/3 binding module does not co-localise with dynamin 
and reduces CME.  Therefore, Arp2/3-mediated actin dynamics regulates endocytosis by 
modulating cortactin accessibility to dynamin. 
Dynamin interacts directly with actin and promotes further F-actin polymerisation 
under the appropriate in vitro conditions, in the absence of any SH3 domain protein (Gu 
et al., 2010; Yamada et al., 2013).  There is increasing evidence that this property of 
dynamin could be modulated by its GTPase activity with the kinetics of actin recruitment 
at the site of scission being regulated in a GTPase-dependent manner (Taylor et al., 
2011).  This raises the unexplored possibility that the mechanism of actin regulation by 
dynamin might be regulated by SH3 domains, which are known to stimulate dynamin 
oligomerisation and GTPase activity.  Some evidence for this comes from a study 
showing the interaction between cortactin and dynamin resulting in the formation of F-
actin bundles in growth cone filopodia (Yamada et al., 2013).  This is assosciated with 
the actin polymers being stabilised by cortactin mediated dynamin GTP hydrolysis.  This 
is a potentially novel means of actin dynamics regulation mediated by dynamin-SH3 
domain interactions. 
 
1.2.2.5 Scaffolding role of SH3 domain proteins 
SH3 proteins act as adaptor proteins by mediating protein-protein interactions apart 
from dynamin.  The functional diversity of individual SH3 domains arises from its ability 
to coordinate its activity with those of other protein binding modules within the target 
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protein or within its own host protein.  In other words, the SH3-PRD interaction between 
a pair of proteins brings together additional functional modules within these two host 
proteins.  Scaffolding acts as general description for the endocytic functions of SH3 
domains distinct from membrane remodelling and actin dynamics. 
Intersectin is regarded as a classical scaffolding protein.  It acts as a cargo receptor in 
CME by binding the adaptor complex AP-2 at the linker region between its SH3A and 
SH3B (Pechstein et al., 2010).  Perturbing this interaction with specific antibodies to this 
region blocks SV recycling and produces large membrane expansions indicative of 
inhibition early on during endocytosis.  The SH3A domain of intersectin associates in 
vivo with synaptojanin at a site in proximity to the SH3A-B linker region (Evergren et al., 
2007).  It is therefore not surprising that AP-2 impairs synaptojanin binding and suggests 
a role for intersectin in the later stages of vesicle formation in common with other 
synaptojanin binding SH3 domain proteins (Pechstein et al., 2010). 
SH3 domain interaction with synaptojanin is another example of the scaffolding 
function of these domains.  SH3 domains of amphiphysin, endophilin and SNX9 bind the 
polyphosphoinositide phosphatase synaptojanin at distinct sites within in its PRD (De 
Heuvel et al., 1997; Cestra et al., 1999; Yeow-Fong et al., 2005).  The physiological 
significance of this interaction for amphiphysin and SNX9 has not been determined but, 
since synaptojanin has been implicated in progression and maturation of SVs by priming 
them for uncoating clathrin, they could somehow be coordinating this process.  
Endophilin on the other hand has been implicated in vesicle uncoating by co-localising 
with synaptojanin in vivo.  The knock-down of endophilin resulted in no synaptojanin 
being recruited to the site of endocytosis (Milosevic et al., 2011).  Moreover the 
disruption of endophilin function results in the accumulation of CCVs rather than CCPs, 
which is the same phenotype observed in synaptojanin KO (Schuske et al., 2003; 
Verstreken et al., 2003; Hayashi et al., 2008; Milosevic et al., 2011). 
 
1.2.2.6 Regulation of SH3 domain activity 
The interactions of SH3 domains with protein and lipids are regulated by a number of 
means, the most notable being phosphorylation.  Among the best established phospho-
dependent interaction involving the SH3 domain is the specific association of syndapin to 
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dephosphorylated dynamin (Anggono et al., 2006).  This interaction has functional 
significance since it is required to elicit the ADBE pathway (Clayton et al., 2009). 
The SNX9 SH3 is phosphorylated on the residue Y56 by the tyrosine kinase Ack2 
(activated Cdc42-associated tyrosine kinase 2) and dimerisation of SNX9 BAR is 
required for this modification (Worby et al., 2001; Childress et al., 2006).  
Phosphorylation blocks SH3 binding to proline-rich motifs and has the unusual effect of 
switching its binding preference from N-WASP to the adaptor protein Nck.  The 
functional significance of this modification seems to be to trigger the degradation of the 
EGF receptor (Lin et al., 2002; Childress et al., 2006). 
An interesting regulation of the BAR domains has been demonstrated for syndapin, 
where the C-terminal SH3 domain folds back and forms intramolecular interaction its N-
terminal BAR domain (Rao et al., 2010).  This intramolecular interaction has the effect of 
regulating syndapin-induced membrane tabulation and competition for syndapin by 
dynamin releases this autoinhibitory effect (Rao et al., 2010).  It is not known whether 
any cellular signalling pathways are involved in regulating this syndapin intra-molecular 
interaction.  The endophilin BAR domain activity is regulated by LRRK2, a kinase 
assosciated with Parkinson’s disease (Matta et al., 2012; Arranz et al., 2014).  
Phosphorylation of the BAR domain at two residues, T73 and S75, has profound 
implications for endophilin mediated membrane tubulation both in vitro and in vivo and, 
consequently, for the role of endophilin in SVE. 
Another way SH3 domains may be regulated is via intracellular Ca2+ levels.  This was 
revealed in a series of studies with endophilin SH3 domain.  Ca2+ signalling regulates the 
binding of the SH3 domain to an internal PxxP motif within endophilin itself (Chen et al., 
2003).  At low Ca2+ concentrations (<1 µM), this intramolecular interaction is weak and 
endophilin is in an open mode, allowing its SH3 to interact with external PRD containing 
proteins such as dynamin.  With an influx of Ca2+ into the cell, endophilin switches to its 
closed conformation, blocking external protein interactions (Chen et al., 2003).  Ca2+-
dependent modal switching of endophilin allows it to regulate endocytosis (Zhang et al., 
2012b).  Endophilin is also autoinhibited via dimer formation.  Thus, endophilin dimers 
lacking the SH3 domain dissociate more rapidly, suggesting that SH3 domain interactions 
regulate the proteins activity, with the inhibition being relieved in the presence of SH3 
binding ligands such as dynamin (Westphal & Chandra, 2013; Chen et al., 2014b). 
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1.3 Sorting nexin (SNX) family – focus on SNX9 
Emphasis is placed in this thesis on the SH3 domain of SNX9, since this proved to be 
the most functionally significant in terms of dynamin stimulation among those 
investigated in this project (Chapters 4 and 5).  In this section the function and properties 
of SNX9 are reviewed. 
The sorting nexin (SNX) family is a group of loosely related proteins which all contain 
the PhoX-homology (PX, with PhoX derived from phagocytic oxidase) domain (Cullen, 
2008).  There are 49 diverse proteins in the mammalian genome containing the PX 
domain.  Among them, at least 33 belong to the SNX family (Seet & Hong, 2006; 
Teasdale & Collins, 2012).  A phenogram (a diagram depicting taxonomic relationships) 
of the proteins in the SNX family is shown in Figure 1.10A.  The PX domain was initially 
discovered as a conserved motif of 70-110 amino acid residues (Ponting, 1996).  It is a 
lipid binding domain for phosphoinositides (PIs) which show a particular preference to 
bind phosphatidylinositol 3-phosphate (PI(3)P) (Yu & Lemmon, 2001). 
The functional versatility of the SNX family proteins arises from the associated 
domains apart from the PX domain.  Twelve of the 33 mammalian SNXs contain the lipid 
binding BAR domain and are grouped together as the PX-BAR sub-family.  The presence 
of the BAR domain broadens the ability of these SNXs to bind a wide range of PIs 
(Carlton et al., 2004; Carlton et al., 2005), enhancing its membrane attachment specificity 
and, by extension, its involvement in diverse membrane trafficking events (Habermann, 
2004; Itoh & De Camilli, 2006; Zimmerberg & McLaughlin, 2004).  The ‘yoke domain’ 
(Yn and Yc) which is located on either side of the PX domain in the SNX9 primary 
structure, interconnects the PX and BAR domains to form a single large membrane 
remodelling unit. 
The PX-BAR family can be classified further on the basis of any additional domain.  
One such group relevant to this thesis is the SNX9 sub-family.  Its three members, SNX9, 
SNX18 and SNX33, all have a low complexity (LC) domain and an SH3 domain in 
addition to the PX and BAR domains (Haberg et al., 2008) (Figure 1.10B). 
 
1.3.1 Sorting nexin 9 (SNX9) and endocytosis 
Due to the ability of SNX family proteins to form varied protein-protein complexes 
and to bind specific lipids, they have been implicated in regulating protein sorting in the 
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endosomal pathway.  Thus, most of the family members function in different trafficking 
pathways in cells.  SNX9 is a prime candidate for coordinating dynamin-mediated 
membrane scission and actin dynamics (Haberg et al., 2008; Kanai et al., 2001).  SNX9 
is known as an endocytic protein that participates in CME, where its role is to interact 
with dynamin, clathrin and AP-2 to promote vesicle scission (Lundmark & Carlsson, 
2003; Lundmark & Carlsson, 2004; Soulet et al., 2005).  TIRF microscopy has shown 
that SNX9 is recruited to the CCP late in CME (Soulet et al., 2005), peaking shortly after 
scission (Taylor et al., 2011).  This recruitment pattern is quite different from that of 
dynamin, the main binding partner for the SNX9 SH3 domain, clouding its precise 
endocytic role. 
Full-length SNX9 stimulates dynamin GTPase activity in vitro by stimulating its 
assembly (Soulet et al., 2005).  This stimulation occurs in the presence of physiological 
concentrations of salt (150 mM KCl), highlighting the significance of SNX9’s action.  As 
touched upon in Section 1.2.2.3, there is a functional relationship between the SH3 
domain of SNX9 and its PX-BAR domains in stimulating GTPase activity.  This was 
demonstrated by a real-time fluorescence study of dynamin membrane interaction where 
the addition of full-length SNX9 to dynamin, pre-incubated with PI(4,5)P2, enhances 
dynamin assembly and membrane binding (Ramachandran & Schmid, 2008).  When the 
same assay was performed in the presence of both SH3-deleted SNX9 and SNX9 SH3 
alone, it did not result in a similar enhancement.  Thus, SNX9 SH3 is necessary but not 
sufficient for stabilising dynamin assembly.  Further evidence for the association between 
SNX9 SH3 and its lipid binding domains comes from mutations in these domains 
resulting in diminished SNX9-stimulated GTPase activity (Yarar et al., 2008).  The PX-
BAR domains, independently of the SH3, also play a role in reshaping the membrane and 
have been implicated in yielding a narrow tubular structure at the invaginating vesicle 
neck (Lundmark & Carlsson, 2009; Haberg et al., 2008; Takenawa & Suetsugu, 2007). 
The LC domain of SNX9 is largely without an ordered secondary structure and 
contains the binding motifs for several proteins including clathrin, Arp2/3 and aldolase 
(Lundmark & Carlsson, 2003).  This domain is proposed to be a major determinant for 
targeting SNX9 to the CCP and may regulate how SNX9 interacts with the clathrin coat 
(Lundmark & Carlsson, 2009).  This domain also binds the glycolytic enzyme aldolase 
which blocks localisation of the SNX9-dynamin complex to the endocytic site (Lundmark 
& Carlsson, 2004).  This may result from mutually exclusive binding of AP2 and aldolase 
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(Rangarajan et al., 2010).  Although aldolase is a glycolytic enzyme it has now been 
found to interact with a variety of trafficking or endosomal proteins such as 
phospholipase D (Kim et al., 2002) and V-ATPase (Lu et al., 2004) and is enriched in 
synaptosomes (Knull, 1978; Knull & Fillmore, 1985) where it binds to SVs (Bahler et al., 
1991).  The data indicate a role for SNX9 in regulating endocytosis and linking dynamin 
and SNX9 to aldolase-dependent metabolic pathways. 
 
1.3.2 Role of SNX9 in actin remodelling 
SNX9, in common with other SH3-BAR proteins as discussed in Section 1.2.2.4, is 
involved in actin dynamics by activating N-WASP with which SNX9 lacking the SH3 
domain is unable to interact (Yarar et al., 2007).  Direct interaction between the SNX9 
SH3 alone and N-WASP was demonstrated, using in vitro fluorometric assays, to be 
sufficient to stimulate actin assembly.  The importance of lipid binding domains in SNX9 
SH3/N-WASP mediated actin dynamics is indicated by their synergistic effect on actin 
stimulation when the above experiment is performed in the presence of the lipid 
PI(4,5)P2 (Yarar et al., 2007).  Maximal actin assembly is only achieved with full-length 
SNX9 which contains the lipid binding PX-BAR domains (Yarar et al., 2008).  This 
suggests N-WASP binding to the SH3 domain to be necessary but not sufficient for actin 
stimulation.  SNX9 mediated actin polymerisation is very efficient and specific to the 
membrane lipid PI(3)P compared to the phosphoinositides which can utilise other 
adaptors such Toca-1 (Gallop et al., 2013).  These results point to a role for actin 
polymerisation in the scission of the invaginating vesicle neck at CCPs which could be 
mediated by SNX9. 
SNX9 has been implicated in endocytosis-independent actin dynamics by being shown 
to localise with N-WASP at peripheral ruffles and dorsal rings (Yarar et al., 2007).  
Mutations in PX and BAR domain did not have any effect on the localisation, suggesting 
that the SH3 domain is sufficient for enriching N-WASP at sites of actin dynamics.  
SNX9 can also bind Arp2/3 directly through its LC domain and it is therefore possible 
that the SNX9-Arp2/3 interaction may play a role in localisation and stabilisation of 
nucleated actin (Yarar et al., 2007; Shin et al., 2008). 
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1.3.3 Role of SNX9 in mitosis 
Mitosis is the other cellular function, alongside endocytosis and actin dynamics, in 
which SNX9 plays a role.  SNX9 is a major binding partner of dynamin II and clathrin, 
both of which are implicated at different stages of mitosis.  SNX9 functions during 
metaphase in an endocytosis-dependent manner, where it recruits clathrin heavy chain 
and transforming acidic coiled coil protein 3 (TACC3) to mitotic spindles to maintain 
spindle stability (Ma et al., 2013).  Knock-down of SNX9 leads to defects in mitotic 
spindle formation by disrupting clathrin heavy chain and TACC3 targeting to the mitotic 
spindle, leading to chromosome mis-alignment and mis-segregation.  SNX9 is also 
involved in the formation of the mitotic spindle by mediating kinetochore fibre (K-fibre) 
organisation and microtubule polymerisation (Ma et al., 2013). 
Apart from the spindle, there is also a role for SNX9 at the cytokinesis step in mitosis, 
where it is involved in the recruitment of the Golgi to the intracellular bridge (Ma & 
Chircop, 2012).  Additionally, it has been implicated in regulating recycling endosomes 
and Golgi trafficking during cytokinesis.  All three SNX9 subfamily members contribute 
to the final phase of cytokinesis by activating the actomyosin II contractile ring during 
ingression and through their involvement in membrane trafficking during abscission (Ma 
& Chircop, 2012). 
Overall SNX9 is a multifunctional protein with diverse roles in cellular functions that 
mostly appear to overlap with the broad cellular roles of dynamin. 
 
1.4 Aims of the thesis 
A diverse subset of the ~300 proteins containing SH3 domains strongly interact with 
dynamin and are thought to be involved in endocytosis.  Due to other protein modules 
present within the 11 proteins comprising this sub-set, they can be further classified as 
linking dynamin to membrane remodelling, protein scaffolding, or to actin dynamics.  
Since some of the SH3 domains from each class expressed as recombinant GST-fusion 
proteins stimulate dynamin oligomerisation into rings and potently stimulate its GTPase 
activity, it is widely assumed that all dynamin-binding SH3 domain proteins regulate 
dynamin oligomerisation and activity.  However, each SH3 domain has been 
inconsistently studied in isolation from the others and sometimes as part of the full-length 
protein and sometimes as a free domain.  Therefore, the primary aim of the work in this 
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thesis was to systematically compare the SH3 domains for their ability to stimulate 
dynamin oligomerisation and GTPase activity.  It was proposed that those with the 
greatest activity would then be systematically examined in the same cell for their role in 
CME. 
However, the surprising outcome of Aim 2 that the GST expression tag was 
systematically producing artefactual dynamin stimulation led to a change in project focus.  
The results of Chapter 4 revealed that upon removal of the GST-tag the stimulation of 
dynamin by each SH3 domain was abolished, except for that of SNX9 SH3.  The 
subsequent aim therefore was to characterise the interaction of SNX9 SH3 with dynamin 
and to identify its binding site on dynamin.  The four specific aims of this study are as 
follows: 
• Undertake a systematic comparison of a library of 13 GST-SH3 domains to 
stimulate dynamin, to determine the most potent regulator of dynamin 
oligomerisation and GTPase activity (Chapter 3). 
• Compare the action of each SH3 domain on dynamin after removal of the GST 
expression tag (Chapter 4). 
• Characterise of the effect of SNX9 SH3 domain on dynamin oligomerisation and 
GTPase activity (Chapter 4). 
• To map the SNX9 binding site within the dynamin I PRD and determine any 
phosphorylation dependent binding (Chapter 5).  Identification of the SNX9-
binding motif would allow the design of future dynamin mutants specifically 
altered in this ability. 
  
Figure 1.1: Domain structure of dynamin family.
All members of dynamin family of large GTPase enzymes consist of 3 conserved
domains: GTPase domain (or G domain) which is involved in GTP binding and
hydrolysis, a middle domain (or stalk) and a GTPase effector domain (GED) both
involved in assembly. It is only the three classical dynamins which contain the
Pleckstrin Homology (PH) domain involved in membrane binding and the
proline/arginine-rich domain (PRD) which interacts with Src-Homology 3 (SH3)-
domain containing proteins. The mitofusin, optic atrophy 1 (OPA1) and atlastin
sub-families have predicted transmembrane domains to insert into different lipid
bilayers. Other proteins in the dynamin family, in addition to classical dynamin,
include dynamin-like protein (DLP), myxovirus resistance protein A and B (MxA
and MxB) and guanylate binding protein 1 (GBP1). Figure adapted from (Praefcke
and McMahon, 2004).
Classical dynamin (Dynamin I, II and III)
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Figure 1.2: Modes of endocytosis at the synaptic nerve terminal
Schematic of the pre-synapse (or nerve terminal) showing the life cycle of
synaptic vesicles. Most synaptic vesicles are functionally (not physically) divided
into different compartments. The fusion of vesicles by exocytosis leads to vesicle
retrieval by three different modes of endocytosis: clathrin-mediated endocytosis
(CME), activity-dependent bulk endocytosis (ADBE) and Kiss-and-Run. CME
and ADBE are mediated by dynamin which wraps around the collar of the
invaginating membrane and pinches it off. The mechanism of Kiss-and-Run is
largely obscure since the vesicle is pinched off without collapsing onto the
membrane but dynamin is involved in this process in non-neuronal cells. Other
distinct properties of the modes are shown below. (Diagram drawn by Prof. Phil
Robinson for general use).
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Figure 1.3: Sequential stages in CME and the proteins involved
CME involves the coordinated action of many endocytic proteins, each with roles
presumed to be in sequential stages of the process.
1) Nucleation (Initiation): AP-2 (adapter protein complex-2, 4 subunits) is the first
protein attracted to new sites of endocytosis at the plasma membrane by binding to the
lipid PI(4,5)P2. It then recruits clathrin from the cytosol via its α subunit, with a build-up
of clathrin commencing. The other major adapter protein is CALM/AP180 (clathrin
assembly lymphoid myeloid leukemia protein, gene name PICALM; and its neuronal
isoform clathrin assembly protein 180).
2) Assembly and Sorting: AP-2 and CALM/AP180 now coordinate clathrin lattice
assembly using multiple clathrin binding motifs to manipulate multiple clathrin triskelia
into position to create a lattice. Cargo proteins and extra adaptors start being recruited by
AP-2 and the globular N-terminal domain of clathrin heavy chain. The tasks of cargo
selection are distributed between AP-2 and CALM. Different AP-2 subunits bind short
amino acid motifs in an array of receptors and other proteins to guide them to the vesicle,
while CALM sorts vesicle fusion machinery components, VAMPs, into the new vesicle.
3) Budding: The clathrin lattice grows into a vesicle coat (clathrin-coated pit or CCP) as
more components are recruited to achieve fission. Multiple adaptor proteins containing
both BAR and SH3 domains are involved in recruiting dynamin and shaping the neck of
the vesicle at this point, although their precise functional roles are still indistinct. The
endocytic checkpoint operates at this stage and the CCP will not proceed to fission if
dynamin is not recruited.
4) Fission: At this point dynamin oligomerisation and GTPase activity cause fission of
the vesicle neck and clathrin-coated vesicle (CCV) release.
5) Uncoating: The lipid phosphatase synaptojanin (synj) triggers uncoating of the new
vesicle, which is mediated by the kinase GAK and by auxilin, which activate Hsc70 to
break apart the clathrin lattice, releasing an uncoated vesicle into the cytoplasm to target
endosomes.
Drawn by Prof. Phil Robinson and updated by Dr. Mark Graham.
Other abbreviations: BAR, BinI–Amphiphysin–Rvs167; GAK, G-associated kinase ;
Hsc70, heat shock chaperone 70; SH3, Src-homology 3; VAMP, vesicle associated
membrane proteins.
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Figure 1.4: Dynamin domain structure and assembly
(A) Line diagram of the common domain structure of the three classical dynamins.
There were major changes to the domain allocation based on the crystal structure of
dynamin I in 2011, in particular the location of the Bundle Signalling Element (BSE)
and recognition that the GTPse Effector Domain (GED) comprises two subdomains that
contribute α-helices to other modules. (B) The dynamin I dimer crystal structure which
is colour-coded based on the line diagram in (A). The dimer consists of two monomers
(indicated by the dotted line) and is a full-length human dynamin I lacking the proline-
rich domain (PRD) (Faelber et al., 2011). A ‘side-on’ view reveals the dimer to have a
GTPase (G domain, orange) surface separated from the pleckstrin homology domain
(PH, green) by the middle domain (light blue) and the bundle signalling element (BSE
in red). The spliced α2 helix of the middle domain is coloured a slightly darker blue
and comprises a complete α-helix. Note that the proline-rich domain (PRD, pink) was
not present in the crystal structure but would be oriented across the G domain since it
starts from the end of the last helix of the BSE. The original data for these images are
from PDB Accession number: 3SNH and the structures drawn by PyMol. The dynamin
dimer is the building block for oligomerised dynamin, with 12-14 dimers forming a
ring (C) or thousands involved in helices (D). The EM images are from Dr. Nick
Gorgani and Dr. Anna Mariana of our group.
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Figure 1.5: Dynamin I-linked disease mutations 
Five sporadic mutations in the human gene for dynamin I, DNM1, cause epileptic 
encephalopathies (Appenzeller et al., 2014).  They are shown below the domain 
structure.  These mutations, T65N, A177P, K206N, A237W and G359A, cluster in the 
G domain and middle domain.  Two dynamin I mutations are known in animals.  
A408T in the middle domain µD¶ splice variant is found in the fitful mouse and is 
associated with non-lethal recurrent seizures (Boumil et al., 2010).  R256K is reported 
in Labrador dogs and results in exercise-induced collapse (Patterson et al., 2008). 
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Figure 1.6: Agents required to stimulate dynamin into rings and helices
The common domain structure of the three classical dynamins is shown at the top.
Listed are agents known to stimulate dynamin oligomerisation to form rings (in the
absence of self-assembly at high dynamin concentrations and low ionic conditions) or
helices (helices require the presence of a template like lipids or microtubules around
which they assemble). The two oligomers appear to have different functions. Dynamin
rings have been associated with actin bundling (Gu et al., 2010; Gu et al., 2014) (EM
image is from a manuscript in preparation from our lab by Dr. Nick Gorgani) and
dynamin helices are involved in vesicle fission during endocytosis (EM images are from
(Koenig and Ikeda, 1989; Marks et al., 2001)). The arrow head in the bottom left panel
indicates dynamin rings adjacent to F-actin (EM image is from (Gu et al., 2010)).
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Figure 1.7: Assembly-dependent stimulation of dynamin GTPase
Activity
Dynamin assembly states differ in their specific GTPase activity. Dynamin I (from
sheep brain) GTPase activity is stimulated to significantly greater extent as helix (in
the presence of a phospholipid (PS) liposome template) than as a ring (in the presence
of SH3 domain proteins Grb2 or endophilin I, or by the small molecule dynamin
stimulatory compound Ryngo-1 (also called Bis-T-23) (Gu et al., 2014)). The
dynamin inhibitor dynole 34-2 does not stimulate basal dynamin activity unlike
Ryngo 1-23 which does. (Experiment performed by Sai Krishnan).
Helix
Ring
Figure 1.8: Typical structure of an SH3 domain complexed with a PxxP
peptide from a PRD
Crystal structures are used to illustrate the classical SH domain fold and the target
protein binding site. Shown is the NMR solution structure of p67Phox Src-
Homology 3 (SH3) domain in complex with a PxxP peptide from p47Phox (PDB
Accession number: 1K4U). The SH3 domain is shown in ribbon mode (A) or space
filling mode (B). The SH3 domain shows the typical five anti-parallel β-strands in
green, surrounded by the RT (reverse transcription), n-Src and distal loops. The RT
and n-Src loops provide much of the specificity for binding target peptides with
PxxP sequences. The bound peptide is shown as amino acid sequence but note that
the peptide is bound in the opposite orientation to the sequence.
N_PQPAVPPRPS_C
N-
-C
A.
B.
n-Src loop
distal loop
RT-loop
Figure 1.9: Modular domain structure of proteins with SH3 domains
The Src-Homology (SH3) domain (in green) is a common protein domain and is
present in approximately 300 proteins in the human genome. Shown are a subset of
SH3 domain proteins which bind dynamin at its PRD and which are known to be
involved in endocytosis (some indirectly). SH3 domain containing proteins are
typically multi-domain and are organised in a modular fashion. The other domains play
a role in coordinating SH3 function through their external interactions. The proteins
can be classified by their functional properties (as listed in Table 1.5) which include:
BinI–Amphiphysin–Rvs167 (BAR) mediated membrane remodelling, actin dynamics
and scaffolding. The BAR domain (in pink) plays an important role in the bending of
the membrane (invagination) resulting in membrane curvature. While many SH3
domains are involved in actin dynamics indirectly by binding the actin nucleation
factors, cortactin and actin binding protein 1 (Abp1) have the ability to directly
modulate actin. Intersectin, p85 and Grb2 are scaffolders, which acts as general
description for the endocytic functions of SH3 domain proteins that are distinct from
membrane remodelling and actin dynamics.
Other domain abbreviations: ADFH, Actin-depolymerising factor homology; CLAP,
clathrin and AP-2 binding sites; DH, Dbl homology domain; EH1/2, eps15 homology
1/2 domain; F-BAR, FCH and BAR; PH, pleckstrin homology domain; PRD, proline
rich domain; PX, PhoX-homology domain; SH1/2, src-Homology 1/2.
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Figure 1.10: SNX9 and related proteins.
(A) Phenogram of the broader SNX family proteins, illustrating the degree of
relationship between the various SNX9 proteins. They all have the phosphoinositide
binding PX-BAR domain in common but not all have SH3 domains. (B) Line
diagram illustrating the domain structure of sorting nexin 9 (SNX9) relative to two
proteins that are closely related, SNX18 and SNX33. SNX9 is uncommon in having
the SH3 domain at the N-terminus, followed by a low-complexity (LC) region, with a
Phox homology (PX)-BAR region at the C terminus. The ‘yoke domain’ (Yn and Yc)
located either side of the PX domain, interconnects the PX and BAR domains to form
a single large membrane remodelling unit. All three SNX proteins have the same
domain structure. Modified from (Park et al., 2010).
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CHAPTER 2: Materials and Methods 
 
2.1 Materials 
2.1.1 Protein biochemistry 
Table 2.1: Kits and reagents for protein biochemistry. 
Kits and Reagents Supplier 
10X Tris/Glycine/SDS upper electrode buffer Bio-Rad Lab (Hercules, CA, USA) 
Acrylamide:bisacrylamide (37.5:1) Bio-Rad Lab 
Ammonium persulphate (APS) Bio-Rad Lab 
Ammonium sulphate AMRESCO LLC (Solon,OH,USA) 
Bromophenol blue Bio-Rad Lab 
Calcium chloride (CaCl2) dehydrate Sigma-Aldrich (St Louis, MO, USA) 
Coomassie Brilliant Blue G-250 Bio-Rad Lab 
Complete EDTA-free protease inhibitor tablets Roche Diagnostics (Mannheim, Germany) 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
Dithiothreitol (DTT) MP Biomedicals LLC (Santa Ana, CA, USA) 
Enzyme linked inorganic phosphate assay 
(ELIPA) Kit 
Jomar Bioscience (Kensington, SA, Australia) 
Ethanol (absolute) Merck (Whitehouse station, NJ, USA) 
Ethylene diamine tetra acetic acid (EDTA) AMRESCO LLC 
Ethylene glycol-bis (2-aminoethylether)- 
N,N,N`,N`-tetraacetic acid (EGTA) 
Sigma-Aldrich 
Glutathione (reduced) Merck 
Guanosine-5`-triphosphate (GTP) Roche Diagnostics 
GTP α-32P (3000 Ci/mmol) Perkin Elmer (MA, USA) 
HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) Sigma-Aldrich 
Hydrochloric acid (HCl) Merck 
Leupeptin Calbiochem (Whitehouse station, NJ, USA) 
Lysozyme Roche Diagnostics 
Magnesium chloride (MgCl2) Merck 
Magnesium sulphate heptahydrate Analar (Kilsyth, VIC, Australia) 
Malachite Green 
Ajax Finechem Pty Ltd. (Thermofisher 
scientific, Taren Point, NSW, Australia) 
β-mercaptoethanol Sigma-Aldrich 
Methanol Merck 
Molecular weight standard (high range) Bio-Rad Lab 
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Molecular weight standard (low range) GE Healthcare (Giles, UK) 
 
Phenyl methyl sulfonyl fluoride (PMSF) Sigma-Aldrich 
Phosphate buffered saline (PBS) tablets MP Biomedicals LLC 
L-α-phosphatidyl-L-serine (PS) Sigma-Aldrich,  
1,4-piperazinediethanesulfonic acid (PIPES) Sigma-Aldrich 
Ponceau S Sigma-Aldrich 
Potassium chloride (KCl) Ajax Finechem Pty Ltd. 
Pre-stained SDS-PAGE standards Bio-Rad Lab 
Skim milk powder Fonterra Foodservices 
Sodium chloride (NaCl) Ajax Finechem Pty Ltd. 
Sodium dihydrogen orthophosphate 
monohydrate Merck 
Sodium dodecyl sulphate (SDS) Bio-Rad Lab 
Sucrose Sigma-Aldrich 
Tetra-methyl-elthylenediamine (TEMED) Bio-Rad Lab 
Tris Bio-Rad Lab 
Triton X-100 Merck 
Tween-20 Sigma-Aldrich 
Tween-80 Sigma-Aldrich 
 
Table 2.2: Materials for protein biochemistry. 
Materials Supplier 
Kodak Biomax ML film Sigma-Aldrich 
Amicon Ultra centrifugal filter Millipore (Co. Cork, Ireland) 
Chromatography column (25 ml) Bio-Rad Lab 
Mini BioSpin™ chromatography columns for pull-
down 
Bio-Rad Lab 
MicroSpin columns for pull-down GE Healthcare 
 
Dialysis membrane (10,000 kDa cut-off) Spectrum Laboratories (Rancho 
Dominguez, CA, USA) 
Paper filter/Cellulose acetate spin cups Thermofisher Scientific (Rockford, IL, 
USA) 
Glass-bottomed 96-well plate Matrical Bioscience (Spokane, WA, USA) 
Glutathione Sepharose™ 4B resin GE Healthcare 
 
Nitrocellulose membrane Perkin Elmer (MA, USA) 
Pre-cast mini-protean SDS-PAGE gels (10% 
and 12%) 
Bio-Rad Lab 
SDS-PAGE apparatus (Mini-PROTEAN Tetra 
Cell for Ready Gel Precast Gels ) 
Bio-Rad Lab  
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SuperSignal West Pico chemiluminescence 
substrate 
Thermofisher Scientific (Rockford, IL, 
USA) 
Transfer apparatus (Trans-Blot® Cell) Bio-Rad Lab 
 
All chemicals used were of analytical grade or higher.  All solutions were prepared in 
Milli-Q water (18.2 Ω) which was filtered (0.22 µm) before use. 
 
 
2.1.2 Molecular biology 
Table 2.3: Reagents and kits for molecular biology. 
Reagents and Kits Supplier 
1kb and 100bp molecular weight DNA ladder Promega 
Agarose Promega 
10× PfuUltra II Reaction Buffer Agilent (Santa Clara, CA, USA) 
Ampicillin sodium salt Sigma-Aldrich 
dNTP nucleotide mix Promega 
Dpn1 Promega 
Ethidium bromide Sigma-Aldrich 
Glycerol Ajax Finechem Pty Ltd. 
Isopropanol Sigma-Aldrich 
Isopropyl-β-D-thiogalactopyranoside (IPTG) 
(dioxane free) 
Promega 
LB-Medium Lennox MP Biomedicals LLC 
LB-Agar MP Biomedicals LLC 
PCR purification kits Qiagen (Hilden, Germany) 
PfuUltra II Fusion HS DNA polymerase Agilent  
PureYield miniprep DNA purification system Promega 
PureYield maxiprep DNA purification system Promega 
Restriction enzymes (BamH1 and EcoR1) Promega 
SOC medium Life Technologies (Carlsbad, CA, USA) 
QIAquick gel extraction Qiagen (Hilden, Germany) 
T4-ligase Promega 
 
2.1.3 DNA plasmids 
The plasmid vectors of the proteins used in this thesis are listed in Table 2.4 along 
with their origin.  Ten of these constructs (amphiphysin I/II, endophilin I, syndapin I, 
SNX9, intersectin I A/B/C/D/E and p85) are the SH3 domains of the parent protein.  
These were sequenced at the Australian Genome Research Facility (Sydney node, NSW, 
Australia) for authenticity and mutations before use.  SNX9 SH3 was found to contain a 
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six histidine tag at the C-terminal and stop codons were introduced before this to prevent 
any artefactual effect arising from this tag (see Section 2.2.9.5).  The rest of the plasmids 
were either the full-length form or, in the case of amphiphysin I, contained an extended 
region.  The SH3 domains from these constructs were subcloned into a pGEX vector and 
sequenced before use (see Section 2.2.9.6). 
The DNA sequences of the SH3 constructs listed in Table 2.4 are aligned in Figure 2.1 
and their percentage sequence similarity is presented in Figure 2.2.  The SH3 domains 
intersectin I SH3B and SH3D mentioned here were demonstrated to not bind dynamin 
using pull-down assays (data not shown) and will therefore not be discussed any further. 
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Table 2.4: Plasmid vectors of SH3 domain proteins 
Construct name Length of 
SH3 domain 
(amino acids) 
Vector Species Source 
Amphiphysin I  
(amino acids 545-695) 
608-695 pGEX-2T Human Pietro de Camilli (Yale 
University School of Medicine, 
USA) 
Amphiphysin II SH3 
domain 
262-435 pGEX-2T Human Pietro de Camilli 
Endophilin I SH3 
domain 
292-352 pGEX-2Tk Mouse Peter McPherson (McGill 
University, Canada) 
Syndapin I SH3 
domain 
386-441 pGEX-6P-1 Mouse Markus Plomann (University 
of Cologne, Germany) 
Sorting nexin 9 (SNX9) 
SH3 domain 
1-62 pGEX-6P-1 Human Generated by Maggie Ma from 
SNX9 cDNA supplied by 
Sandra Schmid (The Scripps 
research institute, USA) 
Formin binding protein 
17 (FBP17) Full-length 
(amino acids 1-617) 
536-617 pGEX-6P-1 Human Pietro de Camilli 
Cdc42 interacting 
protein 4 (CIP4)  
Full-length 
(amino acids 1-601) 
539-601 pGEX-6P-1 Human Pietro de Camilli 
Intersectin I SH3A 
domain 
732-793 pGEX-2T X. leavis Peter McPherson 
Intersectin I SH3B 
domain 
897-955 pGEX-2T X. leavis Peter McPherson 
Intersectin I SH3C 
domain 
986-1044 pGEX-2T X. leavis Peter McPherson 
Intersectin I SH3D 
domain 
1058-1122 pGEX-2T X. leavis Peter McPherson 
Intersectin I SH3E 
domain 
1139-1198 pGEX-2T X. leavis Peter McPherson 
Actin binding protein 1 
(Abp1) Full-length  
(amino acids1-436) 
361-436 pGEX-6P-1 Mouse From www.addgene.org 
(Plasmid 26719: pEGFP-C2 
mAbp1) 
Cortactin Full-length 
(amino acids1-546) 
471-546 pGEX-6P-1 Mouse From www.addgene.org 
(Plasmid 26722: pEGFP-C1 
mcortactin) 
p85 SH3 domain 2-83 pGEX-2T Bovine Provided by Dr. Tony Pawson 
(Mount Sinai Hospital, 
Toronto, Ontario, Canada) 
 
Tables 2.5-2.10 list the rat dynamin I PRD constructs which were used for the Western 
blot analysis of SNX9 binding to dynamin (discussed in Chapter 5).  The two dynamin I 
PRD splice variants GST-Xa and Xb, previously described in (Xue et al., 2011), were 
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used to prepare C2, C10 and C7 constructs in Table 2.5 by Dr. Jing Xue and Dr. Lin Luo 
from the Cell Signalling Unit at the CMRI.  The mutants in the Tables 2.6 and 2.7 were 
generated by Dr. Victor Anggono from the Cell Signalling Unit at the CMRI.  The 
mutants in Tables 2.8-2.10 were generated by Dr. Jing Xue.  Chapter 5 provides the 
figures showing the position of these residues within the dynamin modular structure 
(Figures 5.2-5.9). 
Table 2.5: Rat dynamin I PRD constructs (refer to Figure 5.2 for their location 
within the protein domain structure). 
Dynamin I construct amino acid 
residue range (rat) 
GST-dynamin I PRD 
construct name 
S751- L864 Dynamin I-Xa 
S751-P851 Dynamin I-Xb 
S751-P798 Dynamin I-C2 
G794-L864 Dynamin I-C10 
G794-P851 Dynamin I-C7 (Xb) 
 
Table 2.6: Rat dynamin I PRD GST-Xa mutations in the PxxP and phospho-box-
1 regions (refer to Figures 5.3, 5.4 and 5.5 for their location within the protein).  
Some are single point mutations while others are double. 
Construct name Mutation 
2A P786A/P789A 
2B V788A/P789A 
2C P786A 
2D R783E/R784E 
2E R783A/R784A 
3A R792E/P793A 
3B P793A 
3C R796E 
3D R796A 
PB1 R772A/R773A 
PB2 R772E/R773E 
 
In addition, the mutations T780A and T780E are used alongside PB1 and PB2 in 
Figure 5.5. 
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Table 2.7: Rat dynamin I PRD GST-Xa phosphomimetic mutants in the 4 main 
phosphosites in dynamin I.  S774/S778 are in phospho-box-1 while S851/S857 
are in phospho-box-2 (refer to Figure 5.6 for their location within the protein). 
Construct name Mutation 
GST-Xa S774E/S778E 
GST-Xa S851E/S857E 
C2 S774E/S778E 
C10 S851E/S857E 
 
Table 2.8: Rat dynamin I PRD GST-Xa mutations in the central region of the 
PRD (refer to Figure 5.7 for their location within the protein). 
Mutations in GST-Xa 
G797A 
P798A 
A799G 
P800A 
G801A 
P802A 
G803A 
 
Table 2.9: Rat dynamin I PRD GST-Xa mutations in the long tail (refer to Figure 
5.8 for their location within the protein). 
Mutations 
P852A 
P854A 
P855A 
P858A 
R859A 
P860/P861A 
 
Table 2.10: Rat dynamin I PRD GST-Xa mutations in the common tail (refer to 
Figure 5.9 for their location within the protein). 
Mutations 
P838A 
P840A 
P844A 
P841A/P844A 
R846A 
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2.1.4 Antibodies 
The primary antibody for SNX9 (1:6000 final dilution in PBS containing 1% (v/v) 
Tween 20 (PBST)), was purchased from Proteintech (Chicago, USA).  Anti-SNX9 was 
used at a final dilution of 1:6000 prepared in PBST.  Antibodies that recognise 
amphiphysin I, endophilin I and syndapin I (all 1:2000 final dilutions in PBST) were 
from Santa Cruz Biotechnology (Santa Cruz, CA).  All horse-radish peroxidase (HRP)-
conjugated secondary antibodies (1:10,000 final dilutions in PBST) were from DAKO 
(Carpinteria, CA). 
 
2.2 Methods 
2.2.1 Protein expression and purification 
2.2.1.1 Expression of GST fusion proteins 
The various plasmids listed in Tables 2.4-2.10 were transformed in E. coli (see Section 
2.2.9.2) and stored as glycerol stocks at -80ºC.  Samples from the glycerol stock were 
inoculated in 40 ml of lysogeny broth (LB) media containing ampicillin (100 μg/ml) and 
incubated overnight at 37ºC with shaking at 200 RPM.  The following morning the 
inoculated sample was diluted to a final volume of 400 ml of LB media containing 100 
μg/ml ampicillin.  The culture was incubated with shaking for approximately 2 hours to 
reach an optical density of 0.6-0.9 at 600 nm.  Expression of all the proteins were induced 
by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration 
of 1 mM and the culture was incubated for a further 4 hours at 37ºC with shaking.  The 
bacterial cells were pelleted at 74,368 x g for 10 minutes at 4ºC. 
The expression tag itself, GST, is a 218 amino acid, 26 kDa cytoplasmic protein from 
blood fluke (Schistosoma japonicum) (for the amino acid sequence see GenBank 
Accession P08515 at http://www.uniprot.org/uniprot/P08515).  This represents the only 
sequence used in the experiments in this thesis.  When used in fusion proteins there are 
additional amino acids added to the end of the tail of the native sequence, containing 
different markers or protease cleavage sites depending on the vector used (eg for pGEX-
2T has SDLVPRGSPGIHRD).  These minor sequence differences between the pGEX 
vector series can be found on the supplier’s website (GE Healthcare Life Sciences 
(formerly Amersham Biosciences), http://www.gelifesciences.com/). 
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2.2.1.2 Purification and elution of GST fusion proteins 
The pellets were resuspended in 40 ml of ice cold STE buffer (300 mM NaCl, 10 mM 
Tris final pH 8.0 and 1 mM EDTA) containing 10 μg/ml leupeptin, 1 mM phenyl methyl 
sulfonyl fluoride (PMSF) and 1 EDTA free protease cocktail inhibitor tablet.  The 
resulting suspension was incubated with 6 mg of lysozyme with dithiothreitol (DTT) and 
Triton X-100 added to a final concentration of 1 mM and 1% (v/v) respectively.  The 
suspension was incubated for 20 minutes at 4ºC with rotation followed by two snap 
freeze-thaw cycles and two 1 minute probe sonications (with cooling in between) to 
ensure effective lysis of the bacterial cells.  The lysates were centrifuged at 48,254 x g for 
15 minutes at 4ºC and the supernatant was collected. 
The supernatants containing the expressed GST fusion protein were incubated with 2 
ml of glutathione (GSH) sepharose beads for 1 hour at 4ºC.  The beads, initially stored in 
80% (v/v) ethanol, had been pre-washed twice with TBS (20 mM Tris, 150 mM NaCl at 
pH 7.4) and once with 1% (v/v) Triton X-100.  The mixture was centrifuged at 500 RPM 
(Heraeus Multifuge 3SR) for 5 minutes at 4°C and the supernatant discarded.  The GSH 
sepharose beads with GST fusion proteins bound to them were washed once with TBS 
and then 1.2 M NaCl in TBS.  The beads were then washed twice with TBS before being 
stored in 20 mM Tris pH 7.4 and 20% glycerol at -20ºC as a 50% (v/v) slurry. 
For batch elution GSH sepharose beads with bound GST recombinant protein were 
transferred to a 10 ml Bio-Rad plastic column and incubated six times with 10 mM 
reduced glutathione in 50 mM Tris-HCl, pH 8.0 for 10 minutes at room temperature.  
Aliquots from each fraction were resolved by sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE) on 10% or 12% gels (see Section 2.2.2.1 below) and the 
fractions containing the recombinant protein were pooled.  If the protein was to be 
concentrated, a centricon device (10 kDa or 30 kDa MWCO), was employed.  The eluted 
protein was dialysed overnight in TBS (20 mM Tris, 80 mM NaCl at pH 7.4) to remove 
the glutathione and the samples were aliquoted in microfuge tubes and stored at -80ºC. 
 
2.2.1.3 On-bead GST-tag cleavage 
The GST-tag was used for purification of the protein and in this study it was left in 
place or cleaved off, as required (see Chapter 4).  When removed, it was cleaved off the 
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protein by either PreScission or thrombin protease enzymes, depending on the vector in 
which the protein was expressed.  The GST-removed SH3 proteins will henceforth be 
referred to as CL-SH3s. 
 
PreScission protease cleavage 
The PreScission protease (Pierce Human Rhinovirus 3C) was expressed by IPTG 
induction (Section 2.2.1.1) and the protein purified and eluted from the GSH sepharose 
beads (Section 2.2.1.2).  The purification was performed in the absence of any protease 
inhibitors to prevent them from interfering with PreScission enzyme activity.  The protein 
was dialysed overnight in TBS to remove the glutathione and an equal volume of 100% 
glycerol was added before storing at -80ºC.  On-bead digestion of the GST-tag, on 
proteins expressed in a pGEX-6P-1 vector, was conducted by the addition of 140 μg/ml 
of PreScission enzyme to 100 μl bead volume.  The cleavage reactions were performed at 
room temperature for 4 hours with rotation in PreScission cleavage buffer (50 mM Tris, 
150 mM NaCl, 1 mM EDTA, 0.1% TritonX-100 and 1 mM DTT at pH 7.4). 
The supernatants containing the cleaved proteins were collected by transferring the 
slurry to 10 ml Bio-Rad plastic columns.  The beads were washed three times with equal 
volumes of the cleavage buffer to collect any residual cleaved proteins.  Aliquots of the 
cleaved GSH sepharose beads along with the supernatant and the washes were analysed 
on 10% SDS-acrylamide gels to check for GST-tag proteolysis.  The samples containing 
sufficient of the CL-SH3s were combined and dialysed overnight in TBS.  The samples 
were aliquoted in microfuge tubes and stored at -80ºC. 
 
Thrombin protease cleavage 
The GST-tag on proteins expressed in a pGEX-2T vector was cleaved by the addition 
of 2 units (U) of thrombin to 100 μl bead volume.  1000 U of thrombin from bovine 
plasma was procured from Sigma-Aldrich in powdered form.  0.1% (w/v) BSA was used 
to prepare 1 U/μl of the thrombin solution which was dispensed in to 50 μl aliquots and 
stored at -80ºC.  The cleavage was performed for 4 hours at room temperature with 
rotation in thrombin cleavage buffer containing 50 mM Tris, 150 mM NaCl, 2.5 mM 
CaCl2 and 0.1% (v/v) β-mercaptoethanol at pH 8.0.  The collection and storage of the 
cleaved proteins were performed as above for the PreScission protease. 
81 
 
 
2.2.1.4 Purification of dynamin I 
Dynamin obtained from two sources were used in the biochemical assays: endogenous 
dynamin I purified from whole sheep brain (containing trace dynamin II and III) and 
recombinant human dynamin I overexpressed in insects cells.  On the day before the 
experiment the following buffers were prepared and stored at 4ºC (Table 2.11).  The 
DTT, leupeptin and PMSF in the buffers were added fresh on the day of the experiment.  
The column and dialysis buffers are common to both sources of dynamin purification. 
Table 2.11: Buffers used in the dynamin I purification. 
Buffer A1 20 mM Tris-HCl at pH 7.7 
Buffer A2 20 mM Tris-HCl, 1 mM Ca2+, 2 mM DTT, 10 µg/ml 
leupeptin, 1 mM PMSF at pH 7.7 
Buffer A3 20 mM Tris-HCl pH 7.7, 0.1 mM Ca2+, 2 mM DTT, 10 
µg/ml leupeptin, 1 mM PMSF 
Buffer A4 20 mM Tris-HCl, 2 mM EGTA, 2 mM EDTA, 250 mM 
NaCl, 2 mM DTT, 5 µg/ml leupeptin, 1 mM PMSF at pH 
7.7 
Column buffer A 20 mM HEPES, 200 mM NaCl, 1 mM DTT, 0.1% (v/v) 
Tween-80, 1 mM EDTA at pH 7.3 
Column buffer B 20 mM HEPES, 200 mM NaCl, 1 mM DTT at pH 7.3 
Column buffer C  20 mM PIPES, 1.2 M NaCl, 1 mM DTT at pH 6.5 
Dialysis buffer 1 20 mM HEPES, 200 mM NaCl, 1 mM DTT, 50% (v/v) 
glycerol at pH 7.3 
 
Purification of endogenous dynamin I from sheep brain 
Endogenous dynamin I was purified from sheep brain by extraction from the 
peripheral membrane fraction and by affinity purification on GST-amphiphysin II SH3 
bound to GSH sepharose beads as described previously (Quan & Robinson, 2005). 
Sheep brains were collected on-site at an abattoir and freshly snap-frozen in liquid 
nitrogen to limit protein degradation.  The sheep brain was stored at -80ºC until required.  
On the day of the experiment 400 g of sheep brain was defrosted in 2 L of cold buffer A1 
and homogenised in 1.5 L of cold buffer A2 for 1 minute. (Table 2.11).  The homogenate 
was centrifuged at 74,368 x g at 4ºC for 30 minutes and all subsequent centrifugations 
used this specification unless otherwise specified.  The resulting pellets were combined, 
re-homogenised for 20 seconds in 1.5 L cold buffer A3.  The homogenate was 
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centrifuged and the washing process repeated for a third time.  The pellet was washed and 
re-homogenised for 20 seconds in 1.5 L cold buffer A and the dynamin was extracted by 
stirring the mixture at 4ºC for 30 minutes.  The mixture was centrifuged to collect the 
supernatant and any contaminating residual membranes were removed by another 
centrifugation step. 
Ammonium sulphate was slowly added to the supernatant to a final concentration of 
35% (w/v) and this mixture was stirred for 30 minutes at 4ºC once all the salt had 
dissolved.  This is a salting-out procedure which precipitates a set of proteins including 
dynamin and the protein pellet is collected by centrifugation.  Column buffer A 
(approximately 90 ml) was used to resuspend the pellet and followed by overnight 
dialysis with a 10,000 kDa cut-off dialysis membrane at 4ºC against 4 L of column buffer 
A. 
The following day, the dialysate was subjected to further dialysis for 1 hour at 4ºC in 4 
L of fresh column buffer A.  The dialysate was then centrifuged at 48,384 x g for 20 
minutes, at 4ºC.  The supernatant was filtered through a 1.2 µm filter, followed by 0.45 
µm filter (Sartorius, Germany) which had been blocked with column buffer A to prevent 
non-specific binding.  Affinity chromatography was used to purify dynamin by 
incubating the filtrate with GST-amphiphysin II SH3 beads for 1 hour at 4ºC with 
rotation.  The mixture was then loaded onto a Bio-Rad plastic column and washed three 
times with column buffer B.  Dynamin was eluted by incubating the beads in 3 ml 
column buffer C.  Three incubations lasting 10 minutes were followed by three 5 minute 
incubations, collecting 6 fractions in total.  The eluates were monitored by running the 
samples on a 12% SDS-acrylamide gel and the fractions with the most dynamin (usually 
the first 3) were combined.  The combined fractions were dialysed in dialysis buffer 1 in 
the 10,000 kDa cut-off dialysis membrane overnight, at 4ºC.  The dialysate containing 
pure dynamin I was aliquoted in microfuge tubes and stored at -80ºC. 
 
Purification of recombinant human dynamin I and II from insect cells 
In this study both full-length human dynamin I (ab and bb isoforms) and full-length 
human dynamin II (ab isoform) were custom synthesised and cloned into the pIEx-6™ 
vector by GenScript (USA Inc., NJ).  The cloning sites used in the vector were MfeI (for 
the N terminus) and NotI (for the C terminus).  Unlike the endogenous sheep dynamin I, 
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purified recombinant human dynamin contains an N-terminal six histidine tag that was 
not removed for these investigations.  Importantly the lipid- or SH3 domain-stimulated 
activity and inhibitor sensitivity of recombinant dynamin I was indistinguishable from 
that of endogenous dynamin I (McCluskey et al., 2013). 
The DNA constructs were amplified by expression in E. coli and optimised for their 
transfection into Sf21 insect cell.  The insect cell culture and transfection steps were 
performed by Tram Phan at the NCRIS-Recombinant Protein Production Facility 
(CSIRO, Melbourne, Australia).  Polyethyleneimine (PEI) was the transient transfection 
reagent at a ratio of 1 μg DNA: 5 μg/ml PEI for expression of the recombinant human 
dynamin I.  Following a 48 hour culture at 26.5ºC, the insect cells were harvested and cell 
pellets were snap frozen in liquid nitrogen and stored at -80ºC.  These cell pellets were 
sent back to CMRI for dynamin purification.  The optimisation of transfection conditions 
and purification of these wild-type human dynamin constructs was conducted by Michael 
Collett from the Cell Signalling Unit, CMRI. 
A G397D mutation was introduced into both the human dynamin I isoforms by 
GenScript and transfected into Sf21 using the same approach as for the wild-type 
constructs.  G397D has been reported to disrupt the tetrameric structure of dynamin and 
prevent its ability to self-assemble into higher ordered structures (Ramachandran et al., 
2007; Ford et al., 2011).  The purified G397D dynamin I is therefore a useful tool to 
investigate SH3 domain mediated dynamin oligomerisation (see Chapter 4). 
The insect cell pellets were thawed and resuspended in insect cell lysis buffer (20 mM 
HEPES, 1 mM EGTA pH 8.0, 1 mM EDTA pH 8.0, 1% (v/v) Triton X-100, 250 mM 
NaCl, 1 μg/ml leupeptin, 100 mM PMSF, 1 EDTA-free complete protease inhibitor 
cocktail tablet at pH 7.4).  For every 20 g of insect cell pellet 80 ml of the insect cell lysis 
buffer was used.  The homogenate was sonicated with a probe sonicator for three 1 
minute rounds and incubated on ice for 30 minutes.  The homogenate was then 
centrifuged at 48,384 x g for 20 minutes at 4ºC and the supernatant collected. 
The subsequent steps were done exactly as for the purification of endogenous dynamin 
I from sheep brain.  Following affinity purification of dynamin I in the supernatant with 
GST-amphiphysin II SH3, the beads were washed in column buffer A and the dynamin 
eluted using column buffer B.  The first three eluates containing most of the dynamin 
were combined and dialysed overnight against dialysis buffer 1 at 4ºC with a 10,000 kDa 
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cut-off dialysis membrane.  The dialysate was distributed to 200 µl aliquots and stored at 
-80ºC. 
 
2.2.1.5 Synaptosome lysate 
Synaptosomes are freshly isolated nerve terminals from brain tissue.  The preparation 
of crude synaptosomes (called the P2 pellet) was performed as described previously 
(Robinson & Dunkley, 1983).  A male Sprague-Dawley rat was decapitated and the brain 
was harvested and rinsed in 50 ml of ice-cold sucrose/EDTA solution (0.32 M sucrose 
and 1 mM EDTA in 5 mM Tris pH 7.4).  The brain was minced into smaller pieces and 
transferred into 10 ml of ice-cold sucrose/EDTA solution in a teflon-glass homogeniser.  
The brain was immediately homogenised with seven strokes and homogenate was 
transferred onto ice.  The homogenate was centrifuged in 40 ml tubes for at 4ºC for 10 
minutes at 900 x g and the supernatant (S1) transferred to a cold fresh tube.  The pellet 
was resuspended with 20 ml sucrose/EDTA and centrifuged for 4ºC for 10 minutes at 900 
x g and the supernatant collected (S2).  The S1 and S2 were combined and spun at 4ºC 
for 30 minutes at 22,000 x g. 
The resulting pellet was resuspended by gentle mixing in about 20 ml ice cold Hepes-
buffered Krebs-like solution (HBK control: containing 118.5 mM NaCl, 4.7 mM KCl, 
1.18 mM MgCl2, 10 mM D-glucose and 20 mM HEPES, adjusted to pH 7.4 with a 
saturated Tris base) without any calcium added.  The mixture was centrifuged at 22,000 x 
g for 10 minutes at 4°C.  The resulting pellet was lysed using a buffer containing 5 mM 
Tris pH 7.4, 30 mM NaCl, 1% (v/v) Triton X-100, 1 mM EDTA, 1 mM EGTA, 10 
µg/mL leupeptin, 1 mM PMSF and 1 EDTA-free protease inhibitor tablet/20 ml.  The 
resulting homogenate was stored at -80ºC until required.  Alternatively the homogenate 
was immediately centrifuged, at 48,384 x g for 15 minutes at 4ºC, to collect the 
supernatant for use in pull-down experiments (see below in Section 2.2.5). 
 
2.2.1.6 Whole brain lysate 
Male Sprague-Dawley rats (15-17 weeks) were decapitated and the brain harvested, 
washed in cold PBS to remove the blood and snap frozen in liquid nitrogen.  The brains 
were stored at -80ºC until required.  The brains were homogenised, using glass-Teflon 
homogenizer, in a brain lysis buffer consisting of 20 mM Tris-Cl, containing 1% (v/v) 
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Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 20 μg/ml leupeptin and 1 mM 
PMSF at pH 7.4.  The homogenate was centrifuged at 48,384 x g for 15 minutes at 4ºC.  
The resulting supernatant was used for pull-down experiments and for Western blots 
(Section 2.2.5 and 2.2.6). 
 
2.2.2 Protein analysis 
2.2.2.1 SDS-PAGE 
SDS-PAGE was used to resolve protein samples on a Bio-Rad Protean II gel 
electrophoresis system using the Laemmli method (Laemmli, 1970).  For mini-gels, 10% 
or 12% pre-cast Bio-Rad Protean gels were used and the 10% SDS-acrylamide gel in the 
large format was prepared in house.  The separating gel, in addition to the 10% 
acrylamide and 0.2% bisacrylamide, contains 0.375 M Tris-HCl pH 8.8 and 0.1% (w/v) 
SDS.  Polymerisation was initiated with ammonium persulfate (APS, final concentration 
0.033% (w/v)) and tetramethylethylenediamine (TEMED, final concentration 0.066% 
(v/v)).  The acrylamide solution was poured between two glass plates of either 1 mm or 
1.5 mm thickness.  The gel was overlayed with 100% ethanol to prevent it from drying 
and was allowed to set for at least 1 hour.  The overlay ethanol was discarded and a 
stacking gel solution containing 4.4% acrylamide, 0.12% bis-acrylamide, 0.125 M Tris 
pH 6.8 and 0.1% (w/v) SDS, was poured.  The polymerisation was initiated with APS 
(final concentration 0.1% (w/v)) and TEMED (final concentration 0.1% (v/v)).  A 20- or 
25-well comb was inserted immediately into the separating gel, which was allowed to set 
for at least 1 hour.  If the gel was not going to be used immediately, it was stored at 4ºC 
for a few days to one week. 
The protein samples were suspended in SDS-PAGE sample buffer (375 mM Tris pH 
6.8, 2% (w/v) SDS, 4 mg/ml Bromophenol Blue, 10% (v/v) glycerol, 2 mM EGTA and 
8% (v/v) β-mercaptoethanol) and heated at 85ºC for 5-10 minutes before loading onto the 
gels.  MW (molecular weight) standards from Bio-Rad were loaded on the outside lanes 
of the gels and contained myosin (200 kDa), β-galactosidase (116 kDa), phosphorylase b 
(94 kDa), BSA (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), SBTI (20 
kDa) and β-lactalbumin (14 kDa).  The gels were placed in an electrophoresis tank 
containing 50 mM Tris pH 8.8 lower electrode buffer.  The upper electrode buffer 
consisted of 0.025 mM Tris-base, 0.19 M glycine and 0.1% (w/v) SDS.  The large format 
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gels were resolved overnight at a constant voltage of 120 V with continual cooling at 
10ºC.  The minigels were resolved at 150 V until the Bromophenol Blue dye front just 
ran off the gel.  Those gels not used for Western blotting were stained with colloidal 
Coomassie Blue solution (0.1% Coomassie Brilliant Blue G-250, 17% (w/v) ammonium 
sulphate, 3% (v/v) phosphoric acid and 34% (v/v) methanol) for at least 2-3 hours and 
destained with several changes of Milli-Q water before drying between two sheets of 
cellophane. 
 
2.2.2.2 Protein quantification and normalisation 
The protein concentration in GST-SH3 domain proteins was first determined by 
Bradford assay but the experience of our lab is that this is inaccurate by up to 2-fold and 
subject to sample buffer interference.  Therefore, as a subsequent step to ensure 
approximately equal amounts of protein were used, the recombinant SH3 domains were 
further normalised to each other and to dynamin with respect to protein concentration by 
running samples on SDS-acrylamide gels, staining with Coomassie Blue and visually 
inspecting the results for fine-tuning (Figure 2.3).  MW markers of known concentration 
were used to further fine-tune protein estimations.  The dilutions which gave equal 
amounts of proteins on the gel formed the basis for the amounts of SH3 used in GTPase 
and sedimentation assays. 
CL-SH3s were normalised to each other using the same approach but proved to be 
challenging, since their small size (<10 kDa) resulted in their migration along the dye 
front.  They were therefore harder to visualise.  This was overcome by high sensitivity 
amino acid analysis of the SH3s by gas phase hydrolysis performed commercially by the 
Australian Proteome Analysis Facility (APAF) at Macquarie University, Sydney.  To 
minimise expense, amino acid analysis was performed with only GST-intersectin I SH3E 
and CL-intersectin I SH3E as reference proteins for this study, since they had the least 
amount of impurities (Table 2.12).  The samples were analysed in duplicate and the 
results are expressed as an average.  The absolute protein amounts for the other SH3 
proteins could then be determined based on these results using the gel procedures 
described above. 
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Table 2.12: Amino acid analysis by gas phase hydrolysis for GST-intersectin I or 
CL-intersectin I SH3E domain. 
 
GST-intersectin I SH3E CL-intersectin I SH3E 
Name µg/ml µmol/ml Mole% µg/ml µmol/ml Mole% 
Histidine 63 0.46 2.3 45 0.33 1.4 
Serine 69 0.79 4 109 1.26 5.4 
Arginine 108 0.69 3.5 6 0.04 0.2 
Glycine 98 1.73 8.7 118 2.07 9 
Aspartic acid 285 2.47 12.4 517 4.5 19.5 
Glutamic acid 285 2.47 12.4 331 2.56 11.1 
Threonine 64 0.64 3.2 123 1.22 5.3 
Alanine 56 0.79 4 49 0.7 3 
Proline 119 1.23 6.2 134 1.38 6 
Lysine 228 1.78 8.9 181 1.41 6.1 
Tyrosine 181 1.11 5.6 160 0.98 4.2 
Methionine 91 0.69 3.5 87 0.66 2.9 
Valine 104 1.05 5.3 185 1.87 8.1 
Isoleucine 117 1.03 5.2 122 1.08 4.7 
Leucine 254 2.24 11.3 232 2.05 8.9 
Phenylalanine 116 0.79 4 149 1.01 4.4 
Total 2266 19.91 100 2549 23.11 100 
 
2.2.2.3 Densitometry 
Densitometric analysis was performed for both SDS-acrylamide gels from 
sedimentation analysis and Western blot films.  ImageScanner III LabScan 6.0 (GE 
Healthcare) was used to perform the scan and quantitative analysis was done using the 
ImageQuant TL (GE Healthcare) software.  A manual region of equal size was used to 
determine the relative protein amount in each band and the background intensity of 
individual blots.  The background was subtracted from the intensity of each protein 
sample to obtain the final value for each replicate. 
 
2.2.3 GTPase assay 
In this project, two types of GTPase assay were used.  a) The Malachite Green assay is 
an end-point assay (typically after 60 minutes), not ideal for time-course studies and 
hence not ideal for kinetic investigations.  b) The enzyme-linked inorganic phosphate 
assay (ELIPA) is a kinetic assay whereby GTPase activity of each sample is determined 
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over time, allowing kinetic analysis.  In both assays, there were two “assay protocols” 
employed, based on whether dynamin was preincubated or not with an SH3 domain. 
 
2.2.3.1 Malachite Green GTPase assay 
The Malachite Green GTPase assay is a high-throughput colorimetric assay used for 
the detection of inorganic phosphate (Pi) released from GTP.  The assay procedure has 
been described in detail elsewhere (Quan & Robinson, 2005) and is based on the 
formation of phosphomolybdate complex at low pH with basic dyes, causing a colour 
change (Geladopoulos et al., 1991; Van Veldhoven & Mannaerts, 1987). 
In this project, two types of GTPase assay protocols were used:  no preassembly 
(NPA) and a preassembly (PA) assay (illustrated in Figure 2.4).  The NPA assay was the 
same in principle as previously published assays in this field, whereby all the assay 
reagents were added to the reaction tubes and dynamin protein was added last to initiate 
the GTP hydrolysis.  In brief, for the NPA (or standard assay), the SH3 domains were 
diluted in dynamin dilution buffer (6 mM Tris-HCl, 20 mM NaCl, 0.02% (v/v) Tween-80 
at pH 7.4) at a range of concentrations.  The SH3 samples were added to the GTPase 
assay buffer (10 mM Tris-HCl, 10 mM NaCl, 2 mM Mg2+, 0.05% (v/v) Tween-80, 1 
µg/ml leupeptin, 0.1 mM PMSF at pH 7.4) and 300 µM GTP in a clear polypropylene 
round-bottomed 96-well plate.  Dynamin I was diluted in 5X dynamin dilution buffer to 
give a final concentration of 100 nM dynamin and bringing the final reaction volume to 
150 µl.  The reaction was incubated in the plate with constant shaking at 700 RPM for 60 
minutes at 37ºC. 
All reactions were terminated with the addition of 10 µl of 0.5 M EDTA (pH 8.0) to 
chelate all the Mg2+ and the samples were stable for several hours at room temperature 
(which was typically 23oC).  Phosphate release was quantified by the addition of 40 µl of 
Malachite Green solution (2% (w/v) ammonium molybdite tetrahydrate, 0.15% (w/v) 
Malachite Green, 4 M HCl) and colour was allowed to develop for 5 minutes at room 
temperature.  The absorbance of samples in each 96-well plate was determined on a 
microplate spectrophotometer at 650 nm (VersaMax™ micro-plate reader, Molecular 
Devices, USA). 
The PA assay protocol was developed to allow time for dynamin oligomerisation 
induced by the SH3 domains in the absence of GTP to occur prior to initiating the 
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GTPase assay (Figure 2.4B).  Dynamin is known to self-oligomerise or undergo SH3-
induced oligomerisation in the absence of any nucleotide (Hinshaw & Schmid, 1995; 
Warnock et al., 1996; Ross et al., 2011; Knezevic et al., 2011; Yamada et al., 2013).  
This extra preassembly step was done by incubating dynamin and the recombinant SH3 
domain in the reaction buffer in the absence of GTP but in the presence of Mg2+.  The 
preassembly reaction step was performed in the 96-well plate with shaking at 700 RPM 
for 60 minutes at 37ºC.  The PA reaction was initiated by the addition of GTP to a final 
concentration of 300 µM (in contrast to being initiated by dynamin protein addition in the 
NPA assay).  The incubation proceeded for a further 60 minutes under the same 
conditions.  The reactions were then terminated with EDTA and developed with 
Malachite Green as described above for the NPA. 
In some studies the assay was performed in the presence of ‘high’ salt concentrations.  
The standard assay protocol contains up to 30 mM NaCl and for ‘high salt’ condition 
NaCl was added separately into the reaction mixture to a final concentration of 150 mM.  
In some experiments the studies on dynamin helix formation were performed using PS 
liposomes at a fixed final concentration of 2 µg/ml.  In these experiments, liposomes 
were included in the 60 minute preincubation step along with the SH3 domains tested, 
following which the assay was initiated with the addition of GTP (Figure 2.4B). 
The amount of phosphate release was calculated by converting the absorbance values 
to GTPase activity (µg Pi/mg of dynamin) by comparison with a standard curve of 
sodium dihydrogen orthophosphate monohydrate (0-70 µM) which was run with each 
experiment.  One of the limitations of the Malachite Green GTPase assay that needs to be 
considered is its limited linear dynamic range.  The spectrophotometer has certain 
maximum and minimum absorbance windows within which the curve is linearly related 
to phosphate release from GTP.  Biochemical assays should only be performed in the 
linear range and the absorbance at 650 nm which is used for the detection of Malachite 
Green falls between 0.2-2.5 absorbance units (Quan & Robinson, 2005).  Therefore, only 
the absorbance values of dynamin GTPase activity which fall within that linear range 
were used for analysis. 
All of the SH3 domain proteins used in this study were assayed without dynamin and 
found not to be contaminated with bacterial GTPases.  This confirmed a previous report 
using a [α-32P]-GTP-based radioisotope assay where Pi release was measured by thin 
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layer chromatography on polyethyleneimine-cellulose plates (Gout et al., 1993).  
However, this was not the case using the ELIPA described below. 
 
2.2.3.2 Enzyme-linked inorganic phosphate assay (ELIPA) 
The ELIPA GTPase assay allows the real-time measurement of the phosphate released 
during GTP hydrolysis.  It is a non-colorimetric assay and was used to measure the 
kinetics of dynamin GTPase activity.  The assay is adapted from a method originally 
described for the measurement of glycerol kinase plus D-glyceraldehyde ATPase activity 
and for actin-activated myosin ATPase (Webb, 1992).  The assay is based upon an 
absorbance shift (330 - 360 nm) occurring when 2-amino-6-mercapto-7-methylpurine 
ribonucleoside (MESG) is converted to 2-amino-6-mercapto-7-methyl purine in the 
presence of inorganic phosphate (Pi) (Figure 2.5A).  The enzyme catalysing this reaction 
is purine nucleoside phosphorylase (PNP).  One molecule of inorganic phosphate will 
yield one molecule of 2-amino-6-mercapto-7-methyl purine in an essentially irreversible 
reaction (Cheng et al., 1995).  Thus, the absorbance at 360 nm is directly proportional to 
the amount of Pi generated in the reaction. 
As above, two types of GTPase assay protocols were used with the ELIPA:  NPA and 
PA (illustrated in Figure 2.5B and C).  For the purposes of the present studies, the ELIPA 
was adapted for use under the same in vitro conditions as the Malachite Green GTPase 
assay, by employing both the 10X GTPase assay buffer and 5X dynamin dilution buffer.  
The two assays differed only by the inclusion of MESG and PNP in the reaction buffer to 
a final concentration of 160 μM and 1 U/ml respectively.  For the PA condition, MESG 
and PNP were added after preassembly, i.e. following the 60 minute incubation of 
dynamin and SH3 and along with GTP (Figure 2.5C).  The 96-well plate was placed in 
the spectrophotometer (VersaMax™ micro-plate reader, Molecular Devices, USA) and 
the assay performed over the desired period of time at 37ºC with constant shaking inside 
the instrument. 
NaCl was added separately into the reaction mixture for the ‘high’ salt conditions and 
the GTPase activity was calculated by using the slope and intercept from the sodium 
dihydrogen orthophosphate monohydrate (0-70 µM) standard curve.   
In contrast to the Malachite Green assay, in the ELIPA, both the CL- and GST-tagged 
SH3 domains each had a low background GTPase activity in the ELIPA, presumably 
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from low levels of contaminating bacterial ATPase or GTPase.  Therefore, a time course 
assay of the SH3 domains was performed in the absence of dynamin for the various 
assembly and salt conditions.  This background was subtracted from the assays 
containing dynamin for the appropriate condition.  The dynamin and no dynamin ELIPA 
data were normalised to 0 to remove sample variability before the subtraction and further 
data statistical analysis was performed (see Section 2.2.8). 
 
2.2.4 Sedimentation assay 
SH3 and dynamin were incubated in the same reaction buffers described in Section 
2.2.3.1 for the Malachite Green assay.  The reaction was performed in microfuge tubes 
instead of 96-well plates, at 37ºC with shaking at 700 RPM, on an Eppendorf 
Thermoblock Adaptor.  As with the GTPase assays PA and NPA assay protocols were 
performed, with preassembly and reaction durations of 60 minutes each.  In order to 
visualise assembled dynamin, the following two sedimentation assays were performed. 
 
2.2.4.1 Filter spin cups 
This approach was a rapid method to collect oligomerised dynamin from an incubation 
in a form ready to run on SDS-acrylamide gels without further concentration or 
precipitation.  The reaction mix was transferred from the microfuge tube to the spin cups 
which either had a paper filter or a cellulose acetate filter.  These had been previously 
washed three times with 1% Triton X-100.  The samples were centrifuged at room 
temperature for 2 minutes at 18,000 x g and the supernatants were collected and diluted 
with SDS-PAGE sample buffer followed by heating at 85ºC.  Oligomerised dynamin, 
pelleted onto the spin cup filter, was eluted by the addition of 30 μl of 2X SDS-PAGE 
sample buffer, pre-heated to 85ºC and the spin cup was then centrifuged at room 
temperature for 5 minutes at 18,000 x g.  The pellet and supernatant samples are then 
resolved on large 10% SDS-acrylamide gels and stained with colloidal Coomassie Blue. 
 
Recycling filter spin cups 
The sedimentation samples were performed in duplicates and the spin cups were 
recycled for reuse in a duplicate experiment.  The spin cups were washed three times with 
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1 M NaCl and 100% isopropanol, with a TBS wash in between.  The spin cups were then 
rinsed with 100 mM potassium phosphate to precipitate the SDS and then washed thrice 
with 1% Triton X-100 before being used for the duplicate.  A validation experiment did 
not indicate any change in the amount of pelleted dynamin before or after recycling. 
 
2.2.4.2 Ultracentrifugation 
This approach was a more traditional method to collect oligomerised dynamin but with 
only the supernatant collected.  Due to the low amount of dynamin used in this study, the 
pellets were too small to collect reliably and could not be observed in the plastic tube.  
The reaction mix was transferred from the microfuge tube to the plastic tube and spun in 
an ultracentrifuge (OptimaTM TLX-120) at 70,000 x g for 10 minutes.  The supernatant 
containing unassembled dynamin was mixed with SDS-PAGE sample buffer followed by 
heating at 85ºC.  The samples were resolved on large 10% SDS-acrylamide gels and 
stained with colloidal Coomassie Blue.  Increasing the dynamin concentration was not a 
viable option as it would change the assay conditions and not be precisely comparable to 
the GTPase assay conditions. 
 
2.2.5 Pull-down experiments 
Equal amounts of various GST-fusion proteins still bound on GSH sepharose beads 
were incubated with either synaptosome or whole brain lysates.  For both purposes, the 
incubation was performed in a Mini BioSpin™ chromatography column or GE microspin 
column for 1 hour at 4ºC with rotation.  The plastic filter in these columns allowed bead 
retention and washing without any bead loss.  The beads were washed extensively using 
bead wash solution (20 mM Tris, 1 mM EDTA and 1 mM EGTA at pH 7.4).  Proteins 
were eluted in 2X SDS-PAGE sample buffers with heating at 85ºC followed by 
centrifugation to collect the solubilised proteins (Brymora et al., 2001). 
The synaptosome lysate was used to determine SH3 binding to dynamin (discussed in 
Chapter 3) using the GST-SH3 domains (Table 2.4) as bait.  Dynamin binding was 
visualised by resolving the samples on 10% SDS-acrylamide large gel formats at 250V 
for 4 hours and staining with colloidal Coomassie Blue. 
The GST-dynamin I PRD constructs (Tables 2.5-2.10) were used as baits to map 
SNX9 binding to dynamin (discussed in Chapter 5).  The constructs on GSH sepharose 
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beads were incubated with rat brain lysate containing endogenous SNX9.  Samples from 
these experiments were resolved by SDS-acrylamide gels as above but the gels were 
transferred onto a membrane for Western blot analysis rather than stained with 
Coomassie Blue. 
 
2.2.6 Western blots 
Western blotting was performed according to the method of Towbin (Towbin et al., 
1979).  Following electrophoresis the gel was equilibrated for 10 minutes in transfer 
buffer (25 mM Tris pH 8.3, 192 mM glycine, 20% (v/v) methanol) and the proteins 
transferred onto nitrocellulose membrane at 40V overnight.  The transfer apparatus was 
connected to a water cooling unit which maintained the temperature of the buffer within 
the blotting tank at 4°C.  The transfer gel cassette was assembled in the following order: 
sponge pad, one piece of filter paper, the gel, nitrocellulose membrane, one piece of filter 
paper and another sponge pad which had all been soaked in transfer buffer. 
The membrane was stained for bound protein using Ponceau S (0.5% (w/v) in 5% 
acetic acid) for rapid, reversible detection of protein bands and ensure their appropriate 
transfer from the gel.  The staining was for 10 minutes and the image documented using a 
flatbed scanner.  The membrane was blocked with 5% skim milk in PBST at room 
temperature for 1 hour or for at least 5 hours at 4ºC.  The membrane was washed four 
times in PBST over 40 minutes and all subsequent washes used the same conditions.  The 
membrane was then incubated with the primary antibody in PBST (at the dilutions given 
in Section 2.1.4) for 2 hours at room temperature.  This was followed by washing the 
membrane in PBST and incubating it in HRP conjugated secondary antibody at 1:10,000 
dilution in PBST for 1 hour at room temperature.  The membrane was then washed in 
PBST and incubated for 5 minutes in equal amounts of the chemiluminescence agent 
“Super Signal West Pico”.  The chemiluminescence agent was then removed and the 
membrane was exposed to a Biomax ML film.  The exposure time varied, depending on 
the strength of the antibody and the film was developed by an automated X-ray film 
developer (Konica Minolta SRX 101A). 
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2.2.7 Slot blot assay and autoradiography 
Dynamin I (20 nM / 1.9 µg/ml) diluted in 5X dynamin diluting buffer was 
preassembled in the presence of SH3 domains (40 µg/ml).  The preassembly was 
performed in GTPase assay buffer for 30 minutes at 37˚C with shaking at 700 RPM.  
Non-radioactive and radioactive GTP (α-32P, 5 µCi) were both added to a final 
concentration of 20 nM to each sample.  The samples were then subjected to UV 
crosslinking (Stratalinker 2400, 254 nm) for 30 minutes on ice.  Samples were applied to 
nitrocellulose membrane through a slot blot template which is attached to a vacuum pump 
to create suction.  TBS was passed five times through the slot to wash the sample and 
remove any residual background radiation, followed by the whole membrane being 
washed three times with TBS.  The dried membrane was exposed to a storage phosphor 
screen overnight and phosphorimaging was performed using Typhoo FLA9500 (GE 
biosciences).  The scan obtained from the phosphorimaging software was quantified 
using ImageQuant TL (GE Healthcare) as described in Section 2.2.2.3. 
 
2.2.8 Statistical analysis 
All statistical analysis in this study was conducted using the GraphPad Prism software 
version 5 (GraphPad Software Inc.).  Linear regression analysis was performed on the 
first 2-30 minutes of individual ELIPA time course curves to determine the slope or rate 
of the SH3 stimulation of dynamin GTPase activity.  The software determines the best-fit 
line without any constraints and the best-fit slope, with intercepts not being fixed.  The 
slopes for the majority of the ELIPA had an R2 > 0.95.  In a few cases where there was 
hardly any stimulation in the GTPase activity, the R2 tended to be lower. 
ELIPA GTPase assays and the sedimentation assays were analysed by two-way 
ANOVA followed by the Bonferroni’s post-test using GraphPad Prism.  Statistical 
significance was determined by comparing the t ratio with the t distribution for the 
number of df (degrees of freedom) shown in the ANOVA table for MSresidual 
(MS:Mean squared).  The Bonferroni correction was applied for multiple comparisons 
and lowers the p value that can be considered to be significant to 0.05 divided by the 
number of comparisons. 
The values of the sedimentation, western blot and autoradiography assays was used to 
determine the fold change relative to the negative control.  For Western blots the negative 
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control was the non-mutant construct and for the sedimentation and autoradiography 
assays it was the dynamin without any added SH3 domain. 
The Western blot results were analysed by one-way ANOVA followed by a Dunnett’s 
post-test to compare every mean to the control mean and a Bonferroni’s post-test to 
compare specific means.  The t-statistics for Dunnett’s test were all derived from the 
same estimate of the error variance, which was obtained by pooling the sums of squares 
for error across all (treatment and control) groups.  Comparing to a single control group 
does not lower the p-value, making this test less stringent than Bonferroni. 
When the data was performed in duplicate with n = 2 or greater, then S.E.M. (standard 
error of the mean) is used.  Counter-intuitively, calculations of either S.D. or S.E.M. are 
valid for n = 2 and the equations that calculate the S.D. (standard deviation) and S.E.M. 
all work when there are only duplicate data.  This approach was used for consistency of 
data presentation and also because there is a direct relationship between the range of the 
data (which is the difference between the two values) and the value of the S.D. and S.E.M 
and the width of the 95% confidence interval, such that the S.D. equals 0.7071 times the 
range.  An alternative to calculating S.D. or S.E.M. for n = 2 is to independently graph 
two points.  It was decided not to do this but to calculate S.D. since there is a direct 
relationship between the range of the data (which is the difference between the two 
values) and the value of the S.D. and S.E.M and the width of the 95% confidence 
interval, such that the S.D. equals 0.7071 times the range (GraphPad Software. Inc., 2014 
<http://graphpad.com/support/faq/statistics-with-n2/>). 
 
2.2.9 Molecular Biology 
2.2.9.1 Agarose gel electrophoresis 
DNA was analysed by separating it on a 1% (w/v) agarose gel made up in TBE buffer 
(89 mM Tris pH 8.4, 89 mM boric acid and 2 mM EDTA).  The mixture was cooled to 
50ºC, 1 μl of GelRed nucleic acid stain was added and it was poured onto a sealed gel 
casting platform with the appropriate sized well forming comb.  Once the agarose had set 
the comb was removed and the gel was placed in a tank and submerged in TBE buffer.  
DNA samples were mixed with 6X bromophenol blue and loaded onto the gel along with 
1 kb and 100 bp DNA ladder.  The gel was resolved at 90V for a period of time 
depending on the size of the DNA product and the length of the gel.  DNA was visualised 
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by a UV transilluminator and images taken using a gel documentation system (Furochem 
5500, Alpha Innotech). 
 
2.2.9.2 DNA transformation 
The BL21 and JM109 strains of E. coli for transformation were obtained from 
Stratagene and Promega respectively.  The competent cells were stored at -80ºC.  During 
the transformation, plasmid DNA (1 μl) or PCR ligation product (10 μl) was incubated 
with 50 µl of the competent cells on ice for 10 minutes.  The cells were then subjected to 
a heat shock at 42ºC for 45 seconds and incubated on ice for a further 2 minutes.  Super 
optimal broth (SOC) medium (900 μl) was added to this mixture and incubated for 1 hour 
at 37ºC with shaking at 200 RPM.  The cultures were centrifuged at 1,900 x g for 10 
minutes and the supernatant removed.  The pellets were resuspended in 100 μl of SOC 
media and plated onto LB-agar plates containing 100 μg/ml of ampicillin.  The plate was 
incubated at 37ºC overnight and individual colonies were selected for screening. 
 
2.2.9.3 DNA purification 
Small quantities of plasmid DNA (30 μl at concentration ranging from 100 to 400 
ng/μl) for amplification and sequencing purposes were purified by growing 5 ml of 
bacterial culture overnight and using the PureYield miniprep DNA purification system 
(Promega).  The bacterial cultures were inoculated with a single bacterial colony or 
glycerol stock of the plasmid DNA.  Purifications were performed according to the 
manufacturers’ protocol.  Larger quantities (approximately 1 ml at concentration of 500 
to 1000 ng/μl) of plasmid DNA for Sf21 insect cell expression were purified from 250 ml 
of overnight bacterial culture using the PureYield Maxi kit (Promega) according to 
manufacturers’ protocol.  The concentration and purity of plasmid DNA were measured 
using a UV spectrometer at 260 and 280 nm wavelengths. 
 
2.2.9.4 DNA sequencing 
DNA sequencing was carried out at the Australian Genome Research Facility (Sydney 
node, NSW, Australia) which utilises Sanger sequencing.  The plasmid DNA (500-600 
ng) with the appropriate primer with final volume of 12 μl made up with sterile milli-Q 
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water.  The sequenced samples were analysed using the aligner program (CodonCode 
Corporation) for sequence assembly. 
 
2.2.9.5 Site-directed mutagenesis of SNX9 
GST-SNX9 SH3 was previously generated by Dr. Maggie Ma in the Cell Cycle Unit, 
CMRI by subcloning the SNX9 cDNA from pGEX.KG-SNX9 (Soulet et al., 2005) into a 
pGEX-6P-1-TEV-6×his vector (generated by Dr. Lingshan Chan in the Cell Signalling 
Unit, CMRI) as a BamHI/EcoRI fragment.  Stop codons were inserted before the six 
histidine tag by site-directed mutagenesis in order to limit any artefactual effect from 
these 6 histidines.  The forward and reverse primers used are detailed in Table 2.12. 
Reactions were set up in sterile 0.2 ml PCR tubes containing 5 μl 10X PfuUltra II 
reaction buffer, 1 μl dNTPs (10 mM), 1.25 μl forward primer (100 ng/μl), 1.25 μl reverse 
primer (100 ng/μl), 1.5 μl double stranded DNA template (10 ng/μl), 39 μl sterile MQ 
water and 1 μl PfuUltra II Fusion HS DNA polymerase (2.5 U/μl).  The PCR reactions 
were carried out using the cycling conditions given in Table 2.13. 
Table 2.12: Primers for the site-directed mutagenesis of the SNX9 SH3 domain 
construct. 
Name Primer sequence (5’-3’) 
forward primer- BamH1 GAATTCCCGTGATGACTCGAGCGGCCG 
reverse primer- EcoR1 CGGCCGCTCGAGTCATCACGGGAATTC 
 
Table 2.13: PCR cycling parameters for insertion of stop codon on the SNX9 C-
terminal by site-directed mutagenesis. 
Cycles 
Temperature 
(ºC) 
Duration 
(minutes) Stage 
1 95 5 Denaturation 
16 
 
95 1 Denaturation 
55 1 Annealing 
72 3 Extension 
1 72 12 Final extension 
Hold 4 O/N  
 
The parental (non-mutated template) DNA was digested using the restriction enzyme 
DpnI (10 U/μl) for 1 hour at 37°C.  Transformation of the mutagenesis product (1.5 μl) 
was performed as described in Section 2.2.9.2 and the transformed product was plated 
onto ampicillin containing LB agar plates.  The following day, single colonies were 
inoculated in 5 ml of LB media to purify plasmid DNA using the PureYield miniprep 
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DNA purification system (Promega) according to the manufacturers’ protocols.  Plasmid 
DNA was sent for DNA sequencing to confirm correct mutations. 
 
2.2.9.6 Subcloning of SH3 domains into pGEX-6P-1 vector 
The SH3 domains from different proteins were each amplified and subcloned into the 
pGEX-6P-1 vector.  The parent vector of the SH3 domains with the primer sequences are 
listed in Table 2.14.  The SH3 domains of FBP17, CIP4, cortactin and Abp1 were 
amplified from their respective full-length sequences, while amphiphysin I was trimmed 
from a longer construct consisting of residues 545-695. 
Table 2.14: Primers used in this study for amplifying SH3 domains 
Name Vector Direction Primer sequence (5’-3’) 
Amphiphysin I pGEX-6P-1 forward- BamH1 GGATCCGCATCTGCAAGGGAGGCCT 
Amphiphysin I pGEX-6P-1 reverse- EcoR1 GAATTCCTAATCTAAGCGTCGGGTGAAG 
FBP17 pGEX-6P-1 forward - BamH1 CGGATCCGCCACGGATTTTGACGACG 
FBP17 pGEX-6P-1 reverser- EcoR1 CGAATTCCCTAGGAATCTTTGGCATTTTTG 
CIP4 pGEX-6P-1 forward - BamH1 CGGATCCGAGTTTGATGAGGATTTCGAG 
CIP4 pGEX-6P-1 reverse - EcoR1 CGAATTCTCAATTGAGCGTGACTCGG 
Cortactin pEGFP-C1 forward - BamH1 GGGATCCGCTCCTGGCCACTATCAAGC 
Cortactin pEGFP-C1 reverse- EcoR1 CGAATTCCTACTACTGCCGCAGCTCCAC 
Abp1 pEGFP-C2 forward - BamH1 CGGATCCGCTGGCTCCGAACACATTG 
Abp1 pEGFP-C2 reverse - EcoR1 CGAATTCTCACTCTATGAGCTCCACGATG 
 
Amplification of SH3 domains by PCR 
The PCR reaction was performed in a 50 μl sample containing 100 ng of template 
DNA, 5 μl DMSO, 5 μl 10 × Pfu UltraTM II Reaction Buffer, 10 mM dNTPs, 100 ng of 
each forward and reverse primer, 1 μl of Pfu UltraTM II DNA polymerase (2.5 U/ μl) and 
sterile milli-Q water.  Reactions were carried out on a thermal cycler under the conditions 
given in Table 2.15. 
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Table 2.15: PCR cycling parameters for amplifying SH3 domain DNA. 
Cycles 
Temperature 
(ºC) 
Duration 
(minutes) 
Stage 
1 95 5 Denaturation 
30 
95 1 Denaturation 
60 1 Annealing 
72 2 Extension 
1 72 12 Final extension 
Hold 12 Overnight  
 
Purification of DNA fragments from agarose gels 
The PCR products were resolved by agarose gel electrophoresis.  Bands of interest 
were excised, transferred to a clean microcentrifuge tube and extracted using the 
QIAquick gel extraction kit (Qiagen) according to manufacturer’s instructions. 
 
Restriction endonuclease digestion 
Both purified PCR products and empty pGEX-6P-1 plasmid vectors (Amersham 
Biosciences) were subjected to restriction enzyme digestion.  Reactions were set up in 
sterile microcentrifuge tubes containing 5.5 μl of 10X buffer H (Roche Diagnostics), 48 
μl of DNA, 1 μl of BamHI (40 U) and EcoRI (40 U).  The tubes were gently mixed and 
centrifuged briefly then incubated at 37°C overnight for the subsequent ligation reactions. 
 
Ligation of DNA fragments 
Purified DNA of the different SH3 domains were mixed with cut pGEX-6P-1 with a 
vector to insert ratio of 1:3.  The final volume of insert and vector DNA was made up to 8 
μl, followed by the addition of 1 μl of 10X ligation buffer and 1 μl of T4 DNA ligase.  
The ligation mixture was incubated for 4°C overnight.  Transformations of competent E. 
coli (Section 2.2.9.2) were then carried out using 7 μl of ligation reaction.  Colonies were 
selected and purified plasmid DNA obtained using the PureYield miniprep DNA 
purification system (Promega) according to the manufacturers’ protocols.  The correct 
orientation and sequence of the inserted DNA was confirmed by DNA sequencing. 
Figure 2.1: Sequence alignment of SH3 domains using CLUSTALW omega.
The amino acid sequences of the SH3 domains used in this study (listed in Table 2.4)
were determined by sequencing the DNA plasmid constructs via the Australian Genome
Research Facility (Sydney node, NSW, Australia) which utilises Sanger sequencing. The
alignment was performed using the program CLUSTALW omega.
SH3 abbreviations: AmphI/II, amphiphysin I/II; EndoI, endophilin I; ITNA/B/C/D/E,
intersectin I A/B/C/D/E; SndpnI, syndapin I.
Figure 2.2: Sequence similarity of SH3 domains aligned in Figure 2.1
determined using CLUSTALW omega.
The amino acid sequence similarity of the SH3 domains used in this study (listed in Table
2.4) was determined using the program CLUSTALW omega.
SH3 abbreviations: AmphI/II, amphiphysin I/II; EndoI, endophilin I; ITNA/B/C/D/E,
intersectin I A/B/C/D/E; SndpnI, syndapin I.
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Figure 2.3: Normalisation of GST-SH3 domains.
In this study equal molar amounts of the SH3 domains used were required. The protein
concentrations were adjusted for equivalent staining by Coomassie Brilliant Blue on
gels. (A) and (C) show a typical examples of 10% SDS-acrylamide gels of GST-SH3
domains normalised to endogenous dynamin I purified from sheep brain (in the last 3
lanes). The GST-SH3 domains were bacterially expressed and purified using
glutathione sepharose beads. The GST-SH3 domains were eluted from the beads using
reduced glutathione solution before being dialysed into TBS and run on this gel. (B)
and (D) indicate the dilutions that were used for the proteins in (A) and (C), listed by
referring to the respective lane number. For reference, the sheep dynamin I at 1/12
dilution (lane 7 in (A) and lane 8 in (C)) is 20 µg.
 A.  
  B.  
 C.  
  D.  
Figure 2.4: Flow chart of Malachite Green GTPase protocols.
The dynamin GTPase assay in this study was performed to compare the effect of SH3
domain proteins on dynamin I using one of two protocols. Most, not all, published
studies used only the first protocol. This Malachite Green assay is an end-point assay
that measures GTP hydrolysis after a fixed time, typically 60 minutes. It is a relatively
high throughput format performed here on a 96-well microplate.
(A) No Preassembly Assay (NPA): In this format all the assay reagents were added to
the tubes sitting on ice, including the GTP, but excluding dynamin. The samples were
warmed to 37ºC and the GTP hydrolysis initiated by the addition of ice-cold dynamin
protein. In other words there was no preincubation at 37ºC with dynamin present and
therefore dynamin oligomerisation and GTPase activity were occurring in the same
period. The mixture was incubated with shaking at 700 RPM for 60 minutes at 37ºC.
The reaction was stopped with the addition of 0.5 M EDTA. The colour was developed
with the addition of Malachite Green. The absorbance was read at 650 nm using the
VersaMax™ micro-plate reader in its endpoint mode. The absorbance values were
converted to GTPase activity (µmol Pi/mg of dynamin) using a standard curve of
known amounts of sodium dihydrogen orthophosphate monohydrate (0-70 µM).
(B) Preassembly Assay (PA): In this assay format there were two changes from the
above. Dynamin and all buffer components were preincubated with the SH3 domains
for 60 minutes at 37ºC with shaking at 700 RPM, in the absence of GTP. The
preincubation step allows time for dynamin assembly to rings, which can occur in the
absence of nucleotide. The GTP hydrolysis was then initiated by the addition of GTP
and the tubes incubated for a further 60 minutes. For the assays investigating the effect
of SH3s on dynamin helix formation, PS liposomes were added along with SH3 domain
during the preassembly.
Abbreviations: GTP, Guanosine-5’-triphosphate; PS, phosphatidylserine; RPM,
rotations per minute
Reaction buffer 
(10X GTPase assay 
buffer, GTP)
+ Dynamin
+ SH3 domain
(Concentration curve)
Shaking at 700 RPM
for 60 minutes at 37˚C  
Colour developed with 
Malachite Green
Absorbance 650 nm
GDP + PiGTP
Reaction buffer 
(10X GTPase assay 
buffer)
+ Dynamin
+ SH3 domain 
(Concentration curve)
+ PS liposome
(2 µg/ml)
Shaking at 700 RPM
for 60 minutes at 37˚C  
+ GTP
Shaking at 700 RPM
For 60 minutes at 37˚C  
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Absorbance 650 nm
GDP + PiGTP
A. NPA (no preassembly) assay
B. PA (preassembly) assay
+ SH3 domain 
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Figure 2.5: Flow chart of ELIPA GTPase assay protocols.
The ELIPA is a second GTPase assay format that was performed to compare the
kinetics of SH3 domain proteins on dynamin GTPase activity. It measures the GTP
hydrolysis as a rate, providing kinetic data, but in a relatively low throughput format
performed here on a 96-well microplate.
(A) The ELIPA is a coupled reaction, where the enzyme PNP catalyses the reaction of
MESG with inorganic phosphate (Pi), released from GTP hydrolysis, to produce purine.
The resulting absorbance shift of 340nm to 360nm between MESG and purine is the
read-out for GTP hydrolysis, with a reading taken every 30 seconds for up to 240
minutes. (B-C) This assay was used in the NPA and PA format as described above in
the legend to Figure 2.4, using the same buffer conditions, except that the reaction was
done within the VersaMax™ micro-plate reader in its kinetic mode, with constant
shaking using the ‘Automix’ function. Additionally the reaction contained PNP and
MESG and was not ‘stopped’with EDTA.
Abbreviations: ELIPA, Enzyme-linked inorganic phosphate assay; MESG, 2-amino-6-
mercapto-7-methylpurine ribonucleoside; PNP, purine nucleoside phosphorylase.
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(10XGTPase assay buffer 
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at 37˚C over 240 
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CHAPTER 3: Comparison of multiple GST-SH3 domains 
on dynamin I stimulation 
 
Dynamin I is the main isoform of the classical dynamin family studied in this thesis.  
It is a neuronal protein which is enriched in nerve terminals and is involved in the 
recycling of SVs (Powell & Robinson, 1995).  Dynamin I is subject to a number of 
splicing events which generate functional diversity but the function of most variants 
remains poorly characterised.  Splicing occurs in the middle domain and PRD of dynamin 
I and the variants are named by the use of alphabetical symbols e.g. splice variant 
dynamin Iab and dynamin Ibb (Chan et al., 2010).  For simplicity, from this point 
forwards in Chapter 3, the term “dynamin” refers to dynamin I unless noted otherwise to 
highlight a difference in splice variants or isoform. 
Dynamin is known to oligomerise into higher order assembly states of which there are 
three that predominate, depending on the conditions: tetramer, ring and helices.  Dynamin 
form rings in vitro at high dynamin concentrations (Hinshaw & Schmid, 1995; Tuma & 
Collins, 1994; Warnock et al., 1996), at lower concentrations when in the GTP-bound 
transition state (Carr & Hinshaw, 1997), or by lowering the salt concentration below 
physiological levels (Hinshaw & Schmid, 1995).  This is called self-assembly because no 
templates are required for oligomerisation.  Dynamin also oligomerises to form helices 
when provided with templates such as liposomes, microtubules or nanotubes (see Section 
1.1.5.3). 
Oligomerisation into rings and helices results in a significant stimulation of the 
dynamin GTPase activity and indeed the oligomerisation is thought to induce this 
activation (Warnock et al., 1996; Stowell et al., 1999).  The middle domain of dynamin is 
essential for this ability to oligomerise, as mutations here weaken the assembly-
dependent GTPase activity (Ramachandran et al., 2007) and GTPase domain 
dimerisation also appears to be required for activation (Chappie et al., 2010; Faelber et 
al., 2011).  Certain SH3 domains also stimulate ring oligomerisation in vitro, which 
suggests SH3 domain proteins are potential physiological regulators of dynamin rings in 
cells (Lin et al., 1997; Ross et al., 2011; Knezevic et al., 2011). 
Initial studies demonstrating the abilities of SH3 domains to stimulate dynamin 
GTPase activity were done using non-endocytic proteins and revealed that diverse SH3 
domains were able to stimulate activity to different extents (Gout et al., 1993; Herskovits 
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et al., 1993b).  This was later demonstrated for a range of endocytic proteins such as 
endophilin and intersectin (Ross et al., 2011; Knezevic et al., 2011).  This increase in 
GTPase activity is associated with the assembly of dynamin into oligomers, confirmed by 
obtaining sedimentable dynamin pellets and EM showing dynamin ring formation in the 
presence of proteins with the two SH3 domains in Grb2, or the single SH3 domains of 
amphiphysin I, endophilin II, cortactin, or intersectin I SH3A (Lin et al., 1997; Yoshida 
et al., 2004; Ross et al., 2011; Knezevic et al., 2011; Yamada et al., 2013). 
There has been no systematic study comparing the effect of the SH3 domain proteins 
on dynamin GTPase activity.  Interpreting results of previous studies is complicated by 
their use of varying dynamin concentrations, different buffer conditions and use of only 1 
or 2 SH3 domain proteins in each study.  Most prior studies also use of the full-length 
form of the SH3 domain protein, often including the dimerising and lipid binding BAR 
domain which affects dynamin oligomerisation, obscuring the effect of the SH3 domain 
itself (Ross et al., 2011).  For example, addition of the full-length BAR/SH3 domain 
proteins amphiphysin I and FBP17 with full-length dynamin produces a hybrid dynamin 
helix with altered diameter and pitch (Takei et al., 1999; Itoh et al., 2005).  Dynamin 
GTPase activity is synergistically stimulated (i.e. there is a greater than additive effect) 
by liposomes in the presence of either endophilin II or SNX9 proteins (Soulet et al., 
2005; Ross et al., 2011).  However, in these cases, the full-length protein containing the 
BAR and SH3 domain is required for the synergistic effect, which does not occur when 
the SH3 domain alone is added.  Thus, it is difficult to determine from the literature 
which SH3 domains regulate dynamin activity and how their extent of action compares. 
It is known from the initial publication that a relatively large group of SH3 domains 
can bind the PRD of dynamin but with varying degrees of efficacy (Gout et al., 1993).  A 
panel of 16 GST-tagged single SH3 domains and Grb2-SH3 (full-length, contains 2 SH3 
domains) was used, from a set of signalling proteins (mostly with little relation to 
endocytosis).  They showed the SH3 domains of 8 of them (GST-p85-SH3, GST-PLCγ-
SH3, GST-c-src-SH3, GST-fgr-SH3, GST-Grb2-N-SH3, GST-Grb2-SH3 (full-length), 
GST-Grb2-C-SH3 and GST-fyn-SH3), when attached to GSH sepharose beads, pulled-
down varying amounts of dynamin.  No correlation was reported with their ability to 
stimulate dynamin GTPase activity, although those that failed to bind also had no effect 
on its GTPase activity.  Three stimulated dynamin to a larger extent than the others 
(GST-c-src-SH3, GST-fgr-SH3 and GST-Grb2-SH3 (full-length)) and the rest to variably 
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low extents.  All stimulated dynamin at a lower rate and to a lower extent than helices 
formed around microtubules (Gout et al., 1993).  There has been no similar attempt to 
determine the relative binding of endocytic-related SH3 domains to dynamin or their 
effect on its activity. 
The overall goal of this study is to better characterise the role of SH3 interaction on 
the regulation of dynamin activity and oligomerisation, with a focus on the SH3 domain 
proteins with known association to endocytosis.  This chapter has four specific aims: 
1) Determine the relative binding ability of a set of 13 GST-SH3 domains to 
dynamin.  This is achieved by pull-down experiments using synaptosomal lysates 
enriched for dynamin. 
2) Systematically screen the GST-SH3 domains for their relative ability to stimulate 
dynamin GTPase activity.  This is done using two types of GTPase assay: end-
point and kinetic. 
3) Determine the ability of the GST-SH3 domains to oligomerise dynamin and 
investigate the link between oligomerisation and GTPase activity.  Sedimentation 
experiments are used to detect oligomerised dynamin in the pellet. 
4) Establish whether the middle domain influences the ability of GST-SH3 domains 
to stimulate GTPase activity.  This is achieved by comparison of two human 
dynamin middle domain spliced α2 helix variants, Iab and Ibb. 
The subset of proteins chosen for this study are the SH3 domains which can bind to 
dynamin and which have a role in endocytosis (listed in Table 2.4), although p85 is less 
strictly endocytic.  Grb2, which is among the best characterised dynamin binding SH3 
domain protein in the literature, was not included in this report because of its dual SH3 
domains and since its overexpression in cells does not lead to a modulation of 
endocytosis (Wigge et al., 1997).  However, considerable data with full-length Grb2 was 
obtained as a reference protein for prior studies (this data will not be shown).  The focus 
of the work in this chapter was on the use of GST-tagged SH3 domains, while SH3 
domains with their GST-tags removed will be investigated in the next Chapter. 
 
3.1 Analysis of SH3 domain binding to dynamin 
To first determine the relative binding ability of the endocytic set of SH3 domains to 
dynamin, pull-down experiments were performed using 13 bacterially expressed GST-
111 
 
SH3 domains in pGEX vectors (listed in Table 2.4).  This is a well-characterised and 
established technique for expressing small to medium sized proteins such as SH3 
domains.  Each SH3 was sequenced before expression to check for any mutations or 
insertions throughout the construct and to ascertain that the full domain was encoded.  
Online analysis tools were used to ensure that the complete secondary structures were 
encoded for each SH3 domain.  This gave us confidence that the SH3 domains expressed 
were functional. 
Approximately equal amounts of these GST-tagged SH3 domains coupled to GSH 
sepharose beads were incubated in parallel with equal volumes of rat brain synaptosome 
lysate, which predominantly express the dynamin I isoform by at least 50-fold over the 
other two (Ferguson et al., 2007; Chan et al., 2010).  The results confirmed GST-SH3 
domains bind dynamin to very different extents.  Following incubation with the lysate for 
60 minutes on ice (standard conditions for a pull-down experiment), amphiphysin I SH3 
bound the most dynamin (Figure 3.1A).  In contrast, the three intersectin I SH3s bound 
dynamin relatively weakly and the p85 SH3 bound no detectable dynamin.  The other two 
intersectin I SH3 domains, SH3B and D, which are known to not bind dynamin, were 
used in parallel and no dynamin was detected, as expected (not shown). 
Our lab has noted that when pull-down experiments are performed for longer duration 
on ice, lower affinity interactions are sometimes detected (unpublished).  Therefore, this 
experiment was repeated with the incubation being conducted for 300 minutes.  Only two 
differences were observed in the relative binding or the gross amount of dynamin pulled-
down: relative binding of syndapin I SH3 increased and p85 now can be clearly seen to 
bind dynamin (Figure 3.1B).  The results show a surprising diversity of binding of these 
domains to dynamin, suggestive of broad-ranging affinities not apparent from the 
literature.  The results also establish the functionality of the GST-SH3 domain constructs 
used in the following studies, some of which were newly cloned for this study, before 
testing them on dynamin GTPase activity. 
 
3.2 Differential stimulation of dynamin activity by GST-SH3 
domains (Malachite Green assay) 
The effect of the GST-SH3 domains on stimulating dynamin GTPase activity was 
determined by two means: (1) The colorimetric Malachite Green assay (see Section 
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2.2.3.1), an end-point assay after a fixed reaction time, is discussed in this Section.  The 
GST-SH3 domains were used in a concentration-dependent manner to stimulate the 
GTPase activity of dynamin.  (2) The ELIPA (see Section 2.2.3.2) is a time course assay 
used to determine the rate of GTPase activity and the results are discussed in the 
following section (Section 3.3). 
In both GTPase assays the incubation of dynamin and the GST-SH3 domain was 
performed either under preassembly (PA) or the no preassembly (NPA) conditions.  The 
PA differs from the ‘standard’ NPA assay protocol because it allows the dynamin and 
SH3 to preincubate for 60 minutes before the addition of GTP to initiate the reaction 
(Figure 2.4, see Section 2.2.3.1 for an explanation of these assay protocols).  The 
underlying rationale for this originated from the EM images of dynamin rings formed by 
SH3 domains which were obtained by co-incubation in the absence of GTP (Ross et al., 
2011; Knezevic et al., 2011; Yamada et al., 2013).  Under NPA conditions both dynamin 
assembly and GTP hydrolysis are occurring simultaneously, while under PA conditions 
dynamin assembly occurs before GTP addition.  There is also evidence to suggest that 
GTP can interfere with dynamin assembly by SH3 domains and thus the use of the PA 
condition would allow for better dynamin assembly (Sweitzer & Hinshaw, 1998; Wang et 
al., 2010).  The extent of dynamin activity is widely held to be dependent on the extent of 
its assembly (Hinshaw & Schmid, 1995; Stowell et al., 1999; Song et al., 2004b) (Figure 
1.7).  Cryo-EM studies of full length dynamin I preassembled in the superconstricted 
state strongly suggest that the G domain lies near the PRD (Sundborger et al., 2014).  
This indicates SH3 domains are likely to still interact with oligomerised dynamin and 
further modulate its activity.  Therefore, the experimental design predicts that higher 
stimulation of GTPase activity would be observed under the PA conditions.  The PA 
conditions also allows for the possibility of separating oligomerisation and activity, 
thereby ascertaining the link between these two properties. 
Prior to the main study some control experiments were performed.  In the absence of 
GST-SH3 domains there was no difference in the basal GTPase activity of dynamin 
between the PA and NPA conditions (Figure 3.2A).  The GST fusion tag alone also had 
no effect on basal dynamin activity in either condition (Figure 3.2B and C).  This was 
expected, since the relatively low dynamin concentrations (100 nM / 9.6 µg/ml) of the 
assay are well below those used to elicit self-assembly (Hinshaw & Schmid, 1995; Zhang 
& Hinshaw, 2001; Pawlowski, 2010). 
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The first point to make is that addition of all individual GST-SH3 domains stimulated 
GTPase activity in both assay conditions to widely varying extents (Figure 3.2D).  In 
prior experiments the GST-SH3:dynamin concentration ratio was examined at all ranges 
from 0.125-8 of GST-SH3 to 1 of dynamin.  This amounts to 2.5 - 80 µg/ml of each GST-
SH3 domain relative to a fixed concentration of dynamin (100 nM / 9.6 µg/ml).  The 
GST-SH3:dynamin protein ratio at which the maximal GTPase activity was achieved 
(summarised in Table 3.1) was determined for use in the final assay shown in that figure.  
The specific concentration-response curves from which this data was derived are shown 
in Appendix 8.1. 
The second point is that the data could be clustered into two classes of responses 
according to the PA vs. NPA outcomes and are therefore presented in the figure and table 
in two groups (Figure 3.2D, Table 3.1). 
(1) “NPA<PA” group:  Eight GST-SH3 domains stimulated dynamin GTPase to a 
much greater extent under the PA conditions (Figure 3.2D, right side).  This was the case 
for most GST-SH3s and was the expected result, since the PA condition allows time for 
dynamin ring formation prior to initiating the GTPase activity.  Also, most of the GST-
SH3 domains in this group stimulated dynamin more potently, i.e. at a lower GST-
SH3:dynamin ratio under the PA condition than the NPA condition.  The exceptions were 
intersectin I C (i.e. the SH3C domain of intersectin I), p85 and CIP4 (Table 3.1). 
(2) “NPA=PA” group:  Five GST-SH3 domains produced little or no difference in the 
extent of dynamin stimulation regardless of the preassembly step.  This was unexpected 
since the proteins in this group stimulated dynamin over a broad dynamic range, i.e. to a 
very high or very low extent (for brevity called ‘high or low stimulators’, compare 
intersectin I A with Abp1).  For the high stimulators, this might be explained, since 
proteins like intersectin I A could conceivably induce such rapid oligomerisation that the 
preassembly was not required.  However, for the low stimulators like Abp1, this 
explanation does not fit.  The data demonstrates that the pre-formation of dynamin rings 
(PA condition) does not always lead to greater GTPase activity, indicating a possible 
decoupling between the GST-SH3 domains ability to stimulate and to oligomerise 
dynamin (the first of other such decouplings to be described later).  Most of the GST-
SH3s in this group, except FBP17, stimulated maximal activity at the same GST-
SH3:dynamin ratio in both assay formats (Table 3.1).  No protein produced less GTPase 
activity with PA. 
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Table 3.1: GST-SH3:Dynamin ratio at which maximal stimulation of GTPase 
activity was achieved by the various GST-SH3 domains using the Malachite 
Green assay. 
Refer to Appendix 8.1 for the concentration curve of each GST-SH3 domain under both 
NPA and PA conditions, from which the results in this table have been obtained. 
 
  NPA PA 
 GST-SH3  GST-SH3:Dynamin (X:1) 
 
 
NPA=PA 
Intersectin I A 1 1 
FBP17 8 4 
Intersectin I E 8 8 
Amphiphysin II 8 8 
Abp1 8 8 
 
 
 
NPA<PA 
SNX9 8 2 
Endophilin I 8 2 
Amphiphysin I 8 4 
Cortactin 8 4 
Syndapin 8 4 
Intersectin I C 8 8 
p85 8 8 
CIP4 8 8 
 
When comparing the concentration of the GST-SH3 required for maximal stimulation 
with the extent of that stimulation, no correlation could be found (compare Figure 3.2D 
with Table 3.1).  Similarly neither of these parameters correlated with the relative binding 
of these proteins to dynamin observed in the pull-down experiments (Figure 3.1).  For 
example, intersectin I SH3A bound much less dynamin than most other SH3s, including 
Abp1, yet was the highest stimulator.  Neither is the clustering of the GST-SH3 domains 
influenced by any functional similarity between them.  For example, GST-amphiphysin I 
and II have almost 50% sequence similarity, being members of the same protein family, 
and yet their data fall within different groups.  The same applies to the other pairs of 
GST-SH3 domains, such as cortactin and Abp1, CIP4 and FBP17, which in the full-
length form have much the same physiological functions (Olazabal & Machesky, 2001; 
Shimada et al., 2007). 
Overall the data show that the 13 endocytic-related GST-SH3s all stimulate dynamin.  
However, no correlation between their potency, extent of activation, dynamin binding or 
oligomerisation state could be made.  The level of GTPase activity is considered to reflect 
the assembly state of oligomerised dynamin (Hinshaw & Schmid, 1995; Warnock et al., 
1996; Stowell et al., 1999; Song et al., 2004b).  These two biochemical properties are 
directly linked such that one is used as the predictor of another.  The data presented here 
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challenges this assumption and, thereby, the current understanding of the mechanism of 
action of GST-SH3 domains on dynamin oligomerisation and activity.  
 
3.3 Differential rate of dynamin stimulation by GST-SH3 domains 
(ELIPA) 
To probe into the possible decoupling between dynamin stimulation and 
oligomerisation an alternative GTPase assay was used.  The ELIPA time course assay 
takes phosphate release readings every 30 seconds, allowing dynamin activity to be 
monitored over time (Figure 2.5, for explanation see Section 2.2.3.2).  Only one previous 
study has used a time course study to evaluate dynamin activation by two SH3 domain 
full-length proteins: GST-SNX9 and GST-SNX18 (Park et al., 2010) and did not use their 
GST-SH3 domains alone.  Their ELIPA data was skewed by the use of dynamin at very 
high concentrations (1 µM) that promotes its self-assembly, making it difficult to 
distinguish self-assembly induced dynamin activity from any SH3-mediated assembly.  
That study was also limited to a short time course of 10 minutes. 
The ELIPA experiments performed in this study used the same buffer conditions as 
the Malachite Green assay, except for the requisite presence of MESG and PNP for 
phosphate detection.  Unlike the Malachite Green assay, a fixed GST-SH3:dynamin ratio 
of 4:1 (40 µg/ml) was used, since this was shown to be the minimum concentration at 
which all the GST-SH3s stimulated dynamin to an appreciable extent.  It was not possible 
to use a range of SH3 domain concentrations due to limitations in protein resources.  A 
fixed dynamin concentration (100 nM / 9.6 µg/ml) was used for the ELIPA in common 
with the Malachite Green assay. 
 
3.3.1 Technical limits of the ELIPA 
An advantage of ELIPA is that it can be run over an extended period of time, 
potentially providing information about time-dependent oligomerisation and this was 
used to study the GST-SH3 domains under NPA and PA conditions.  As with the 
Malachite Green assay, the GST-tag alone had no stimulatory effect on dynamin (data not 
shown).  However, the extended time course did reveal some technical limitations of this 
assay, illustrated for the NPA condition performed over 240 minutes (Figure 3.3). 
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All 13 GST-SH3 domains were tested under NPA conditions and a representative four 
are shown in the figure.  The GTPase curves have not been subtracted for the basal 
dynamin activity in order to better display the time course.  The lower curves in each 
panel (starting at time point 0) show a steady increase in Pi release (GTPase activity) until 
a plateau was reached at a different time for each GST-SH3 domain.  This was expected 
and was due to depletion of GTP.  For example, GST-intersectin I SH3A, which 
consistently produced the highest stimulation in this Chapter, produces an earlier GTPase 
activity plateau than the other proteins (Figure 3.3D).  Also, the plateau at 8.2 µmoles of 
Pi released/mg of dynamin indicated the GTP limit and only data below this point of GTP 
exhaustion was considered below. 
The rate of dynamin activity could be detected as the initial slope and was typically 
(not always) linear over the first 150 minutes for all the GST-SH3s except for that of 
intersectin I SH3A (initial rates are discussed further below).  However, the final plateau 
reached for each GST-SH3 domain appeared to be at a different point well below the 8.2 
µmoles Pi /mg of dynamin indicated above for GST-intersectin I SH3A.  For example, 
the assay reached a plateau at 5.5 µmoles of Pi released/mg of dynamin for GST-
amphiphysin I (Figure 3.3A).  This suggested a second assay limitation linked to the 
degradation of the MESG substrate over time.  MESG is the substrate for the enzyme 
PNP used in this assay and its loss could produce a decline in the assay over time.  To test 
this, the reaction was repeated with an aliquot of fresh MESG being added 120 minutes 
into the assay rather than at the beginning.  This result is shown as the black upper curve 
in each of the graphs (Figure 3.3).  The Pi released was immediately elevated and the 
latter part of the dynamin activity time course continued for each GST-SH3, except that 
of GST-intersectin I SH3A which has already depleted the GTP supply.  This confirmed 
MESG depletion late in the assay. 
Next, the PA condition was examined with the ELIPA.  Based on the Malachite Green 
data a greater stimulation of GTPase activity was expected for the “NPA<PA” group and 
indeed this was observed (Figure 3.4).  In addition, the three GST-SH3 domains each 
showed the sigmoidal effect more clearly than the NPA condition.  While activity was 
initially linear, it rose sigmoidally at a point late in the assay, regardless of the MESG 
loss.  Again GST-intersectin I SH3A was the outlier, with the greatest rate of activity and 
no sigmoidality (Figure 3.4D).  The “sigmoidal effect” occurring at different times late in 
each assay (except for GST-intersectin I SH3A) may potentially represent a secondary 
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burst of oligomerisation and this hypothesis will be investigated further in Section 3.3.3 
below, after first considering the initial reaction rates of individual GST-SH3 domains on 
dynamin. 
 
3.3.2 GST-SH3 domains stimulated dynamin activity at different rates 
The initial GTPase activity rates were robust and reliable during the 2-30 minute 
interval of the reaction where there was minimal MESG degradation and none of the 
sigmoidal effect (Figure 3.5A).  The initial rates (µg Pi/mg of dyn/min) allowed for the 
quantification of GST-SH3 domain stimulation of dynamin activity and were determined 
by linear regression analysis.  The increase in activity during this early period of the 
reaction was linear, with the coefficient of determination (R2) typically greater than 0.95.  
The basal rate of dynamin activity, obtained in the absence of any SH3, was calculated 
separately and was subtracted from the stimulated activity.  The 2-30 minute interval was 
used because of the relatively weak stimulation by GST-SH3 domains of dynamin at low 
concentrations, as noted in the early literature on SH3 proteins (Gout et al., 1993).  This 
creates variation in the first 2 minutes of the reaction, which was therefore ignored for 
further analysis and quantification in the present study.  Thus, for all SH3 domains used 
in this study activity in the 2-30 minute period showed linear rates.  From this point 
forward in this thesis the initial stimulated rates, subtracted for basal activity, are 
primarily used. 
The rate results for the NPA conditions showed that GST-intersectin I SH3A has a 
high stimulatory effect but the other GST-SH3 domains have no effect on dynamin 
activity at all (Figure 3.5B).  This is in contrast to the Malachite Green data under NPA 
for the equivalent GST-SH3:dynamin of 4:1 used in ELIPA (Appendix 8.1A, C and E).  
At this amount of each protein, the GST-SH3 domains other than intersectin I A did 
stimulate dynamin, albeit weakly.  Since the initial rates with the NPA conditions were so 
low, all subsequent ELIPAs in this thesis were performed with PA conditions, unless 
otherwise indicated. 
Under the PA conditions, 11 of the 13 GST-SH3 domains stimulated dynamin activity 
to detectable extents in the presence of low salt and their rate results are compared to the 
GTPase values of end point Malachite Green assay under the PA condition for the same 
GST-SH3 concentration (Table 3.2).  The data for both assays in this table is summarised 
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in descending order of SH3 potency on dynamin.  There was no disparity in the relative 
position of the SH3 domains between the two assays, with most falling into the NPA<PA 
category.  The GST-SH3s of amphiphysin II and CIP4 were exceptions since they alone 
were unable to stimulate dynamin activity in the ELIPA.  It was also notable that while 
GST-intersectin I SH3A was the best stimulator in both assays, it was an outlier in the 
ELIPA whereas in the Malachite Green assay its effect was closer to the other SH3 
domains, such as amphiphysin I, SNX9 and syndapin I, which were potent stimulators of 
dynamin activity.  The reason for these discrepancies between ELIPA and Malachite 
Green assay is unclear and potentially relates to different batches of purified sheep 
dynamin used between the two assays.  Importantly, as with the Malachite Green data, 
there was no correlation between the ELIPA data and the relative binding of the GST-
SH3s to dynamin (Figure 3.1). 
Table 3.2: Comparison of the SH3 domain-stimulated dynamin GTPase activity 
observed by ELIPA (data from Figure 3.5C) and Malachite Green end point 
assays (data from Appendix 8.1B, D and F) under PA condition. 
Values for the GST-SH3:dynamin ratio are 4:1 for both data sets.  The GST-SH3 
domains for both assays are in descending order of their stimulatory effect on dynamin.  
Those exhibiting poor correlation between the two assays are indicated in bold. 
 
GST-SH3 
domain 
ELIPA: Rate of GTPase 
activity (µg Pi/mg of dyn/min) 
Malachite Green: GTPase 
activity (µg Pi/mg of dyn) 
Intersectin I A 0.111 9.150 
Amphiphysin I 0.035 7.780 
SNX9 0.033 7.650 
Syndapin I 0.032 7.600 
Cortactin 0.029 6.800 
FBP17 0.017 5.250 
Endophilin I 0.009 4.780 
Intersectin I E 0.008 4.020 
Intersectin I C 0.006 3.960 
p85 0.006 2.740 
Abp1 0.004 2.190 
Amphiphysin II 0.000 1.160 
CIP4 0.000 0.830 
 
3.3.3 ELIPA reveals the “sigmoidal effect” on dynamin activity 
The sigmoidal effect occurring late in the time course is a response not previously 
observed for dynamin.  Since this was first observed in the NPA condition (Figure 3.3, 
MESG after 2 hours), it was initially proposed that the effect might represent a secondary 
burst of dynamin oligomerisation, with dynamin being known to show cooperativity for 
its self-assembly activity.  If so, it was occurring at a surprisingly late time point. 
119 
 
It was expected that preassembly of dynamin prior to the ELIPA (in the PA condition) 
would eliminate most dynamin oligomerisation prior to the assay start, thus sigmoidality 
in the GTPase assay should be reduced or absent.  This did not occur.  The sigmoidal 
effect occurred at a different time for each GST-SH3 domain but always after about 80 
minutes when the MESG would be relatively less degraded than later into the reaction 
(Figure 3.4 and Appendices 8.2 and 8.3).  Due to the MESG effect, it cannot be 
determined whether there might be a consistent relationship between sigmoidality and the 
maximum GTPase activity at which the curve plateaus.  For example, GST-endophilin I 
(Appendix 8.2B) and GST-Abp1 (Appendix 8.2C) SH3s were both weak stimulators of 
dynamin but the latter had a pronounced increase in GTPase activity at around 120 
minutes.  GST-cortactin (Appendix 8.2D) and GST-syndapin I (Appendix 8.3A) SH3 
domains stimulated dynamin to similar extents but the latter has a much weaker 
sigmoidal curve. 
It was therefore next determined whether the sigmoidal effect is indeed occurring due 
to changes in dynamin oligomerisation following preassembly.  A reliable approach to 
quantifying dynamin oligomerisation is sedimentation, based on the fact that rings and 
helices are easily separated from unassembled dynamin in this way (Lin et al., 1997; 
Yoshida et al., 2004; Ross et al., 2011; Knezevic et al., 2011; Yamada et al., 2013).  
However, such assays have not previously been done in the presence of GTP (in the 
absence of a lipid template), which is required for our experiment to be fully comparable 
to the GTPase assay conditions.  Three GST-SH3 domains that most clearly exhibit the 
sigmoidal effect, cortactin, FBP17 and Abp1, were chosen for this analysis. 
Since the sigmoidal effect did not occur for GST-intersectin I SH3A, it was reasoned 
that it alone does not lead to a change in dynamin assembly over time within the assay 
but may occur so fast that it cannot be detected in this way.  Under the PA condition, 
where dynamin was shown to self-assemble prior to the GTPase assay (data not shown), 
the hypothesis predicts that there should be a significant secondary increase in dynamin 
oligomerisation at the time point at which the sigmoidal effect is observed for each GST-
SH3 protein.  The sedimentation assay was performed under the same PA conditions used 
for the ELIPA except for the absence of MESG and PNP.  Sedimentation was performed 
at three times points in the assay, 60, 120 and 200 minutes following the addition of GTP, 
to clearly reflect times before, during and well after the sigmoidal effect was detected for 
each of the three GST-SH3 domains (Figure 3.6A).  Dynamin and the GST-SH3 domains 
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were incubated for 60, 120 and 200 minutes following the addition of GTP and the 
sedimentation was performed using filter spin cups which traps any oligomerised 
dynamin (for simplicity its referred to as the “pellet”) and the supernatant is collected.  
The filter spin cup approach was introduced to avoid the disadvantages of 
ultracentrifugation, a technique used in other laboratories to sediment assembled 
dynamin.  The primary disadvantage of using ultracentrifugation is that it makes it harder 
to collect the dynamin pellets, since they are not visible in the centrifugation tubes at the 
low dynamin concentrations used in this study.  The poor visibility of the tiny pellet made 
it harder to be certain whether it has not been dislodged while removing the 
unoligomerised dynamin contained in the supernatant.  Unlike ultracentrifugation, 
sedimentation using filter spin cups is easier to perform with a very short assay time (2 
minutes), enabling the selected time points to be evaluated with confidence. 
Dynamin was visualised in the supernatant and pellet by Coomassie Blue staining of 
SDS-acrylamide gels (Figure 3.6B).  At the 60 minutes time point, prior to any sigmoidal 
effect, each GST-SH3 sedimented different amounts of dynamin protein, presumably 
indicative of the extent of oligomerisation.  The amount in the pellet correlated with their 
increasing rates of dynamin stimulation, i.e. greatest GTPase activity and sedimentation 
with GST-cortactin SH3 and least with GST-Abp1 SH3 (Figure 3.6A vs. B).  During or 
after the sigmoidal effect no changes in sedimentable dynamin were found.  For GST-
cortactin SH3 the sigmoidal effect was complete at 120 minutes, yet no further changes in 
sedimented dynamin were detected from 60-200 minutes.  For GST-FBP17 SH3 the 
sigmoidal effect started at 120 minutes but dynamin sedimentation did not further change 
from 60-200 minutes.  The extent of pre-assembly prior to initiation of the assay was 
confirmed to be the same as the level of assembly observed at 60, 120, 200 minutes (data 
not shown).  In the case of GST-Abp1 SH3 the sigmoidal effect started after 120 minutes 
and was complete before 200 minutes.  Yet again no sedimentation changes were 
observed.  The exponential increase in GTPase activity cannot therefore be explained by 
a secondary or additional increase in dynamin oligomerisation.  It is therefore unclear 
what this sigmoidality could signify and without further information is was deemed likely 
to be a technical artefact of the unusually long assay.  Nonetheless, this provides direct 
evidence that the sigmoidal effect on dynamin GTPase activity can be decoupled from its 
ability to oligomerise further. 
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3.4 Sedimentation analysis of dynamin oligomerisation by GST-
SH3 domains 
Having demonstrated no further change in dynamin assembly following PA, the 
relative ability of all 13 GST-SH3 domains to oligomerise dynamin was next examined in 
parallel.  The rationale behind this approach is informed by the five reports showing the 
ability of dynamin to form rings in the presence of at least 5 SH3 domains (Grb2, 
amphiphysin I, endophilin I, cortactin, or intersectin I SH3A) (Lin et al., 1997; Yoshida 
et al., 2004; Ross et al., 2011; Knezevic et al., 2011; Yamada et al., 2013).  A direct 
correlation was previously demonstrated between stimulating dynamin activity and the 
amount of sedimentable dynamin, using GST-Grb2 and GST-removed Grb2 (Barylko et 
al., 1998).  Therefore, the next aim was to compare these parameters for the 13 
endocytic-related GST-SH3 domains. 
The sedimentation analysis was performed using two methods: (1) Filter spin cups as 
described above for Figure 3.6B.  (2) Ultracentrifugation of the reaction sample at 72,000 
x g to precipitate and pellet any oligomerised dynamin.  The “pellet” and supernatant 
from the filter spin cup assay and the supernatant alone from the ultracentrifugation assay 
were resolved on gels (Figure 3.7A-C).  As negative control, both assays typically 
included GST alone for an index of basal oligomerisation.  Figure 3.7B shows dynamin 
in the presence of PS liposomes, which were used a positive control for maximum helical 
oligomerisation, since it can be sedimented easily.  This was evident in the gels where, in 
the presence of PS, the amount of dynamin increased in the pellet with an accompanying 
decrease in the supernatant.  In the absence of GST-SH3 or in the presence of GST alone, 
dynamin was primarily detected in the supernatant.  Dynamin, at the low concentration 
conditions used in this study, is predominantly a tetramer in the absence of either PS or 
SH3 domains.  All dynamin in the pellet is rings except for the helical dynamin formed in 
the presence of PS, which is a control for maximum assembly.  It therefore follows that 
the dynamin in the supernatant is in the tetrameric form.   
The sedimentation promoted by each GST-SH3 protein was quantified by 
densitometric analysis of the pellet and is presented as a fold change relative to the basal 
(No SH3) control (Figure 3.7D).  The results are also summarised in Table 3.3, with the 
GST-SH3s listed in descending order by their ability to sediment dynamin.  The table 
allows a comparison with their ability to stimulate dynamin GTPase activity under the 
same PA low salt conditions (from Figure 3.5C).  The SH3 domains highlighted in bold 
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in Table 3.3 are deemed to have a poor correlation between dynamin activation and 
oligomerisation by using a threshold of 2-fold change between these parameters. 
Table 3.3:  Summary of GST-SH3 domain stimulated rate of dynamin GTPase 
activity (from ELIPA data in Figure 3.5C) and spin cup oligomerisation (from 
Figure 3.7D). 
Both parameters are represented as fold change relative to dynamin basal (no SH3) 
control.  GST-SH3 domains with poor correlation between GTPase activity and 
oligomerisation are indicated in bold. 
 
GST-SH3  Rate of GTPase 
activity 
(Fold change) 
Oligomerisation 
(Fold change) 
Intersectin I A 15.80 4.54 
Amphiphysin I 5.67 3.23 
SNX9 5.40 3.46 
Syndapin I 5.27 4.84 
Cortactin 4.87 5.33 
FBP17 3.27 4.49 
Endophilin I 2.20 4.40 
Intersectin I E 2.07 1.64 
Intersectin I C 1.80 1.89 
p85 1.80 1.72 
Abp1 1.53 2.08 
Amphiphysin II 1.00 2.34 
CIP4 1.00 3.19 
 
GST-intersectin I SH3A, which had a potent effect on dynamin GTPase activity, is not 
a striking outlier in oligomerising dynamin.  The results show considerable decoupling 
between activity and assembly in the presence of this protein and a similar trend is 
observed to a smaller degree with GST-amphiphysin I and GST-SNX9 SH3 domains.  
GST-endophilin I exhibits decoupling but in the opposite direction; greater 
oligomerisation relative to dynamin activity.  Surprisingly, while GST-amphiphysin II 
and GST-CIP4 SH3s elicited no stimulation of GTPase activity, they did cause an 
increase in dynamin oligomerisation.  This increase for amphiphysin II and CIP4 was 
statistically significant (Figure 3.7E), suggesting that stimulation of dynamin activity can 
occur in the absence of any assembly.  Overall, this challenges the consensus in the 
literature regarding the relationship between elevated dynamin GTPase activity and 
oligomerisation to be directly correlated. 
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3.5 Salt dependency of the ability of GST-SH3 domains to 
stimulate dynamin activity 
In vitro studies of dynamin can be highly influenced by the buffer conditions, in 
particular the salt (NaCl, KCl) concentration being used.  Varying salt concentration 
changes the monomer-tetramer equilibrium such that the monomer predominates at high 
salt concentrations while the tetramer predominates at lower salt (Binns et al., 1999; 
Ramachandran et al., 2007).  Since tetramers are the building blocks of dynamin 
oligomers, the ionic concentration of the buffer is an important determinant of helical 
formation, with higher salt concentrations (≥100 mM) strongly inhibiting both 
oligomerisation and GTPase activity stimulated by liposomes or microtubules (Binns et 
al., 1999).  Salt bridges are a key part of dynamin oligomerisation, potentially explaining 
these observations (Faelber et al., 2011).  In contrast to the helix, rings induced by SH3 
domains are less well characterised in terms of salt-sensitivity.  In one key study, 
recombinant dynamin stimulated by Grb2 is insensitive to inhibition by NaCl of up to 
200 mM, conditions which abolish helical activity, but again note that Grb2 is bivalent 
with two SH3 domains (Lin et al., 1997).  No other study has visited this issue with 
single SH3 domains.  A weakness of past studies on SH3 stimulation of dynamin may lie 
within the wide variety of buffer conditions employed in each, making it challenging to 
compare and interpret the data.  The ability of factors to stimulate dynamin activity in the 
presence of high salt (at physiologically relevant 150 mM NaCl or KCl) has been used as 
an argument of the potential for that in vitro stimulation to also occur in cells (Lin et al., 
1997).  Therefore, the goal of the next experiments was to rank the SH3 domains against 
this criterion. 
The next experiments examined the effect of salt on the ability of the 13 GST-SH3 
domains to stimulate dynamin GTPase activity.  The hypothesis was that the high salt 
(defined here as 150 mM NaCl) conditions would significantly reduce the ability of 
dynamin to hydrolyse GTP across the set of 13 GST-SH3 domains.  Firstly, each GST-
SH3 domain was used to stimulate dynamin in the presence of low (30 mM NaCl) or high 
salt (Figure 3.8A, the low salt data being the same as shown in Figure 3.5C).  The low vs. 
high salt experiments were conducted at the same time to reduce variation with the initial 
rate of activity, using the ELIPA as the most sensitive and reliable index of activation. 
The presence of high salt almost abolished the stimulation of dynamin activity for 
some GST-SH3s (e.g. endophilin I, cortactin and FBP17) or had small inhibitory effects 
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on others (e.g. amphiphysin I, intersectin I A and intersectin I E).  In contrast, high salt 
significantly increased the ability of GST-SNX9 SH3 to stimulate the rate of dynamin 
activity (Figure 3.8B).  This increase cannot simply be explained by the extent of 
stimulation, since amphiphysin I, cortactin and syndapin I SH3s all show very similar 
values to GST-SNX9 SH3 at low salt conditions but produce different outcomes when 
salt is elevated. 
The data reveals there is no single “rule” for the effect of high salt on the ability of 
SH3s to stimulate dynamin activity and not all SH3s behave the same as the early Grb2 
data (Lin et al., 1997).  Since the intracellular Na+ + K+ concentration is usually around 
150 mM, the results suggest that only three of the SH3 domains might be relevant 
activators in cells (amphiphysin I, SNX9 and intersectin I A).  Among these, SNX9 
stands out by virtue of showing increased activity under these conditions. 
 
3.6 Role of middle domain splicing in dynamin stimulation by SH3 
domains 
The fourth aim of this Chapter was to establish whether the dynamin middle domain 
influences the ability of GST-SH3 domains to stimulate dynamin GTPase activity.  This 
is achieved by comparison of two human dynamin middle domain splice variants, Iab and 
Ibb.  The experiments shown to this point have all been performed with endogenous 
sheep dynamin I, which consists of numerous splice variants (Graham et al., 2007; Chan 
et al., 2010).  The predominant dynamin forms in neurons are two PRDs and two middle 
domains.  The two main PRD splice variants are the long (Xa) and short forms (Xb), with 
the latter having a specific calcineurin recruitment function (Xue et al., 2011).  The two 
middle domain splice variants, aX or bX, produce alternative α2 helices which form part 
of the 4-helix bundle that comprises the middle domain.  The functional significance of 
these splice forms remains largely unknown. 
The middle domain splice variants consist of two alternate exons from residues 400-
444 of both dynamins I and II called the ‘aX’ and ‘bX’ forms (Appendix 8.4A).  These 
alternate exons mainly comprise conservative amino acid changes.  A mutation at A408T 
in the aX variant causes epilepsy in mice (Boumil et al., 2010).  The crystal structure of 
the dynamin dimer shows the splice residues form a complete α-helix within the middle 
domain helical bundle (Figure 3.9B, with the colour coded dynamin domain structure in 
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Figure 3.9A).  The middle domain is essential for dynamin oligomerisation and this 
spliced α2 helix does not directly participate in formation of the basic dimer.  It is 
involved in tetramer formation, where α2 forms an interaction interface between two 
adjacent dynamin dimers, by making salt bridges with the BSE of a neighbouring 
dynamin dimer (Figure 3.9C).  Therefore, its unique location suggests that the spliced α2 
helix may play a key role in dynamin oligomerisation, potentially leading to two dynamin 
I isoforms with distinct GTPase activity or assembly properties. 
To test the role of the middle domain splicing in dynamin activation by SH3 domains, 
a collaboration was established with Michael Collett, a PhD candidate from the Cell 
Signalling Unit, CMRI.  For his project, Mr. Collett cloned the two middle domain splice 
variants of dynamin I into the short PRD variant of human sequence to make human 
dynamin Iab and bb.  The common PRD variant ‘Xb’ was used, since the longer ‘Xa’ 
form contains additional phosphorylation and protein binding sites which may make data 
interpretation more difficult.  The two recombinant proteins were expressed in Sf21 
insect cells and purified by Mr. Collett.  The initial pilot work performed by him with 
these 2 variants using the Malachite Green assay showed 1.2-fold less extent of activity 
for Iab in stimulation by PS liposomes and 2 fold less for Grb2 SH3 (Figure 3.9D).  This 
may indicate a preferential role for the ‘bb’ middle domain in dynamin oligomerisation 
with the middle domain splice forms not being functionally equivalent.  This work forms 
the basis of a manuscript in preparation by Mr. Collett relating to helical dynamin.  Based 
on this small difference in oligomerisation, the two recombinant human dynamin I forms 
were used in the following sections to determine the role of the splice site in GST-SH3 
domain-stimulated dynamin activity. 
 
3.6.1 Most GST-SH3 domains preferentially stimulate dynamin bb isoform 
The GST-SH3 domains were tested on the two human dynamin I middle domain 
variants using the ELIPA (PA condition) and their activity was compared at low (Figure 
3.10A) or high salt (Figure 3.10B).  Overall, major differences were revealed between 
them.  In the presence of low salt, all GST-SH3 domains except endophilin I stimulated 
the activity of human dynamin Ibb to a greater or similar rate than Iab.  This was similar 
to the greater stimulation of Ibb in presence of PS (Figure 3.9D) but the splice variant 
difference between the SH3s was much greater.  Thus, the ‘b’ middle domain form has a 
higher rate of stimulated GTPase activity, whether as rings or helices.  The opposite 
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selectivity displayed by GST-endophilin I domain compared to the other 12 was striking 
and indicates a high degree of specificity in the action of individual SH3 domains. 
The results for the middle domain splice variants are summarised in Tables 3.4 and 
3.5.  Here they are compared by rank order analysis to the sheep dynamin data (from 
Figure 3.5C) and some interesting results are highlighted.  It is notable that GST-FBP17 
SH3 is the best stimulator of both Iab and Ibb whereas it is very poor at evoking sheep 
dynamin activity.  In considering the ‘a’ α2 helix (human dynamin Iab), GST-intersectin I 
SH3A was much less potent in stimulating this variant compared to the sheep dynamin 
(Table 3.4).  GST-endophilin I is another SH3 where its potency is reversed in the 
presence of Iab.  Interestingly, in the ‘b’ α2 helix (human dynamin Ibb), GST-intersectin 
I SH3A yet again ceases to be the outlier in its ability to stimulate GTPase activity (Table 
3.5).  GST-cortactin SH3 is much better at stimulating the Ibb variant than sheep 
dynamin and is another example of a change in selectivity.  Unlike in the presence of 
sheep dynamin and ‘a’ variant, GST-CIP4 SH3 did stimulate the ‘b’ middle domain 
dynamin, albeit moderately.  These results reveal a major effect of the middle domain 
isoform on mediating the ability of different GST-SH3 domains to stimulate dynamin 
activity. 
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Table 3.4: Stimulation of sheep dynamin (data from Figure 3.5C, an endogenous 
isoform mixture) and human dynamin Iab (data from Figure 3.10A, single 
isoform) by 13 GST-SH3 domains. 
The rate of GTPase activity (µmoles Pi/mg of dyn/min) for each dynamin was 
determined using the ELIPA data under PA and low salt conditions.  The GST-SH3 
domains for both assays are listed in descending order of their stimulatory effect.  Those 
exhibiting poor correlation with sheep dynamin I, either in terms of stimulation or rank 
order, are indicated in bold. 
 
Sheep dynamin I Human dynamin Iab 
GST-SH3 
domains 
Rate of 
GTPase 
activity 
GST-SH3 
domains 
Rate of 
GTPase 
activity 
Intersectin I A 0.111 FBP17 0.082 
Amphiphysin I 0.035 Endophilin I 0.030 
SNX9 0.033 SNX9 0.028 
Syndapin I 0.032 Cortactin 0.028 
Cortactin 0.029 Syndapin I 0.025 
FBP17 0.017 Amphiphysin I 0.024 
Endophilin I 0.009 Intersectin I A 0.024 
Intersectin I E 0.008 Intersectin I E 0.020 
Intersectin I C 0.006 Amphiphysin II 0.007 
p85 0.006 p85 0.007 
Abp1 0.004 Abp1 0 
Amphiphysin II 0 Intersectin I C 0 
CIP4 0 CIP4 0 
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Table 3.5: Stimulation of sheep dynamin (data from Figure 3.5C, an endogenous 
isoform mixture) and human dynamin Ibb (data from Figure 3.10A, single 
isoform) by 13 GST-SH3 domains. 
The rate of GTPase activity (µmoles Pi/mg of dyn/min) for each dynamin was 
determined using the ELIPA data under PA and low salt conditions.  The GST-SH3 
domains for both assays are listed in descending order of their stimulatory effect.  Those 
exhibiting poor correlation with sheep dynamin I, either in terms of stimulation or rank 
order, are indicated in bold. 
 
Sheep dynamin I Human dynamin Ibb 
GST-SH3 
domains 
Rate of 
GTPase 
activity 
GST-SH3 
domains 
Rate of 
GTPase 
activity 
Intersectin I A 0.111 FBP17 0.116 
Amphiphysin I 0.035 Cortactin 0.101 
SNX9 0.033 Intersectin I A 0.092 
Syndapin I 0.032 Syndapin I 0.072 
Cortactin 0.029 Amphiphysin I 0.058 
FBP17 0.017 SNX9 0.039 
Endophilin I 0.009 Intersectin I E 0.032 
Intersectin I E 0.008 p85 0.022 
Intersectin I C 0.006 CIP4 0.019 
p85 0.006 Abp1 0.015 
Abp1 0.004 Endophilin I 0.008 
Amphiphysin II 0 Intersectin I C 0.006 
CIP4 0 Amphiphysin II 0.004 
 
In the presence of high salt most of the splice form selectivity was abolished (Figure 
3.10B).  GST-SNX9 and GST-intersectin I A were the only SH3 domains which not only 
stimulated the strongest activity, in common with the result for the sheep dynamin under 
high salt (Figure 3.8A), but also retained the comparative selectivity for human dynamin 
Ibb observed with low salt.  GST-amphiphysin I was no longer a stand out protein, as in 
the presence of endogenous sheep dynamin, either in terms of strength of stimulation or 
selectivity.  Statistical analysis revealed that between the two salt conditions, GST-SNX9 
SH3 and GST-intersectin I SH3A domains significantly stimulate dynamin activity 
differentially, according to the middle domain splice variant (Figure 3.11).  GST-SNX9 
SH3 was a better stimulator of human dynamin Ibb GTPase activity in the presence of 
high salt, with no significant difference observed between the two salt conditions for 
human dynamin Iab (Figure 3.11A).  The analysis revealed that the effect of GST-
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intersectin I SH3A to be the opposite, showing greater selectivity for human dynamin Iab 
in the presence of high salt (Figure 3.11B). 
These results add a further layer of complexity to the previous data and demonstrate 
the SH3 domains not only act differently but do so in a middle domain splice-dependent 
manner.  Thus, the middle domain strongly influences the stimulation of dynamin 
GTPase activity by the SH3 domains. 
 
3.6.2 Combining the middle domain splice variants of human dynamin I 
Endogenous sheep dynamin, purified from whole brain (see Section 2.2.1.4), consists 
of a mixture of splice variants of unknown precise composition of each isoform.  To gain 
insight into what middle domain splicing might occur in the sheep brain, since ovine 
dynamin I has yet to be sequenced, a species sequence analysis was performed.  For this 
analysis the cow dynamin I was used in place of sheep.  A GenBank search revealed the 
cow (bovine) dynamin I to have 18 transcript variants, each of which harbour either the 
‘a’ or ‘b’ middle domain splice variant (Appendix 8.5D and 8.6D).  There are gaps in the 
transcript variants because these are predicted sequences derived from EST (express 
sequence tag) evidence and other sources.  These missing residues can be observed when 
the human dynamin I is aligned with the complete coding DNA sequence (cds) of cow 
dynamin I (Appendix 8.7).  Since cow dynamin I has more than 98% similarity to the rat 
variant, it is reasonable to assume equal or greater similarity with a much closer species 
such as sheep.  This analysis suggests that the ‘a’ and ‘b’ middle domain splice variants 
are likely to also occur in sheep, as it does in rat, mouse, human and cow. 
Based on this assumption and that dynamin I and II can form heterodimers in vitro 
(Okamoto et al., 1999), an attempt was next made to determine whether mixing the two 
recombinant human splice variants might alter their SH3 domain response.  It was 
hypothesised that mixing might alter the composition of the dynamin tetramer, thus 
regulating the oligomerisation.  The human Iab and bb were combined in equal amounts, 
assuming equal concentration of these middle domain variants in the cell (no other 
information on their likely ratio being available).  The combined human splice forms 
(ab+bb) (100 nM) were then stimulated with the GST-SH3 domains in the presence of 
low salt, using the same ELIPA conditions in the previous section (note that the total 
dynamin concentration in the assay was kept constant at 100 nM so that there was no 
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change in dynamin concentration across this assay).  The results for ab+bb are compared 
to the single isoform results from Figure 3.10A (Figure 3.12A).  Each GST-SH3 domain, 
except that of SNX9, stimulated the combined dynamin to either the same extent as one 
of the single splice variants or to an extent that is an average of the two.  Only GST-
SNX9 SH3 produced an increased stimulation of the Ia+b mix, especially relative to the 
‘a’ single splice form (Figure 3.12B).  This further distinguishes the action of SNX9 SH3 
from that of the other SH3 domains in its stimulation of dynamin I GTPase activity.  The 
studies presented in this chapter suggest the SNX9 SH3-dynamin interaction could have a 
distinct functional significance relative to the interaction of other SH3s. 
When the human dynamin Iab+bb mix is compared to sheep dynamin data from 
Figure 3.5C, obtained under the same conditions (PA low salt), there are significant 
differences between the two (Figure 3.13).  Many GST-SH3 domains stimulate the 
combined human dynamin I better than the sheep, with the opposite result being observed 
for GST-intersectin I SH3A.  These differences are less likely to be explained by the 
middle domain since they are elicited by the combined dynamin, which is proposed to 
mimic the endogenous mixture of splice forms.  These differences are perhaps better 
explained by PRD splice variations in sheep dynamin, since both the human dynamins 
being used contain the short form (Xb) of the PRD, while the sheep dynamin is a more 
divergent mix.  The PRD sequence is the same between the cow dynamin I transcript 
variants and human dynamin Ibb, with the sole exception of alanine 824 on the human 
dynamin which is threonine in the cow (Appendix 8.5E and 8.6E).  There are however 
big differences in the PRD splice site (R901 on human dynamin I onwards) since the cow 
dynamin I transcript variants consists of short (7, 8, 9 and 10) and long forms (14, 17, 1, 
3, 11, 15, 16, 18, 12, 2 and 6), in addition to two new PRD splice forms (4, 5 and 13) 
(Appendix 8.5H and 8.6H).  Moreover, trying to fathom the effect of GST-SH3 domains 
between different species of dynamin is further complicated by these SH3 domains 
themselves originating from different species (as summarised in Table 2.4).  In 
conclusion, the differences between single splice form combined and endogenous 
dynamin indicate the ability of SH3 domains to stimulate dynamin is influenced not just 
by the middle domain but potentially other splice variants as well. 
 
3.7 Discussion 
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The first three aims of this Chapter were to compare the effect of multiple GST-SH3 
domains from endocytic proteins on dynamin association, activity and assembly and to 
identify any correlation between binding and oligomerisation by each SH3 with dynamin 
GTPase activity.  The fourth aim was to determine the role played by the dynamin middle 
domain in this interaction.  Together, this was addressed by performing the first 
systematic study of a panel of 13 GST-SH3 domains to assess their ability to stimulate 
dynamin activity and oligomerisation.  The key findings are summarised below: 
 Contrary to the initial hypothesis, no correlation was found between the ability 
to bind or to stimulate dynamin activity, both of which vary greatly between 
the 13 endocytic GST-SH3 domains.  This shows that the ability to bind 
dynamin is not a good index of its ability to stimulate the enzyme. 
 Contrary to hypotheses in the literature, a disconnect was demonstrated 
between the ability of the 13 GST-SH3 domains to stimulate dynamin GTPase 
activity and oligomerisation.  This challenges the prevailing hypothesis that 
dynamin oligomerisation is required for its stimulated activity. 
 Revealed that alternative splicing at the middle domain of dynamin 
differentially regulates the ability of each GST-SH3 to stimulate dynamin.  The 
SH3 proteins preferentially stimulated dynamin Ibb relative to Iab to varying 
extents.  This reveals a surprising role for the middle domain in transmitting 
signals from the SH3-PRD interaction to the G domain. 
 Revealed GST-SNX9 SH3, GST-intersectin I SH3A and GST-amphiphysin I 
SH3 to be the most consistently strong dynamin activators under most 
parameters examined.  Their ability to retain dynamin stimulation in the 
presence of physiological salt concentrations suggests they are the SH3s most 
likely to be of physiological significance to dynamin regulation in cells. 
 
3.7.1 Stimulation of dynamin activity by GST-SH3 domains 
This is the first study to perform a systematic screening of the relative effectiveness of 
multiple GST-tagged SH3 domains to stimulate dynamin by comparing their effects in 
parallel.  There have been no studies which were performed using more than two SH3 
domains in parallel.  The one exception being an in vitro transferrin uptake study which 
tested the effect of five GST-SH3 domains (intersectin I A, intersectin I E, syndapin I, 
endophilin I, amphiphysin I) on endocytosis but was without any accompanying 
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biochemistry (Simpson et al., 1999).  Increasing concentrations of these GST-SH3 
domains suppressed endocytosis in this cell-free assay, with GST-intersectin I SH3A 
eliciting the most potent effect, suggesting it to be the best at sequestering dynamin from 
the site of endocytosis. 
While there are hundreds of SH3 domains, the focus was on the 13 which bind 
dynamin and are involved in or linked to endocytosis mechanisms.  Since no correlation 
was observed for the GST-SH3 stimulation of dynamin GTPase activity, it is concluded 
that it was divorced from both dynamin binding and assembly.  This was particularly 
clear in the Malachite Green assay where the varied effect of the GST-SH3s on dynamin 
under both PA and NPA assay conditions indicates each SH3 has a uniquely specific 
effect on dynamin activity.  It was striking that while GST-intersectin I SH3A can 
stimulate GTPase activity of endogenous sheep dynamin to a very high extent, it bound 
about the least dynamin.  Unlike the GTPase assays, exhaustive experimental conditions 
were not employed for the pull-down binding assays.  Using different amounts of SH3 
bait and/or buffer conditions may have provided more exhaustive results concerning the 
relationship between dynamin binding and GTPase activity.  This was not pursued, since 
the primary focus of the study was to investigate the effect of GST-SH3 domains on 
dynamin activity.  Future studies should determine the affinity of interaction of each 
protein for dynamin using, for example, Biacore or similar technology based on surface 
plasmon resonance. 
This is the first study to undertake a systematic comparison between NPA or PA 
performed prior to providing dynamin with GTP.  The underlying premise was that PA 
would allow time for dynamin to assemble with each SH3 domain, assuming that each 
requires a different time to promote oligomerisation.  In general, this hypothesis was 
supported by most of GST-SH3 domains, each of which produced larger activity after 
PA.  However, five GST-SH3 domains in the Malachite Green assay showed no 
difference (intersectin I A and E, FBP17, amphiphysin II and Abp1).  This might have 
been explained if they had all produced the greatest stimulatiory activity, suggesting they 
all assemble dynamin at the fastest rate, as was the case for intersectin I SH3A.  Yet this 
was clearly not the case for the other four, none of which showed greater ability to 
oligomerise dynamin in the sedimentation assay than the other proteins.  Instead of 
revealing which SH3s promote more rapid dynamin oligomerisation this data added to 
the mounting evidence that oligomerisation and extent of activity did not correlate. 
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Sedimentation analysis to study oligomerisation was performed alongside GST-SH3 
domain stimulated dynamin activity to determine the possible relationship between these 
two properties.  ELIPA was used instead of Malachite Green for this comparison because 
the ELIPA and sedimentation assays were performed in parallel using the same batch of 
dynamin and GST-SH3 domains.  The comparison revealed that the extent of dynamin 
activity and oligomerisation to be decoupled in the presence of certain GST-SH3 
domains.  This was particularly evident for GST-intersectin I SH3A but also to a lower 
extent with GST-SH3 domains of amphiphysin I, SNX9 and endophilin I.  GST-
amphiphysin II and GST-CIP4 SH3s stimulated dynamin oligomerisation despite no 
observable increase in dynamin activity, suggesting GTPase activity-independent 
oligomerisation. 
These were unexpected observations since dynamin GTPase activity is widely held to 
reflect the extent of assembly (Hinshaw & Schmid, 1995; Warnock et al., 1996; Stowell 
et al., 1999; Song et al., 2004b).  This is evidenced by the >100 fold increase in activity 
when dynamin is in the highly assembled helical form (Stowell et al., 1999) and the 
dynamin as a helix having a higher GTPase activity than in its ring state (Figure 1.7).  
One of the advantages of using the systematic approach taken here is that it highlights 
previously undiscerned aspects of dynamin biochemistry.  This lead to the formulation of 
the hypothesis that under certain assay conditions the extent of dynamin GTPase activity 
is decoupled from oligomerisation.  Thus, there are subtleties in their dynamin interaction 
which are not yet understood.  This idea is addressed in greater detail in the following 
Chapter. 
The apparent specific effect of GST-SH3 domains on dynamin activity, along with the 
observation that the extent of activity and dynamin oligomerisation do not necessarily 
correlate, raises new questions about whether oligomerisation is always required for 
activity.  There seems to be something more than simply dynamin assembly taking place.  
These observations lend themselves to the hypothesis that dynamin is a morpheein which 
oligomerises into distinct kinds of oligomers (conformers) by the SH3s and the different 
activities may reflect distinct dynamin conformation within each.  Morpheeins are a class 
proteins which can form polymeric complexes that are dependent on the conformation of 
the unassembled unit (Selwood & Jaffe, 2012).  It can therefore be speculated that each of 
the GST-SH3s may act to stabilise distinct conformations of the dynamin tetramer 
building block, which in turn can form distinct oligomers with varying activities.  For 
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example, GST-intersectin I SH3A was clearly the greatest outlier on sheep dynamin 
activity compared to every other GST-SH3 domain that was studied.  This might partly 
be explained by GST-intersectin I SH3A forming an unusually compact dynamin ring 
structure which is very stable and unable to change conformation (Knezevic et al., 2011).  
Thus, it is possible that the conformers elicited by GST-SH3s each have different 
activities due to differential packing within the dynamin oligomer.  Indirect evidence that 
dynamin may be a morpheein came from comparing the cryo-EM structures of GTP-
unbound vs. bound K44A mutant (Sundborger et al., 2014).  The two resultant helices in 
the presence of liposomes showed entirely different packing due to single or double 
helical structures respectively.  This can act as unifying hypothesis for the data in this 
Chapter and might go some way towards explaining the results discussed in this and the 
following Chapters. 
 
3.7.2 Dynamin activity determined by its middle domain 
The data in this Chapter clearly established that the ability of different GST-SH3 
domains to stimulate dynamin GTPase activity is mediated by alternative splicing at the 
middle domain.  The dynamin middle domain is known from other studies to be primarily 
responsible for its oligomerisation and lacks sequence homology to any known structural 
motif (Ramachandran et al., 2007).  The middle domain is a conserved feature of the 
larger dynamin family and mediates oligomerisation in all tested members 
(Ramachandran et al., 2007; Gao et al., 2010; Daumke et al., 2010; Moss et al., 2011; 
Haller & Kochs, 2011; Byrnes & Sondermann, 2011; Takahashi et al., 2012).  Cryo-EM 
and crystal structures indicated the middle domain forms the ‘stalk’ of the dynamin 
monomer, suggesting a role for this domain in mediating intramolecular interactions in 
self-assembled dynamin (Zhang & Hinshaw, 2001; Chen et al., 2004; Mears et al., 2007).  
Direct evidence for this came from mutational analysis of the middle domain, where 
R361S, R399A and G397D disrupt the tetrameric structure of dynamin and prevent its 
ability to self-assemble into higher ordered structures (Ramachandran et al., 2007; Ford 
et al., 2011).  The importance of this domain in dynamin function is further underlined by 
dynamin linked disease phenotypes that result from mutations which tend to cluster 
around the middle domain (Boumil et al., 2010; Gonzalez-Jamett et al., 2014; 
Appenzeller et al., 2014). 
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The comparison of two recombinant human dynamin middle domain splice variants 
Iab and bb, undertaken here with endogenous sheep dynamin containing a mix of splice 
variants, revealed that the spliced α2 helix is a key determinant of how each SH3 domain 
stimulates dynamin.  In one study, the same middle domain α2 helix splice variants were 
functionally characterised for dynamin II, where both the ‘a’ and ‘b’ forms rescued CME 
equally well (Liu et al., 2008).  However, a differential effect was observed for export of 
the protein p75 from the Golgi with dynamin IIbX being more effective at restoring 
exocytosis.  Dynamin I middle domain has similarly been investigated for splice 
dependent biochemical effects by Michael Collett but the data is in preparation for 
submission at the time of writing.  Mr. Collett in collaboration Drs. Peter Hains and Jing 
Xue, from the Cell Signalling Unit, CMRI, demonstrated dynamin I middle splice 
variants to be differently regulated during development.  They found that the Iax isoform 
is predominant in the adult rat brain (82% of the total dynamin), its expression correlating 
with synapse formation and maturation, while the Ibx isoform is the dominant embryonic 
brain isoform and changes little in abundance during development.  Upon reintroduction 
of dynamin Iab or Ibb into triple dynamin KO fibroblast cells (Park et al., 2013), the Ibb 
form rescued endocytosis of transferrin by 89.5%, while dynamin Ibb showed 
significantly less rescue at 67.8%.  This indicates that dynamin Iab and bb do not have 
equivalent endocytic capacity and their study suggests they play different functional 
roles. 
Notably the form that more efficiently rescues CME, Ibb, is the same one identified in 
the present study to be stimulated to greater extents by most GST-SH3 domains as well as 
by PS liposomes.  Differential activation of each isoform was shown to occur for each 
SH3.  The splice variant difference in response to liposomes is small but in low salt 
conditions, this changes into varied, frequently large, differences across the GST-SH3 
domains.  Despite similar, though not identical, stimulation of both isoforms by PS 
liposomes, most GST-SH3 domains, except notably endophilin I, stimulated the activity 
of human dynamin Ibb to a much greater rate than Iab.  The observation of opposite 
selectivity, for Iab, by GST-endophilin I indicates a high specificity of SH3 domain 
action on dynamin.  This suggests there is a fundamental oligomerisation difference 
between the isoforms that may indicate distinct functional roles in cells.  The data raises 
the possibility that the differential action of SH3 domain proteins might be preferentially 
mediated by one or other dynamin isoform in cells. 
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Cortactin and intersectin I A GST-SH3 domains elicit big differences between the 
splice variants but with FBP17 and amphiphysin I this was much reduced.  Moreover, 
GST-intersectin I SH3A ceases to be an outlier in its stimulation of human dynamin 
splice variants, as it was with endogenous sheep dynamin.  This was particularly 
noticeable with a considerable drop in it stimulatory effect on human dynamin Iab.  It 
was remarkable to see such differences across the SH3s with the GTPase domain and the 
PRD being the same between the splice variants.  These differential effects lend further 
credence to the hypothesis put forward regarding dynamin forming distinct conformers.  
A new hypothesis is suggested to explain how this could occur, whereby the SH3-PRD 
interaction has an allosteric effect on the dynamin GTPase domain and which is mediated 
in two distinct ways by its two middle domains.  However, the PRD of dynamin is 
disordered and it is hard to envisage how it could transmit the proposed middle domain-
mediated allosteric effect.  A crystal structure of dynamin with the disordered PRD, 
which has not yet been generated, could help test this hypothesis.  It is possible that an 
independent mechanism to stimulate GTPase activity by SH3 domains may be regulated 
by the middle domain splice site. 
The human dynamin constructs used in this study contain only one PRD isoform 
variant - the short ‘b’ form of the PRD.  The endogenous sheep dynamin used in the 
previous assays was made up of, not just a mixture of middle domain isoforms, but also 
PRD isoform variants.  Appendix 8.5 and 8.6 shows the bovine dynamin transcript 
variants to consist of up to four PRD sequences including the established long and short 
forms.  In order to determine where there is any effect the PRD variants on SH3 
stimulated GTPase activity, the sheep dynamin results were compared to human dynamin 
Iab+bb mixed isoform data.  The comparison did not provide any clear answer, since no 
discernible pattern could be observed.  Human dynamin Iab+bb stimulated activity 
tended to be higher than the sheep dynamin results, with GST-intersectin I SH3A being a 
notable exception.  It should be noted that the differences observed may not necessarily 
be due to the PRD variation but down to differences in post-translational modification, 
such as phosphorylation, between the dynamins which are yet to be investigated.  
However, the use of equal amount of and b isoforms was shown at the end of this 
investigation not to be physiologically representative, with the brain found to contain five 
times more a than b form of the middle domain (unpublished data by Michael Collett and 
Dr. Peter Hains).  Due to time and resource constraints the assays weren’t repeated with 
the appropriate ratios of dynamin isoforms. 
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3.7.3 Technical considerations 
The conclusions derived from this chapter were missed in previous studies for several 
reasons.  A drawback of prior investigations, alongside the use of single SH3 domain 
proteins, was they tended to use quite high concentrations of dynamin.  Given that 
dynamin self-assembly (without SH3s or templates) occurs at such concentrations, using 
a low dynamin concentration has been a strength of this study in terms of appropriate 
assay conditions.  Other studies were not consistent in examining salt effects on dynamin, 
such as using low salt for activity and high salt for assembly assays (Ross et al., 2011) 
whereas others used PA for one assay and NPA for another (Lin et al., 1997; Yoshida et 
al., 2004; Soulet et al., 2005; Ross et al., 2011).  Previous studies were also not thorough 
in performing activity-oligomer comparisons and in their use of dynamin either with 
regards to its source (endogenous vs. single isoform recombinant) or species (sheep vs. 
human).  A major advantage of this study was that it systematically addressed all these 
inconsistencies and is a possible reason for the differences observed here in comparison 
to other studies. 
The experimental approach here involved the use of two GTPase assays: an end point 
assay (Malachite Green) and a kinetic assay (ELIPA).  The relative stimulation of 
dynamin between GST-SH3 domains is largely the same for the two assays, with GST-
intersectin I SH3A being the best stimulator in both.  However, a few anomalies were 
noted in this study that were never explained.  One such outlier was GST-endophilin I 
SH3, which was a good stimulator in the Malachite Green assay but not under ELIPA.  
The other anomalous observation was for CIP4 SH3 domain.  CIP4 pulled-down 
intermediate dynamin levels from brain, suggesting good binding.  Its ability to stimulate 
dynamin was strongly enhanced by preassembly, suggestive of the formation of dynamin 
oligomers, which were indeed observed in this study.  Yet, while CIP4 stimulated sheep 
dynamin in the Malachite Green assay, it was unable to do so in the ELIPA.  At this stage 
the reason for this disparity between the two GTPase assays remains unknown.  One 
possibility is that the anomalies relate to the dynamin middle domain isoform.  For 
example, CIP4 was able to recover some ability to stimulate dynamin in the ELIPA but 
only the Ibb isoform, an effect abolished when the Iab isoform was mixed with Ibb 
(Figure 3.12).  It has also been previously noted in the lab that there can be significant 
variation between batches of purified endogenous sheep brain dynamin for unknown 
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reasons.  This may partly explain the discrepancies since different batches were used 
between Malachite Green and ELIPA. 
A confounding observation was a sigmoidal increase in the GTPase curve in the 
ELIPA approach, which did not lead to any detectable changes in dynamin assembly.  
This effect might be explained by some indefinite artefactual effect of the assay or the 
induction of unique changes in dynamin conformation as discussed above.  The 
sigmoidality may represent a secondary change in dynamin conformation, occurring at 
time points at which GTPase activity has not previously been assayed, with changes in 
the existing oligomer rather than formation of new ones.  This could possibly be resolved 
using dynamic light scattering (DLS) technique but was not pursued further.  However, it 
does not affect the data reported in this chapter since only the first 30 minutes of the 
assay was used to obtain the initial rates of activity.  The sigmoidal effect did not occur 
before the 60-minute assay time with any GST-SH3 domain used herein. 
Other experimental techniques which were considered to detail dynamin 
oligomerisation, and test the hypothesis discussed, include electron microscopy (EM) of 
oligomerised dynamin.  It would therefore appear to be useful for future studies to 
explore the oligomerisation in this chapter using EM techniques.  This was not deemed 
feasible, as all previous reports, and experience of the host lab, required 1-5 µM dynamin 
in order to detect rings by EM.  This is 10 to 50 times higher than the concentration used 
here and was considered to have an extremely high potential for artefact for reasons given 
above.  This was therefore not attempted.  Similarly, the binding affinity between the 
SH3 domain and dynamin, while easier to perform than EM, is well established for a 
number of SH3 domains.  This was however partly addressed by the pull-down 
experiments, which showed relative differences in dynamin binding between the SH3 
domains. 
 
3.7.4 The SH3 domains potentially most ‘relevant’ to dynamin and endocytosis 
The GTPase assays in this chapter were also performed in the presence of high salt 
(150 mM NaCl) instead of the low salt (30 mM) previously used by most laboratories, 
since this better mimics the physiological intracellular environment in which these 
proteins reside.  A high ionic concentration is known to be a stringent condition for 
dynamin assembly and any SH3, which stimulates dynamin at these conditions, has been 
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considered in the field to be of greater potential significance (Lin et al., 1997).  The 
extent of GTPase stimulation under high salt condition was therefore used as a measure 
of relevance of the SH3 to dynamin interaction. 
Dynamin ring formation has been only shown to occur in prior studies with the use of 
low ionic strength buffer (<50 mM NaCl) and stimulation at high salt conditions 
occurring only in the presence of an anionic lipid template (Hinshaw & Schmid, 1995; 
Sweitzer & Hinshaw, 1998; Stowell et al., 1999).  Performing this comparison in the 
present study therefore served the purpose of narrowing the number of SH3 domains that 
might be considered of greater relevance to cellular endocytic mechanisms.  The studies 
on sheep dynamin revealed the GST-SH3 domains of intersectin I A, SNX9 and, to a 
smaller extent, amphiphysin I as being strong dynamin activators under low and high salt 
conditions.  These results cannot be entirely attributed to these SH3 domains being good 
at simulating dynamin or promoting its pelleting at low salt, since that applies to GST-
syndapin I and GST-cortactin SH3s as well.  This further underlines that SH3 domains 
have a very specific effect on dynamin activity as explained by the distinct conformer 
hypothesis.  A future investigation should consider repeating the sedimentation analysis 
in Figure 3.7 at high salt to see if they are the only SH3s of the set to promote 
oligomerisation. 
It was GST-SNX9 SH3 domain which stood out as being the most unique, since it was 
the only one to be a better stimulator at high salt conditions.  This was in contrast to a 
previous study where GST-SNX9 full-length, but not the GST-SNX9 SH3 domain, 
stimulated dynamin GTPase activity in the presence of 150 mM KCl (Soulet et al., 2005).  
This raises the question of the influence of the other domains in each of the 13 proteins, 
not something feasible to be considered in the present study. 
Salt was also shown to have a role in switching splice variant sensitivity in stimulating 
human dynamin GTPase activity, with GST-SNX9 and GST-intersectin I A SH3s yet 
again being prominent.  In the presence of high salt, GST-SNX9 SH3 preferentially 
stimulates human dynamin Ibb while GST-intersectin I SH3A preferentially stimulates 
human dynamin Iab.  Physiological salt levels therefore helped illustrate that the middle 
domain is a major player in how the dynamin G domain activity is regulated by SH3 
domains. 
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3.7.5 Summary 
The underlying goal of this study was to use the GTPase stimulatory effect of SH3 
domains as a measure of their physiological relevance and to ultimately shed light on 
why so many endocytic SH3 domain proteins would bind dynamin.  By this measure 
GST-SNX9, GST-intersectin I A and GST-amphiphysin I SH3s, by their high stimulation 
of dynamin under most parameters examined, emerge as proteins of potentially greater 
functional relevance to cellular endocytosis. 
Finally, all SH3 domains used in this chapter retained their GST-tag, which is an 
artificial purification tag that introduces significant questions concerning the potential 
role for SH3 domain dimerisation in the interpretation of the data.  The ability of GST to 
dimerise and to sometimes dimerise the proteins to which it is tagged is well known and 
the following chapter will explore the role of this tag.  Moreover, dynamin activity is 
reported to be regulated by multivalent proteins such as divalent antibodies (Warnock et 
al., 1995) or Grb2 dual SH3 domains (Barylko et al., 1998).  Therefore, use of GST-
tagged proteins may not be a valid sole criterion for assessing the potential in vivo 
functional significance of these interactions (Warnock et al., 1995).  To obtain a more 
physiologically reliable effect of SH3 domains on dynamin GTPase activity a subset of 
SH3 domains were examined in detail in the absence of the GST-tag in the following 
chapter.  Surprisingly, it will be demonstrated that the removal of the GST-tag abolishes 
the stimulatory effect of all SH3 domains except that of SNX9.  The SNX9-dynamin 
interaction will therefore be the focus of investigation in the following two chapters. 
 
  
Figure 3.1: Pull-down of dynamin from synaptosomal lysate using GST-
SH3 domains as bait.
The relative binding of dynamin to individual GST-SH3 domains was compared by
incubation of each protein attached to GSH sepharose beads with rat brain
synaptosome lysate for 60 minutes (A) or 300 minutes (B) on ice. The beads for the
indicated GST-SH3 domains were washed and resolved on 10% SDS-acrylamide gels.
A Coomassie Blue stained gel is shown. The position of dynamin and the synapsin
doublet was determined by Western blot and by Mass Spectrometry of cut bands (not
shown). The position of each purified GST-SH3 domain is shown. Images are
representative of n = 3 independent experiments.
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Figure 3.2: Comparing maximum stimulation of dynamin by GST-SH3
domains using the Malachite Green assay.
(A) The basal sheep brain dynamin (100 nM / 9.6 µg/ml) GTPase activity in the
absence of SH3 stimulation is shown for NPA and PA conditions using the Malachite
Green GTPase assay. The basal activity results are compared to dynamin activity in the
presence of GST alone for the NPA (B) and PA (C) conditions. An equimolar GST-
SH3:dynamin protein concentration ratio of 1:1 was used for both assays. (D) A
concentration curve for each GST-SH3 domain was used to stimulate a fixed amount of
dynamin (100 nM / 9.6 µg/ml) and the maximum activity after incubation for 60
minutes is shown. The GST-SH3:dynamin protein concentration ratio at which
maximum GTPase activity was achieved for each SH3 domain is summarised in Table
3.1. The assay was performed under NPA and PA assembly conditions for all the GST-
SH3 domains, with NPA shown as the black column and the PA as red column. Each
assay was performed in the presence of low salt (30 mM NaCl). The X-axis indicates
the name of the GST-SH3 domain used. For both assays, the y-axis indicates the
GTPase activity (µmoles Pi/mg of dyn). All assays were performed in triplicate and n =
3 independent experiments, with values shown as mean activity ± S.E.M.
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Figure 3.3: Time course of GST-SH3 domain stimulation of dynamin under 
NPA conditions.
The ELIPA time course assay showing the stimulation of sheep brain dynamin (100 nM /
9.6 µg/ml) GTPase activity by GST-amphiphysin I SH3 (A), GST-SNX9 SH3 (B), GST-
FBP17 SH3 (C) and GST-intersectin I SH3A (D). A reading was taken every 30 seconds
over 240 minutes. The assay was performed under NPA condition in the presence of low
salt (30 mM NaCl), with the GST-SH3 domain being used at a fixed concentration (40
µg/ml). The curves above in black indicate the assay being initiated with the addition of
MESG 120 minutes into the reaction rather than at the beginning. For all the GST-SH3s,
neither of the ELIPA curves was subtracted for basal GTPase activity (dynamin alone,
without SH3 domain stimulation). The data is expressed as GTPase activity (µmole
Pi/mg of dyn) ± S.E.M. for every time point at which a reading was taken. For these and
subsequent ELIPA curves the error symbols are too small to be easily distinguishable by
eye. Data are means of n ≥ 3 for MESG added from the start, or n = 2 for MESG
addition after 2 hours.
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Figure 3.4: Time course of GST-SH3 domain stimulation of dynamin
activity under PA conditions using the ELIPA.
ELIPA time course assays showing the GTPase stimulation of sheep brain dynamin
(100 nM / 9.6 µg/ml) by GST-amphiphysin I SH3 (A), GST-SNX9 SH3 (B), GST-
FBP17 SH3 (C) and GST-intersectin I SH3A (D). The assay was performed under PA
conditions in the presence of low salt (30 mM NaCl), with the GST-SH3 domain being
used at a fixed concentration of 40 µg/ml. The ELIPA curves were not subtracted for
basal GTPase activity (dynamin alone, without SH3 domain stimulation). All data is
expressed as GTPase activity (µmole Pi/mg of dyn) ± S.E.M., at every time point at
which a reading was taken, and is means of n ≥ 3 independent experiments.
Figure 3.5: GST-SH3 domains stimulate different rates of dynamin
activity.
(A) GST-FBP17 SH3 stimulated dynamin GTPase curve under PA condition (same as
Figure 3.4C) is displayed as an example to illustrate the appearance of the sigmoidal
curve that starts about 120 minutes into the reaction (this is called the ‘sigmoidal
effect’). The rate of GTPase activity was derived by performing linear regression
analysis using GraphPad Prism software on the initial 2-30 minutes reaction time of
individual curves. (B-C) The initial rate of GTPase activity (µmoles Pi/mg of
dyn/min) is shown in the presence of 13 GST-SH3 domains under NPA (B) and PA (C)
conditions. The GTPase rate was derived from the ELIPA curves in Figure 3.4 and
Appendices 8.2 and 8.3. Basal dynamin activity (dynamin alone, without SH3 domain
stimulation) was subtracted from all values so that only the SH3-stimulated effect is
shown. This basal subtraction was performed for all rate data presented in this study.
All data is shown as means ± S.E.M. and n ≥ 3.
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Figure 3.6: The sigmoidal effect does not indicate a change in
dynamin assembly.
(A) ELIPA time course assay, from Figure 3.4 and Appendices 8.2 and 8.3,
showing the stimulation of dynamin GTPase activity by GST-cortactin SH3
(blue), GST-FBP17 SH3 (red) and GST-Abp1 SH3 (green). For all the GST-
SH3s, the ELIPA curves were not subtracted for basal dynamin GTPase activity
(dynamin alone, without SH3 domain stimulation). (B) Sedimentation analysis
of dynamin incubated with these GST-SH3 domains performed using filter spin
cups. The filter trapped oligomerised dynamin (called ‘pellet’) and the resulting
supernatant were collected and resolved on 10% SDS-acrylamide gels. The
protein was visualised following Coomassie Blue staining. Both the ELIPA and
sedimentation were performed under PA conditions in low salt (30 mM NaCl),
with incubation for 60, 120 or 200 minutes following GTP addition. These
reaction time points are indicated with an arrow in (A).
Figure 3.7: Sedimentation analysis of dynamin oligomerisation by 13 GST-
SH3 domains.
(A-C) Sedimentation analysis showing the effect of 13 GST-SH3 domains on
sedimentation of sheep dynamin under PA conditions in the presence of low salt (30
mM NaCl). The incubation of each GST-SH3 (40 µg/ml) with dynamin (100 nM / 9.6
µg/ml) was performed as for the Malachite Green assay, with the reaction following
preassembly lasting for 60 minutes in the presence of GTP. Two forms of sedimentation
analysis were used: ultracentrifugation at 70,000 x g for 10 minutes to precipitate the
oligomerised dynamin from the supernatant and filter spin cups to collect the
oligomerised dynamin (pellet) and supernatant following centrifugation for 2 minutes at
18,000 x g. All the samples were resolved on 10% SDS-acrylamide gels and the protein
was visualised using Coomassie Blue. The reaction volumes for sedimentation assays
were the same as for the GTPase assays (150 µl) to ensure enough dynamin to visualise
on the gel. Dynamin without any SH3 (“No SH3”) and dynamin incubated with GST
alone was a control for basal oligomerisation. The gel in (B) shows dynamin incubated
with PS liposome (10 µg/ml) as a maximum oligomerisation control. Each image is
representative of multiple experiments with the samples run in duplicate in each
experiment. In (D) the amount of oligomerisation was quantified by densitometric
analysis of the Coomassie stained SDS-acrylamide gels of the dynamin pellet. All data
expressed as fold change relative to No SH3 ± S.E.M. (n = 2). (E) A zoom is shown of
the amphiphysin II and CIP4 GST-SH3s from (D) comparing it statistically to the No
SH3 basal control. With the sedimentation assay being performed in duplicate, 4 data
points in total were used for the statistical analysis. One-way ANOVA was applied
followed by the Dunnett’s post-test (***, p < 0.001 against No SH3).
Abbreviations: AmphI/II, amphiphysin I/II; Endo I, endophilin I; ITNA/C/E, intersectin
I A/C/E; Sndp\nI, syndapin I.
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Figure 3.8: Salt dependency of the ability of GST-SH3 domains to
stimulate the rate of dynamin GTPase activity.
(A) The effect of purified recombinant GST-SH3 domains (40 µg/ml) on stimulation
of dynamin (100 nM / 9.6 µg/ml) GTPase activity under the PA conditions using
ELIPA in the presence of low (30 mM NaCl) and high (150 mM NaCl) salt. The rate
of GTPase activity stimulated by GST-SH3 domains under low salt (data from Figure
3.5C, shown here in red) is compared to the assay performed in parallel in the presence
of high salt (150 mM NaCl) (shown in blue). The GTPase rate was derived by
performing linear regression analysis of the initial 2-30 minutes of the time course
assay. Basal dynamin activity (dynamin alone, without SH3 domain stimulation),
performed under identical conditions (buffers, PA, salt concentration etc.), was
subtracted from the respective values so that only the SH3-stimulated effect is shown.
All data is shown as means ± S.E.M. and n ≥ 3. (B) A zoom of the low and high salt
values for GST-SNX9 SH3 shown from panel (A). A two-tailed Student t-test showed
significance (*, p < 0.05).
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Figure 3.9: Dynamin middle-domain splice variants.
(A) A line diagram of the primary structure of dynamin with domains labelled and the
‘a’ and ‘b’ middle domain alternative splice variants indicated in yellow. The three
purple domains dispersed in the linear sequence comprise the bundle signalling element
(BSE) in the crystal structure. (B) X-ray crystal structure of dimeric human dynamin
IbX colour-coded to match the line diagram above. (C) The top panel shows how the
tetramer consists of a dimer-of dimers. This tetramer represents the dominant species
of unassembled dynamin in solution. A zoom in the lower panel shows the interface
between the splice site α-helix (called the α2 helix) and the BSE that occurs between
two adjacent dimers, suggestive of a role for α2 in oligomerisation or tetramerisation,
but not in dimers. The spliced helix is shown in yellow. These images were prepared
using the program PyMol and the data from PDB Accession number: 3SNH
(http://www.rcsb.org/) (Faelber et al., 2011). (D) Middle domain splice variants have
different maximal activity. Relative GTPase activity (Malachite Green assay) of
recombinant purified human dynamin Iab or bb isoforms (200 nM) activity was
measured after 15 minutes in the presence of 300 μM GTP and PS liposomes (4 μg/mL)
or Grb2 (2.2 μM). The data is shown as means ± S.E.M. and n = 3.
The image in panel C was done by Michael Collett and the experiment in panel D was
performed by Michael Collett and Ainslie Whiting, both from the Cell Signalling Unit,
CMRI.
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Figure 3.10: GST-SH3 domain stimulation of the rate of GTPase activity is
determined by the middle-domain.
Effect of GST-SH3 domains (40 µg/ml) on the GTPase activity rate of purified
recombinant human dynamin middle domain splice variants Iab (red) and bb (blue)
(both at 100 nM / 9.6 µg/ml) determined using ELIPA. The assays were performed
under PA conditions in the presence of low salt (30 mM NaCl) (A) or high salt (150 mM
NaCl) (B). Basal dynamin activity (dynamin alone, without SH3 domain stimulation),
performed under identical conditions (buffers, PA, salt concentration etc.), was
subtracted from the respective values so that only the SH3-stimulated effect is shown.
All data is shown as means ± S.E.M. and n ≥ 2.
B.
Human dynamin Iab vs. bb
Low salt
Human dynamin Iab vs. bb
High salt
A.
Figure 3.11: Statistical analysis shows GST-SNX9 and GST-intersectin I
SH3A elicit a greater rate of GTPase activity in the presence of high salt
for both splice variants.
Statistical analysis by two-way ANOVA followed by Bonferroni’s post-test on the
human dynamin Iab and bb values shown in Figure 3.10 for GST-SNX9 SH3 (A) and
GST-intersectin I SH3A (B). The rate values for low salt (30 mM NaCl) are in red and
high salt (150 mM NaCl) values in blue. All data shown is ± S.E.M. with n ≥ 2 (*, p <
0.05 and **, p < 0.01).
A.
B.
hudynI ab hudynI bb 
*
hudynI ab hudynI bb 
**
Human dynamin Iab and bb
Low vs. High salt
GST-SNX9 SH3
Human dynamin Iab and bb
Low vs. High salt
GST-Intersectin I SH3A
Figure 3.12: Comparison of the ability of 13 GST-SH3 domains to
stimulate the rate of a mix of middle domain splice variants.
(A) The effect of GST-SH3 domains (40 µg/ml) on the GTPase rate of human dynamin
Iab+bb splice variants, which were mixed together at an equal molar ratio to a final
concentration of 100 nM / 9.6 µg/ml (green). These results are compared to the effect
of GST-SH3 domains on the GTPase rate of individual Iab (red) or Ibb (blue) splice
variants under PA conditions in the presence of low salt (30 mM NaCl) (from Figure
3.10A). Basal dynamin activity (dynamin alone, without SH3 domain stimulation),
performed under identical conditions (buffers, PA, salt concentration etc.), was
subtracted from the respective values so that only the SH3-stimulated effect is shown.
All data is shown as means ± S.E.M. and n = 3. (B) Statistical analysis by one-way
ANOVA followed by Bonferroni’s post-test applied to the GST-SNX9 SH3 data for the
three human dynamin I samples from (A) (***, p < 0.001).
**
hudynI ab hudynI bb   hudynI ab+bb 
Human dynamin Iab+bb vs. Human dynamin Iab and bb
Low salt
GST-SNX9 SH3    
A.
B.
Human dynamin Iab+bb vs. Human dynamin Iab and bb
Low salt
Figure 3.13: Species-dependent effect of GST-SH3 domains on
dynamin stimulation
The GST-SH3 domain stimulated rate of GTPase activity for combined human
dynamin Iab+bb (mixed at a 1:1 molar ratio) from Figure 3.12A (red) is compared
to the effect of GST-SH3 domain on the rate of endogenous purified sheep
dynamin I GTPase activity from Figure 3.5C (blue). The assays were done under
PA conditions with low salt (30 mM NaCl). The data is shown as means ± S.E.M.
and n = 3.
Human dynamin Iab+bb vs. Sheep dynamin I
Low salt
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CHAPTER 4: Effect of SNX9 SH3 domain on dynamin 
GTPase activity and oligomerisation 
 
GSTs are a seven class group of cytosolic detoxification enzymes that can exist as 
either homo- or heterodimers (Armstrong, 1997).  Both dimer subunits contain a 
glutathione-binding site and a xenobiotic site that can accommodate a wide variety of 
compounds.  The use of recombinant GST-tagged SH3 domains complicates the 
interpretation of experiments on dynamin, since all known GSTs are dimers (Armstrong, 
1997), which creates a risk of causing GST-tagged proteins to also dimerise (Panayotou 
et al., 1993).  Two types of dimers involving the SH3s are considered here: a) direct SH3-
SH3 dimers (rare) and b) indirect dimers involving other parts of the protein in which the 
SH3 domain is located (common, eg BAR domain proteins dimerise).  With the exception 
of endophilin SH3, the other SH3 domains used in this study are not known to be direct 
SH3-SH3 dimers but the potential exists for the second indirect dimer type due to the tag 
addition.  The NMR solution structure of endophilin A1 SH3 shows it forms a direct 
dimer (PDB accession number 3IQL, (Trempe et al., 2009)) and in CryoEM images this 
SH3 domain is able to dimerise in the full-length protein in some circumstances (Mim et 
al., 2012).  Those SH3 domains which are part of BAR domain proteins already form 
indirect dimers because BAR domains dimerise and structural studies have shown that 
typically the SH3 domain itself is not forming SH3-SH3 interactions within such dimers 
(Rao et al., 2010; Mim et al., 2012).  It has been suggested that the potential for GST-
fusion proteins to form indirect dimers could lead to artefactual cross-linking of dynamin 
and thereby potentially alter their binding and activation of dynamins, however none of 
these studies provided experimental support for these hypotheses (Gout et al., 1993; 
Warnock et al., 1995; Barylko et al., 1998).  For example, the dimerisation of GST-SH3 
from p85 did not affect its dynamin binding but its activity was not assessed (Gout et al., 
1993). 
Despite these concerns, Grb2 is the only SH3 domain-containing protein among those 
considered in this thesis which has previously been examined in both the GST-tagged and 
untagged forms for dynamin studies (Barylko et al., 1998).  In that study, the removal of 
the GST-tag decreased its ability to stimulate dynamin GTPase activity and assembly.  
This was interpreted by the authors as a potential cross-linking effect of the purification 
tag, although direct evidence was not provided for this conclusion.  In another study, 
163 
 
Grb2 was tagged with monomeric maltose binding protein and its dynamin binding 
properties were unchanged from the GST-tagged version, although GTPase activity was 
not assessed (Gout et al., 1993).  Grb2 is a non-ideal protein to use for such a study since 
it is already bifunctional through possession of two different SH3 domains, thus retaining 
any hypothetical crosslinking activity.  Untagged Grb2 is also known to dimerise in the 
crystal although not in solution (Maignan et al., 1995). 
A number of other studies have reported GST-tagged proteins expressed in bacteria as 
dimers detected by gel filtration, such as SH2 domains (Panayotou et al., 1993; Yang et 
al., 2009; Ladbury et al., 1995) or protein kinases (Baer et al., 2001).  Thus, the protein 
domain they are tagged to form indirect dimers.  The work in this Chapter specifically 
refers to such indirect dimers.  The GST-tag has also been reported to be beneficial in 
stabilising protein-protein interactions (Zhao et al., 2001; Kim et al., 2004).  In contrast, 
our lab previously reported that the GST-tagged SH3 domain of mixed lineage kinase 2 is 
not a dimer as judged by gel filtration (Rasmussen et al., 1998). 
The initial hypothesis of this Chapter was that the GST-tag was not interfering with 
the primary action of the SH3 domains on dynamin, supported by the lack of effect of 
GST alone on dynamin by two GTPase assays (Figure 3.2B and C for Malachite Green, 
ELIPA not shown) and sedimentation (Figure 3.7D).  However, the first outcome in this 
Chapter from screening the 13 SH3s where the GST-tag was cleaved away (referred to as 
CL-SH3s) was surprising.  Each one lost their ability to activate dynamin, with the single 
exception of SNX9, the only CL-SH3 domain to stimulate dynamin GTPase activity.  
This observation strongly correlated with the identification of SNX9 SH3 from the results 
in Chapter 3 as one of the three SH3s with potentially greater functional relevance to 
dynamin and cellular endocytosis (the other two being intersectin I and amphiphysin I).  
Given the importance of SNX9 in endocytosis, actin dynamics and mitosis and that it 
interacts with both dynamins I and II (Section 1.3), the focus of the subsequent work in 
this Chapter turned to SNX9. 
The specific goals of the work in this Chapter are to better characterise the SNX9 SH3 
interaction with multiple dynamins and to evaluate the action of the GST-tag.  This 
chapter has the following aims. 
1) Identify whether the GST-tag has an impact on the action of SH3 domain proteins.  
This will be achieved by re-evaluating the action of 10 SH3 domains on dynamin 
GTPase activity after removal of the GST expression tag by proteolytic cleavage 
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and purifying each in sufficient quantity to conduct relatively large scale 
biochemical assays.  This led to a subsequent focus on CL-SNX9 SH3 domain. 
2) Determine whether CL-SNX9 SH3 domain differentially stimulates multiple 
dynamin I isoforms or dynamin II.  This will be achieved using GTPase assays for 
endogenous sheep dynamin I, recombinant human dynamin Iab and bb middle 
domain splice variants and recombinant human dynamin IIab isoform. 
3) Evaluate the effect of SH3 domain mediated dynamin ring preassembly and the 
effect of salt on the stimulation of dynamin GTPase activity by CL-SNX9 SH3 vs. 
the GST-tagged protein to identify any effect of the tag. 
4) Test the decoupling hypothesis from the previous Chapter, which states that 
dynamin I GTPase activity do not always correlate, indicating the relative 
independence of these two properties.  This will be achieved using statistical 
analysis to help determine whether there is a link between these two dynamin 
properties. 
 
4.1 Most GST-cleaved SH3 domains fail to stimulate dynamin 
activity 
To determine whether the GST-tag was influencing the data collected in Chapter 3, the 
tag was removed by the use of either PreScission or thrombin protease, depending on the 
DNA plasmid construct in which the GST-SH3 domain was initially expressed 
(summarised in Table 2.4).  The proteolytic cleavage was performed on 10 of the 13 
GST-SH3 domains studied in the previous chapter.  GST-intersectin I SH3C, GST-CIP4 
and GST-p85 SH3s were not included, due to their low effects on dynamin GTPase 
activity, e.g. Figure 3.8 and 3.10.  The protein concentrations of the resulting CL-SH3 
domains were normalised to dynamin by Coomassie Blue staining on SDS-acrylamide 
gels and quantified by amino acid analysis using gas-phase chromatography (Table 2.12) 
to ensure they were used in equal concentrations to each other for these studies.  The 
GST-cleaved proteins used in this Chapter were all prepared from their GST-tagged 
counterparts and each was dialysed into the same buffer (TBS) as their GST-cleaved 
equivalent.  These steps were designed to ensure no residual buffer or contaminant issues 
could confound interpretation of the results. 
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4.1.1 Only CL-SNX9 SH3 stimulates dynamin activity 
The 10 CL-SH3 domains were first used to stimulate sheep dynamin I GTPase activity 
with same assay conditions used for their GST-SH3 domain counterparts in the previous 
Chapter and using both GTPase assay formats.  All purified CL-SH3s were used at 40 
µg/ml in both the assays, which is the same concentration used for the GST-SH3s used in 
the ELIPA in Chapter 3. 
Surprisingly, only CL-SNX9 SH3 stimulated sheep dynamin I in either assay, using 
the PA and low salt conditions (Figure 4.1A-B, data in 4.1B being presented as a time 
course).  The failure of the other 9 proteins, especially that of GST-intersectin I SH3A, to 
significantly stimulate dynamin raises the possibility that the GST-tag may have been 
increasing SH3 domain-stimulated dynamin activity non-specifically, such as through its 
ability to dimerise the SH3 domains. 
Next, the activity of CL- vs. GST-tagged SNX9 SH3 were directly compared in the 
same assay and a significantly higher rate of dynamin activity was detected for the CL-
SH3 species (Figure 4.1C and D).  Thus, CL-SNX9 SH3 is more potent than its 
corresponding GST-fusion form.  This contrasts with the previous report for a different 
SH3, where the GST-tag removal from Grb2 SH3 decreased but did not abolish dynamin 
stimulatory activity (Barylko et al., 1998).  The consequences of the GST-tag are 
therefore not universal across SH3 domains.  The results show that the effect of SH3 
domain itself can be distinct from the stimulation elicited by GST-SH3s.  One possibility 
is that the GST and CL forms modulate dynamin activity by different mechanisms. 
 
4.1.2 CL-SNX9 SH3 domain induces the greatest dynamin oligomerisation 
Sedimentation analysis was performed to assess the ability of 10 CL-SH3 domains to 
induce dynamin oligomerisation.  The same methods and buffers were used as described 
earlier in Chapter 3 for their GST-tagged counterparts (Section 3.4, Figure 3.7), using 
sheep dynamin I, PA and low salt conditions, as well as both spin cup and 
ultracentrifugation assays.  The results are shown on gels (Figure 4.2A and B) and 
quantified in the pellet from the spin cup method using densitometry (Figure 4.2C).  
Three of the 10 SH3s significantly increased dynamin oligomerisation (CL-Abp1, CL-
FBP17 and CL-SNX9 SH3), while the others did not.  Strikingly, that of SNX9 had the 
greatest effect, while intersectin I SH3A had none at all.  The result for CL-Abp1 and 
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CL-FBP17 is similar to the previous result for GST-amphiphysin II and GST-CIP4 SH3s, 
which significantly promoted dynamin oligomerisation without any increase in GTPase 
activity (summarised in Table 3.3, Figure 3.7E).  This is further evidence showing 
decoupling between GTPase activity and oligomerisation and indicates dynamin 
oligomerisation can occur in the absence of evoked GTPase activity. 
 
4.2 SH3 domains do not stimulate activity of an oligomerisation-
deficient dynamin mutant 
Before proceeding further, it is important to validate that the GTPase activity 
stimulated by CL-SNX9 SH3 domain involves dynamin oligomerisation rather than 
aggregation.  This was achieved by testing CL-SNX9 SH3, alongside the previous set of 
13 GST-tagged SH3 domains, on an oligomerisation-deficient dynamin mutant.  
Oligomerisation-deficient mutants were previously designed for dynamin crystallography 
studies, which were hindered for decades by the propensity of dynamin to self-assemble 
at the high concentrations required for crystal growth.  One of two such mutants is 
G397D in the middle domain, initially derived from a dynamin mutant screen in yeast.  
This was used to solve the first crystal structure of rat dynamin G domain (Ford et al., 
2011).  Binding of non-hydrolysable GTP causes wild-type dynamin to oligomerise in 
vitro but the G397D mutant is unable to self-assemble beyond a dimer.  The assembly-
deficiency is also reflected in the inability of this mutant to be activated by lipid. 
In the present study, the G397D point mutation was introduced into full-length human 
dynamin in both the Iab and Ibb middle domain splice variants and the proteins expressed 
in insect cells and purified (refer to Section 2.2.1.4).  Only the Ibb mutant was used for 
the study, since the other was poorly expressed in insect cells and protein yields were too 
low.  Firstly, the 13 GST-tagged SH3 domains from Chapter 3 were tested and none 
stimulated the activity of dynamin Ibb G397D above basal activity, except GST-
intersectin I SH3A (Figure 4.3).  This protein was by far the best stimulator of 
endogenous sheep dynamin I (Figure 3.8A) and maintained its potency with human 
dynamin Ibb even under high salt conditions (Figure 3.10B).  However, the stimulation of 
G397D by GST-intersectin I SH3A was very low, being about 6-fold lower than achieved 
with wild-type human dynamin Ibb in the same assay (Figure 4.3B). 
167 
 
Importantly, CL-SNX9 SH3 was also unable to stimulate G397D dynamin at all.  
Together, these observations support the concept that the increase in GTPase activity 
being observed with SNX9 SH3 domain is specifically dependent on dynamin 
oligomerisation, rather than non-specific protein aggregation.  It can be further concluded 
from this and previous data that while oligomerisation is necessary for any increase in 
GTPase activity, formation of oligomers doesn’t necessarily result in enhanced activity. 
 
4.3 Detailed characterisation of SNX9 stimulated dynamin activity 
The unique effect of CL-SNX9 SH3 was next investigated in more detail.  The cleaved 
domain and GST-tagged versions were compared using PA or NPA, low and high salt 
conditions and across four different dynamins (endogenous sheep dynamin I and 
recombinant human dynamins Iab and bb and IIab middle domain splice variants) to 
determine whether there may be isoform-specific differences in their actions.  Dynamin II 
was included at this point since much of the published work on SNX9 was done on this 
isoform (Lundmark & Carlsson, 2003; Lundmark & Carlsson, 2004; Shin et al., 2008; 
Haberg et al., 2008).  Only the IIab middle domain splice variant was available at the 
time of these experiments and the sequence of the two middle domains of dynamin II are 
equally different to the two in dynamin I, ie the ‘a’ middle domain of dynamin II is not 
equivalent to that of dynamin I (Appendix 8.8).  The CL- and GST-tagged versions of 
this SH3 were compared across all these parameters to delineate the effect of the GST-tag 
on SH3-dynamin interactions, since the data to this point does not support the idea that 
the GST-tag is crosslinking the proteins in all cases.  Modifying assembly and salt 
concentration is expected to help elucidate whether the assay conditions may be 
important determinants of the GST-tag effect. 
The results in Figures 4.4 to 4.6 compare CL- and GST-tagged SNX9 SH3 stimulation 
of the GTPase activity across the different dynamins in a complex series of multiple 
comparisons.  Due to the multivariate parameters being tested, the same data is organised 
in different formats across these three figures to provide a clearer picture of the effect of 
assembly and salt on dynamin, based on pair-wise comparisons in each figure (CL- vs. 
GST-SH3, low or high salt, or PA vs. NPA).  Each figure includes a schematic in panel 
A, summarising the variable and constant components of each assay in the graphs below.  
In the following three sections the results are systematically presented. 
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4.3.1 Stimulation of dynamin GTPase activity by CL-SNX9 SH3 
The data in Figure 4.4 is organised as pair-wise columns with the CL-SNX9 SH3 
(white bars) compared to the GST-SNX9 SH3 (red bars) across the four dynamins.  The 
PA low and high salt data for GST-SNX9 SH3 for all the dynamins, except dynamin II, 
comes from figures in the previous chapter.  This was valid as all these experiments used 
the same batches of enzyme and SH3 domain and results were highly reproducible 
between experiments.  Each panel in Figure 4.4 presents data from a particular assay 
condition:  Panel B and C show the results for PA in the presence of low and high salt 
respectively, with the results for NPA shown in panels D (low salt) and E (high salt). 
Firstly, the effect of CL-SH3 alone on the GTPase activity of the four dynamins is 
considered (white bars in Figure 4.4).  The effect of CL-SNX9 SH3 is compared between 
the dynamins, with the results that are statistically significant marked below each graph.  
Among the four dynamins used, CL-SNX9 SH3 stimulated the GTPase activity of 
dynamin IIab to the greatest extent, being significantly higher than sheep dynamin I 
across all tested conditions. 
Considering the dynamin I isoforms, CL-SNX9 SH3 stimulated the Ibb isoform to a 
greater extent relative to Iab in all conditions, consistent with the conclusions from the 
previous chapter about the sensitivity of the ‘b’ middle domain for GTPase stimulation 
and oligomerisation.  No statistical difference was detected between sheep dynamin I and 
Ibb activity under any condition.  There was however a noticeable increase in Ibb activity 
in the PA/low salt condition which was not statistically significant (Figure 4.4B).  
Considering the stimulation by CL-SNX9 SH3 of the dynamin Iab isoform, under PA 
conditions its action was reduced by about half in high salt (Figure 4.4C).  The NPA 
condition greatly reduced its activity under low salt (Figure 4.4D) but now high salt had 
little effect (Figure 4.4E). 
Overall, dynamin II appears to be the slightly preferred target for CL-SNX9 SH3 
stimulation.  This is compared not just to sheep dynamin I but also human dynamin Iab, 
which is stimulated to weaker extent than the endogenous variant across most conditions.  
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4.3.2 Analysis of the GST-tag effect on dynamin function 
Next, the effect of CL- vs. GST-SNX9 SH3 on the GTPase activity of the four 
dynamins is considered (Figure 4.4).  For the purpose of describing the data, CL-SNX9 
SH3-stimulated dynamin activity is considered the reference point.  Compared to this the 
GST-SNX9 SH3 stimulated dynamin to lower extent across all the dynamins, however 
significance was observed only for the human dynamin Ibb isoform, under the condition 
of PA and low salt (Figure 4.4B).  This trend was reversed with high salt, accompanied 
by its selectivity changing to the dynamin Iab isoform (Figure 4.4C).  Thus, the GST-tag 
has opposite effects for each dynamin isoform in the presence of low vs. high salt, i.e. the 
salt concentration in the assay determines both the middle domain isoform selectivity as 
well as the sensitivity to the GST-tag.  Similar results were obtained under the NPA 
conditions, when there was no pre-formation of dynamin rings by the SH3 domains, but 
the extent of difference became much greater (Figure 4.4D and E).  With NPA, low salt 
abolished GST-SNX9 stimulation of all three dynamin I samples but not that of dynamin 
II (Figure 4.4D).  In contrast, high salt reversed this effect such that the GST-tagged 
proteins stimulated all isoforms to an equal or greater extent than the cleaved version 
(Figure 4.4E). 
The influence of both the salt and assembly on the GST-tag effect can be statistically 
summarised by the use of the interaction P-value, which is a measure of overall 
variability generated by the two-way ANOVA.  The measure was performed between 
three dynamins by excluding dynamin II from this analysis.  Dynamin II is a different 
enzyme rather than a splice or species variant and excluding it avoids skewing the 
statistical analysis for the dynamin I forms. 
Interaction P-value tests the null hypothesis that any systematic differences between 
columns are the same for each row.  With the GTPase data organised in the format as 
shown in Figure 4.4, the null hypothesis can be formulated thus: any difference as a result 
of the GST-tag is consistent between the dynamins.  The interaction P-value was 
significant only for the data in panel E (NPA and high salt).  This shows that the GST-tag 
has a systematic effect across the dynamins under these conditions.  This significance 
arises because of the very high stimulation by GST-SNX9 SH3 of both the human 
dynamin I isoforms but also because of the lack of any GST effect on sheep dynamin I.  
Since the human dynamin I middle domain variants has a single PRD variant (the short 
‘b’ form) and the endogenous sheep dynamin I consist of a mixture of 2 or more PRD 
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isoforms, the result shows that not just the middle domain but also the PRD isoforms are 
contributing to differences in stimulation in a way that is influenced by the assay 
condition.  Under NPA high salt conditions, the mixture of multiple isoforms seems to 
suppress the GST-effect compared to the short form (‘b’) PRD in human dynamin I. 
In summary, the CL-SNX9 SH3 lacking the GST is able to stimulate dynamin GTPase 
activity but is highly influenced by the assay conditions.  While it stimulates to a 
significantly greater extent than GST-SNX9 SH3 across different dynamins in low salt 
(PA or NPA), this is reversed in the presence of high salt, where the GST-tag elicits 
greater activation.  This is more evident when there is no preassembly of dynamin by 
GST-SNX9 SH3 (Figure 4.4D and E).  This is a surprising series of observations, since 
increasing ionic strength typically reduces protein-protein interactions such as those 
necessary for dynamin stimulation.  The results show that the influence of the GST-tag is 
sensitive to both salt and assembly conditions, in a manner inconsistent with simple 
dimerisation alone.  Since salt up to 2 M does not reduce dimerisation of GST alone 
(although this statement is for the mammalian sigma GST rather than the recombinant 
blood fluke form used here), altered dimerisation of the GST-tag does not readily explain 
these effects (Stevens et al., 2000).  This suggests that the GST-tag induces a different 
activation mechanism to that of CL-SNX9 SH3, potentially by altering the conformation 
of the SH3 domain which it is tagging.  Alternatively, the GST-tag could result in 
formation of bifunctional SH3 proteins and have a crosslinking effect as shown by Sandi 
Schmid for bivalent antibodies of dynamin (Warnock et al., 1995).  It is possible to 
speculate that the same mechanism operates with the other GST-tagged SH3s. 
 
4.3.3 Effect of varying assembly and salt conditions on SH3 stimulated 
dynamin GTPase activity 
The data above was next re-organised using a different display format to provide 
additional insights into dynamin stimulation.  Figure 4.5 is organised as pair-wise 
columns across the four dynamins to more clearly show the salt effects comparing the 
low salt (white bars) with high salt (red bars).  Among the four panels a significant 
interaction P-value was only found for panel E.  This demonstrates that the increase in 
salt concentration under NPA conditions leads to a systematic difference in the GST-
SNX9 SH3 stimulated GTPase activity between the dynamins (Figure 4.5E).  The low 
difference between the salt conditions for the same assay conducted under PA reinforces 
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that the salt effect is weak when the GST-SNX9 SH3 is allowed to pre-form dynamin 
rings (Figure 4.5C). 
This comparison also highlights that removal of the GST-tag resulted in a greater salt 
inhibitory effect when the SH3 is allowed to pre-form the dynamin rings (Figure 4.5B).  
It is under the PA conditions that CL-SNX9 SH3 stimulation of GTPase activity was 
consistently better for low salt, which is opposite to the GST-SNX9 SH3 data.  The 
interaction P-value is not significant for this graph since the trend between the dynamins 
is the same.  In summary, the CL- and GST-SNX9 SH3 domains have very different 
effects on dynamin GTPase stimulation for both assembly and salt conditions, 
emphasising the above conclusion that these two proteins are acting by distinct 
mechanisms. 
Finally, the data in Figure 4.4 was re-organised a third time to observe the assembly 
effects.  Figure 4.6 more clearly show the effects of the PA (white bars) against the NPA 
condition (red bars).  In general, the effect of preassembly of dynamin rings results in 
greater stimulation of GTPase activity for both CL- and GST-SNX9 SH3 domains but not 
in all cases.  The main new observation emerging from this display format is in Figure 
4.6E, which uses the GST-tagged SH3 at high salt and compares the PA and NPA 
conditions.  The absence of preassembly of dynamin rings elicited a significantly greater 
stimulation of the Ibb than the Iab isoform.  In contrast, dynamin II activation was not 
different.  This underlines how the assembly conditions and not just salt concentration 
contributes to middle domain mediated stimulation.  This is also the only panel in this 
figure to have a significant interaction P-value, largely due to PA of sheep dynamin I by 
GST-SNX9 SH3 eliciting a significantly opposite effect relative to the dynamins Iab or 
Ibb.  A similar effect is observed on sheep dynamin I by CL-SNX9 SH3 under the same 
assay conditions (Figure 4.6D).  The interaction P-value is low (0.0513) but not 
significant.  This reinforces the conclusion arrived at in Figure 4.4E that the isoforms 
containing a mix of different PRDs are particularly sensitive to changes in assembly 
conditions. 
 
4.4 Sedimentation analysis of dynamin oligomerisation by SNX9 
SH3 
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With this data in hand it was necessary to extend the sedimentation analysis performed 
in Figure 4.2 to address the question of the correlation between dynamin oligomerisation 
and activation in more detail.  The goal was to compare oligomerisation of sheep 
dynamin I using CL- or GST-tagged SNX9 SH3 in the same experiment.  The incubation 
of dynamin and SH3s was performed under PA or NPA conditions and using low and 
high salt for each.  The sedimentation was performed using filter spin cups with both the 
pellet and supernatant run on SDS-acrylamide gels.  The pellet data was used for 
quantification by densitometry. 
The sedimentation assay was only performed on sheep dynamin I and the results are 
shown in Figure 4.7.  The sedimentation for PA (Figure 4.7B) and NPA (Figure 4.7D) 
was calculated as fold change relative to the No SH3 control for the high and low salt 
conditions respectively.  CL-syndapin I SH3 was included as a common control for the 
two conditions (NPA vs. PA) and the amount of dynamin in the pellet is a background 
oligomerisation. 
Both CL- and GST-SNX9 SH3s significantly increased oligomerisation after PA, 
regardless of the salt level (Figure 4.7B).  With NPA, dynamin oligomerisation was 
observed for SH3s under the all conditions except for GST-SNX9 SH3 under low salt 
(Figure 4.7D).  The latter result is consistent with GST-SNX9 SH3 not stimulating 
dynamin activity under NPA and low salt conditions (Figure 4.6C).  This confirms the 
previous conclusion (Section 4.2) that while oligomerisation may occur without an 
increase in GTPase activity above basal, the opposite does not apply. 
The higher oligomerisation under PA relative to the NPA assay protocol raises the 
issue of how well does the sedimentation correlate with the changes in GTPase activity 
under comparable assay conditions.  One of the aims of this chapter was to confirm the 
decoupling between dynamin oligomerisation and GTPase activity.  In the following 
section the sedimentation results in Figure 4.7 are statistically compared to the GTPase 
data for sheep dynamin I from Figure 4.4 to further investigate the link between SH3 
stimulated oligomerisation and GTPase activity. 
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4.4.1 Weak relationship between SNX9 SH3 oligomerisation of dynamin and     
stimulation of its GTPase activity 
As done above, the data for oligomerisation and activation was next re-organised 
using a three different display formats to better illustrate the conclusions.  To identify any 
correlation between activity and oligomerisation a pair-wise comparison was first done to 
compare PA with NPA conditions.  CL-SNX9 SH3 (red bars) was plotted pair-wise 
against GST-SNX9 SH3 (white bars) stimulation of sheep dynamin I GTPase activity 
across the salt conditions, to highlight the impact of PA assay conditions (Figure 4.8).  
Graphs on the left (panels A and C) show the oligomerisation data from Figure 4.7 while 
graphs on the right (B and D) show GTPase activity data from Figure 4.4.  The PA data is 
shown above (A and B) and the NPA below (C and D). 
Looking first at the PA conditions, the sedimentation data shows the GST-tagged form 
oligomerised better than the CL-SH3 in salt conditions (Figure 4.8A).  However, this is 
not reflected in the GTPase activity where, under low salt, GST-SNX9 SH3 stimulation is 
much reduced and the correlation is not retained (Figure 4.8B).  This contributes to the 
very low interaction P-value for activity, unlike the sedimentation data where this value is 
insignificant.  Turning to the NPA conditions, the same break in correlation between the 
two assays was observed for the low salt condition (Figure 4.8C and D).  Again, the 
outlier was the GST-tagged construct in low salt. 
Secondly, re-formatting the data to compare the effect of low vs. high salt the same 
trend was repeated (Figure 4.9).  The sedimentation shows either a relative decrease 
(Figure 4.9A) or no change (Figure 4.9C) in oligomerisation in the presence of high salt.  
This corresponds with effect of CL-SNX9 SH3 on GTPase activity but not with GST-
SNX9 SH3, which stimulates to markedly higher extent in the presence of high salt as 
attested by significant interaction P-values for both NPA and PA. 
Thirdly, comparison for the assembly effect again reveals the sedimentation analysis 
matched what would be expected.  With PA, where dynamin rings are pre-formed, there 
is significantly greater oligomerisation for both salt conditions (Figure 4.10A and C).  
However, unlike the previous two comparison formats, these changes are largely matched 
by the GTPase data for both the SH3s.  Both the sedimentation and GTPase data elicit a 
significant P-value at low salt assay conditions (Figure 4.10A and B), which is absent 
with an increase in salt concentration (Figure 4.10C and D).  The differences between 
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oligomerisation and GTPase activity of dynamin are less obvious when compared for 
changes elicited by assembly effect. 
In summary, statistical comparison of SNX9 SH3 data reinforces the novel finding in 
the previous chapter that changes in dynamin oligomerisation are not always reflected in 
changes to its GTPase activity.  Overall, this clearly illustrates that all activated dynamin 
examined in this study was oligomerised but all oligomerised dynamin detected was not 
necessarily activated.  Therefore, it can be concluded that the ability to oligomerise may 
be necessary for any increase in GTPase activity but the extent of oligomerisation does 
not always correlate with extent of GTPase activity. 
 
4.5 Unique effect of SNX9 SH3 on helical dynamin GTPase activity 
Next the effect of the GST-tag was examined in the context of helical dynamin, 
stimulated in vitro in the presence of the lipid PS (Takei et al., 1995; Sweitzer & 
Hinshaw, 1998; Stowell et al., 1999).  Most previous studies using lipid and SH3 
domains together have used the full-length forms which also contains the lipid tubulating 
BAR domain (Soulet et al., 2005; Yoshida et al., 2004; Ross et al., 2011).  However, this 
cannot reveal any specific effect of the SH3 domain itself and was therefore not done 
here.  CL- and GST-SNX9 SH3 domains were compared for their effect on PS-stimulated 
sheep dynamin I helical activity.  The Malachite Green assay was used to perform a 
concentration curve of the SH3 domains at a fixed PS concentration (2 µg/ml) under the 
standard PA conditions (Figure 2.4B).  It was performed as a competition assay with PS 
and the SH3s added simultaneously in the presence of dynamin, with GTP added 
following incubation.  The assay differed from the above studies in using much lower 
amounts of dynamin, 20 nM as opposed to 100 nM, since helical dynamin has higher 
intrinsic GTPase activity than dynamin rings.  Using a lower dynamin concentration 
allowed the read-out to be within the linear range of spectrophotometer. 
Both the CL- and GST-SNX9 SH3 domains had an inhibitory effect on helical 
dynamin GTPase activity at higher SH3:dynamin ratios of 4 and 8 (Figure 4.11A and B).  
This decrease was not observed with a different SH3 domain, GST-amphiphysin I SH3 
(Figure 4.11C).  The mechanism of this inhibition is not understood, partly due to the 
distinct action of SNX9 SH3 in forming dynamin rings, while the lipids stimulate helices 
around the template.  The protein constructs tested here have been shown to stimulate and 
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oligomerise dynamin by PA in the absence of a liposome template, therefore the effect 
observed is highly specific to SNX9.  Yet again, the data shows the unique action of the 
SNX9 SH3 domain on dynamin activity, which appears to be independent of its GST-tag. 
 
4.6 SNX9 is the only SH3 domain able to promote GTP binding 
Dynamin has a dual role during CME, which is characterised by differences in its 
oligomerisation state.  At the initial stages of endocytosis, dynamin is GTP-bound but 
unassembled and functions as a fidelity monitor (Mettlen et al., 2009; Aguet et al., 2013).  
The second stage involves dynamin constricting the invaginating vesicle by 
oligomerisation-stimulated GTPase activity around the membrane neck (Hinshaw & 
Schmid, 1995; Mettlen et al., 2009).  The stimulation of GTPase activity by SNX9 shown 
in this study suggests it could be involved as an accessory protein in facilitating the 
second stage.  This however does not rule out that increased GTP binding could be 
important.  It is possible that some of the CL-SH3s which were unable to stimulate 
dynamin activity or oligomerisation may instead be promoting GTP binding to dynamin 
but not its hydrolysis. 
To test this a GTP binding assay using the slot blot technique was developed.  All the 
CL-SH3s that did not stimulate dynamin GTPase activity, along with CL- and GST-
SNX9 SH3 domains, were used to preassemble sheep dynamin I in the presence of low 
salt.  Radioactive GTP (α-32P) and non-radioactive GTP were added, followed by UV 
crosslinking of the bound GTP to dynamin.  In this design, α-32P is used so that even after 
GTPase activity the labelled phosphate stays with the GDP product, such that binding of 
both GTP and any newly generated GDP are detected.  The samples were applied to a 
nitrocellulose membrane using the slot blot apparatus and the dried membrane was 
exposed to a storage phosphor screen overnight with phosphorimaging performed using 
Typhoon FLA9500 (GE biosciences).  Representative images are shown (Figure 4.12A 
and B) and the data from replicate experiments was quantified from the phosphorimaging 
software (Figure 4.12C).  The data revealed that CL- and GST-SNX9 SH3s were the only 
SH3 domains tested able to increase GTP binding.  Most of the other 9 CL-SH3s had no 
effect, except for CL-Abp1 SH3, which caused a much smaller increase in GTP binding.  
The results show that none of the tested SH3s promote GTP binding to dynamin, in 
addition to not stimulating GTP hydrolysis.  Therefore, these CL-SH3s are unable to 
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affect dynamin at all.  In contrast, the data confirms by another independent method the 
unique action of the SNX9 SH3 domain which stimulates both GTP binding and 
hydrolysis. 
 
4.7 Discussion 
All previous studies have utilised recombinantly expressed fusion proteins of the SH3 
domain and GST purification tag.  However, the GST has a tendency to dimerise (Gout et 
al., 1993; Herskovits et al., 1993b; Barylko et al., 1998) and this was also demonstrated 
for the one SH3 domain protein, Grb2, which was studied in its non-fusion form (Barylko 
et al., 1998).  GST-Grb2 was found to exist primarily in a dimeric state and the cleavage 
of the GST resulted in significant reduction in its ability to oligomerise dynamin and 
stimulate its activity.  Amphiphysin I is the only other SH3 protein to be studied without 
a purification tag and was shown not stimulate or assemble dynamin in the CL form 
(Yoshida et al., 2004).  The aim of this study therefore was to remove the GST-tag from 
the constructs investigated in Chapter 3 in order to study the effect SH3 domains 
themselves could be having on dynamin. 
Based on the previous literature on GST proteins it was hypothesised that all the CL-
SH3s would have a reduced stimulation of dynamin GTPase activity and assembly.  
However, the results demonstrated all the CL-SH3s, with the exception of SNX9, have no 
effect on dynamin, in sharp contrast to their GST-fusion forms.  CL-SNX9 SH3 had a 
unique and potent effect on dynamin GTPase activity and further detailed studies on 
SH3-dynamin interaction were limited to this protein. 
The key findings in this chapter showed remarkable diversity in the way SH3 domains 
stimulate dynamin GTPase activity and/or oligomerisation and provide further evidence 
that oligomerisation of dynamin does not always stimulate its activity.  The main results 
are summarised below: 
 Discovered the SNX9 SH3 domain to be unique among all 10 endocytic CL-SH3s 
in its ability to stimulate dynamin GTPase activity under the standard assay 
condition (PA low salt) and to promote GTP binding to dynamin. 
 Demonstrated that the increase in GTPase activity in the presence of all SH3 
domains was dependent on dynamin oligomerisation using an assembly deficient 
dynamin Ibb mutant, G397D. 
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 Revealed CL-SNX9 SH3 can stimulate dynamin GTPase activity to a 
significantly greater extent than GST-SNX9 SH3. 
 Uncovered major differences between isoforms of human dynamin I middle 
domain to be activated by SH3 domains. 
 Revealed that CL-SNX9 SH3 stimulated the greatest GTPase activity for dynamin 
IIab compared to sheep dynamin I and human dynamin Iab variant, across the 
different salt and assembly assay conditions. 
 Established, using statistical comparison of sheep dynamin I GTPase and 
oligomerisation data that changes in these two properties of dynamin can be 
decoupled under certain assay conditions. 
 Discovered that helical dynamin GTPase activity is inhibited by the SNX9 SH3 
domain in both its CL and GST forms. 
 
4.7.1 SNX9 SH3 domain has a unique effect on dynamin activity 
Apart from SNX9, removal of the GST-tag abolished the ability of all tested SH3 
domains to stimulate dynamin, although the ability to oligomerise dynamin was retained 
in many of them.  It is not surprising that SNX9 SH3 was the outlier in the group of 10 
domains since it was a standout protein in the GST-SH3 domain analysis performed in 
the previous chapter.  For example, GST-SNX9 SH3 was unique in being able to 
stimulate dynamin activity to a greater extent in the presence of high salt (Figure 3.8B).  
However, given the potent and rapid GST-intersectin I SH3A effect, it was surprising to 
observe essentially no activity in its GST free form.  Increasing the concentration of the 
non SNX9 CL-SH3s by up to 10 times did not lead to an increase in dynamin GTPase 
activity (data not shown) as it did for CL-Grb2 (Barylko et al., 1998), ruling out a 
concentration artefact. 
Did removal of the GST-tag cause most of the SH3 domains to fold improperly?  
Future studies can control for this possibility by generating the functional CL-Grb2 in 
parallel with the set of SH3s studied here before testing them on dynamin.  Without a tag, 
and being such small proteins, unique assays would need to be developed to check for 
dynamin binding by another method.  Performing circular dichroism (CD) to determine 
appropriate protein folding was considered but was deemed not necessary since protease 
cleavage of SH3 domain fusion proteins is reasonably well established in structural 
studies and the domains robustly fold.  It is also well established from previous studies in 
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our lab that at least two tested CL-SH3 domains can fold properly.  Dr. Lin Luo, Cell 
Signalling Unit, CMRI, had used CL-syndapin I and CL-endophilin I SH3 domains to 
determine the nature of their binding to dynamin PRD by employing NMR spectroscopy 
and ELISA (Usyd PhD thesis (Luo, 2012)).  These CL-SH3 domains were produced by 
the same on-bead digestion protocol used in this study.  There are also a number of 
crystal structures of SH3 domain proteins which have been generated using CL-SH3s.  
Moreover, improper folding would possibly have resulted in the formation of insoluble 
precipitates, which were not observed. 
The studies of CL-SNX9 SH3 on human dynamin I middle domain isoforms 
demonstrated that this splice site has a major influence on how dynamin is oligomerised 
and activated, despite it not being the binding site for the SH3 domains.  The observations 
reinforced the conclusions regarding the isoform specificity and GTPase activity from the 
Chapter 3.  CL-SNX9 SH3 activated human dynamin Ibb to a significantly greater extent 
than human dynamin Iab.  This isoform selectivity was maintained in the presence of all 
assembly and salt conditions and not just PA low salt, as demonstrated previously in this 
study for GST fusion proteins.  Moreover, the sensitivity of CL- and GST-SNX9 SH3 to 
a particular middle domain isoform can switch depending on the salt condition, as shown 
by the comparison between low and high salt conditions in Figure 4.4 for both PA and 
NPA.  This demonstrates that the middle domain of dynamin confers specific functional 
properties due to both the salt condition and GST-tag effect.  Endogenous sheep dynamin 
I, which consists of a mixture of PRD isoforms, was shown to be particularly sensitive to 
changes in assembly conditions.  This indicated not just the middle domain but also the 
PRD isoforms contributing to differences in GTPase activity in a way that was influenced 
by the assay condition. 
One potential explanation for this data lies within the dynamin crystal structure and 
the role of the spliced middle domain α2 helix in dynamin oligomerisation.  The crystal 
structure of dynamin IbX IHGIR-395-399 ΔPRD shows that a tetramer is produced by a 
unique interaction between the middle domain of one dynamin dimer with the BSE of the 
neighbouring dimer (intermolecular BSE-stalk interaction) (Faelber et al., 2011).  The 
intermolecular BSE-stalk interaction is mediated by a salt bridge between R440 (in the 
spliced α2 helix) and D744 (in the BSE) and cells overexpressing alanine mutants of 
these residues in dynamin II show increased transferrin uptake (Faelber et al., 2011).  The 
Faelber and Daumke study therefore proposed that the middle domain influences the G 
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domain via the intervening BSE.  In relation to the present study, the two different middle 
domain α2 helices from the Iab and Ibb isoforms may therefore respond differently to salt 
conditions used here.  In turn this could be reflected in differences in splice variant 
oligomerisation and activity. 
The CL-SNX9 SH3 preferentially stimulated the dynamin II variant compared to 
sheep dynamin I and the human dynamin Iab.  As noted in the Introduction Chapter, 
dynamin II has a greater propensity to self-assemble than dynamin I (Warnock et al., 
1997).  This suggests dynamin II could be the preferred physiological target of SNX9 in 
terms of GTPase stimulation.  Similar specificity was noted for the action of the Ryngo® 
chemical compounds which Dr. Anna Mariana from CMRI showed to activate dynamin 
and induce conformational changes in that protein (USyd PhD thesis (Mariana, 2014)).  
The compounds in the Ryngo® series had a high degree of selectivity for dynamin II.  The 
action of the Ryngo® series, like the SH3 domain proteins, induces dynamin ring 
formation rather than template mediated helix oligomer.  This lends support to the 
hypothesis that Ryngo® compounds mimic the effect of SH3 domains on dynamin in 
vivo. 
In some actin-based diseases such as chronic kidney disease, dynamin is degraded by 
proteolysis mediated via cathepsin-L (CatL) protease.  Dr. Nick Gorgani from CMRI 
found all the Ryngo® compounds stabilise dynamin in vitro against such proteolysis for 
hours (manuscript to be submitted).  CatL was previously found to be involved in 
proteinuric kidney disease and it is upregulated in rodent models for nephropathy (Sever 
et al., 2007).  Elevation in cytoplasmic CatL occurs due to expression of the short form of 
the protein and correlates with dynamin protein loss during the induction of glomerular 
kidney disease (Sever et al., 2007).  Due to the similarity in action with the Ryngos, this 
raises the possibility that SNX9 could potentially be preventing such proteolysis in vivo. 
There is also increasing evidence which suggests an in vivo association between 
dynamin rings and actin filaments (Sever et al., 2013).  Short F-actin filaments are able to 
promote the formation of dynamin rings, which act by uncapping gelsolin (an actin-
capping protein), resulting in actin polymerisation and elongation (Gu et al., 2010).  
Mutant dynamin forms which favour the ring state have been demonstrated to stabilise 
actin cytoskeleton in podocytes (Sever et al., 2007).  SNX9 SH3 domain could be a 
potential physiological regulator of such dynamin rings in cells.  There could potentially 
be a role for SNX9 in regulating actin dependent mode of endocytosis, which is 
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demonstrated to occur in certain cells (Kaksonen et al., 2006; Fricke et al., 2010).  
Furthermore, since the site of actin interaction with dynamin is the spliced α2 helix, it is 
possible that the two middle domain splice variants could play distinct roles in this 
process. 
The data overall indicates that SNX9 SH3 is acting on dynamin by a different 
mechanism to the other GST-fusion proteins.  One of the most striking results in favour 
of a distinct mechanism of action for CL-SNX9 SH3 came from the assay comparing the 
salt effect.  GST-SNX9 SH3 was better at stimulating dynamin at high ionic condition 
than in a low salt environment.  This is opposite to what was observed for CL-SNX9 SH3 
and was most evident in the NPA low salt condition (Figure 4.4D) where GST-SNX9 
SH3 does not stimulate at all.  This was surprising since protein-protein interactions, 
necessary for dynamin stimulation, occur more readily under low salt conditions.  It may 
also be that weak ionic interactions could in turn reduce the hydrophobic interactions, 
which might be particularly necessary for GST-SNX9 SH3 stimulation of dynamin 
activity.  The lack of effect on dynamin activity under this particular condition was 
consistent with the result for GST-SNX9 SH3 in literature and underlines the importance 
of a systematic approach before making conclusions about SH3-dynamin interactions 
(Soulet et al., 2005). 
This supports the morpheein hypothesis discussed in the previous chapter (Section 
3.7.1) whereby CL-SNX9 SH3 elicits formation of active dynamin conformers with 
particular properties that are distinct from dynamin oligomerised by GST-tagged SH3 
domains.  To test this hypothesis future studies will be required to show that the active 
and inactive oligomerised dynamin have distinct structural characteristics.  This might be 
revealed by future EM or cryo-EM studies to compare the dynamin rings generated under 
each condition.  Alternatively, DLS or chemical cross-linking studies may distinguish the 
oligomer types and show whether either represents specific ring or other form of 
oligomerisation. 
An alternative explanation for the data in this chapter is that removal of the GST-tag 
dramatically reduces the affinity of each SH3 domain for dynamin, except that of SNX9.  
This hypothesis can be tested in the future by specific affinity studies.  This was not done 
here as most such studies rely on the presence of the GST-tag.  However, they are 
possible with DLS or surface plasmon resonance approaches 
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4.7.2 Dynamin assembly can be decoupled from its activity 
Statistical comparison of SNX9 SH3 domain’s ability to stimulate or oligomerise 
dynamin demonstrated that the two properties can be decoupled.  This supported and 
extended the idea first suggested in Chapter 3, which was largely based on sheep 
dynamin I.  The comparison of GST-SH3 stimulated activity and oligomerisation in 
Chapter 3 (Table 3.3) revealed decoupling to occur in the presence of GST-intersectin I 
SH3A but also to a lower extent with GST-SH3 domains of amphiphysin I, SNX9 and 
endophilin I.  In this Chapter, this decoupling was evident when comparisons were made 
in the CL- vs. GST-SNX9 (Figure 4.8) or high vs. low salt (Figure 4.9) formats but much 
less evident when the format was changed to PA vs. NPA (Figure 4.10).  The statistical 
comparison of SNX9 SH3 data reinforces the novel observation in the previous chapter 
that dynamin oligomerisation is not always directly correlative to changes in its GTPase 
activity. 
In Chapter 3, the GST-SH3 domains of amphiphysin II and CIP4 SH3s stimulated 
dynamin oligomerisation, despite no observable increase in dynamin activity, suggesting 
GTPase activity-independent oligomerisation (Table 3.3, Figure 3.7E).  This was 
extended in this Chapter for CL-Abp1 and CL-FBP17 SH3 domains, which pelleted 
dynamin without a concomitant stimulatory effect on activity.  The data for G397D 
oligomerisation deficient mutant, where all GST-SH3s and CL-SNX9 SH3 failed to 
stimulate its activity (Figure 4.3), indicated that dynamin oligomerisation is a prerequisite 
for any stimulation of GTPase activity.  In other words, GTPase active dynamin always 
appears to be oligomerised but oligomerisation does not always result in stimulated 
activity or GTP binding.  This conclusion was missed in previous studies that all utilised 
a single SH3 domain and was possible only by the multiple comparisons employed here.  
The converse, an increase in GTPase stimulation in the absence of oligomerisation was 
not observed. 
The findings shed new light on dynamin function, since it is almost an axiom in this 
field that the extent of GTPase activity is directly dependent on its assembly state 
(Hinshaw & Schmid, 1995; Warnock et al., 1996; Stowell et al., 1999; Song et al., 
2004b) (Figure 1.7).  Unassembled dynamin has a low intrinsic GTPase activity, referred 
to as its basal activity.  Assembly into rings results in a 2-10-fold increase in GTPase 
activity relative to the basal activity (Warnock et al., 1996) and further assembly into 
helices in the presence of templates such as liposomes can result in 20-100-fold increase 
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in GTPase activity (Hinshaw & Schmid, 1995; Stowell et al., 1999; Song et al., 2004b).  
It is however not clear what the physiological significance of this finding could be.  This 
decoupling conclusion provides further support for the morpheein model of dynamin 
assembly.  In this model dynamin oligomerisation occurs in at least two conformational 
states, or conformers, where only one supports stimulation of activity.  This is supported 
by the crystal structure of the dynamin tetramer that is structurally dynamic with multiple 
conformations present (Reubold et al., 2015).  It is possible that SH3 domains can 
interfere with tetramer equlibrium to promote distinct dynamin conformations, which 
form oligomers with varying activities or none. 
There is the possibility of a technical limitation by arriving at these conclusions based 
only on sedimentation analysis.  In particular, the conclusion arising from the SH3s 
eliciting assembly in the absence of a stimulatory effect on activity needs to be tested 
using alternative techniques such as DLS.  However, the decoupling of oligomerisation 
and GTPase activity under different conditions and multiple comparisons strengthens the 
conclusion about there being a less than clear relationship between these two properties.  
An added novelty of this study was that GTPase and sedimentation assays were 
performed under the exact same assay conditions and protein concentrations, unlike some 
previous investigations (Ross et al., 2011). 
 
4.7.3 SNX9 SH3 and dynamin helical activity 
Previous studies demonstrated a synergistic effect on helical dynamin activity in the 
presence full-length SH3 domain proteins which also contain the lipid tubulating and 
dimerising BAR domain (Barylko et al., 1998; Yoshida et al., 2004; Ross et al., 2011).  
The SH3 domain itself has not been demonstrated to have any effect on this mode of 
dynamin activity.  Here SNX9 SH3 was demonstrated to be an exception to this by 
suppressing the helical dynamin GTPase activity.  A previous study on dynamin-
membrane interactions, not GTPase activity, showed SNX9 SH3 domain alone has no 
influence (Ramachandran & Schmid, 2008).  The results of the current study suggest that 
the inability to enhance dynamin-membrane interactions doesn’t necessarily translate into 
any alteration in GTPase activity. 
It is difficult to interpret this data due to its apparent contradiction with the effect of 
SNX9 SH3 in promoting dynamin ring formation.  It does appear that ring or helix 
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structures are conformationally distinct species, which might play different biological 
roles.  However, it remains unclear to what extent dynamin ring function is distinct from 
its role as helices.  Dynamin helices are well known to be involved in endocytosis, at the 
point of vesicle fission and release into the cytosol.  Since GTP hydrolysis drives this 
process, the data for SNX9 suggests it could be having a role in suppressing endocytosis 
or alternatively be involved in disassembling the dynamin helix just as fission occurs.  
This latter role for SNX9 is consistent with TIRF microscopy data which showed SNX9 
to have an unusually late localisation pattern with its concentration at the site of clathrin 
pits peaking soon after vesicle scission (Taylor et al., 2011).  Alternatively, SNX9 SH3 at 
higher concentrations may be sequestering the dynamin into another complex, which 
prevents it from forming a helix rather than directly affecting helix activity. 
The effect of SH3 domain proteins on dynamin helical activity is often dependent on 
the type of template being used, with full-length amphiphysin I shown to massively 
stimulate or inhibit dynamin in the presence of large or small liposomes (Yoshida et al., 
2004).  Since the main focus of the study was on SH3 stimulated dynamin ring formation, 
the effect of SH3 domains on lipid stimulated helical dynamin activity was not 
extensively studied. 
 
4.7.4 Other possible mechanisms of SNX9 SH3 action on dynamin 
Changes in the properties of dynamin do not appear to be sufficient to explain the 
specificity of SNX9 SH3.  Therefore, changes in the SH3 itself could be significant.  
Alongside the morpheein conformer hypothesis mentioned earlier, further speculation is 
possible on the distinct mechanism of action of CL-SNX9 SH3.  It cannot simply be 
explained by sequence alignment, since the divergence of SNX9 SH3 relative to other 
SH3 domain sequences is not particularly unusual (Figure 2.1 and Figure 2.2). 
The absence of the GST-tag could be eliciting a change in the folding of other SH3 
domains which is distinct from that of SNX9 SH3.  Such a proposed structural difference 
might in turn lead to changes in the way these SH3 domains interact with dynamin and 
can be experimentally determined by CD spectroscopy.  Such a structural change in the 
SH3 domain with or without the tag is unlikely, since SH3 domains are always found as 
independently folding entities within large proteins, with a well defined β-barrel structure 
(Figure 1.8) providing it with stability.  Its conformation is unlikely to be influenced by 
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the neighbouring GST.  However, only future systematic structural studies can clearly 
resolve these questions. 
In the following Chapter, mutational analysis to map the SNX9 SH3 domain binding 
site in the dynamin I PRD revealed it has an unusual binding mechanism relative to other 
SH3 domain proteins.  This was particularly striking in relation to the role of the dynamin 
I PRD central region (residues G797 to P803).  Performing GTPase assays using 
recombinant dynamin constructs consisting of mutants from this region would help 
determine the contribution of this region to the unique effect of SNX9 SH3 on dynamin 
activity.  Furthermore, the SNX9 SH3 domain has a phosphosite at Y56 (Worby et al., 
2001; Childress et al., 2006), located in a position predicted to block binding to target 
proteins like dynamin.  Thus, it will be useful to investigate whether phosphorylation at 
this site has a regulatory role in SH3 dimer formation and its subsequent activity. 
The full-length form of 6 of the SH3 domains (amphiphysin I/II, endophilin I, 
syndapin I, CIP4 and FBP17) contain the BAR domain, which has a well-established 
ability to dimerise (Peter et al., 2004; Shimada et al., 2007).  The other non-BAR domain 
containing proteins, intersectin, cortactin and Abp1 also have the capacity to form dimers 
in their full-length form but the evidence for this is relatively weak (Ahmad & Lim, 2010; 
Wong et al., 2012; Weihing, 1988; Huang et al., 1997; He et al., 1998; Dieckmann et al., 
2010).  The GST-tag studies performed here indicate that these SH3 domains have no 
effect on dynamin activity in their monovalent forms.  The SH3 domain of SNX9 is 
likely to be an exception to this since it has been demonstrated by NMR structural studies 
not to form a dimer in solution (PDB: 2ENM, the structure is not published but available 
in the database).  The role of SH3 valency and GST dimerization in stimulating dynamin 
activity could be investigated in future studies by modulating the GST-SNX9 SH3 to 
mimic CL-SNX9 SH3.  One way to do this is by generating a GST-SNX9 SH3 construct 
where the GST has mutations introduced which prevent dimer formation. 
SNX9 SH3 was also shown to have an unusual structure with an extended RT-loop.  
This divergent SH3 structure might explain the exceptional biochemical effect of SNX9 
on dynamin.  Precedence for such a structural relationship on SH3 activity exists for 
amphiphysin II SH3 (Owen et al., 1998).  A specialised assay, not employed in this 
study, was used to demonstrate that dynamin which was self-assembled at a high 
concentration (500 nM) could be specifically disassembled by amphiphysin II SH3 
(containing a six histidine purification tag but not a GST).  Mutational analysis combined 
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with binding assays suggested that this occurs as a result of an unusual n-src loop and a 
prominent patch of negatively charged residues in the SH3 domain of amphiphysin II.  A 
similar approach could be employed to establish details of the link between SNX9 SH3 
activity and its structure. 
 
4.7.5 Summary 
The present studies on SH3 domains showed that the GST-tag has a major influence 
on the ability to each to stimulate dynamin activity and oligomerisation.  Each GST-SH3 
acts specifically on dynamin with no general effect being observed.  However, the 
removal of the GST-tag abolished the stimulatory function of all but one of the SH3 
domains.  The data provides a new evaluation of the previous conclusions that 
oligomerisation and activity are always coupled and confirmed that oligomerisation is 
necessary for any increase in GTPase activity but revealed that formation of oligomers 
doesn’t necessarily result in enhanced activity.  The lack of GTPase stimulation by most 
CL-SH3s raises the possibility that this may not be a significant function of SH3 domain 
proteins in vivo, unless these proteins were endogenously present in a bivalent structure.  
In contrast, it is possible that the SH3 domain of SNX9 is a physiological stimulator of 
dynamin.  This protein is also unique in promoting GTP binding to dynamin.  It is 
possible to speculate that the other SH3 domains, which did not promote GTPase activity 
or oligomerisation, may instead act as adaptors in localising dynamin to the site of 
endocytosis. 
In summary, this Chapter highlighted the SNX9 SH3 domain as being able to 
consistently stimulate dynamin oligomerisation, GTP binding and activity, regardless of 
the GST-tag.  This protein also had remarkably different actions on either dynamin I or II 
or on the splice variants of dynamin I, suggesting that each isoform oligomerises by 
distinct mechanisms.  Due to the unique and specific action of SNX9 it was decided to 
investigate its binding mechanism to the dynamin I PRD in the following chapter.  This is 
a crucial step towards further investigations into SNX9’s functional role in regulating 
dynamin in cells. 
 
 
 
Figure 4.1: Only CL-SNX9 SH3 stimulates dynamin GTPase activity.
(A) Ten GST-tagged SH3 domain proteins were cleaved by proteolysis to remove the
GST-tag and were repurified. The CL-SH3 domains were incubated at single
concentration (40 µg/ml) with endogenous purified sheep brain dynamin I (100 nM /
9.6 µg/ml) to determine their effect on maximum dynamin GTPase activity using the
Malachite Green assay. The experiment was performed under the PA and low salt (30
mM NaCl) conditions. The data is shown as ± S.E.M. and n = 2 experiments, each
performed in triplicate. (B) The same experiment was conducted using the ELIPA time
course assay and time curves are shown rather than activity rates. The SH3 domains
were: CL-SNX9 SH3 (red), CL-Abp1 (green), other CL-SH3s (blue) and the no SH3
basal dynamin curve (black). The activity curves shown are the mean ± S.E.M. for n 
3 independent experiments. The error bars are not easily distinguishable for the ELIPA
curves since the individual data points are close to each other with the readings taken
every 30 seconds. (C) ELIPA time course curves for CL-SNX9 SH3 from (B) and
GST-SNX9 SH3 from Figure 3.4B for up to 240 minutes. (D) The initial rates of
GTPase activity by ELIPA are compared between CL- and GST-SNX9 SH3s, in red and
purple respectively. Basal dynamin activity (dynamin alone, without SH3 domain
stimulation) was subtracted from all values so that only the SH3-stimulated effect is
shown. All data is shown as means ± S.E.M with n  3. Two-tailed Student t-test was
performed for CL- and GST-SNX9 SH3 values (*, p < 0.05).
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Figure 4.2: Dynamin oligomerisation stimulated by CL-SH3 domains.
(A-B) Sedimentation analysis of ten CL-SH3 domains which were incubated with sheep
dynamin I under PA condition in the presence of low salt (30 mM NaCl). The
incubation conditions of each SH3 domain (40 µg/ml) with dynamin (100 nM / 9.6
µg/ml) was performed exactly as for the Malachite Green assay, with 60 minutes PA
followed by 60 minutes in the presence of GTP. Two forms of sedimentation analysis
were used; ultracentrifugation at 70,000 x g for 10 minutes to remove oligomerised
dynamin from the supernatant and filter spin cups to collect the oligomerised dynamin
(pellet) and supernatant following centrifugation for 2 minutes at 18,000 x g. Dynamin
without any SH3 (No SH3) was the control for basal oligomerisation. Dynamin
incubated with PS liposome (10 µg/ml) was the control for maximal oligomerisation as
shown in (A). All the samples were resolved on 10% SDS-acrylamide gels and the
protein was visualised using Coomassie Blue staining. The reaction volumes for
sedimentation assays were the same as for the GTPase assays (150 µl) to ensure enough
dynamin to visualise on the gel. Each image is representative of multiple experiments
each run with the samples in duplicate. (C) The amount of oligomerisation was
quantified by densitometry analysis of the Coomassie stained SDS acrylamide gels of
the dynamin pellet. The data is expressed as a fold change relative to No SH3 ± S.E.M.
and n = 2. With the sedimentation assay being performed in duplicate, four data points
in total were used for the statistical analysis. One-way ANOVA was applied followed
by the Dunnett’s post-test (**, p < 0.01; ***, p < 0.001 against No SH3).
Abbreviations: AmphI/II, amphiphysin I/II; Endo I, endophilin I; ITNA/E, intersectin I
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Figure 4.3: SH3 domains do not stimulate assembly deficient mutant
dynamin.
(A) Effect of SH3 domains (40 µg/ml) on the GTPase rate of human dynamin Ibb
G397D (100 nM / 2 µg/ml) under PA with the assays being performed at low salt (30
mM NaCl) condition. The GTPase rate was derived by performing linear regression
analysis of the initial 2-30 minutes of the time course assay, as illustrated in Figure
3.5A. Basal dynamin activity for each splice variant (dynamin alone, without SH3
domain stimulation) was subtracted from all values so that only the SH3-stimulated
effect is shown. All data is shown as means ± S.E.M. and n = 3. (B) The G397D
data for GST-intersectin I SH3A in (A) is compared to the wild-type result of human
dynamin Ibb generated in the presence of low salt from Figure 3.10A.
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Figure 4.4: Effect of GST-tag on SNX9 SH3 domain stimulated dynamin
GTPase activity.
CL- and GST-SNX9 SH3 domains (both at 40 µg/ml) were tested for their effect on
stimulating the GTPase activity of sheep dynamin I, human dynamin Iab and bb and
human dynamin IIab (all at 100 nM / 2 µg/ml). ELIPA was used to perform these
experiments and the GTPase rate was derived by performing linear regression analysis of
the initial 2-30 minutes of the time course assay, as illustrated in Figure 3.5A. Basal
dynamin activity (dynamin alone, without SH3 domain stimulation), performed under
identical conditions (buffers, PA, salt concentration etc.), was subtracted from the
respective values so that only the SH3-stimulated effect is shown. All data is shown as
means ± S.E.M. and n ≥ 3. (A) Schematic table indicating the parameter which is varied
or constant in every graph. In each graph the CL-SNX9 SH3 values is the white column
and the GST-SNX9 SH3 is the red column. The effect of CL- and GST-SNX9 SH3 was
compared between the dynamins under PA: low salt (30 mM NaCl) (B) and high salt (150
mM NaCl) (C) conditions and under NPA: low salt (D) and high salt (E) salt conditions.
Statistical analysis between the CL-SNX9 SH3 alone was performed by applying One-
way ANOVA followed by Dunnett’s post-test (against sheep dynamin I) and Bonferroni’s
post-test (hudynIab vs. hudynIbb). The statistical significance for this analysis is shown
below each graph (*, p < 0.05; **, p < 0.01; ***, p < 0.001). Two-way ANOVA followed
by Bonferroni’s post-test was applied to determine the statistical significance between the
CL- and GST-SNX9 SH3 domains (*, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p <
0.0001). The interaction P-value for the three dynamin I results was determined by the
ANOVA is shown on each graph.
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Figure 4.5: Effect of salt (low or high) on SNX9 SH3 stimulated dynamin
GTPase activity.
The data shown in Figure 4.4 is organised in a different format in order to compare
the effects of low salt (30 mM NaCl) (white column) and high salt (150 mM NaCl)
(red column) across the four dynamins. The effect of SNX9 was compared between
the dynamins under PA: CL-SNX9 SH3 (A) and GST-SNX9 SH3 (B) and NPA: CL-
SNX9 SH3 (C) and GST-SNX9 SH3 (D). Refer to Figure 4.4 for further details.
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Figure 4.6: Effect of assembly (PA or NPA) on SNX9 SH3 domain
stimulated dynamin GTPase activity.
The data shown in Figure 4.4 is organised in a different format in order to compare the
effects of PA (white column) and NPA (red column) across the four dynamins. The
effect of SNX9 was compared between the dynamins at low salt (30 mM NaCl): CL-
SNX9 SH3 (A) and GST-SNX9 SH3 (B) and high salt (150 mM NaCl): CL-SNX9 SH3
(C) and GST-SNX9 SH3 (D). Refer to Figure 4.4 for further details.
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Figure 4.7: Sedimentation analysis of dynamin oligomerisation by SNX9
SH3.
The CL- and GST-SNX9 SH3 domains (both at 40 µg/ml) were used for the
sedimentation analysis of sheep dynamin I (100 nM / 9.6 µg/ml) under PA (A) and NPA
(C) using low (30 mM) and high (150 mM) NaCl as indicated. The incubation of both
SH3 domains with dynamin was performed as for the Malachite Green assay, with the
reaction lasting for 60 minutes in the presence of GTP, with the PA condition having a
preincubation in the absence of GTP for the same duration. No SH3 and the non-
oligomerising CL-syndapin I SH3 were used as controls. Sedimentation analysis was
performed using filter spin cups to collect the oligomerised dynamin (pellet) and
supernatant following centrifugation for 2 minutes at 18,000 x g. All the samples were
resolved on 10% SDS-acrylamide gels and the protein was visualised using Coomassie
Blue. The reaction volumes for sedimentation assays were the same as for the GTPase
assays (150 µl) to ensure enough dynamin to visualise on the gel. Each image is
representative of multiple experiments with the samples in duplicate. The amount of
oligomerisation for PA (B) and NPA (D) was quantified by densitometric analysis of the
Coomassie stained SDS-acrylamide gel of dynamin pellet. All data expressed as fold
change relative to No SH3 ± S.E.M. for the appropriate salt condition (n = 3). Two-way
ANOVA was applied followed by Bonferroni’s post-test (*, p < 0.05, ***, p < 0.001 and
****, p < 0.0001).
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Figure 4.8: The effect of GST-tag on the relationship between SNX9 SH3
oligomerisation and GTPase stimulation of dynamin.
The sedimentation results for CL- and GST-SNX9 SH3 in Figure 4.7 were compared
to sheep dynamin I GTPase activity values for the two SH3s from Figure 4.4. In each
graph the CL-SNX9 SH3 values is the white column and the GST-SNX9 SH3 is the
red column. The results for oligomerisation and GTPase activity under PA (A and B
respectively) and NPA (C and D respectively) are compared across low salt (30 mM
NaCl) and high salt (150 mM NaCl) conditions. Two-way ANOVA followed by
Bonferroni’s post-test was applied to determine the statistical significance between the
CL- and GST-SNX9 SH3 domains (*, p < 0.05; **, p < 0.01; ****, p < 0.0001). The
interaction P-value determined by the ANOVA is shown below each graph.
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Figure 4.9: The effect of salt on the relationship between SNX9 SH3
oligomerisation and GTPase stimulation of dynamin.
The data shown in Figure 4.8 is organised in a different format in order to compare the
effects of low salt (30 mM NaCl) (white column) and high salt (150 mM NaCl) (red
column) for sheep dynamin I. The effect of CL- and GST-SNX9 SH3 was compared
between oligomerisation: low salt (A) and high salt (B) and GTPase activity: low salt (C)
and high salt (D). Refer to Figure 4.8 for further details.
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Figure 4.10: The effect of assembly (PA or NPA) on the relationship
between SNX9 SH3 oligomerisation and GTPase stimulation of dynamin.
The data shown in Figure 4.8 is organised in a different format in order to compare the
effects of PA (white column) and NPA (red column) conditions for sheep dynamin I.
The effect of CL- and GST-SNX9 SH3 was compared between oligomerisation: low
salt (30 mM NaCl) (A) and high salt (150 mM NaCl) (B) and GTPase activity: low salt
(C) and high salt (D). Refer to Figure 4.8 for further details.
Figure 4.11: SNX9 SH3 domains in both CL and GST forms have a unique
effect on PS liposome stimulated dynamin GTPase activity.
Concentration curve of CL-SNX9 (A) and GST-SNX9 (B) SH3 domains (both at 40
µg/ml) incubated with sheep dynamin I (20 nM / 1.9 µg/ml) and PS liposome (2 µg/ml)
to determine their effect on dynamin GTPase activity using the Malachite Green assay.
The assay was performed at low salt (30 mM NaCl) under standard PA conditions with
the SH3 and PS preincubated with dynamin before the addition GTP (n = 2 in triplicate,
with the data shown as ± S.E.M.). (C) The same assay was performed for the GST-SH3
domain of amphiphysin I (n = 2 in triplicate, with the data shown as ± S.E.M.).
A. B.
C.
Figure 4.12:  SNX9 is the only SH3 domain able to promote GTP binding to 
dynamin.
Sheep dynamin I (20 nM / 1.9 µg/ml) was preassembled in the presence of SH3 domains
(40 µg/ml) in GTPase assay buffer for 30 minutes at 37˚C with shaking at 700 RPM.
Non-radioactive and radioactive GTP (α-32P, 5 µCi) were both added to a final
concentration of 20 nM to each sample. The samples were then subjected to UV
crosslinking (Stratlinker 2400, 254 nm) for 30 minutes on ice and were applied to
nitrocellulose membrane through a slot blot template followed by TBS wash. The dried
membrane was exposed to a storage phosphor screen overnight and phosphorimaging
was performed using Typhoo FLA9500 (GE biosciences). (A) and (B) are representative
phosphorimages of GTP binding from multiple experiments with the samples in
duplicate. In (C) the amount of dynamin bound GTP was quantified from the
phosphorimaging software. All data is expressed as fold change relative to No SH3 ±
S.E.M. (n = 3).
CL-SH3 domains
CL-SH3 domains
A.
B.
C.
CL-SH3 domains
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CHAPTER 5:  Mapping the SNX9 SH3 domain binding site 
on dynamin I 
 
SH3 domains bind to proline (P)-rich sequences containing a conserved PxxP motif, 
which occupies a canonical hydrophobic pocket within the target SH3 domain, located 
between the RT and n-Src loops (Fontayne et al., 2002; Arbuckle et al., 2010).  The 
binding orientation of the SH3 to the PRD is determined by basic residues such as 
arginine or lysine in the regions flanking the PxxP motif, known as class I or class II 
binding modes (Feng et al., 1994). 
The binding sites for a few of the SH3 domains used in this study within the dynamin I 
PRD have previously been mapped.  Its PRD has 13 PxxP motifs, numbered from the N 
to the C-terminus of the PRD sequence, each with the potential to bind SH3 domain 
proteins (Anggono & Robinson, 2007).  The first 10 of the motifs (Sites 1-10) are present 
in both splice variants while the last 3 (Sites 11-13) are unique to the long form (Figure 
5.1).  The core amphiphysin I SH3 domain binding site is at Site 9, in the sequence 
833PSRPNR838, which it binds using the class II mode (Grabs et al., 1997).  This was 
determined by site-directed mutagenesis and later confirmed by surface plasmon 
resonance (SPR) analysis (Solomaha et al., 2005).  Endophilin I SH3 binds to an 
extended sequence 786PAVPPARP793 (Site 2 and Site 3) (Anggono & Robinson, 2007).  
Mutational analysis demonstrated syndapin I to bind at Site 2 (786PAVP789), which 
overlaps the endophilin I binding site (Anggono & Robinson, 2007).  The binding modes 
for syndapin I and endophilin I are unusual among SH3 domains in showing properties of 
both class I and II orientation.  Syndapin I is also the only known phosphorylation-
regulated partner for dynamin and its binding is regulated by the dynamin I 
phosphorylation sites S774 and S778 in the first phospho-box, phospho-box-1 (Anggono 
et al., 2006). 
Two unpublished studies from Dr. Lin Luo of our lab suggest there is more to high 
affinity binding than the core PxxP motif and the immediate flanking basic residues.  
Atypically, mutants near the Site 9 PxxP, more than 40 residues downstream of Site 2 and 
3 in the PRD, inhibited endophilin I and syndapin I binding (Anggono & Robinson, 
2007).  Dr. Luo revealed that apart from the core PxxP sequences and their flanking basic 
residues the SH3 domains of syndapin I and endophilin I additionally interact with 
spatially separated and extended regions within the PRD (USyd PhD thesis (Luo, 2012)).  
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These amino acid sequences were referred to as the short distance elements (SDE) and 
long distance elements (LDE) elements, which are sequence elements in dynamin that 
confer high affinity binding to syndapin I and endophilin I but are not necessarily PxxP 
motifs (Usyd PhD thesis (Luo, 2012)).  He defined SDEs as amino acid sequences which 
are 5-15 amino acids on either side of the core PxxP motif and which are required for 
high affinity binding at the core, while LDEs are located >15 amino acids on either side.  
SDEs are distinct from the flanking basic residues, which are usually 2-4 amino acids on 
either side of the core PxxP.  The SDE and LDE for syndapin I and endophilin I are not 
the same sequences, suggesting other SH3s might use different sequences as their own 
SDE or LDE and more than one of each element may be involved.  Endophilin I binding 
involves a site approximately 40 amino acids downstream at the distal end of the PRD, 
which represents an LDE in the long PRD variant Xa.  Syndapin I SH3 binding involves 
previously unidentified amino acids in both the middle (SDE) and the distal (LDE) ends 
of the dynamin I PRD.  For example, mutation at P844A, over 40 amino acids distal to 
the Site 2, massively inhibits syndapin I SH3 domain from binding the dynamin PRD 
(Dr. Luo, manuscript in preparation).  These novel binding elements within the dynamin I 
PRD allow these SH3 domains to make multiple contacts throughout most of the PRD 
and significantly increase its binding affinity. 
SNX9 is the only GST-removed SH3 domain in the present study found to be able to 
stimulate dynamin GTPase activity and promote its oligomerisation.  Given the high 
affinity binding to dynamin by other SH3 domains tested, this suggests there is something 
unique about the SNX9-dynamin I interaction which, for example, could potentially 
feature a unique binding mechanism.  The binding site for SNX9 has not been determined 
and in dynamin II it has been only approximated.  Screening of the SNX9 SH3 domain 
against a randomised library of 1010 peptides revealed it to preferentially bind a class I 
mode sequence motif, RxAPxxP (Alto et al., 2007).  A single amino acid sequence in the 
PRD of dynamin II matches this motif, 849RRAPAAP855, close to the C-terminus and 
point mutations in this sequence reduce binding to the dynamin II PRD, suggesting not 
proving, that SNX9 binds this site in dynamin II (Haberg et al., 2008).  We found a 
different single sequence in the dynamin I PRD which matches this motif, at 
783RRAPAVP789.  Notably, this includes the same Site 2 motif used by both syndapin I 
and endophilin I. 
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The main aim of the work presented in this Chapter is to map the SNX9 binding site 
within the PRD of dynamin I, to determine the effect of dynamin phosphorylation on this 
binding and to search for potential novel elements to this binding such as the possibility 
of secondary binding sites.  This was achieved by an extensive site-directed mutagenesis 
approach, with an extensive mutational analysis of the dynamin I PRD and Western 
blotting for the SNX9 binding to these mutants.  All the experiments performed in this 
section were done using dynamin I GST-PRD constructs designed by Drs. Victor 
Anggono, Lin Luo or Jing Xue in our lab. 
 
5.1 Mapping the binding region of SNX9 to the dynamin I PRD 
The dynamin I PRD has two major alternatively spliced tail variants (also known as 
long tail (Xa) and short tail (Xb), Figure 5.2A).  To initially determine the approximate 
region of SNX9 binding, these PRD splice variants were used in conjunction with 
dynamin I PRD truncation constructs (Figure 5.2A).  These constructs were previously 
generated by Dr. Lin Luo and include three truncations: 
- C2 (amino acids 751-798, includes PxxP Sites 1-3):  This is from the N-terminal 
half of dynamin I-Xa and includes the PxxP motifs which are the core binding 
sites for syndapin I and endophilin I (Site 2 and Site 3).  It also includes the first 
phospho-box-1 region containing the depolarisation-dependent phosphorylation 
sites S774 and S778. 
- C10 (amino acids 794-864, includes PxxP Sites 4-13): This is from the C-terminal 
half of the long dynamin I-Xa and starts before the Site 4 (800PGPP803) and 
includes Site 11 to Site 13 PxxP and the phospho-box-2 region.  This lacks Sites 
1-3 but includes the primary binding site for amphiphysin I at Site 9.  Note that 
the studies in Chapter 3 and 4 using full-length recombinant dynamin used the 
short tail, Xb, while the GST-tagged C10 construct used here was the long tail, 
Xa. 
- C7 (amino acids 794-851, includes PxxP Sites 4-10):  This is the same as C10 
except that it is the short splice variant, Xb, with replacement of long tail amino 
acids 852-864 (852SRSGQASPSRPESPRPPFDL864) and replacement with the 
short form (845RITISDP851), i.e. loss of Sites 11-13 PxxP.  Also note that the first 
arginine in these two tails (underlined) shifts closer to the splice site.  This has 
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implications for its ability to serve as a flanking basic residue for Site 10 PxxP 
which is found on the N-terminal side of the splice border. 
 
All DNA plasmid constructs studied in this chapter were expressed in E. coli as GST-
tagged proteins which were purified on GSH sepharose beads.  They were then incubated 
with rat brain lysate to perform pull-down experiments and Western blots were used to 
detect the binding of endogenous SNX9 or other endocytic protein from brain.  The blots 
were all quantified using densitometry, with the mutations and truncations being plotted 
in each case as percentage change relative to the PRD from the long variant, dynamin I-
Xa.  No GST-tag removal was done in this chapter, because the tags were required for 
pull-down experiments and in order to be consistent with previous SH3 binding sites.   
SNX9 bound to the same extent to both Xa and Xb full-length PRD splice variants 
(Figure 5.2C).  Truncated PRD proteins C2 and C10 both bound SNX9, although each 
had significantly lower SNX9 binding, with binding to C2 being somewhat higher than 
for C10.  This clearly indicates there are at least two independent SNX9 binding sites in 
the PRD.  No binding was detected for C7, suggesting there is a role for the long tail in 
interacting with SNX9 at the second binding site.  This was a curious observation, since 
there was no decrease in binding detected for Xb, which is also missing the same C-
terminal part of the long tail.  Given that C7 could not detectably bind SNX9 on its own, 
these results indicate C2 and C10 each feature an independent binding site, with a 
possible role for amino acids at the junction between these two truncated constructs not 
being ruled out.  Given involvement of the long tail, the point mutants used in all 
subsequent experiments were done with the Xa variant, unless specified otherwise. 
 
5.2 Identification of Site 2 as the first core PxxP motif for SNX9 
To begin narrowing down the first (N-terminally located) binding site, point mutation 
analysis of dynamin I PRD was performed and the results for SNX9 compared with 
binding of syndapin I and endophilin I to these constructs.  Given that relative SNX9 
binding to C2, which contains Sites 2 and 3 PxxPs, was slightly higher than to C10 and 
that the full-length long and short forms bound similar levels, it was hypothesised that the 
main binding site was in C2.  Mutations within both of the tandem Site 2 and 3 PxxP 
motifs (Figure 5.3A) were previously generated by Dr. Victor Anggono (Anggono & 
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Robinson, 2007).  Both the Site 2 (sequence 786PAVP789) double mutants (2A and 2B) 
abolished SNX9 binding, while with the single proline mutation (2C) significantly 
decreased binding (Figure 5.3C).  The Site 3 (790PARP793) mutation (3B) did not affect 
binding, while the charge-swapped double mutant within Site 3 (3A), R792E/P793A 
slightly reduced binding.  The results for syndapin I and endophilin I mutants served as 
specificity controls and the results were the same as previously observed (Anggono & 
Robinson, 2007).  These observations clearly indicate that the first binding site for SNX9 
is the Site 2 PxxP, which serves as the main binding site in the N-terminal half of the 
PRD.  The near complete loss of binding, despite this being the full-length PRD, indicates 
that binding to this site may be much greater than to the second site within the C-terminal 
half, since the latter site is still present in this sequence (see below). 
 
5.3 SNX9 binds Site 2 via a Class I orientation mode 
Next, the binding of SNX9 to residues adjacent to the Site 2 and 3 PxxP motifs in the 
PRD were investigated to determine whether binding occurs via class I or II orientation.  
Basic residues adjacent to the core PxxP sequence are known to both enhance binding 
affinity and determine binding orientation.  PxxPs bind to the hydrophobic groove in the 
SH3 domain predominantly by assuming a left-handed polyproline type II (PPII) helix 
conformation (Agrawal & Kishan, 2002; Li, 2005).  A characteristic of the PPII helix is a 
3 residue pitch, where every third amino acid is positioned on the same side of the helix 
and can make contact with the residues of other proteins.  For the dynamin I Site 2 and 3 
PxxPs, the flanking amino acids which are at +3 or -3 position relative to the PxxP cores 
are basic (positively charged) arginines (Figure 5.4A).  The contribution of these residues 
to SNX9 binding was investigated using two sets of mutations from Dr. Victor 
Anggono’s initial study (Anggono & Robinson, 2007). 
To determine the orientation of SNX9 binding, the following arginines were mutated: 
R783/R784 (2D and 2E) oriented N-terminal to the PxxP core and R796 (3C and 3D) 
oriented on the C-terminal side to glutamate and alanine respectively.  Alanine is a 
neutral residue and abolishes the basic charge, while glutamate has a net negative charge 
that introduces a charge swap.  SNX9 binding was massively reduced with both the 
alanine (2D) and glutamate (2E) mutants (Figure 5.4C).  In contrast the 3C and 3D 
mutants had no effect, in common with the Site 3 PxxP mutant 3B, which also had no 
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effect (Figure 5.3C).  The observations reveal that SNX9 bind to dynamin I involves a 
class I mode linked to Site 2, not Site 3.  This is in contrast to syndapin I and endophilin 
I, which were shown here (Figure 5.4C) and previously (Anggono & Robinson, 2007) to 
have bi-directional orientation (Anggono & Robinson, 2007).  Therefore, SNX9 binding 
to dynamin I shares a binding site in common with syndapin I and endophilin I, yet uses 
flanking basic amino acids in different ways. 
Since the SNX9 has a single binding orientation in the direction of the main dynamin I 
phospho-box-1, we next asked how much further upstream this binding extends.  The 
phospho-box-1 region contains two additional arginine residues that are important for 
syndapin I binding.  They were each mutated to alanine (PB1) or glutamate (PB2) to 
effect charge neutralisation or charge-swap respectively (Figure 5.5A).  Neutralising the 
basic charge slightly reduced binding, while the charge swap reduced binding by more 
than half (Figure 5.5C).  It was initially proposed that introduction of negative charges 
anywhere in this phospho-box-1 region would reduce syndapin I binding, contributing to 
this region being a ‘highly tuned phospho-sensor’ (Anggono & Robinson, 2007).  T780 in 
the phospho-box-1 was also mutated to alanine (T780A) or glutamate (T780E) and 
almost identical results were obtained (Figure 5.5C).  Therefore, SNX9 binding to 
dynamin I PRD is charge dependent in this region, in a manner distinct from that reported 
for endophilin I, yet similar to that reported previously for syndapin I.  This raises the 
question whether SNX9 binding to dynamin I, like that of syndapin I, may be regulated 
by phosphorylation in this region. 
 
5.4 Phospho-dependent binding of SNX9 to dynamin I 
The first phospho-box-1 region contains the S774/S778 residues, which are known to 
be in vivo phosphorylation sites regulated by nerve terminal depolarisation (Tan et al., 
2003).  Syndapin I is the only known phospho-dependent binding partner for dynamin at 
these sites (Anggono et al., 2006).  Similarly, dynamin I has two additional 
phosphorylation sites present in the long spliced tail at phospho-box-2, S851/S857, which 
are also stimulus-sensitive, but they have much lower phosphorylation stoichiometry than 
S774/S778 (Graham et al., 2007).  The binding partner for these sites in phospho-box-2 
and their function are presently unknown.  Therefore, the next aim was to determine 
whether SNX9 could be a phosphorylation-sensitive binding partner of dynamin at either 
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region.  The S774/S778 mutants, used in the previous studies by Dr. Anggono to establish 
syndapin I binding, were employed for this purpose.  These serine residues were mutated 
to glutamate which, being negatively charged, acts a phosphorylation mimic.  The 
mutations were introduced into the C2 constructs (C2EE), in addition to the full-length 
Xa PRD (Xa S774E/S778E) (Figure 5.6A).  Additionally, the phospho-mimetic glutamate 
mutants of the tail residues, S851/S857, were introduced in both the C10 truncation 
constructs (C10EE) and Xa-PRD (Xa S851E/S857E). 
In the full-length PRD, Xa, the S774/S778 phospho-mimetic mutants significantly 
inhibited SNX9 binding by about half, while no phospho-dependent binding was 
observed for the residues S851/S857 (Figure 5.6C).  When the two SNX9 binding sites 
were separated from each other in the C2EE and C10EE truncation constructs, both the 
phospho-sites elicited a significant binding reduction (Figure 5.6C).  The data reveals 
SNX9 as a novel phospho-dependent binding partner for dynamin, at two distinct regions. 
 
5.5 Role of Site 4 or the central region of the PRD in SNX9 binding 
In this section, the potential role for regulation by SDE of the core PxxP binding was 
explored for SNX9.  For this purpose, the region C-terminal to the Site 2/3 PxxPs, 
referred to as the “central region”, was examined with mutants generated by Dr. Jing Xue 
(Figure 5.7A).  This region was demonstrated by Dr. Lin Luo to be involved as SDEs in 
binding syndapin I and endophilin I.  Since these residues (G797-P803) constitute the 
SDE for the SH3 domains of these two proteins (manuscript in preparation), it was 
hypothesised here to have a similar role for SNX9 binding.  The central region lies near 
the junction between the C2 and C10 truncation constructs and includes the Site 4 PxxP 
motif (800PGPP803).  However, the impact of this region may not be detectable using C2 
or C10 alone because the central region is almost bisected in these constructs.  Since 
SNX9 binding to either C2 or C10 constructs was significantly reduced relative to the 
full-length dynamin I PRD, it was possible that this central region may play a role in its 
binding. 
The residues in the central region of the full-length PRD were mutated in the form of 
an alanine-scan (or glycine was used if the target amino acid was already an alanine) to 
generate single mutants for pull-downs and Western blot assays.  The results for syndapin 
I, endophilin I or amphiphysin I have not been published and the mutants and initial pull-
213 
 
downs for these three proteins were initially performed by Dr. Jing Xue for these three 
SH3 proteins.  All the experiments were repeated here as a reference frame for the new 
SNX9 experiments.  The data reveal that the central region plays a major role in SNX9 
binding to the dynamin I PRD and that the residues involved in SNX9 binding are distinct 
from those required for the other SH3 domain proteins (Figure 5.7C).  SNX9 binding was 
unaffected by the first three mutations at G797A, P798A and A799G, some of which 
significantly decreased or increased syndapin I and endophilin I (Figure 5.7D and E).  In 
this set of mutations the effect of A799G was the greatest, with strong inhibition of 
syndapin I and endophilin I but not of SNX9.  Mutagenesis of the next 4 amino acids 
from P800A to P803A, which encompasses the Site 4 PxxP motif (800PGPP803), had 
approximately the reverse effect: significantly reducing SNX9 binding but increasing that 
of syndapin I and endophilin I (although P800A was an outlier for syndapin I).  
Amphiphysin I was used as a negative control since its binding site is well distal to those 
of the other three proteins and accordingly it was not significantly affected by any of 
these mutations (Figure 5.7F). 
Overall, this data shows that the PRD central region is critically involved in SNX9 
binding.  However, it is not yet possible to conclude whether Site 4 PxxP is another 
putative core binding site or whether it is an SDE for the Site 2 binding motif. 
 
5.6 Identification of Site 10 as a second core PxxP motif for SNX9 
Since both C2 and C10 truncated dynamin constructs bound to SNX9 a second 
binding site must exist within the C-terminal PRD that possibly binds less well than 
binding at the first site, Site 2.  This represents another mechanistic difference between 
SNX9 interaction with dynamin and that of syndapin I, endophilin I and amphiphysin I 
which all use a single core PxxP site.  Therefore, attempts were made to identify this site. 
The long spliced tail of dynamin, Xa, contains three partially overlapping PxxP motifs 
unique to this variant (underlined: 850ASPSRPESPRPPFDL864 at the C-terminus).  This 
region also contains the phospho-box-2 phosphorylation sites S851/S857.  An alanine 
scan mutagenesis was performed across all five prolines and the two arginines by Dr. Jing 
Xue and the recombinant proteins expressed and used for pull-down experiments in this 
study (Figure 5.8A).  Overall, these mutations had little impact on dynamin I binding to 
any of the four SH3 domain proteins tested.  There was a small but significant inhibition 
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of SNX9 and endophilin I binding with P852A and the P860A/P861A double mutant, 
with no corresponding changes observed for syndapin I or amphiphysin I (Figure 5.8C-
F).  A minor increase in binding was observed for amphiphysin I with P855A and P858A 
mutations.  This series of experiments show that the long spliced tail is not likely to 
represent a major core PxxP binding site for SNX9, ruling out PxxP Sites 11-13 as being 
core motifs.  Although this matches earlier observations that SNX9 did not bind 
preferentially to either the Xa or Xb splice variants (Figure 5.2C), this does not explain 
how SNX9 binding is abolished for the C7 truncation construct relative to C10. 
Finally, the role of Site 10 PxxP (836PNRAPPGVPSRSG848) was tested as a potential 
second SNX9 binding site on the PRD (Figure 5.9A).  This PxxP motif is immediately 
upstream from the splice site boundary (which occurs after the second proline in the 
motif, P844).  Since Site 10 is located in the splice site boundary it is common to both 
long and short tail variants (thus also common to C7 and C10 truncations).  To explore 
the role of Site 10, a similar alanine scan was performed for its two prolines P840A and 
P844A, the double mutant P840A/P844A and the two adjacent arginine residues R838A 
and R846A (the latter being only present in the long Xa isoform) in the full-length Xa 
variant.  Each of these significantly decreased SNX9 binding to dynamin by 50-60% 
(Figure 5.9C).  The fact that there was not a much stronger reduction in binding was 
interpreted as being due to the presence of Site 2 in the sequence as an alternative binding 
site.  This identifies Site 10 as being the second core PxxP for SNX9 and suggests that 
the binding mode is not class I or II but a mixed mode, as occurs for syndapin I at Site 2.  
On this basis, the cental region examined above (Section 5.5) could form an LDE to Site 
10, being almost 40 residues upstream of it.  The observation of a role for R846, which is 
not present in the short Xb isoform, suggests a possible reason for increased binding of 
SNX9 SH3 to the C10 relative to the C7 truncation from the long vs. short variants 
(Figure 5.2C).  
Surprisingly, P840A significantly increased, while P844A significantly blocked 
syndapin I binding (Figure 5.9D).  This may appear unexpected, as its core binding 
sequence at Site 2 and Site 3, is over 40 amino acids distal to this Site 10.  However, 
using mutagenesis and NMR structural studies, P844 was one of the amino acids initially 
recognised by Dr. Lin Luo to form part of the LDE for syndapin I binding to Site 2 
(manuscript in preparation and USyd PhD thesis (Luo, 2012)).  The results for the control 
proteins were as expected for amphiphysin I which binds Site 9 (833PSRPNR838) and thus 
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R838A also significantly reduced its binding, while there was no effect of the other 
mutants in this series (Figure 5.9F).  This mutation also significantly reduced endophilin I 
binding, while the others did not (Figure 5.9E).  Overall, Site 10 is important for SH3 
interactions with dynamin, with a single arginine in the spliced long tail conferring a 
preference for this isoform.  The mechanisms of SNX9 SH3 binding are highly distinct 
from those of the 3 other characterised SH3 proteins. 
 
5.7 Discussion 
The data presented in this chapter successfully mapped two SNX9 binding sites in the 
PRD of dynamin I and revealed a key role for the central region, discovered that this 
interaction is regulated by phosphorylation and revealed a more complex binding 
mechanism for SNX9 than known for other SH3 domain proteins.  This was achieved by 
an extensive mutational analysis of the dynamin I PRD and determining its binding to 
endogenous SNX9 by pull-down and Western blot experiments.  This study followed on 
from previous work by Drs. Anggono (Anggono et al., 2006; Anggono & Robinson, 
2007), Xue and Luo (unpublished data for the latter two, (Usyd PhD thesis (Luo, 2012)) 
on mapping and investigating the nature of syndapin I and endophilin I SH3 binding to 
dynamin I.  Here, the mutations produced for these three studies were brought together to 
understand how SNX9 binding compared with the binding of other SH3 domain proteins.  
The results support the overall hypothesis that SNX9 does have a unique mechanism of 
binding to the dynamin I PRD compared to other well characterised proteins.  This might 
ultimately be used to explain its unique ability to stimulate dynamin activity, GTP 
binding and oligomerisation.  The following is the summary of the main results: 
 The first investigation of SNX9 binding to the dynamin I isoform.  Previous 
studies examined only dynamin II. 
 Revealed SNX9 has at least two independent core PxxP binding sites: Site 2 and 
Site 10, located at either ends of the dynamin I PRD. 
 Demonstrated that Site 2 PxxP binding occurs in a class I mode, in contrast to 
syndapin I and endophilin I which have bi-directional binding orientation at this 
site. 
 Showed that SNX9 also binds Site 10 PxxP, using a class II mode.  This is the 
first SH3 protein found to interact with dynamin I at this PxxP motif. 
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 Revealed that Site 10 binding is isoform-specific.  Thus, binding occurs primarily 
to the long I-Xa isoform rather than the shorter I-Xb form, due to a splice site 
flanking arginine that is in a unique position in the former isoform. 
 Provided evidence to suggest that SNX9, like syndapin I, does not make direct 
contact with phospho-box-1 region, located on the N-terminal of Site 2 PxxP, yet 
their interaction is strongly regulated by negative charges in this region 
 Discovered that SNX9 is a phospho-dependent binding partner regulated by 
phospho-box-1.  Previously only syndapin I was known to show such properties 
and this makes phospho-box-1 a phospho-sensor region for both SNX9 and 
syndapin I. 
 Identified a role for the central region of the dynamin I PRD in SNX9 binding.  
Site 4 PxxP was shown to form either a third binding site or to be acting as an 
SDE or LDE that regulates binding at one or more of the other PxxP Sites. 
 
The mutational analysis used here has advantages over other approaches, such as 
peptide competition assays, by providing a more specific set of outcomes in a relatively 
rapid time frame.  A variety of previous studies used peptide competition assays to 
localise PxxP binding sites which have been shown to not provide definitive results 
(Anggono & Robinson, 2007).  This is because the peptides used may contain multiple 
binding motifs rather than the specific binding site and non-specifically disrupt many 
PxxP interactions at the same time, creating discrepancies between published studies.  
While large numbers of mutants were employed for the binding analysis here, the results 
are not exhaustive due to the limited experimental assay conditions employed in this 
study and the mutations not yet made.  Performing these assays by changing the buffer or 
incubation period may give a different and a more comprehensive result.  Similarly, the 
strategy of using GST-tagged dynamin I PRD as bait to capture full-length SH3 proteins 
does not reveal how the isolated SH3 domains themselves might behave in the absence of 
the protein in which they reside.  This is particularly important given the results of 
previous chapters showing that the GST-tagged SH3 domains alone can influence 
dynamin activity.  Despite these and other shortcomings, the approach used here is the 
best available, short of highly time-consuming structural studies using NMR (two or three 
dimensional) or protein crystallography. 
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5.7.1 Two independent SNX9 binding sites in the PRD 
The ability of SNX9 to bind the both C2 and C10 truncation constructs, which are 
essential two halves of the PRD, indicated that SNX9 has two independent core binding 
sites at the proximal and distal ends of the PRD (Figure 5.2C).  This was confirmed and 
expanded by the point-mutagenesis study, showing that the SNX9 specifically binds to 
Site 2 and Site 10 PxxP motifs, which are well separated from one another in the 
truncation constructs.  Circumstantial evidence suggested that Site 2 was the major 
binding site with weaker binding to Site 10.  The apparent affinity difference between the 
two sites should be investigated in future studies to determine the specific affinity for 
each site. 
Mutational studies of the PxxP core Site 2 and 3 binding motifs showed that SNX9 
binding mechanisms are more similar to syndapin I than endophilin I but with some 
important differences.  Binding at the N-terminal region was mapped to the Site 2 
786PAVP789 motif, which is the same core binding site as syndapin I.  Unlike endophilin I, 
SNX9 does not have an extended dual PxxP binding pattern, since mutations in Site 3 
(790PARP793), important to endophilin I binding, do not adversely affect its interaction.  A 
small but significant reduction in SNX9 binding was observed with the mutation of 
R792E in Site 3.  This suggests positive charges in and around the PxxP can contribute to 
binding, in addition to the hydrophobic proline.  This charge sensitivity does not extend 
to all arginines proximal to the PxxP.  Mutational analysis of arginines flanking the Site 2 
and 3 PxxP motifs reveal SNX9 has a typical class I binding orientation at this region.  
This is a common binding mode between SH3 and proline-rich sequences.  It was distinct 
from syndapin I and endophilin I which have unusual bi-directional binding orientations, 
showing characteristics of both class I and class II modes.  The flanking arginines are 
believed to confer specificity and affinity of binding to the core PxxP motif.  Future 
studies should compare the NMR or crystal structures of dynamin peptides bound to 
SNX9, syndapin I and endophilin I SH3 domains to verify these observations and 
validate the binding orientation.  However, initial attempts by Dr. Lin Luo to do this for 
syndapin I SH3 failed due to a massive affinity drop when using PxxP peptides relative to 
the full-length PRD (unpublished). 
A second core binding site was identified at the Site 10 PxxP motif in the isoform-
common sequence of the C-terminal tail region, more than 40 amino acids downstream of 
the Site 2 PxxP.  Evidence for this site was based on mutagenesis of the full-length PRD.  
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Binding was reduced by mutations to the conserved prolines of the PxxP and also to the 
flanking arginines, R838A and R846A.  A Class II orientation was identified at Site 10 
PxxP.  Notably, these Site 10 mutations did not abolish detectable SNX9 binding, unlike 
some mutations in the full-length PRD in the Site 2 which did.  The likely explanation for 
this is the presence of two alternative binding sites.  The full-length constructs used for 
these studies contained both Sites 2 and 10, providing alternative binding sites should 
either one be mutated.  Thus, mutations at Site 10 did retain some binding, presumably 
due to the presence of Site 2 in these constructs.  Future studies should consider 
replicating the alanine scan using the C10 construct, which lacks Site 2.  Future studies 
using techniques such as SEC-MALLS (Size exclusion chromatography-Multi angle laser 
light scattering) should also determine whether a single SNX9 SH3 binds the dynamin I 
PRD or whether two can bind simultaneously at Site 2 and Site 10 respectively.  One 
interpretation of this data is that Site 2 is the only binding site and it is possible that Site 
10 represents an LDE for Site 2.  Alternatively, Site 10 binding could be of such low 
affinity that it was not detected under these conditions unless the C10 construct is used. 
The results for Site 10 do not explain the lack of any binding observed for the C7 
truncation construct (Figure 5.2C), which is the same sequence as C10 except it 
terminates with the short 7 amino acid splice tail (Xb) rather than the 20 amino acid long 
tail (Xa).  This was at first a confounding observation, since the mutational analysis in the 
long tail-specific sequences showed them not to be involved in SNX9 binding (Figure 
5.8C).  Also, the full-length Xb short splice variant bound SNX9 just as well as the Xa 
long form.  However, upon closer inspection the data suggests that the lack of detectable 
binding to C7 is likely due to Site 10, which, although being common to both the PRD 
splice variants, has an unusual location precisely on the splice site boundary.  This raises 
the possibility that some amino acids on the C-terminal side of Site 10 might 
differentially regulate affinity at this site for the two tail variants: e.g. 840PPGVPSRSG848 
in Xa and 840PPGVPRITI848 in Xb.  Here, Site 10 is bolded and the underlined sequences 
are the splice variants showing the shifted position of the basic arginine residue.  The 
subtle change in location of the basic residue flanking Site 10, between the two variants, 
may be contributory factor in SNX9 not binding C7.  Thus, S846A mutation in Xa 
reduced binding by as much as mutating the PxxP motifs, yet the analogous amino acid is 
shifted in the Xb such that it is no longer 2-4 amino acids after the core PxxP but only 1.  
Therefore, this arginine may act as a flanking basic residue for Site 10 in the context of 
the long (Xa) but not for the short (Xb) splice variant.  To obtain a more comprehensive 
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picture of SNX9 interaction with dynamin I and to address the C7 anomaly, future studies 
should consider performing similar mutational analysis in the short tail Xb PRD variant.  
Overall, this is an important example illustrating how a splice site boundary appears to 
exert a selective effect on modulating an SH3 binding site. 
In summary, both Site 2 and Site 10 are independent core binding sites for SNX9, 
which provides for dynamin I PRD isoform-selectivity and is a major difference relative 
to other dynamin I interacting SH3s.  It is likely that Site 2 represents the major binding 
site, while Site 10 may prove to be of low affinity.  The existence of two separate binding 
sites in the dynamin I PRD has been previously observed for endophilin SH3, which 
binds to the N and C-terminal halves of the PRD with high and low affinity respectively 
(Solomaha et al., 2005).  This dual binding was used to propose two separate roles for the 
endophilin-dynamin I interaction in cells and, based on findings of the current study, 
similar predictions can be made for the SNX9-dynamin I complex. 
 
5.7.2 Phospho-box regions and phospho-dependent binding of SNX9 
Apart from basic residues flanking 2-4 amino acids from the PxxP, the dynamin-
syndapin I SH3 interaction is also regulated by charges in the region on the N-terminal 
side of the Site 2 PxxP.  This provides the basis for dynamin I phosphorylation at 
phospho-box-1 to block syndapin I binding, since each phosphorylation event introduces 
two acidic charges.  A similar effect of charge was found for SNX9 binding in two 
separate observations. 
Firstly, the introduction of negative charges to the phospho-box-1 region, located on 
the N-terminal side of Site 2 decreases SNX9 binding, as it does for syndapin I.  
Although this type of evidence for syndapin I was originally interpreted as showing that 
there was direct contact with dynamin I over an extended sequence region (Anggono & 
Robinson, 2007), it was later shown that this was not the case (USyd PhD thesis (Luo, 
2012)).  The key point is that mutation of amino acids in the phospho-box-1 did not 
reduce binding of syndapin I unless a negatively charged amino acid was introduced.  
Thus, the binding here was indirectly influenced, since mutations in the phospho-box-1 
only reduced syndapin I interaction in the presence of negatively charged glutamic acid 
and not alanine.  Furthermore, 2D NMR studies with C2 and another shorter PRD 
construct that terminates before Site 2, but includes the phospho-box-1, did not reveal any 
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evidence that would support direct dynamin I contact by this region (USyd PhD thesis 
(Luo, 2012)).  Therefore, in the present study virtually the same data was found for SNX9 
as previously reported for syndapin I, in that only charge substitutions in the phospho-
box-1 region reduced its binding while changing the primary amino acids to neutral ones 
did not. 
The phospho-box-1 region appears unlikely to directly interact with syndapin I or 
SNX9 but forms a specific regulatory element to control binding at the nearby PxxP site, 
i.e. providing the phospho-sensing ability.  Overall, this suggests that the phospho-box-1 
amino acids themselves may not directly contact SNX9 but that the introduction of 
negative charges can block binding.  Importantly, this distinguishes a phospho-sensor 
interaction from an SDE or LDE situation, where the alanine mutations reduce binding, 
suggesting those PRD amino acids might directly participate in SNX9 binding.  Future 
studies solving the 3D NMR or crystal structure of syndapin I or SNX9 SH3 domain 
bound to the C2 or a longer peptide will be required to definitively prove this 
interpretation. 
Extending these studies to mutation of the known phosphosites in phospho-box-1 
(S774/S778) revealed that SNX9 is only the second protein reported to show reduced 
dynamin I binding by phospho-mimetic substitutions, also called pseudo-
phosphorylation.  Evidence to suggest a second phospho-sensing region was potentially 
found in dynamin I-Xa for SNX9 phospho-dependent interaction with phophospo-box-2 
residues S851/S857.  The evidence supporting that this is the same type of interaction is 
not yet compelling since it occurred only in the truncated C10 construct but not in the 
full-length dynamin I-Xa PRD (Figure 5.6C).  Additionally, only a double charge 
mutation of the phospho-residues was used in this study and without corresponding 
alanine mutations.  However, future studies should probe the amino acids in the phospho-
box-2 region more deeply to determine whether this is a true phospho-sensor (does not 
directly bind SNX9) rather than an SDE for Site 10 (potentially these amino acids 
directly bind SNX9). 
The structural basis of the phospho-box role in regulating SH3 interaction is not 
known.  There are examples from NMR or crystal structures of other PxxP peptide-SH3 
domains that may shed light on the mechanism.  An acidic “side” pocket (relative to 
defining the PxxP binding pocket as the “top”) called the “specificity zone” has been 
identified in most SH3 domains as forming a groove between the RT and n-src variable 
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loops (Saksela & Permi, 2012).  A small number of proteins are known from the 
structures to interact with the specificity zone as well as the core PxxP binding pocket 
(Src (PDB ID 1JEG) (Ghose et al., 2001), p67 (phox) (PDB ID 1K4U) (Kami et al., 
2002), Lyn (PDB ID 1WA7) (Bauer et al., 2005), β-PIX (PDB ID 1ZSG) (Mott et al., 
2005) and insulin receptor tyrosine kinase substrate (IRTKS) (PDB ID 2KXC) (Aitio et 
al., 2010)).  These interactions are not observed with the majority of other reported 
protein-SH3 structures.  However, the structural evidence indicates that some target 
proteins for SH3 domains contact this acidic pocket.  A unifying hypothesis is that 
syndapin I and SNX9 may not directly bind the specificity zone but that their binding 
affinity is reduced through electrostatic repulsion by the introduction of negative charges 
like phosphate in this region.  Such a hypothetical model would potentially explain the 
phospho-sensing ability of syndapin I and SNX9. 
The overall results for SNX9 in this chapter provides further support for the idea that 
the purpose of the phospho-box-1 region might be to act as a phospho-sensor making 
disruption by dynamin I phosphorylation relatively easy.  Previously only syndapin I was 
known to show such phospho-sensor properties and for the phospho-box-1 only. 
Syndapin I interaction with dephosphorylated dynamin I specifically regulates ADBE in 
neurons, while pseudo-phosphorylation at these sites blocks this function (Anggono et 
al., 2006; Clayton et al., 2009).  Our observation that SNX9 is a phospho-dependent 
binding partner raises the possibility that this interaction may occur in neurons and may 
be regulated by neuronal activity.  Future studies using point mutations in a series of 
GFP-tagged SNX9 constructs, transfection into neurons and various endocytosis assays 
should together help reveal whether the dynamin I interaction is phospho-regulated in 
neurons and uncover its physiological significance. 
 
5.7.3 Is Site 4 PxxP a third binding motif? 
It was observed early on that the binding extent to either truncated C2 and C10 were 
both much lower than to the full-length Xa PRD.  This suggests that amino acid 
sequences (‘elements’) elsewhere within the full-length PRD are important for the 
affinity of binding.  Indeed, mutational analysis of the dynamin I PRD revealed the 
central region to strongly regulate binding, suggesting that it may represent an SDE for 
Site 2. 
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Insufficient evidence was obtained to discriminate whether the central region acts as a 
third core PxxP binding motif at Site 4 (800PGPP803) or as an SDE for regulating the 
binding affinity at Site 2.  The central region was previously shown by Dr. Jing Xue to 
regulate binding of both syndapin I and endophilin I (manuscript in preparation).  
Although this region also strongly regulated SNX9 binding, the residues involved and 
their effects were almost the opposite.  The mutations in the Site 4 residues, P800A-
P803A all reduced binding to SNX9 and yet had the opposite effect of mostly increasing 
syndapin I and endophilin I.  Mutation of the three amino acids N-terminal to the PxxP 
motif, G797A, P798A and A799G, had no effect on SNX9 binding but significantly 
reduced syndapin I and endophilin I interaction.  It therefore does not appear that P798 is 
part of an extended Site 4 motif. 
Most of the mutations performed here in the central region were proline to alanine, 
which potentially provides for a large disruption to dynamin’s possible polyproline fold.  
Thus, it was not surprising to see this often lead to a change in protein binding.  However, 
when an alanine was already present in the native PRD sequence, it was instead mutated 
to glycine in this study.  Glycine to alanine mutations are relatively conservative 
modifications and it was surprising to observe large changes in binding resulting from 
them.  According to two commonly used hydrophobicity scales (Eisenberg-Weiss and 
Goldman, Engelman, Steitz scales), the change from glycine to alanine results in an 
approximately 1.6 fold increase in hydrophobicity (Engelman et al., 1986; Eisenberg et 
al., 1984).  In comparison the change from glycine to phenylalanine, the most 
hydrophobic amino acid, would result in an approximately 3.7 fold increase.  Therefore, 
the results for SNX9 and syndapin I illustrates how hydrophobic interactions might be 
more important for certain SH3 interactions than others.  All three such mutations in this 
study, G797A, G801A or A799G had unexpectedly dramatic impact on binding that was 
different for each of the three proteins.  Regardless, they did not affect amphiphysin I 
binding, which is the only one of this group of SH3s whose binding does not involve 
Sites 2/3. 
The amino acids that reduce binding represent the entire Site 4 PxxP motif and this 
may represent another primary SNX9 binding site alongside Site 2 and Site 10.  
However, the sequence of Site 4 is also a little unusual in dynamin because it lacks the 
flanking basic residues normally found 2-3 amino acids on either side.  In this case there 
is only a single flanking basic residue R796, -4 amino acids N-terminal to the motif, and 
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none on the C-terminal side.  It can be ruled out from our data that R796 is important, 
since its mutation to either alanine or glutamic acid had no effect on SNX9 binding (3C 
and 3D mutants in Figure 5.4C).  This shows that R796 does not act as a flanking basic 
residue for Site 4.  However, some rare protein interactions with SH3 domains have been 
reported to involve no flanking basic residues at all (Sawyers et al., 1994; 
Alexandropoulos et al., 1995).  If Site 4 is a novel binding site for SNX9, it does not 
appear to utilise any flanking basic amino acids. 
No other proteins is known to bind this motif and the conclusion that Site 4 is a third 
core binding site cannot be cleanly made from the present data.  For example, SNX9 
would be expected to bind Site 4 when Site 2 was mutated in the full-length PRD.  Yet 
this was not observed and indeed SNX9 binding was massively reduced with both the 
alanine (2D) and glutamate (2E) mutants in the Site 2 region.  Therefore, Site 4 is unable 
to compensate for the almost complete block in the full-length PRD following disruption 
in binding at Site 2.  Future experiments should utilise a new construct that starts after 
Site 2 and ends before Site 10 in order to prove that Site 4 is indeed a third core binding 
site.  Additionally, the types of studies listed earlier may resolve this question, including 
new mutations, SEC-MALLS and structural studies. 
Two other observations suggest the central region may not be acting as a primary 
PxxP motif.  Firstly, the G801A mutation in the centre of the PxxP motif would be 
expected to have the least or minimal impact, yet it also reduced SNX9, while increasing 
syndapin I and endophilin I binding.  This is not a characteristic of any reported core 
PxxP binding pattern, where the xx residues normally have little impact.  Secondly, 
residues in this region affected all three proteins that use Site 2 (or Site 2+3) as their core 
binding sites, suggesting it is a common regulatory element.  The opposite effects of the 
point mutations on SNX9 vs. syndapin I or endophilin I suggest they might each 
modulate Site 2 binding in different ways.  Most striking was the completely opposite 
effects of two adjacent residues, P798A and A799G, on increasing or decreasing 
endophilin I.  This indicates that this region is of particular significance for the binding of 
all three proteins.  Thus, its role is more consistent with the SDE concept than a PxxP 
binding motif. 
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5.7.4 Is the central region an SDE? 
The primary molecular basis of SH3 binding to core PxxP motifs (including their 
flanking basic residues) is well known (Li, 2005; Kaneko et al., 2008) but there are some 
exceptions.  In particular, this interaction is known to be significantly influenced by 
amino acid sequence elements proximal to the motifs but which are not part of them.  
Among all the many NMR or crystal structures a small group have been shown to utilise 
proximal sequences in their target PRD, located approximately 5-15 amino acids from the 
core PxxP motif (i.e. outside the location of the flanking basic residues that form part of 
the PxxP motif).  We now call these proximal sequences SDEs, such as those found in: 
Src (PDB ID 1JEG) (Ghose et al., 2001), p67 (phox) (PDB ID 1K4U) (Kami et al., 
2002), Lyn (PDB ID 1WA7) (Bauer et al., 2005), β-PIX (PDB ID 1ZSG) (Mott et al., 
2005) and insulin receptor tyrosine kinase substrate (IRTKS) (PDB ID 2KXC) (Aitio et 
al., 2010).  As discussed above in relation to the phospho-sensor, the extra residues of the 
SDE in these proteins make direct contacts in the specificity zone of the SH3 domain and 
each of these SH3s have unusually high affinity substrate interactions as a result of 
possessing the SDE (Saksela & Permi, 2012).  In all of these cases where it was tested, 
the SDE cannot bind to the SH3 binding partner by itself, without an associated PxxP 
motif; however, mutations in the SDE reduce or abolish binding of the SH3 binding 
partner.  No other protein-SH3 interactions have been reported to involve such proximal 
sequences because NMR and crystal structures are mostly produced using the shortest 
possible peptide that binds in the PxxP binding pocket.  Therefore, it is not yet known if 
they are common or rare. 
Binding specificity and/or interaction affinity is enhanced by the additional contacts 
made between the SDE and the RT and n-src variable loops of the SH3 domain.  For 
example, the interaction of p46phox with the SH3 domain of p67phox involves a 20 
amino acid helix-turn-helix SDE extending C-terminal to the core PxxP that contacts 
multiple residues on the SH3 domain outside the main PxxP binding groove and thus 
increases their interaction affinity (Kami et al., 2002).  In another example, proximal 
sequence located 11 amino acids away from the core PxxP motif in herpes virus tyrosine 
kinase interacting protein (Tip) confer substrate binding specificity SH3 domains of the 
Src family kinase Lyn, in preference to binding other closely related members of the Src 
family (Bauer et al., 2005).  In these cases, the conventional PxxP core and the non-PxxP 
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proximal sequence work in conjunction to enhance both affinity and specificity of 
protein-protein interactions (Bauer et al., 2005; Batra-Safferling et al., 2010). 
Initial evidence that this binding mode also occurs for endocytic SH3 proteins came 
from observations that mutations to the arginines flanking Site 2 and 3 significantly 
inhibited amphiphysin I binding (Anggono & Robinson, 2007), which binds about 40 
amino acids distal to these regions.  This hinted at the existence of distal as well as 
proximal sequences in SH3 interactions with target proteins.  The work by Dr. Luo 
provided the first concrete evidence that dynamin I PRD indeed has two separate 
proximal and distal binding elements, which he referred to as SDE or LDE, depending on 
their distance from the core PxxP.  He demonstrated that the central region of the PRD is 
an SDE for syndapin I and endophilin I binding using 2D NMR studies.  By 
amalgamating NMR spectroscopy, site-directed mutagenesis and measurements of 
binding kinetics, he found two sequence elements in the central and the distal end of the 
dynamin I PRD that account for a 23-fold increase in syndapin I binding affinity (USyd 
PhD thesis (Luo, 2012)).  The SDE is the central region while the LDE is located about 
50 amino acids distal to the Site 2 and Site 3 PxxP.  These two elements combine to 
create a considerably more extensive interface with the SH3 domain, beyond the well-
described polyproline binding groove. 
The data presented in this thesis is consistent with the SDE model for SNX9 
interaction with the PRD.  Distinct mutations in the PRD central region differentially 
affected the SNX9 interaction compared to that of syndapin I and endophilin I.  The SDE 
for the latter two proteins involves different amino acids within the region G797-A799.   
In contrast the putative SDE for SNX9 involves residues between P800-P803.  As 
observed for syndapin, this putative SDE potentially enhances the binding affinity of 
SNX9 for Site 2.  Notably the dynamin I PRD is known to interact with several SH3 
domains in the low nM affinity range (Solomaha et al., 2005) and the comparative studies 
performed here as pull-down experiments rather than Kd calculations suggests that this 
would likely also be true for SNX9. 
Supporting evidence for the SDE hypothesis came from data using the C2 and C10 
truncations, both of which show reduced SNX9 binding compared to full-length PRD.  
The reduced SNX9 binding to C2 relative to full-length is consistent with the central 
region being its SDE, required for higher affinity interactions.  In other words, the 
missing central region from this construct may be viewed as being similar to point 
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mutations in the central region.  A future study could more directly test this hypothesis by 
designing a longer C2 construct that is truncated at A805 instead of P798.  Such a 
construct should show greatly increased binding relative to C2.  The converse argument 
also applies to the C10 construct, which includes the central region.  An alternative 
hypothesis that cannot yet be fully ruled out is that the central region could be an LDE for 
improved affinity at Site 10, being more than 30 residues upstream of this site.  If it were 
an LDE supporting Site 10 binding, then its presence would be expected to enhance 
binding to Site 10.  However, our data shows no evidence that this occurs in either C7 or 
C10, which begin at G794 and contain the central domain sequences yet bind SNX9 at 
relatively low levels. 
 
5.7.5 Summary 
Overall, the data in this thesis strongly supports the hypothesis that the central region 
of the dynamin I PRD serves as a proximal binding element, SDE, that increases the 
affinity of SNX9 for Site 2.  Despite this, the alternative that the central region is a third 
PxxP binding site cannot be fully ruled out at this stage. 
At every stage in this study SNX9 demonstrated a distinct binding mechanism relative 
to the other SH3 domains, suggesting that it interacts with dynamin in a different way.  It 
will be important for a future study to compare the relative binding affinities of these 
proteins to determine whether the SNX9 interaction may be of unusual affinity or uses a 
different binding mode.  It is possible that the unique mechanism of binding highlighted 
here may contribute to the specific stimulation by SNX9 SH3 of dynamin GTPase 
activity, GTP binding and oligomerisation observed in Chapter 4. 
 
 
  
Figure 5.1:  Dynamin I PRD long splice variant (Xa) contains 13 PxxP motifs. 
(A) Protein domain structure of dynamin I showing the long (Xa) and short (Xb) variants of 
its proline rich domain (PRD).  Other splice variants are not shown.  (B) Zoom of the PRD 
amino acid sequence for the long tail.  The Xa and Xb isoforms share identical amino acid 
sequence up to P844.  The 13 PxxP motifs in Xa are highlighted in red text, from Site 1 at 
the N-terminal end to Site 13 at the C-terminal end of the PRD.  Sites 11, 12 and 13 are 
specific to the long tail.  Syndapin I primarily binds Site 2 while endophilin I binding 
clearly overlaps both Site  2 and 3.  Grb2 and amphiphysin I SH3 domains bind Site 8 and 
Site 9 respectively.  A few additional binding sites for SH3 domains not in this study are 
known but not illustrated.  There is no known partner for the Site 10 motif, after which is 
the splice site border (starting at residue S845). 
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Figure 5.2: Mapping the binding region of SNX9 to the dynamin I PRD.
(A) Schematic diagram of key features of the wild-type dynamin I PRD from the two
major PRD splice variants Xa and Xb (blue). The dynamin PRD truncation mutants used
in this Chapter, C2, C7 and C10, are shown in grey or green. The black bars represent the
pairs of in vivo phosphosites located within two phospho-box regions, with phospho-box-
2 being present only in the long isoform. This schematic was prepared by Dr. Jing Xue.
(B) Bacterially expressed GST-dynamin I PRD coupled to glutathione sepharose beads
was incubated with rat brain lysates for pull-down experiments followed by washing the
samples and resolving them on a gel. The samples were transferred on to a nitrocellulose
membrane and binding of endogenous brain full-length SNX9 to individual dynamin I
PRD constructs was visualised by blotting with anti-SNX9 antibody. This is a
representative blot of multiple experiments with the samples in duplicate. (C) The
amount of SNX9 was quantified by densitometry analysis of Western blots (n = 2, each in
duplicate) and the data is presented as a percent of dynamin I-Xa  S.E.M. One-way
ANOVA was applied followed by the Dunnett’s post-test (**, p < 0.01; ***, p < 0.001
against dynamin I-Xa).
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Figure 5.3: Identification of core PxxP SNX9 binding sequences in
dynamin I.
(A) Schematic diagram of dynamin I-Xa PRD where black bars represent the pairs of in
vivo phosphosites located within two phospho-box regions. The Site 2 and Site 3 PxxP
motifs are enlarged to illustrate the mutants 2A, 2B, 2C, 3A and 3B used in these
experiments. The indicated prolines, valine or arginine were mutated to alanine. (B)
The recombinant GST-tagged dynamin I-Xa PRD and mutants bound to glutathione
sepharose beads were incubated with total rat brain lysate for pull-downs. After washing
the samples, they were resolved on a gel and transferred on to a nitrocellulose
membrane. The samples were then blotted with antibodies to detect the binding of
endogenous brain SNX9, syndapin I (sndpn I) and endophilin I (endo I). Each blot is
representative of multiple experiments with the samples in duplicate. (C) The amount of
SNX9 bound was quantified by densitometric analysis of the Western blot (n  2, each in
duplicate). Data is presented as a percent of dynamin I-Xa  S.E.M. One-way ANOVA
was applied followed by the Dunnett’s post-test (***, p < 0.001 against dynamin I-Xa).
SNX9
DynI PRD Xa 2A 2B 2C 3A 3B
A.
B.
C.
*** ***
***
***
Sndpn I
Endo I
S751 L864
Phospho-box-1
S774/S778
Phospho-box-2
S851/S857
PAGRRSPTSSPTPQRRAPAVPPARPGSRGP-
786  788/9     792/3
Site  2A   A      A EA   Site  3A
Site  2B         AA         A   Site  3B 
Site  2C   A
Phospho-box-1 Site 2  Site 3
Figure 5.4: SNX9 binds in a single orientation to extended sequences
flanking the core Site 2 PxxP.
(A) Schematic diagram of dynamin I-Xa PRD where black bars represent the pairs of in
vivo phosphosites located within two phospho-box regions. The sequences flanking the
Sites 2 and 3 PxxP motifs are shown to illustrate the Site 2+3 flanking mutants 2D, 2E,
3C and 3D used in these experiments. The indicated arginines were mutated to alanine.
(B) The recombinant GST-tagged dynamin I-Xa PRD and mutants bound to glutathione
sepharose beads were incubated with total rat brain lysate for pull-downs. After
washing the samples, they were resolved on a gel and transferred on to a nitrocellulose
membrane. The samples were then blotted with antibodies to detect the binding of
endogenous brain SNX9, syndapin I (sndpn I) and endophilin I (endo I). Each blot is
representative of multiple experiments with the samples in duplicate. (C) The amount
of SNX9 bound was quantified by densitometry analysis of the Western blot (n  2,
each in duplicate). Data is presented as a percent of dynamin I-Xa  S.E.M. One-way
ANOVA was applied followed by the Dunnett’s post-test (***, p < 0.001 against
dynamin I-Xa).
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Figure 5.5:  SNX9 binds in a single orientation to extended sequences 
revealed by phospho-box mutants.
(A) Schematic diagram of dynamin I-Xa PRD where black bars represent the pairs of
in vivo phosphosites located within two phospho-box regions. The sequences flanking
the Sites 2 and 3 PxxP motifs are shown to highlight the sequence of phospho-box-1
and show the position of mutants PB1, PB2, T780A and T780A. The indicated
arginines or threonine were mutated to either alanine or glutamic acid (as phospho-
mimetics). (B) The recombinant GST-tagged dynamin I-Xa PRD and mutants
coupled to glutathione sepharose beads were incubated with total rat brain lysate for
pull-downs. After washing the samples, they were resolved on a gel and transferred
on to a nitrocellulose membrane. The effect of SNX9 binding to individual dynamin I
PRD constructs was visualised by blotting the samples with anti-SNX9 antibody. This
is a representative blot of multiple experiments with the samples in duplicate. (C) The
amount of SNX9 bound was quantified by densitometric analysis of the Western blot
(n  2, each in duplicate). Data is presented as a percent of dynamin I-Xa  S.E.M.
One-way ANOVA was applied followed by the Dunnett’s post-test (***, p < 0.001
against dynamin I-Xa).
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Figure 5.6: Phospho-dependent binding of SNX9 to dynamin I.
(A) Schematic diagram of dynamin I-Xa PRD where black bars represent the pairs of
in vivo phosphosites located within two phospho-box regions. The sequences within
the two phospho-box regions are shown to highlight the position of four phosphosite
mutants. The indicated serines were mutated to glutamic acid (as phospho-mimetics).
S774 and S778 were double mutated to EE, similarly S851 and S857 were double
mutated. Other truncated constructs are shown in Figure 5.2. (B) Bacterially
expressed GST-dynamin I full-length PRD or the truncations C2 or C10, coupled to
glutathione sepharose beads, were incubated in pull-down experiments with total rat
brain lysates. After washing the samples they were resolved on a gel and transferred
on to a nitrocellulose membrane. The effect of SNX9 binding to individual dynamin I
PRD constructs was visualised by blotting the samples with anti-SNX9 antibody. This
is a representative blot of multiple experiments with the samples always run in
duplicate. (C) The amount of SNX9 bound was quantified by densitometric analysis
of the Western blot (n  2, each in duplicate). Data is presented as a percent of
dynamin I-Xa  S.E.M. One-way ANOVA was applied followed by the Dunnett’s
post-test (***, p < 0.001 against dynamin I-Xa) and Bonferroni’s post-test (#, p < 0.05
for truncations C2 vs. C2EE and C10 vs. C10EE).
Abbreviations: Xa 774/8E, S774E/S778E double mutation in Xa; Xa 851/7E,
S851E/S857E double mutation in Xa; C2 EE, S774E/S778E in double mutation C2;
C10 EE, S851E/S857E double mutation in C10.
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Figure 5.7: Role of the dynamin I PRD central region in SNX9 binding.
(A) Schematic diagram of dynamin I-Xa PRD highlighting the position and sequence of
the central region, containing Site 4 PxxP. Each residue from G797 to P803 were
individually mutated to alanine (alanine-scan). (B) The recombinant GST-tagged
dynamin I-Xa PRD and mutants on glutathione sepharose beads were incubated with
total rat brain lysate for pull-downs. After washing the samples, they were resolved on a
gel and transferred on to a nitrocellulose membrane. The samples were then blotted and
probed with antibodies for SNX9, syndapin I (sndpn I), endophilin I (endo I) and
amphiphysin I (amph I). Each blot is representative of multiple experiments with the
samples in duplicate. The amount of SNX9 (C), syndapin I (D), endophilin I (E) and
amphiphysin I (F) bound was quantified by densitometric analysis of the Western blot (n
 2, each in duplicate). Data is presented as a percent of dynamin I-Xa  S.E.M. One-
way ANOVA was applied followed by the Dunnett’s post-test (*, p < 0.05; **, p < 0.01;
***, p < 0.001 against dynamin I-Xa).
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Figure 5.8: The dynamin I PRD long tail is not required for SNX9 binding.
(A) Schematic diagram of dynamin I-Xa PRD highlighting the position and sequence of
the long tail, I-Xa, containing Sites 11-13 PxxP motifs. Using the alanine-scan
approach, each proline residue and two arginines were individually mutated to alanine
from P852 to P859, while P860 and P861 were double mutated to alanine. (B) The
recombinant GST-tagged dynamin I-Xa PRD and mutants on glutathione sepharose
beads were incubated with total rat brain lysate for pull-downs. After washing the
samples, they were resolved on a gel and transferred on to a nitrocellulose membrane.
The samples were then blotted and probed using antibodies for SNX9, syndapin I (sndpn
I), endophilin I (endo I) and amphiphysin I (amph I). Each blot is representative of
multiple experiments with the samples in duplicate. The amount of SNX9 (C), syndapin
I (D), endophilin I (E) and amphiphysin I (F) bound was quantified by densitometric
analysis of the Western blot (n  2, each in duplicate). Data is presented as a percent of
dynamin I-Xa  S.E.M. One-way ANOVA was applied followed by the Dunnett’s post-
test (*, p < 0.05 against dynamin I-Xa).
Abbreviation: P860/1A, P860A/P861A double mutation.
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Figure 5.9: SNX9 has a unique binding to the dynamin I PRD common tail.
(A) Schematic diagram of dynamin I-Xa PRD highlighting the position of the start of the
tail splice site. Sequences preceding the splice site are common to both Xa and Xb
isoforms up to the end of the Site 10 PxxP motif. The sequence up to this residue, P844,
represents the ‘common tail’. This is the PRD splice site boundary after which the
sequence shown is specific to the I-Xa isoform. The two flanking proline residues were
singly or double mutated to alanine and the flanking basic arginines were singly mutated.
Note that R838 is part of the common tail, while R846 is unique to the I-Xa long tail
isoform. (B) The recombinant GST-tagged PRD and mutants on glutathione sepharose
beads were incubated with total rat brain lysate for pull-downs. After washing the
samples, they were resolved on a gel and transferred on to a nitrocellulose membrane.
The samples were then blotted and probed using antibodies for SNX9, syndapin I (sndpn
I), endophilin I (endo I) and amphiphysin I (amph I). Each blot is representative of
multiple experiments with the samples in duplicate. The amount of SNX9 (C), syndapin
I (D), endophilin I (E) and amphiphysin I (F) bound was quantified by densitometry
analysis of the Western blot (n  2, each in duplicate). Data is presented as a percent of
dynamin I-Xa  S.E.M. One-way ANOVA was applied followed by the Dunnett’s post-
test (*, p < 0.05; **, p < 0.01; ***, p < 0.001 against dynamin I-Xa).
Abbreviations: P841/44A, P841A/P844A double mutation.
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CHAPTER 6: General discussion and future directions 
 
Endocytosis mediated by dynamin is an important biological process with complex 
cellular regulation and one that is mediated by a large number of proteins.  This includes 
many proteins with an SH3 domain which binds dynamin.  While many of these SH3 
domains proteins have been implicated in dynamin-dependent endocytosis, it is unclear 
with which endocytosis mode or what stage within that mode each of these proteins may 
be involved.  The diversity of dynamin-binding SH3 proteins and endocytic modes 
indicates a subtlety in the interaction between SH3 domains and dynamin which is not 
understood.  This study sought to address these issues by comparing the ability of 
multiple SH3 domains to stimulate dynamin GTPase activity and oligomerisation as a 
measure of their potential relevance to endocytosis.  A systematic approach was 
undertaken by examining a large number of SH3 domains in parallel under different 
assay conditions.  The outcome was a focus on the SH3 domain of one particular protein 
with unique properties, SNX9. 
 
6.1 Insights into dynamin function 
All the GST-SH3 domains stimulated dynamin GTPase activity to varying extents 
with no general effect being observed.  The removal of the GST-tag abolished the 
stimulatory effect of all of the SH3s except that of SNX9.  This result supports the well 
known ability of GST sometimes artefactually dimerise the protein to which it is tagged 
but also highlighted SNX9 as being a protein of particular interest.  It was striking to 
observe most SH3s having an all or none effect on dynamin activity, with the removal of 
the GST resulting in not just a decrease in dynamin stimulation but the complete lack of 
it.  Due to the established dimerising properties of the GST-tag, this suggests that the 
valency of SH3 binding may be necessary for its effect on dynamin.  It indicates that the 
mono-valent binding proteins have no effect and they need to be divalent (SH3-GST-
GST-SH3) complexes to modulate dynamin activity in most cases.  The exception, SNX9 
SH3, may therefore be mediating dynamin stimulation through a different mechanism to 
the other 9 SH3 domains tested. 
These studies revealed that the ability of most GST-SH3 domains to stimulate 
dynamin GTPase activity is not necessarily a good indicator on its own of their potential 
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role in endocytosis.  If the inability of most tested SH3 domains to oligomerise or 
stimulate dynamin translated to the cellular context, then the function of these SH3 
domains in cells would appear more likely to be as adaptors in localising dynamin to the 
site of endocytosis, rather than regulators of its oligomerisation and the burst of GTPase 
activity required to complete fission. 
In spite of this, some of these SH3 proteins are dimers in the context of their full-
length form, although their dimer structure may be unrelated to the GST-induced dimer.  
The full-length form of 6 of the SH3 domains (amphiphysin I/II, endophilin I, syndapin I, 
CIP4 and FBP17) contain the BAR domain, which has a well-established ability to 
dimerise (Peter et al., 2004; Shimada et al., 2007).  Through BAR domain dimerisation, 
the physiologically relevant full-length complexes would be divalent dynamin binding 
proteins.  However, the other non-BAR proteins used in this study (cortactin, Abp1 and 
intersectin) have a less well established ability to dimerise and their GST free forms did 
not stimulate activity either.  Therefore, the ability of the parent protein to dimerise does 
not seem to correlate with the data on dynamin stimulation presented in this study. 
 
6.2 SH3s reveal novel dynamin properties 
Despite potential questions of other unidentified in vitro artefacts, the use of GST-SH3 
domains in this study was nonetheless able to uncover two key novel aspects of 
dynamin’s properties.  Firstly, comparison between GST-SH3 domains revealed that the 
GTPase activity of dynamin is decoupled from its oligomerisation under certain 
conditions, refuting published hypothesis.  In some cases the SH3 failed to stimulate 
dynamin activity and yet oligomerisation was observed.  In order to explain this 
phenomenon the morpheein model of dynamin assembly was posited.  In this model 
dynamin oligomerisation may occur in different conformational states, or conformers.  
Dynamin may oligomerise into distinct conformers by the SH3s and the different 
activities may reflect distinct dynamin conformation within each.  It however remains 
unclear what the significance of this observation might be for dynamin in endocytosis.  
One plausible idea is that some SH3 domains preferentially stimulate dynamin that has 
been preassembled into the most appropriate structure, an idea supported by structural 
data (Sundborger et al., 2014).  In this model SH3s might not need to promote further 
oligomerisation but act to stimulate the GTPase activity of preassembled dynamin.  On 
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this basis, in the presence of GTP, they may promote fission and dynamin disassembly at 
the latest stages of CME.  It will take considerable effort to test this hypothesis. 
Secondly, the SH3 domains revealed major differences between dynamin I middle 
domain splice variants that suggest the two have different functional roles.  Large 
differences were observed across different GST-SH3 domains in their stimulation of the 
dynamin Ibb middle domain isoform relative to Iab.  Assuming equal binding to the 
isoforms, since they have identical PRDs, this shows that the middle domain has a major 
effect on dynamin GTPase activity, despite that it is not the binding site for the SH3 
domains.  This indicates the SH3s are acting in a middle domain splice-dependent 
manner.  The data raises the possibility that the differential action of SH3 domain 
proteins might be preferentially mediated by one or other dynamin isoform in cells.  A 
plausible model that may explain these observations is that the middle domain may 
control the way in which the BSE and PRD interact with the G domain.  The two middle 
domains allosterically regulate the G domain in different ways (Michael Collett, 
manuscript submitted) while the PRD is close to the G domain (Sundborger et al., 2014).  
This model predicts that the two dynamin isoforms have different tertiary or quaternary 
structure and hence function. 
 
6.3 Insights into SNX9 function 
The emergence of SNX9 as a protein of interest from the GTPase assays allows 
speculation on the possible function of SNX9 in endocytosis and suggests experiments 
that would enable testing these ideas.  It has been difficult to functionally place SNX9 in 
the pathway with any precision from the current literature.  Its role in endocytosis can be 
considered by discussing the endocytosis mode with which it may be involved. 
The main modes in neurons are CME, SVE (a specialised CME mode for SV retrieval) 
and ADBE.  Current evidence suggests SNX9 has a role in endocytosis but not 
necessarily a crucial one (Shin et al., 2007; Rangarajan et al., 2010).  The use of SH3 
domain-deleted SNX9 constructs and RNAi interference revealed that it is required for 
dynamin recruitment to the membrane for CME (Lundmark & Carlsson, 2003; Lundmark 
& Carlsson, 2004).  The LC domain in SNX9 interacts with clathrin and the adaptor 
protein AP-2 and this domain is proposed to be a major determinant for targeting SNX9 
to the CCP and regulating its interaction with the clathrin coat (Rangarajan et al., 2010).  
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Through the LC domain, SNX9 affects the spatial clustering of CCPs but not the number 
of nucleations (Nunez et al., 2011). 
However, most previous functional studies on SNX9 have been performed in non-
neuronal cells and focussed on dynamin II.  The studies here focused on its interaction 
with dynamin I, which is enriched in the neuronal synapse.  It was shown in the present 
study that SNX9 interaction with the PRD of dynamin II differs from that of dynamin I, 
thus their conclusions do not yet translate to dynamin I and neurons.  One key study in 
neurons showed that over or under-expression strongly impacts on SVE and that mutation 
of W39A in its SH3 domain abolishes its dynamin I interaction and its effects on SVE 
(Shin et al., 2007).  Thus, the ability of the SNX9 SH3 to bind dynamin I is important for 
normal levels of SVE as well as CME.  However, SVE differs from CME in many 
functional aspects and it is unclear whether this data shows that SNX9 is important to 
CME in neurons as well as SVE.  The ability of SNX9 to bind clathrin and AP-2 
implicates it in neuronal CME and/or SVE rather than the clathrin-independent mode, 
ADBE. 
We can also speculate on the temporal organisation of the SNX9-dynamin interaction 
and in which endocytic stage it may be involved.  It is established that dynamin functions 
at two distinct stages during endocytosis (Mettlen et al., 2009).  The early, rate-limiting, 
step where dynamin is GTP-bound but unassembled is followed by the later 
mechanochemical stage where dynamin assembles into a short collar around the 
invaginated vesicle neck and GTP hydrolysis catalyses fission.  The unique effect of 
SNX9 on dynamin activity and oligomerisation demonstrated in this study, implicates a 
role in this second assembly-dependent stage, since both oligomerisation and GTP 
hydrolysis are regulated.  This is supported by localisation of SNX9 to the CCP in non-
neuronal cells peaking just following scission (Taylor et al., 2011).  This would seem 
unusual for a BAR domain protein like SNX9, since its ability to invaginate lipid 
membranes would suggest a role in the earlier stage of endocytosis during vesicle 
formation.  Another interpretation is that SNX9 action may differ from other SH3s in 
stimulating the GTPase activity of dynamin after it has already assembled around a 
vesicle neck.  In such a model, SNX9 would be the final step in the activation of GTPase 
activity, hence fission.  This concept arises from a recent study showing that the dynamin 
PRD is in direct contact with the G domain in the cryo-EM structure of the full length 
dynamin and that SH3 domains are still able to dock to this site (Sundborger et al., 2014).  
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Unfortunately, this model does not explain why the full length SNX9 possesses a BAR 
domain and an LC domain for binding clathrin and AP-2. 
In addition to its role in modulating dynamin activity, SNX9 is involved in actin 
dynamics by activating by its SH3 domains binding and activating the actin nucleator N-
WASP (Yarar et al., 2007).  It is also well established that dynamin GTPase activity is 
involved in the regulation of actin dynamics, including the remodelling of actin filaments, 
podosomes maintaining cell shape and cell migration (Damke et al., 1994; Ezekowitz et 
al., 1991; Mooren et al., 2009; Lees et al., 2015).  Since SNX9 SH3 is demonstrated here 
to have a specific effect on dynamin activity and ring formation, a systematic study needs 
to be undertaken to establish whether its stimulatory effect on dynamin could be 
mediating actin dynamics.  Furthermore, this role of SNX9 in actin dynamics may be 
linked to its endocytic role, since SNX9 has been proposed to physically couple F-actin 
nucleation to plasma membrane remodelling during endocytosis (Yarar et al., 2007). 
 
6.4 SNX9 binding to dynamin I and future studies to determine 
SNX9 neuronal function 
A practical starting point towards gaining a better understanding of SNX9 SH3 
domain interaction with dynamin is to find out precisely how they interact in vitro as a 
key to future understanding of their interactions within cells.  To this end, a 
comprehensive mutational analysis was performed to map SNX9 binding to the dynamin 
I PRD.  This showed a distinct binding pattern of SNX9 to the dynamin I PRD relative to 
endophilin I and syndapin I, which accompanied the unique stimulatory ability of SNX9.  
SNX9 bound to Site 2 and 10 PxxP motifs located at either ends of the PRD.  
Circumstantial evidence suggested that binding to Site 2 was much greater than for Site 
10, predicting a major affinity difference.  A role for the central region of the PRD, as an 
SDE for Site 2, was also revealed in modulating how SNX9 interacts with the other two 
core binding sites.  Although SNX9 shares Site 2 with endophilin I and syndapin I, it 
binds in a different orientation and with a distinct SDE regulation.  It remains to be 
determined how this binding mode might account for its unique action on dynamin 
activity.   
Despite this, these studies significantly expand the idea of Dr. Lin Luo that the 
interaction of the dynamin I PRD with its targets involves considerably more sequence 
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interaction than just the core PxxP sites with their immediately flanking arginines.  The 
concept that sequence elements proximal (SDE) or distal (LDE) from the PxxP have 
major contributions to the SH3-dynamin interactions is significantly expanded through 
the studies here.  This concept may account for the presence of an unusually long PRD in 
dynamin relative to other proteins.  The data suggest that the PRD makes multiple 
additional contacts with the SH3 domains, essentially encircling them.  A consequence of 
this hypothesis is that there should be other binding sites for these SDEs and LDEs on the 
surface of the SH3 domain that, apart from the established major hydrophobic groove, 
remain to be identified. 
The observations in this study suggest that the interaction of SNX9 with dynamin I is 
particularly important in neurons, analogous to the established syndapin I-dynamin I 
interaction (Anggono et al., 2006; Anggono & Robinson, 2007).  Previous studies of 
dynamin KO mice support this idea.  For example, in lysates from the brains of double 
KOs of dynamin I and III, the levels of both syndapin I and SNX9 were reduced by 
around 60% while most other endocytic proteins are unperturbed (Raimondi et al., 2011).  
The authors proposed that this may arise from unique aspects of their abilities to form 
complexes with dynamin, which are destabilised in the absence of dynamin I and III 
perhaps leading to their proteolysis.  Given that many other proteins bind dynamin I and 
III it is difficult to explain why these two in particular should be down-regulated, other 
than that they may have unique modes or affinities of interactions with dynamin.  SNX9 
binding to dynamin was indeed found to be unique in the present study and the mutants 
identified here can serve as useful tools, which can be used in future studies to 
specifically, investigate SNX9 role in cells.   
The extensive and detailed studies here combined with previous studies from our 
group provide important tools to design future experiments that may selectively modulate 
dynamin binding to SNX9, syndapin I or endophilin I.  Such experiments have been 
difficult to design in the past since each point mutation previously published has effects 
on multiple SH3 domain proteins and therefore do not provide sufficient specificity for 
in-cell studies to enable specific conclusions.  In this regard, only mutations in the central 
region of the PRD have provided any specificity between these three SH3 proteins.  For 
example, A799G reduces syndapin I and endophilin I but not SNX9 binding.  Similarly, 
the P800A mutant in the central region and R846A in the C-terminal region substantially 
decrease SNX9 binding without eliciting any change in the other SH3 domains.  
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Dynamin I PRD, containing such single mutants, can be overexpressed in neurons to 
specifically investigate the functional role of SNX9.  It is possible for future studies to 
use the same approach and express SNX9 with its clathrin and/or AP-2 binding sites 
removed.  This can help clarify the question posed earlier about SNX9 being involved in 
clathrin-mediated or -independent endocytosis. 
Gene editing technology has the potential to have a strong impact on these questions.  
It is a new strategy to replace the endogenous dynamin I in the genome with a dynamin 
that contains either of the above mutants.  This has the advantage of having the mutant 
dynamin under control of the endogenous promoter and overcomes the issues associated 
with overexpression.  The genome-edited cell can be studied in detail for changes in 
endocytosis and other functional processes such as change in neuronal morphology. 
 
6.5 Does the phospho-regulated SNX9–dynamin interaction 
regulate dynamin functions? 
The binding studies have revealed that SNX9 has a phospho-dependent interaction 
with dynamin I at the sites S774/S778, in common with syndapin I.  This was determined 
by mutating the two serines into glutamate, which mimics the negative charge arising 
from phosphorylation.  While this phospho-mimetic approach is widely employed and 
was used to determine the confirmed syndapin I phospho-dependent binding, it is not 
without shortcomings.  For example, the carboxylic acid group in glutamate has a charge 
differential and a different acid dissociation constant relative to the phospho-serine group.  
Moreover, the negative charge on the phospho-mimetic dynamin I construct is present 
constitutively and is not dynamic (i.e. it is permanent) unlike in endogenous dynamin I in 
the synapse which is dephosphorylated in an activity-dependent manner at S774/S778.   
The possibility of a false positive result using phospho-mimetic mutants can be addressed 
by determining SNX9 SH3 binding to 32Pi labelled endogenous dynamin I followed by 
autoradiography assay. 
The proposed phospho-dependent binding of SNX9 may have a functional role in 
regulating its role in endocytosis, since dynamin I involvement in ADBE is reliant upon 
syndapin I binding to phosphorylated S774/S778 (Anggono et al., 2006; Clayton et al., 
2009).  However, the functional analysis of any phospho-dependent role for SNX9 in 
cells is complicated by syndapin I competing for the same Site 2 core PxxP site.  This 
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competition suggests that SNX9 and syndapin I may not operate at the same time with 
dynamin I and potentially not even within the same endocytic mode.  Further 
investigation would therefore require designing a neuronal cell that lacks endogenous 
syndapin I, followed by a knock-down of SNX9 and followed by overexpressing the 
dynamin I phospho-mimetic mutants.  It is however unlikely that such a cell line could 
develop normally and survive; alternate approaches would have to be used.  Comparing 
the co-localisation of SNX9 and syndapin I with dynamin phospho-mutants would be a 
useful starting point.  Alternatively, in vivo FRET analysis can help determine 
competitive protein-protein interaction between the two proteins for phospho-dynamin I. 
Activity-dependent dephosphorylation of S774 has also been implicated in fusion-pore 
expansion in adrenal chromaffin cells and, as with ADBE, syndapin I binding is 
necessary for this process to occur (Samasilp et al., 2012).  Although SNX9 has no 
reported role in this process yet, it is however possible that such a role could be masked 
by an increased affinity for syndapin I following dephosphorylation.  Future studies 
should investigate the possibility of competitive binding between SNX9 and syndapin I at 
these phospho-sites. 
Dynamin II phosphorylated at S764 is enriched at the midbody and the mitotic 
centrosome.  Phospho-dynamin II has not been demonstrated to have any physiological 
relevance at the latter site but its presence at the midbody is necessary for regulating 
cytokinesis.  SNX9 has been separately been shown to be involved in both mitotic spindle 
formation and cytokinesis completion (Ma & Chircop, 2012; Ma et al., 2013).  It is not 
known whether the function of phospho-dynamin II is regulated by changes in protein 
binding but possible phospho-dependent binding of SNX9 at S764 can be a topic for 
future investigation. 
 
6.6 Concluding Remarks 
The studies in this thesis present a comprehensive investigation of how a large set of 
SH3 domains from endocytic proteins interact with dynamin to regulate its GTPase 
activity and oligomerisation.  The outcomes have provided many novel insights on 
dynamin function.  However, it was the SH3 domain of SNX9, removed free from its 
GST expression tag, which was unique among all the SH3 domains in promoting 
dynamin oligomerisation and GTP binding and stimulating its GTPase activity.  
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However, the functional role of SNX9 in cells needs to be re-evaluated, making it an 
interesting candidate for further research.  The burning question remains as to what is the 
exact function of SNX9 in cells.  Unlike dynamin I which is neurally enriched, the 
protein is widely expressed in all tissues in the body.  It does not have any human or 
animal diseases associated with its gene locus on chromosome 6q25.3, making functional 
interpretations even more difficult.  The protein interacts with multiple targets in addition 
to those involved in endocytosis, such as SNX18, ADAM9 and 15 and N-WASP, that 
each have distinct functions, suggesting it plays a different role in multiple cell types.  
Our studies show that SNX9 uses a unique mechanism to interact with and regulate the 
oligomerisation and activity of dynamin I, which mediates the final fission step of 
endocytosis.  All this makes SNX9 an interesting candidate for further research. 
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Appendices 
 
 
 
Appendix 8.1: Concentration curve of GST-SH3 domains stimulating
dynamin GTPase activity using Malachite Green assay.
A concentration curve of GST-SH3 domains was incubated with dynamin (100 nM / 2
µg/ml) to determine their effect on dynamin GTPase activity (µmoles Pi/mg of dyn)
using the Malachite Green assay. The X-axis provides the GST-SH3:dynamin
concentration ratio from 0.25 to 8. The assay was performed at low salt (30 mM NaCl)
under NPA (A, C and E) and PA (B, D and F) conditions for all the GST-SH3 domains.
The experiment was repeated a minimum of three times and performed each time in
triplicate, with the GTPase activity  S.E.M. at each concentration point.
E.                                                     F.
C.                                                    D.         
GST-SH3 concentration curve
NPA
GST-SH3 concentration curve
PA
GST-SH3 concentration curve
NPA
A.                                                  B.
GST-SH3 concentration curve
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GST-SH3 concentration curve
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GST-SH3 concentration curve
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GST-Amphiphysin II SH3 GST-Endophilin I SH3
Appendix 8.2: ELIPA time course of GST-SH3 domains stimulating
dynamin GTPase activity.
The ELIPA time course assay showing the stimulation of sheep brain dynamin (100 nM
/ 9.6 µg/ml) GTPase activity by GST-amphiphysin II SH3 (A), GST-endophilin I SH3
(B), GST-abp1 SH3 (C) and GST-cortactin SH3 (D). A reading was taken every 30
seconds over 240 minutes. The assay was performed under PA in the presence of low
salt (30 mM NaCl), with all GST-SH3 domains being used at a fixed concentration of
40 µg/ml. For all the GST-SH3s, the ELIPA curves were not subtracted for basal
GTPase activity (dynamin alone, without SH3 domain stimulation). All data is
expressed as GTPase activity (µmole Pi/mg of dyn) ± S.E.M. for every time point at
which a reading was taken (n ≥ 3).
A. B.
GST-Abp1 SH3 GST-Cortactin SH3
C. D.
Appendix 8.3: ELIPA time course of GST-SH3 domains stimulating dynamin
GTPase activity.
The ELIPA time course assay showing the stimulation of sheep brain dynamin (100 nM /
9.6 µg/ml) GTPase activity by GST-syndapin I SH3 (A), GST-p85 SH3 (B), GST-CIP4
SH3 (C), GST-intersectin I SH3C (D) and GST-intersectin I SH3E (E). A reading was
taken every 30 seconds over 240 minutes. The assay was performed under PA in the
presence of low salt (30 mM NaCl), with all GST-SH3 domains being used at a fixed
concentration of 40 µg/ml. For all the GST-SH3s, the ELIPA curves were not subtracted
for basal GTPase activity (dynamin alone, without SH3 domain stimulation). All data is
expressed as GTPase activity (µmole Pi/mg of dyn) ± S.E.M. for every time point at
which a reading was taken (n ≥ 3).
GST-Syndapin I SH3
A.
GST-p85 SH3
B.
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Appendix 8.4A: Sequence alignment of human dynamin Iab and bb using 
CLUSTALW omega. 
The differences in sequence identity are highlighted in red.   
Sequence similarity: hudyn1ab vs bb is 98.34%. 
Appendix 8.4B 
Appendix 8.5A: Sequence alignment of human dynamin Iab and cow 
dynamin I transcript variants using CLUSTALW omega. 
The differences in sequence identity are highlighted in red. 
Appendix 8.5B 
Appendix 8.5C 
Appendix 8.5D 
Appendix 8.5E 
Appendix 8.5F 
Appendix 8.5G 
Appendix 8.5H 
Appendix 8.6A: Sequence alignment of human dynamin Ibb and cow 
dynamin I transcript variants using CLUSTALW omega  
The differences in sequence identity are highlighted in red .                                        
Appendix 8.6B 
Appendix 8.6C 
Appendix 8.6D 
Appendix 8.6E 
Appendix 8.6F 
Appendix 8.6G 
Appendix 8.6H 
Appendix 8.7A: Sequence alignment of rat and cow dynamin I complete 
coding DNA sequence using CLUSTALW omega. 
The differences in sequence identity are highlighted in red.   
Sequence similarity : ratdyn1 vs cowdyn1= 98.67% 
Appendix 8.7B 
Appendix 8.8: Amino acid sequence of the middle domain splicing across 
all the classical dynamins (human) using CLUSTALW omega. 
Middle domain splicing of dynamin arises from two alternate exons coding for the 
residues 400-444 of the middle domain.  This splice site is conserved between dynamin I 
(DynI), II (DynII) and III (DynIII) , as well being conserved in amino acid sequence 
across mammalian species.  The sequence similarity relative to the DynIA is: 
DynIB  =  67.4% 
DynIIA = 76.1% 
DynIIA = 71.7% 
DynIII = 65.2% 
DynIA  TGLFTPDLAFEATVKKQVQKLKEPSIKCVDMVVSELTATIRKCSEK 
DynIB  TGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKK 
DynIIA TGLFTPDMAFEAIVKKQIVKLKEPSLKCVDLVVSELATVIKKCAEK 
DynIIB TGLFTPDLAFEAIVKKQVVKLKEPCLKCVDLVIQELINTVRQCTSK 
DynIII TGLFTPDMAFEAIVKKQIVKLKGPSLKSVDLVIQELINTVKKCTKK 
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